The Rapid Assessment of the Burden of Malaria ... - ReproLinePlus
The Rapid Assessment of the Burden of Malaria ... - ReproLinePlus
The Rapid Assessment of the Burden of Malaria ... - ReproLinePlus
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong><br />
<strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong><br />
<strong>Malaria</strong> during Pregnancy
<strong>Rapid</strong> <strong>Assessment</strong> Manual<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong><br />
<strong>Malaria</strong> during Pregnancy<br />
Package Contents<br />
Executive Summary<br />
Acknowledgements<br />
Abbreviations<br />
1 <strong>Malaria</strong> during Pregnancy: Addressing <strong>the</strong> <strong>Burden</strong><br />
2 Planning a <strong>Rapid</strong> <strong>Assessment</strong><br />
3 Conducting <strong>the</strong> <strong>Assessment</strong><br />
4 Data Management and Analysis<br />
5 Report Preparation and Use<br />
References<br />
Glossary<br />
<strong>Rapid</strong> <strong>Assessment</strong> Modules and Tools<br />
For each survey tool, a module is provided.<br />
1: Antenatal Clinic Survey<br />
2: Delivery Unit Survey<br />
3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease<br />
4: Antenatal Clinic Facility <strong>Assessment</strong><br />
5: Health-Care Worker Observation<br />
6: Focus Group/Individual Interviews with Health-Care Workers<br />
7: Focus Group/Individual Interviews with Traditional Birth Attendants and Midwives<br />
8: Client Exit Interview<br />
9: Focus Group/Individual Interviews with Recently/Currently Pregnant Women<br />
10: Individual Interviews with Key Informants<br />
<strong>Rapid</strong> <strong>Assessment</strong> Resources<br />
Note: <strong>The</strong> CD-ROM enclosed<br />
in <strong>the</strong> inside back pocket <strong>of</strong><br />
this hard copy contains all<br />
<strong>the</strong> package contents.<br />
<strong>The</strong> manual, modules, tools,<br />
and most resources are<br />
also available in Word files;<br />
when pdfs and Word files<br />
differ, use <strong>the</strong> pdfs, as <strong>the</strong>y<br />
are most up-to-date.<br />
Resource 1: Articles and Guidelines<br />
• Relevant Articles: <strong>Malaria</strong> in Pregnancy<br />
• Guidelines: A Strategic Framework for <strong>Malaria</strong> Prevention and Control During Pregnancy in <strong>the</strong> African Region.<br />
WHO, 2004. In English, French, and Portuguese (only on CD-ROM).<br />
Resource 2: Resources for <strong>the</strong> Qualitative <strong>Assessment</strong><br />
• Sample Interviewer Training Manual<br />
• List <strong>of</strong> Resources<br />
Resource 3: PowerPoint Presentations for Training Sessions<br />
(On CD-ROM only)<br />
• Overview <strong>of</strong> rapid assessment: <strong>Rapid</strong> assessment: general issues<br />
• Overview <strong>of</strong> modules: 1 & 2; 3; 4, 5 & 8; 6, 7, 9 & 10<br />
• Epidemiology <strong>of</strong> malaria: Epidemiology and control <strong>of</strong> malaria in pregnancy<br />
• Clinical and laboratory methods: <strong>Assessment</strong> <strong>of</strong> gestational age, Body measurements, Laboratory methods<br />
• O<strong>the</strong>r assessment topics: Data management and sample size calculation<br />
Resource 4: S<strong>of</strong>tware and Planning Tools<br />
• Costing Tool<br />
• Epi Info (for information and to download go to www.cdc.gov/epiinfo/)
For fur<strong>the</strong>r information, please contact:<br />
<strong>Malaria</strong> Branch/DPD<br />
Centers for Disease Control and Prevention<br />
1600 Clifton Rd, Atlanta, GA 30333, U.S.A<br />
nciddpdmalaria@cdc.gov ▪ www.cdc.gov/malaria<br />
Department <strong>of</strong> Making Pregnancy Safer<br />
Global <strong>Malaria</strong> Programme<br />
World Health Organization<br />
20 Avenue Appia-CH-1211 Geneva 27<br />
infogmp@who.int ▪ www.who.int/malaria ▪ www.who.int/making_pregnancy_safer
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong><br />
<strong>Malaria</strong> during Pregnancy<br />
Contents<br />
1. <strong>The</strong> Manual<br />
Executive Summary.....................................................................................................................................................................ii<br />
Acknowledgements.....................................................................................................................................................................iii<br />
Abbreviations................................................................................................................................................................................iv<br />
1 <strong>Malaria</strong> during Pregnancy: Addressing <strong>the</strong> <strong>Burden</strong>.................................................................................. 1<br />
1.1 <strong>The</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy........................................................................................................................ 2<br />
1.1.1 Infection with Plasmodium falciparum.............................................................................................................................. 2<br />
1.1.2 Infection with O<strong>the</strong>r <strong>Malaria</strong> Parasites.............................................................................................................................. 3<br />
1.2 <strong>Malaria</strong> Prevention Interventions for Pregnant Women............................................................................................ 3<br />
1.3 Information for Action.............................................................................................................................................................. 6<br />
1.4 Use <strong>of</strong> <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong> Package............................................................................................................................... 8<br />
2 Planning <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong>....................................................................................................................... 9<br />
2.1 Objectives <strong>of</strong> <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong>................................................................................................................................... 9<br />
2.2 Potential Information Sources............................................................................................................................................... 9<br />
2.3 Designing <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong>.........................................................................................................................................12<br />
3 Conducting <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong>..................................................................................................................13<br />
3.1 Selecting a Time Period............................................................................................................................................................13<br />
3.2 Determining a Timetable and Budget................................................................................................................................13<br />
3.3 Building and Organizing <strong>the</strong> <strong>Assessment</strong> Team.............................................................................................................14<br />
3.4 Selecting <strong>Assessment</strong> Areas, Sites, and Sample Sizes..................................................................................................18<br />
3.5 Adapting, Translating, and Preparing <strong>Assessment</strong> Materials..................................................................................21<br />
3.6 Conducting <strong>Assessment</strong> Training.........................................................................................................................................21<br />
3.7 Assuring <strong>Assessment</strong> Quality................................................................................................................................................23<br />
3.8 Providing Information about <strong>the</strong> Survey/Obtaining Informed Consent.............................................................25<br />
3.9 Providing Treatment for <strong>Malaria</strong> and Anemia................................................................................................................25<br />
4 Data Management and Analysis.......................................................................................................................26<br />
4.1 Data Management ......................................................................................................................................................................26<br />
4.2 Data Analysis.................................................................................................................................................................................29<br />
5 Report Preparation and Use <strong>of</strong> Results.........................................................................................................31<br />
References .....................................................................................................................................................................................33<br />
Glossary .....................................................................................................................................................................................34<br />
<strong>The</strong> Manual<br />
i
Executive Summary<br />
Each year, more than 30 million women living in areas where malaria is transmitted<br />
become pregnant, and an estimated 200,000 newborns die as a result <strong>of</strong> <strong>the</strong>ir mo<strong>the</strong>rs’<br />
infection. Nine <strong>of</strong> 10 malaria deaths worldwide occur in Sub-Saharan Africa, <strong>the</strong> part <strong>of</strong> <strong>the</strong><br />
world most affected by malaria, and in that region, as many as 10,000 pregnant women<br />
die each year <strong>of</strong> malaria-related causes, chiefly anemia. Less is known about <strong>the</strong> effects <strong>of</strong><br />
malaria during pregnancy in o<strong>the</strong>r parts <strong>of</strong> <strong>the</strong> world, but large numbers <strong>of</strong> pregnant women<br />
are at risk. Safe and effective interventions for pregnant women—intermittent preventive<br />
treatment, insecticide-treated mosquito nets, and febrile case management—can help<br />
prevent <strong>the</strong> consequences <strong>of</strong> malaria infection. <strong>Malaria</strong>-affected countries vary widely in <strong>the</strong>ir<br />
knowledge <strong>of</strong> <strong>the</strong> burden <strong>of</strong> malaria in pregnancy within <strong>the</strong>ir borders and <strong>of</strong> <strong>the</strong> impact <strong>of</strong><br />
any interventions or programs.<br />
This rapid assessment package is designed to help countries obtain <strong>the</strong> information <strong>the</strong>y<br />
need to assess <strong>the</strong> burden <strong>of</strong> malaria during pregnancy, to develop a policy or program, to<br />
assess program implementation, and to evaluate impact. <strong>The</strong> information can also be used<br />
to advocate for policy change and to provide baseline data. When planning assessments,<br />
countries are encouraged to make use <strong>of</strong> pertinent recent data from reliable sources. However,<br />
because data may be lacking and because worldwide a relatively high number <strong>of</strong> women visit<br />
an antenatal clinic at least once during pregnancy (in sub-Saharan Africa, a high proportion<br />
visit at least once), this package provides sample surveys and interview guides that can be<br />
used to conduct assessments in health facilities that serve pregnant women. By conducting<br />
an assessment, health staff can increase <strong>the</strong>ir knowledge <strong>of</strong> issues regarding malaria during<br />
pregnancy, while improving <strong>the</strong>ir ability to conduct operational research related to malaria<br />
during pregnancy.<br />
<strong>The</strong> package provides most <strong>of</strong> <strong>the</strong> materials needed to conduct a rapid assessment: general<br />
guidance about planning and conducting a rapid assessment (including where to locate<br />
existing data); sample assessment instruments, both quantitative and qualitative, which can<br />
and should be adapted to local circumstances; specific information about how to use each tool;<br />
and guidance about <strong>the</strong> use <strong>of</strong> <strong>the</strong> information obtained. O<strong>the</strong>r resources, including relevant<br />
guidelines, sample PowerPoint presentations for training sessions, training videos, and data<br />
analysis s<strong>of</strong>tware (Epi Info), are also included.<br />
<strong>The</strong> assessment has been piloted in several countries in sub-Saharan Africa and in Asia.<br />
<strong>The</strong>lessons learned from conducting assessments in <strong>the</strong>se regions are reflected in<br />
this package.<br />
ii<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Acknowledgements<br />
We thank malaria control programs in <strong>the</strong> countries that have participated in conducting<br />
rapid assessments — Bangladesh, Benin, Burkina Faso, Ethiopia, India, Indonesia,<br />
Kenya, Madagascar, Mali, Mauritania, Myanmar, Niger, and Senegal — and all <strong>the</strong> women<br />
(and <strong>the</strong>ir babies) in those countries who participated. In particular, we thank our key<br />
collaborators: Dr. Rukhsana Ahmed, Dr. Ralisimalala Andriamampianina, Dr. Eleonore<br />
Antoinette Ba-Nguz, Dr. Kaounde Calixte, Dr. Magda Robalo Correia e Silva, Dr. Amadou<br />
Baïlo Diallo, Dr. Ogobara Doumbo, Dr. M. Abdul Faiz, Dr. Ibrahima Socé Fall, Dr. Afework<br />
Hailemariam, Dr. Mohamed Nezhir Ould Hamed, Dr. Kaythwe Han, Ms. Jenny Hill, Dr. Daddi<br />
Jima, Dr. Ranjalahary Rasol<strong>of</strong>omanana Justin, Dr. Midou Kailou, Dr. Edward Kamau, Dr. Ardi<br />
Kaptiningsih, Dr. Kassoum Kayentao, Dr. Mamadou Kodio, Dr. Amadou Konate, Dr. Ravi Kumar,<br />
Dr. Gita Maya, Mr. Etienne Minkoulou,Dr. Saroj K. Mishra, Ms. Allisyn Moran, Dr. Richard Muga,<br />
Dr. Bernard L. Nahlen, Dr. Jean Louis Ndiaye, Dr. S.K. Sharif, Dr. Neeru Singh, Dr. Sodiomon B.<br />
Sirima, Dr. Madion Silé Nguembayo Souam-Nguelé, Dr. Dianne Terlouw, Dr. Feiko ter Kuile,<br />
Dr. Anniemieke Van Eijk, and Dr. Holly Williams. We thank also health pr<strong>of</strong>essionals in Asia<br />
and Africa who have attended training workshops for rapid assessments and have <strong>of</strong>fered<br />
suggestions for making this package more useful. We thank <strong>the</strong> World Health Organization,<br />
in particular <strong>the</strong> Global <strong>Malaria</strong> Programme and Making Pregnancy Safer Department,<br />
Regional and Country <strong>of</strong>fices, for reviewing and approving this publication and supporting <strong>the</strong><br />
workshops. We are indebted to Dr. Penny Phillips-Howard, who first conceived <strong>of</strong> <strong>the</strong> idea<br />
<strong>of</strong> a rapid assessment manual in order to share this methodology with o<strong>the</strong>rs.<br />
Suggested citation: US Centers for Disease Control and Prevention (CDC) and World Health<br />
Organization. <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy: A Toolkit.<br />
Atlanta: Centers for Disease Control and Prevention, 2009.<br />
<strong>The</strong> contents <strong>of</strong> this toolkit do not necessarily represent <strong>the</strong> <strong>of</strong>ficial position <strong>of</strong> <strong>the</strong><br />
Centers for Disease Control and Prevention.<br />
Cover credit: Virginia Jacobs, Centers for Disease Control and Prevention<br />
<strong>The</strong> Manual<br />
iii
Abbreviations<br />
CDC<br />
DHS<br />
HCW<br />
ID<br />
IPTp<br />
ITN<br />
LBW<br />
MICS<br />
MIPESA<br />
MoH<br />
MIS<br />
RAOPAG<br />
RBM<br />
SP<br />
UNICEF<br />
USAID<br />
WHO<br />
Centers for Disease Control and Prevention<br />
Demographic and Health Survey<br />
health-care worker<br />
identification<br />
intermittent preventive treatment for<br />
pregnant women<br />
insecticide-treated net<br />
low birth weight<br />
Multiple Indicator Cluster Survey<br />
<strong>Malaria</strong> in Pregnancy East and Sou<strong>the</strong>rn Africa:<br />
Coalition for Prevention and Control<br />
Ministry <strong>of</strong> Health<br />
<strong>Malaria</strong> Indicator Survey<br />
Réseau d’Afrique de l’Ouest contre le Paludisme<br />
pendant la grossesse<br />
Roll Back <strong>Malaria</strong><br />
sulfadoxine-pyrimethamine<br />
United Nations Children’s Fund<br />
U.S. Agency for International Development<br />
World Health Organization<br />
iv<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
1. <strong>Malaria</strong> during Pregnancy: Addressing <strong>the</strong> <strong>Burden</strong><br />
1.1 <strong>The</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy<br />
Pregnant women and children are particularly vulnerable to infection with any <strong>of</strong> <strong>the</strong><br />
parasites that cause malaria in humans: Plasmodium falciparum, P. vivax, P. malariae, and P.<br />
ovale. Each year, approximately 50 million women in malaria-endemic areas (25 million <strong>of</strong><br />
<strong>the</strong>se live in Africa) become pregnant and are at risk <strong>of</strong> <strong>the</strong> adverse consequences <strong>of</strong> malaria<br />
during pregnancy [1, 2]. <strong>Malaria</strong> is a threat both to <strong>the</strong>mselves and <strong>the</strong>ir babies, leading<br />
to about 200,000 newborn deaths each year as a result <strong>of</strong> malaria in pregnancy [1, 3]. <strong>The</strong><br />
problem <strong>of</strong> malaria in pregnant women has not been extensively studied outside sub-Saharan<br />
Africa, and limited information exists about <strong>the</strong> burden <strong>of</strong> <strong>the</strong> problem in o<strong>the</strong>r areas.<br />
<strong>The</strong> infecting parasite and <strong>the</strong> level <strong>of</strong> transmission (high or low) are key determinants <strong>of</strong> <strong>the</strong><br />
consequences <strong>of</strong> malaria infection during pregnancy. 1<br />
Global <strong>Malaria</strong> Transmission (Endemicity) Levels<br />
Pregnant women<br />
and children<br />
are particularly<br />
vulnerable to<br />
infection with<br />
any <strong>of</strong> <strong>the</strong> parasites<br />
that cause malaria<br />
in humans.<br />
Source: WHO and UNICEF, 2005 World <strong>Malaria</strong> Report.<br />
1 O<strong>the</strong>r determinants can include gravidity, parity, age, HIV infection, and access to prompt and<br />
effective treatment.<br />
<strong>The</strong> Manual<br />
1
1.1.1 Infection with Plasmodium falciparum<br />
Areas <strong>of</strong> High (or Stable) Transmission<br />
Sub-Saharan Africa is <strong>the</strong> region <strong>of</strong> <strong>the</strong> world most affected by malaria, and in high (or<br />
stable) transmission areas in that region, P. falciparum, <strong>the</strong> most lethal <strong>of</strong> <strong>the</strong> four parasites,<br />
predominates.<br />
While most adults in areas <strong>of</strong> high or stable transmission (<strong>the</strong> majority <strong>of</strong> sub-Saharan<br />
Africa) have developed a partial immunity to malaria that largely prevents clinical illness, a<br />
woman’s immune system changes during pregnancy, making her more vulnerable to malaria<br />
infection. Infected red blood cells can sequester in <strong>the</strong> placenta, evading immune detection<br />
and clearance. This infection can endanger <strong>the</strong> pregnant woman’s health, as well as that <strong>of</strong> <strong>the</strong><br />
unborn baby she is carrying, and cause maternal anemia, fetal loss, prematurity, intrauterine<br />
growth retardation, and low birth weight (LBW)(
1.1.2 Infection with O<strong>the</strong>r <strong>Malaria</strong> Parasites<br />
<strong>The</strong> effects <strong>of</strong> <strong>the</strong> o<strong>the</strong>r three malaria parasites are less well-known. Pregnant women in<br />
Africa at risk <strong>of</strong> P. vivax infection live principally in areas <strong>of</strong> low or unstable transmission, and<br />
in <strong>the</strong>se areas, P. vivax infections are likely to result in febrile illness. Most data on P. vivax<br />
infections are from outside Africa, where women have been shown to be at increased risk <strong>of</strong><br />
P. vivax during pregnancy, although <strong>the</strong> risk is less pronounced than it is among women with<br />
P. falciparum[16]. A study among nonimmune pregnant women in Thailand reported that<br />
even single infections with P. vivax in <strong>the</strong> peripheral blood are associated with reductions in<br />
birthweight and maternal hemoglobin but to a lesser extent than are those with P. falciparum<br />
[17, 18]. Robust data on <strong>the</strong> prevalence <strong>of</strong> P. ovale and P. malariae are currently unavailable in<br />
any population.<br />
1.1.3 <strong>Malaria</strong> and HIV<br />
In sub-Saharan Africa, where more than three-fourths (13.5 million) <strong>of</strong> <strong>the</strong> world’s HIVinfected<br />
women reside approximately 25 million pregnant women are at risk <strong>of</strong> P. falciparum<br />
infection every year. A review <strong>of</strong> studies in Africa shows that coinfection with HIV exacerbates<br />
<strong>the</strong> burden <strong>of</strong> malaria in pregnancy. HIV increases <strong>the</strong> degree to which malaria is associated<br />
with severe anemia and low birth weight beyond <strong>the</strong> effect <strong>of</strong> HIV itself on <strong>the</strong>se outcomes.<br />
HIV also puts women <strong>of</strong> all gravidities at risk for placental infection with malaria, not only<br />
women in <strong>the</strong>ir first or second pregnancy [19].<br />
1.2 <strong>Malaria</strong> Prevention Interventions<br />
for Pregnant Women<br />
In areas <strong>of</strong> high (or stable) malaria transmission, prevention <strong>of</strong> <strong>the</strong> ill effects <strong>of</strong> malaria during<br />
pregnancy requires a preventive approach because most women do not become clinically ill.<br />
<strong>The</strong> World Health Organization (WHO) has recommended a three-pronged strategy (IPTp,<br />
ITNs, case management) for controlling malaria during pregnancy in areas <strong>of</strong> high or stable<br />
transmission in Africa [2] (see box). WHO recommends intermittent preventive treatment<br />
(IPTp) as an essential component <strong>of</strong> antenatal care for all pregnant women in areas <strong>of</strong> high or<br />
stable transmission. IPTp involves <strong>the</strong> administration <strong>of</strong> an effective antimalarial at treatment<br />
doses at predefined intervals during pregnancy and at regularly scheduled antenatal visits.<br />
<strong>The</strong> remaining two interventions, insecticide-treated mosquito nets (ITNs) and effective case<br />
management, are recommended for all pregnant women, regardless <strong>of</strong> <strong>the</strong> area’s malaria<br />
transmission level. ITNs are intended to prevent infection, while case management with<br />
an effective antimalarial is a treatment intervention. Each intervention is safe, effective,<br />
affordable, and deliverable.<br />
<strong>The</strong> Manual<br />
3
If <strong>the</strong>se interventions are <strong>of</strong>fered through antenatal clinics, <strong>the</strong>y can reach many to most<br />
pregnant women, since surveys show that a relatively high proportion <strong>of</strong> women worldwide<br />
have at least one antenatal visit with a skilled provider during pregnancy. In many countries in<br />
sub-Saharan Africa, East Asia and <strong>the</strong> Pacific, and Latin America and <strong>the</strong> Caribbean, more than<br />
70% attend an antenatal clinic at least once.<br />
Antenatal Care Coverage by Region<br />
Prevention and control <strong>of</strong> malaria in pregnant women should <strong>the</strong>refore be a critical component<br />
<strong>of</strong> antenatal services, and WHO’s strategic framework for prevention and control <strong>of</strong> malaria<br />
during pregnancy in <strong>the</strong> African region underscores <strong>the</strong> need for close collaboration between<br />
malaria and reproductive health programs [2].<br />
4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
WHO’s Recommended Interventions for<br />
<strong>Malaria</strong> Prevention and Control during Pregnancy<br />
in Areas <strong>of</strong> Stable Transmission in Africa<br />
<strong>The</strong> policy for malaria prevention and control during pregnancy in areas <strong>of</strong> stable<br />
transmission in <strong>the</strong> African region should emphasize a preventive package <strong>of</strong> intermittent<br />
preventive treatment (IPTp) and insecticide-treated bed nets (ITNs) and ensure effective case<br />
management <strong>of</strong> malaria illness and anemia.<br />
Intermittent Preventive Treatment<br />
All pregnant women in areas <strong>of</strong> stable malaria transmission should receive at least 2 doses <strong>of</strong><br />
IPTp after quickening. <strong>The</strong> World Health Organization recommends a schedule <strong>of</strong> 4 antenatal<br />
clinic visits, with 3 visits after quickening. <strong>The</strong> delivery <strong>of</strong> IPTp with each scheduled visit after<br />
quickening will likely assure that a high proportion <strong>of</strong> women receive at least 2 doses. IPTp<br />
doses should not be given more frequently than monthly.<br />
Prevention and<br />
control <strong>of</strong> malaria<br />
in pregnant<br />
women is a critical<br />
component <strong>of</strong><br />
antenatal services.<br />
<strong>The</strong> most effective drug for IPTp is sulfadoxine-pyrimethamine (SP) because <strong>of</strong> its safety for use<br />
during pregnancy, effectiveness in reproductive-age women, and feasibility for use in programs,<br />
as it can be delivered as a single-dose treatment under observation by <strong>the</strong> health worker.*<br />
Insecticide-Treated Bed Nets<br />
ITNs should be provided to pregnant women as early in pregnancy as possible, and <strong>the</strong>ir use<br />
should be encouraged for women throughout pregnancy and during <strong>the</strong> postpartum period.<br />
ITNs can be provided ei<strong>the</strong>r through <strong>the</strong> antenatal clinic or through o<strong>the</strong>r systems in <strong>the</strong><br />
private and public sectors that may be available at <strong>the</strong> community level.<br />
Effective Case Management <strong>of</strong> <strong>Malaria</strong> Illness and Anemia<br />
Effective case management <strong>of</strong> malaria illness for all pregnant women in malarious areas must<br />
be assured. Iron/folate supplementation for anemia, an important consequence <strong>of</strong> malaria<br />
infection, should be given to pregnant women as part <strong>of</strong> routine antenatal care package.<br />
Pregnant women should also be screened for anemia, and those with moderate to severe<br />
anemia should be managed according to national reproductive health guidelines.<br />
* Current scientific evidence suggests <strong>the</strong> following: 1) At least 2 IPTp doses are required to achieve optimal<br />
benefit in most women; 2) HIV-infected pregnant women receiving daily cotrimoxazole (CTX) should not<br />
receive IPTp with SP due to concerns with additive sulfa toxicity; 3) In settings where <strong>the</strong> HIV prevalence in<br />
pregnant women is greater than 10%, and where <strong>the</strong> daily CTX recommendation is not implemented among<br />
HIV-infected individuals, it is more cost effective to treat all women with at least a 3-dose IPTp regimen<br />
than to screen for HIV and provide this regimen only to HIV-infected women; 4) In HIV-uninfected pregnant<br />
women, <strong>the</strong>re is no evidence that a third dose <strong>of</strong> IPTp causes any additional risk, that more than 3 IPTp doses<br />
during pregnancy <strong>of</strong>fers additional benefit, or that receiving 3 or more doses <strong>of</strong> IPTp with SP will result in an<br />
increased risk <strong>of</strong> adverse drug reactions. Research to assess <strong>the</strong> safety, efficacy, and program feasibility <strong>of</strong> o<strong>the</strong>r<br />
antimalaria drugs for use in IPTp among both HIV-uninfected pregnant women, and HIV-infected pregnant<br />
women receiving daily CTX, is ongoing.<br />
Source: World Health Organization. A Strategic Framework for <strong>Malaria</strong> Prevention and Control during<br />
Pregnancy in <strong>the</strong> African Region. Brazzaville: WHO Regional Office for Africa, 2004. AFR/MAL/04/01.<br />
However <strong>the</strong> details <strong>of</strong> <strong>the</strong> specific interventions and tools used within this strategy have been updated in<br />
subsequent documents. <strong>The</strong> updated treatment recommendation <strong>of</strong> uncomplicated and severe malaria in<br />
pregnancy is part <strong>of</strong> <strong>the</strong> WHO Guidelines for <strong>the</strong> treatment <strong>of</strong> malaria, (http://www.who.int/malaria/docs/<br />
TreatmentGuidelines2006.pdf), while an updated recommendation on intermittent preventive treatment in<br />
pregnancy (IPTp) is in this report: http://www.who.int/malaria/docs/IPTp/TechnicalExpertMtgIPTpReport.pdf<br />
<strong>The</strong> Manual<br />
5
1.3 Information for Action<br />
<strong>The</strong> following four scenarios describe potential information gaps malaria-endemic countries<br />
may have. Each numbered scenario highlights <strong>the</strong> key unanswered questions and suggests what<br />
implications <strong>the</strong> answers might have for action.<br />
1. <strong>The</strong> magnitude <strong>of</strong> <strong>the</strong> problem <strong>of</strong> malaria during pregnancy is not well known.<br />
• Does malaria present a problem for pregnant women and <strong>the</strong>ir infants in this area? Does<br />
malaria affect women in <strong>the</strong>ir first trimester? How big is <strong>the</strong> problem? Does malaria<br />
infection during pregnancy affect maternal morbidity and mortality?<br />
Even though it can be assumed that malaria during pregnancy is a significant problem and<br />
requires intervention in areas with high transmission <strong>of</strong> P. falciparum infections, a more<br />
precise documentation <strong>of</strong> <strong>the</strong> problem locally can also be used to advocate for increased<br />
resources and commitment to develop or enhance a program that addresses malaria during<br />
pregnancy. Also, in areas with o<strong>the</strong>r malaria transmission patterns (low-intermediate,<br />
seasonal, unstable), relatively little may be known about <strong>the</strong> burden <strong>of</strong> malaria during<br />
pregnancy. If malaria infection affects women in <strong>the</strong>ir first trimester, women will need to be<br />
encouraged to come in for care early, and <strong>the</strong> National <strong>Malaria</strong> Control Program will need to<br />
look for a strategy to control <strong>the</strong> adverse effects <strong>of</strong> malaria during pregnancy that includes<br />
women in <strong>the</strong>ir first trimester.<br />
2. <strong>The</strong> burden <strong>of</strong> malaria in pregnancy is known, but policy and program strategy have<br />
not yet been developed.<br />
• What proportion <strong>of</strong> pregnant women seek antenatal care in antenatal clinics? What is <strong>the</strong><br />
coverage <strong>of</strong> antenatal clinics? What barriers do pregnant women face when obtaining care<br />
from antenatal clinics?<br />
If antenatal clinics provide services for <strong>the</strong> majority <strong>of</strong> pregnant women in <strong>the</strong> area,<br />
resources should be directed to provide or improve interventions in antenatal clinics.<br />
If antenatal clinic coverage is not high, it is important to learn why and address<br />
<strong>the</strong> causes.<br />
• What should be done if <strong>the</strong> prevalence <strong>of</strong> malaria infection in pregnant women is low? Does<br />
it make a difference if pregnant women are symptomatic or asymptomatic?<br />
If prevalence is low, IPTp should not be <strong>of</strong>fered. If most cases <strong>of</strong> malaria infection are<br />
symptomatic, <strong>the</strong> country may decide to treat cases ra<strong>the</strong>r than <strong>of</strong>fer IPTp; if most<br />
cases are asymptomatic, <strong>the</strong>n preventive treatment is necessary.<br />
3. Policy has been developed, programs have begun, and information is needed on<br />
program implementation.<br />
Coverage <strong>of</strong> interventions<br />
• What percentage <strong>of</strong> pregnant women is <strong>the</strong> program reaching?<br />
If coverage is low, it will be important to determine <strong>the</strong> causes, which can be better<br />
understood by examining issues relating to <strong>the</strong> facility and <strong>the</strong> clients <strong>the</strong>mselves.<br />
6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Facility-dependent aspects <strong>of</strong> providing interventions<br />
• Are antenatal clinics equipped to provide <strong>the</strong> recommended interventions? Do <strong>the</strong>y have<br />
trained health workers who can provide <strong>the</strong> needed interventions and care? Are drugs and<br />
supplies available? Are health workers aware <strong>of</strong> what <strong>the</strong> policy says? Are <strong>the</strong> antenatal<br />
clinic health workers providing <strong>the</strong> needed interventions appropriately?<br />
Lack <strong>of</strong> needed supplies point to <strong>the</strong> need for improvement. Any deficiencies<br />
revealed in health-care worker knowledge or provision <strong>of</strong> services can identify<br />
specific training needs.<br />
Client-dependent aspects affecting acceptance and use <strong>of</strong> malaria interventions<br />
• Are pregnant women able to obtain and willing to take antimalarial medications for<br />
IPTp and treatment <strong>of</strong> malaria illness? Do women have access to and do <strong>the</strong>y use ITNs?<br />
What are pregnant women’s knowledge <strong>of</strong> and attitudes about malaria and its effects<br />
during pregnancy? What cultural taboos affect how <strong>the</strong>y seek care if <strong>the</strong>y have malaria<br />
infection during pregnancy? Where do <strong>the</strong>y receive <strong>the</strong>ir information and advice<br />
about malaria prevention? What is <strong>the</strong> best way to provide information about malaria<br />
prevention?<br />
Understanding what facilitators and barriers exist to women’s access and use <strong>of</strong><br />
needed interventions can help in understanding program implementation issues.<br />
Understanding where and how <strong>the</strong>y receive information about malaria can aid in<br />
<strong>the</strong> development <strong>of</strong> health education and communication campaigns, if needed.<br />
4. Intervention coverage is substantial, and <strong>the</strong> country wants to determine <strong>the</strong><br />
impact <strong>of</strong> <strong>the</strong> program.<br />
• Are <strong>the</strong> programs achieving <strong>the</strong>ir goals—improved health for pregnant women and<br />
<strong>the</strong>ir infants?<br />
Measures <strong>of</strong> coverage, placental infection, and LBW, as well as o<strong>the</strong>r indicators can give<br />
a snapshot <strong>of</strong> <strong>the</strong> effectiveness <strong>of</strong> <strong>the</strong> current program. <strong>The</strong>se measures can also serve<br />
as baseline data against which to evaluate <strong>the</strong> impact <strong>of</strong> new interventions.<br />
Information alone is not sufficient to respond to <strong>the</strong> problem <strong>of</strong> malaria during pregnancy.<br />
Commitment and resources are needed to translate this information into action.<br />
►Commitment by malaria programs and reproductive health programs at national<br />
levels and below to use <strong>the</strong> information obtained to develop or refine policy and<br />
guide successful program implementation. <strong>The</strong> conduct <strong>of</strong> <strong>the</strong> assessment may seem<br />
to raise awareness <strong>of</strong> malaria in pregnancy among stakeholders and policymakers—a<br />
crucial step toward mobilizing necessary human and capital resources.<br />
►Adequate human and financial resources to conduct <strong>the</strong> assessment, develop<br />
strategies for local and subregional programs, and provide ongoing monitoring<br />
and evaluation <strong>of</strong> <strong>the</strong>se activities. In <strong>the</strong> process <strong>of</strong> conducting <strong>the</strong> assessment and<br />
obtaining necessary information, <strong>the</strong> country streng<strong>the</strong>ns its capacity to conduct<br />
operational research, which will likely be needed to continue to guide programs<br />
focusing on malaria as well as o<strong>the</strong>r diseases that threaten <strong>the</strong> health <strong>of</strong> its people.<br />
<strong>The</strong> Manual<br />
7
1.4 Use <strong>of</strong> <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong> Package<br />
<strong>The</strong> manual does<br />
not lay out a<br />
"one-size-fits-all"<br />
approach and is<br />
intended to be<br />
adapted for use<br />
by countries in<br />
all regions <strong>of</strong> <strong>the</strong><br />
world affected by<br />
malaria.<br />
This rapid assessment 2 package is intended to assist a country quickly and comprehensively<br />
ga<strong>the</strong>r information it needs about <strong>the</strong> problem <strong>of</strong> malaria during pregnancy and opportunities<br />
for successful intervention.<br />
A country may be able to take advantage <strong>of</strong> a wealth <strong>of</strong> information about <strong>the</strong> problem <strong>of</strong><br />
malaria during pregnancy — current, relevant, available at no cost —within <strong>the</strong> Ministry <strong>of</strong><br />
Health (MoH), for example. Information may also be available from o<strong>the</strong>r reliable sources,<br />
including Demographic Health Surveys (DHS), Multiple Indicator Cluster Surveys (MICS),<br />
and <strong>Malaria</strong> Indicator Surveys (MIS). Regional information from networks such as <strong>Malaria</strong><br />
in Pregnancy East and Sou<strong>the</strong>rn Africa: Coalition for Prevention and Control (MIPESA) and<br />
Réseau d’Afrique de l’Ouest contre le Paludisme pendant la grossesse (RAOPAG) can be<br />
ano<strong>the</strong>r important source <strong>of</strong> information.<br />
Available sources may not supply all <strong>the</strong> information needed; thus, this assessment package<br />
was developed. <strong>The</strong> tools in this package are largely designed to obtain information from<br />
antenatal clinics and delivery units, even though not all women seek care from antenatal<br />
clinics or deliver <strong>the</strong>ir babies at a health facility. <strong>The</strong> currently recommended interventions are<br />
facility-based, and most countries that provide interventions for pregnant women concentrate<br />
<strong>the</strong>ir efforts on expanding implementation in facilities. See Chapter 4 for limitations <strong>of</strong> this<br />
approach.<br />
<strong>The</strong> package contains a manual with general guidance:<br />
• Chapter 2 outlines <strong>the</strong> design <strong>of</strong> a rapid assessment.<br />
• Chapter 3 gives general information about preparing for and conducting<br />
a rapid assessment.<br />
• Chapter 4 outlines how to manage, analyze, and interpret <strong>the</strong> data collected.<br />
• Chapter 5 provides information about preparing a report and using <strong>the</strong><br />
assessment information ga<strong>the</strong>red.<br />
<strong>The</strong> rest <strong>of</strong> <strong>the</strong> package has more specific tools and information:<br />
• Modules 1-10 have assessment tools ready to be adapted to <strong>the</strong> needs <strong>of</strong> each<br />
country. Each module contains most <strong>of</strong> <strong>the</strong> information and written materials needed<br />
for that part <strong>of</strong> <strong>the</strong> assessment.<br />
• Resources 1-4 contain a list <strong>of</strong> relevant articles, guidelines, sample PowerPoint<br />
presentations useful for training, and data analysis s<strong>of</strong>tware (Epi Info).<br />
<strong>The</strong> manual does not lay out a “one-size-fits-all” approach and is intended to be adapted for<br />
use by countries in all regions <strong>of</strong> <strong>the</strong> world affected by malaria.<br />
2 <strong>The</strong> term “rapid assessment” can be used in multiple ways. As described in this manual, a rapid assessment<br />
provides a “snapshot” at one point in time <strong>of</strong> <strong>the</strong> problem <strong>of</strong> malaria and opportunities for intervention.<br />
A rapid assessment does not replace program monitoring and evaluation activities, but can form part <strong>of</strong> a<br />
monitoring and evaluation strategy.<br />
8 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
2. Planning <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong><br />
2.1 Objectives <strong>of</strong> <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong><br />
Depending on a country’s information needs, its rapid assessment could have one or<br />
more <strong>of</strong> <strong>the</strong> following objectives:<br />
• Determine <strong>the</strong> burden <strong>of</strong> malaria<br />
• Determine what sort <strong>of</strong> policy and program should be developed<br />
and implemented<br />
• Assess implementation progress<br />
• Assess <strong>the</strong> program’s impact on infant and maternal health.<br />
It is important to note that regardless <strong>of</strong> which malaria-related objectives are selected,<br />
ano<strong>the</strong>r objective—to build national capacity to conduct operational research—will be<br />
achieved through <strong>the</strong> process <strong>of</strong> planning, conducting, and analyzing <strong>the</strong> assessment.<br />
2.2 Potential Information Sources<br />
Information may be readily available that fills some, although perhaps not all, <strong>of</strong> <strong>the</strong><br />
information gaps. Sources 3 <strong>of</strong> ready and recent (e.g., within <strong>the</strong> previous 5 years data are<br />
various and may include<br />
<br />
• Demographic Health Surveys (DHS) (see 2.2.1)<br />
• Multiple Indicator Cluster Surveys (MICS) (see 2.2.2)<br />
• <strong>Malaria</strong> Indicator Surveys (MIS) (see 2.2.3)<br />
• Roll Back <strong>Malaria</strong> (RBM) baseline surveys<br />
• National routine health information systems<br />
• Reports by nongovernmental organizations<br />
• Published scientific articles about malaria in pregnancy in <strong>the</strong> country<br />
or <strong>the</strong> region<br />
Numerous household surveys have been conducted since 2000, including DHS, MICS,<br />
Population Services International surveys, and RBM baseline surveys.<br />
<strong>The</strong> following Web site tracks major household surveys and data collection tools:<br />
http://www.internationalsurveynetwork.org/home/<br />
Pertinent studies include those conducted not only in <strong>the</strong> country or district itself, but<br />
also in <strong>the</strong> subregion (“subregion” denotes an area that is part <strong>of</strong> a WHO-defined “region”).<br />
Subregional data are an <strong>of</strong>ten underutilized source <strong>of</strong> information and may provide adequate<br />
information, especially about <strong>the</strong> magnitude <strong>of</strong> <strong>the</strong> problem (e.g., prevalence <strong>of</strong> malaria<br />
infection in pregnant women’s blood and placenta) from a country with similar geoclimatic<br />
characteristics. In addition, since customs and taboos vary by ethnic group, data from <strong>the</strong><br />
same ethnic group in a neighboring country may provide sufficient information about <strong>the</strong><br />
cultural aspects <strong>of</strong> malaria and its treatment and prevention.<br />
3 It is important to note that some <strong>of</strong> <strong>the</strong> surveys above, for example DHS and MICS, are population-based<br />
ra<strong>the</strong>r than facility-based, and thus cannot be used to validate results <strong>of</strong> this facility-based assessment.<br />
<strong>The</strong> Manual<br />
9
In recognition <strong>of</strong> <strong>the</strong> importance <strong>of</strong> subregional information and approaches to malaria<br />
control and prevention, several subregional networks have been established in <strong>the</strong> African<br />
region that focus on <strong>the</strong> prevention and control <strong>of</strong> malaria during pregnancy. MIPESA was<br />
created in 2002 to bring toge<strong>the</strong>r five countries (Kenya, Malawi, Tanzania, Uganda, Zambia),<br />
all <strong>of</strong> which had adopted policy for control <strong>of</strong> malaria in pregnancy (IPTp, ITNs, and effective<br />
case management), in line with WHO recommendations. In West Africa, RAOPAG was formed<br />
in 2003 and includes malaria-endemic countries <strong>of</strong> West Africa. <strong>The</strong>se organizations routinely<br />
share <strong>the</strong>ir data and experiences at network meetings.<br />
Because using available data can save time and money,<br />
• Determine if a recent 4 study has been done ei<strong>the</strong>r in <strong>the</strong> country or in a country with a<br />
similar malaria pr<strong>of</strong>ile.<br />
• If a recent study has been done, consider when, where, and among whom it was<br />
conducted.<br />
2.2.1 Demographic and Health Surveys<br />
Demographic and Health Surveys (DHS) are nationally representative household surveys that<br />
focus on reproductive and child health. Organized by Macro International, Calverton, MD,<br />
USA, and sponsored by <strong>the</strong> United States Agency for International Development (USAID), a<br />
typical DHS has a large sample size (usually between 5,000 and 30,000 households) and uses<br />
a multiple-stage cluster design. Because questionnaires are standardized and structured and<br />
change little between surveys, DHS outcomes are comparable between countries and over<br />
time. <strong>The</strong> average interval between two DHS is approximately 5 years.<br />
Since 1998, some DHS have used specific questions relevant to malaria prevention and<br />
treatment, including<br />
• antenatal clinic coverage<br />
• delivery unit coverage<br />
• type <strong>of</strong> antimalarial drugs given, timing, and dosage<br />
• possession <strong>of</strong> mosquito nets and <strong>the</strong>ir use for children less than 5 years old and<br />
pregnant women<br />
• use <strong>of</strong> IPTp by pregnant women.<br />
• prevalence <strong>of</strong> anemia by hemoglobin measurement in children less than 5 years old<br />
and pregnant women.<br />
<strong>The</strong> DHS survey package also includes an optional malaria module, which can be used in all<br />
surveys conducted in malarious countries.<br />
Data are available at http://www.measuredhs.com. For more information about DHS, consult<br />
http://www.measuredhs.com/ or contact MEASURE DHS+, Macro International Inc., 11785<br />
Beltsville Drive, Suite 300, Calverton MD 20705 USA; tel: 301-572-0456; fax: 301-572-0999;<br />
e-mail: measure@orcmacro.com.<br />
4 <strong>The</strong> meaning <strong>of</strong> “recent” varies by situation. In some cases, where no new programs have been initiated,<br />
no initiatives to improve services have been instituted, and <strong>the</strong> malaria transmission level is considered to<br />
be about <strong>the</strong> same, a 5-year-old survey may provide adequate information.<br />
10 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
2.2.2 Multiple Indicator Cluster Surveys<br />
Multiple Indicator Cluster Surveys (MICS) are also nationally representative household<br />
surveys. <strong>The</strong>y use a two-stage cluster sampling design, with an average sample size <strong>of</strong> around<br />
6,000 households. <strong>The</strong> questionnaire covers living conditions and household assets, allowing<br />
<strong>the</strong> data to be stratified by such factors as place <strong>of</strong> residence, education <strong>of</strong> <strong>the</strong> mo<strong>the</strong>r, and<br />
wealth quintile <strong>of</strong> <strong>the</strong> household. MICS are conducted approximately every 3 years in about 70<br />
countries worldwide.<br />
This survey also has questions about<br />
• prevalence <strong>of</strong> fever in <strong>the</strong> previous 2 weeks<br />
• type <strong>of</strong> treatment received and place <strong>of</strong> treatment<br />
• use <strong>of</strong> any nets and <strong>of</strong> ITNs by children less than 5 years old.<br />
Data are collected on indicators such as all-cause mortality among children less than 5 years<br />
old and coverage <strong>of</strong> antenatal care.<br />
Survey results and questionnaires are available at http://www.childinfo.org/. Like DHS, most<br />
MICS are conducted outside <strong>the</strong> peak malaria season.<br />
2.2.3 <strong>Malaria</strong> Indicator Survey Package<br />
RBM’s Monitoring and Evaluation Reference Group has a package <strong>of</strong> tools for assessing<br />
coverage <strong>of</strong> key RBM interventions at <strong>the</strong> household level: coverage <strong>of</strong> ITNs, antimalarial<br />
treatment among children under 5 with fever, and IPTp. It includes defined indicators;<br />
questionnaire and data tabulation plans for calculation <strong>of</strong> indicators; and guidance on<br />
conducting surveys, designing sampling frames, and calculating sample sizes. <strong>The</strong> sample size<br />
is usually about 3,000 households, smaller than that required for a DHS or MICS. <strong>The</strong> MIS<br />
should be conducted during <strong>the</strong> peak malaria season. <strong>The</strong> MIS package can be accessed at<br />
http://www.rollbackmalaria.org/<br />
<strong>The</strong> following information taken from WHO's World <strong>Malaria</strong> Report 2008 provides an<br />
example <strong>of</strong> data available from recent surveys.<br />
Survey data: Percentage <strong>of</strong> pregnant women who<br />
slept under an insecticide-treated net <strong>the</strong> night before <strong>the</strong> survey<br />
Africa Year Source Percentage<br />
Benin 2006 DHS 2006 20.0<br />
Congo 2005 DHS 2005 4.0<br />
Ethiopia 2007 MIS 2007 35.0<br />
Guinea 2005 DHS 2005 1.0<br />
Kenya 2003 DHS 2003 5.0<br />
Malawi 2004 DHS 2004 15.0<br />
Mali 2006 DHS 2006 29.0<br />
Niger 2006 DHS 2006 7.0<br />
Rwanda 2005 DHS 2005 17.0<br />
Senegal 2006 MIS 2006 17.0<br />
Tanzania 2004 DHS 2004-05 16.0<br />
Uganda 2006 DHS 2006 10.0<br />
Zambia 2006 MIS 2006 24.0<br />
<strong>The</strong> Manual<br />
11
2.3 Designing <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong><br />
<strong>The</strong> table below links potential information needs with <strong>the</strong> appropriate assessment tools in<br />
this package.<br />
Scenarios, Information, <strong>Assessment</strong> Tools<br />
Scenario Information Tool(s)<br />
Size <strong>of</strong> problem<br />
<strong>of</strong> malaria<br />
in pregnancy<br />
Development<br />
<strong>of</strong> policy and<br />
strategy<br />
Program<br />
implementation<br />
Program<br />
impact<br />
Measures <strong>of</strong> impact:<br />
• Prevalence <strong>of</strong> peripheral and placental<br />
malaria and anemia<br />
• Relationship <strong>of</strong> malaria to LBW and<br />
prematurity<br />
• Illness and adverse pregnancy outcomes<br />
due to severe malaria<br />
Sources <strong>of</strong> care:<br />
• Where pregnant women receive care<br />
• Antenatal clinic coverage<br />
Prevalence pr<strong>of</strong>ile:<br />
• Level <strong>of</strong> prevalence, prevalence<br />
by gravidity and locale, symptoms<br />
associated with infection<br />
Coverage <strong>of</strong> interventions:<br />
• Percentage <strong>of</strong> pregnant women<br />
reached by program<br />
Facility-dependent aspects <strong>of</strong><br />
providing interventions:<br />
• Availability <strong>of</strong> equipment, supplies<br />
(including ITNs), medications<br />
• Staffing patterns; schedule; services<br />
• Current practices<br />
• Medications dispensed<br />
• Health education<br />
• Relationship between community<br />
services (traditional birth<br />
attendants 1 ) & facility-level staff<br />
Client-dependent aspects <strong>of</strong> <strong>of</strong>fering<br />
interventions:<br />
• Sources <strong>of</strong> information and advice<br />
about malaria prevention<br />
• Barriers to obtaining antenatal<br />
are and using recommended<br />
interventions<br />
Measures <strong>of</strong> impact:<br />
• Prevalence <strong>of</strong> peripheral parasitemia<br />
and anemia<br />
• Prevalence <strong>of</strong> placental and cord<br />
parasitemia<br />
• Severe malaria outcomes<br />
• Low birth weight<br />
• Incidence <strong>of</strong> prematurity<br />
1: Antenatal clinic surveys<br />
2: Delivery unit surveys<br />
3: Hospital surveillance <strong>of</strong> malaria<br />
disease<br />
Note: No assessment tools will yield<br />
this information. DHS and MIS can<br />
supply information on source <strong>of</strong><br />
care; MICS can supply some <strong>of</strong> this<br />
information.<br />
1: Antenatal clinic surveys<br />
2: Delivery unit surveys<br />
3: Hospital surveillance <strong>of</strong> malaria<br />
Note: No assessment tools will yield<br />
this information. DHS and MIS can<br />
supply information on source <strong>of</strong><br />
care; MICS can supply some <strong>of</strong> this<br />
information.<br />
4: Antenatal clinic facility assessment<br />
5: Health-care worker (HCW)<br />
observation<br />
6: Individual interviews and focus<br />
groups with HCWs<br />
7: Individual interviews and focus<br />
groups with midwives 2 and<br />
traditional birth attendants.<br />
6: Individual interviews and focus<br />
groups with HCWs<br />
7: Individual interviews and focus<br />
groups with midwives and<br />
traditional birth attendants<br />
8: Antenatal clinic client exit<br />
interview<br />
9: Individual interviews and focus<br />
groups with pregnant women<br />
10: Individual interviews with key<br />
informants<br />
1: Antenatal clinic surveys<br />
2: Delivery unit surveys<br />
3: Hospital surveillance <strong>of</strong> malaria<br />
disease<br />
Tools 1, 2, 3, 4, 5, and 8 are quantitative; Tools 6, 7, 9, and 10 are qualitative. Ideally, if<br />
Tool 6, 7, or 9 is selected, both interviews and focus group techniques should be used, as<br />
<strong>the</strong>y may provide different data and can also serve to validate data from o<strong>the</strong>r techniques<br />
(“triangulation”). If both cannot be done, <strong>the</strong> more appropriate technique should be chosen<br />
based on <strong>the</strong> local situation. See Modules 6, 7, and 9 for each technique’s advantages and<br />
disadvantages <strong>of</strong> each technique.<br />
1 Traditional birth attendant refers to a person without formal training who delivers babies.<br />
2 Midwife refers to a person who has pr<strong>of</strong>essional training in <strong>the</strong> delivery <strong>of</strong> babies.<br />
12 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
3. Conducting <strong>the</strong> <strong>Rapid</strong> <strong>Assessment</strong><br />
This chapter provides information about specific activities that are relevant to all assessment<br />
instruments: selecting a time period for <strong>the</strong> assessment; determining a general timetable and<br />
budget; building a team; selecting assessment areas and sites and determining sample sizes;<br />
selecting and organizing team members; adapting and translating questionnaires; training <strong>of</strong><br />
<strong>the</strong> assessment team; and conducting <strong>the</strong> assessment (including assuring assessment quality<br />
and providing information to participants about <strong>the</strong> survey/informed consent).<br />
3.1 Selecting a Time Period<br />
<strong>The</strong> following are important considerations for deciding when to conduct <strong>the</strong> assessment:<br />
• Seasonal patterns <strong>of</strong> malaria transmission: It is ideal to maximize <strong>the</strong> number <strong>of</strong> cases<br />
<strong>of</strong> malaria parasitemia by attempting to schedule <strong>the</strong> assessment during periods <strong>of</strong> high<br />
transmission (i.e., during or soon after <strong>the</strong> rainy season). <strong>Assessment</strong>s during this time<br />
capture <strong>the</strong> worst-case scenario and are important for planning and advocacy purposes.<br />
In addition, data can be collected most efficiently during <strong>the</strong>se periods. However, if<br />
prevalence differs markedly by season, it might be preferable to conduct <strong>the</strong> assessment<br />
during both high and low transmission periods. <strong>The</strong> benefit <strong>of</strong> obtaining this information<br />
would need to be balanced against <strong>the</strong> additional use <strong>of</strong> resources required to repeat <strong>the</strong><br />
assessment.<br />
Demographic and<br />
Health Surveys,<br />
Multiple Indicator<br />
Surveys, and<br />
<strong>Malaria</strong> Indicator<br />
Surveys contain<br />
questions related<br />
to malaria<br />
interventions<br />
and outcomes.<br />
• Road conditions and facility/community access: All data collection must take place when<br />
facilities and communities are accessible by road. Travel can be difficult during <strong>the</strong> rainy<br />
season. In addition, one must confirm that <strong>the</strong> health facilities that<br />
will be included in <strong>the</strong> assessment will be open and in use during <strong>the</strong> proposed<br />
assessment dates.<br />
• Availability <strong>of</strong> assessment staff: <strong>Assessment</strong> staff must be available for <strong>the</strong> training and<br />
during <strong>the</strong> entire assessment period.<br />
3.2 Determining a Timetable and Budget<br />
<strong>The</strong> total duration <strong>of</strong> <strong>the</strong> assessment, as well as <strong>the</strong> cost, depends on which, how many, and in<br />
what sequence (simultaneously or sequentially) <strong>the</strong> rapid assessment tools are conducted. It<br />
also depends on <strong>the</strong> number <strong>of</strong> areas where <strong>the</strong> assessment is conducted and <strong>the</strong> number <strong>of</strong><br />
participants selected. See Modules 1 and 2 for sample survey timetables for <strong>the</strong> antenatal clinic<br />
and delivery unit surveys.<br />
If all tools are to be used, it is recommended that <strong>the</strong> qualitative components <strong>of</strong> <strong>the</strong> assessment<br />
(e.g., focus groups, individual interviews) be conducted at <strong>the</strong> same time as <strong>the</strong> quantitative<br />
component. This could be facilitated by, for example, having a local university or o<strong>the</strong>r<br />
institution <strong>of</strong> higher learning conduct <strong>the</strong> individual and focus group interviews while <strong>the</strong> MoH<br />
conducts <strong>the</strong> o<strong>the</strong>r studies.<br />
It is possible that both national and external sources <strong>of</strong> funding may be found to help<br />
finance <strong>the</strong> assessment. A sample costing tool is provided in Resource 4 to assist in<br />
determining a budget.<br />
<strong>The</strong> Manual<br />
13
3.3. Building and Organizing <strong>the</strong> <strong>Assessment</strong> Team<br />
3.3.1 Roles, Responsibilities, and Requirements<br />
<strong>Assessment</strong> Coordinator<br />
An assessment coordinator is essential for planning and supervising all assessment activities.<br />
He or she may do this alone or in conjunction with his or her supervisor. <strong>The</strong> assessment<br />
coordinator is key to building assessment teams that can successfully conduct <strong>the</strong> assessment.<br />
If <strong>the</strong> assessment will include collection <strong>of</strong> qualitative data, ideally <strong>the</strong> assessment coordinator<br />
will have had experience in qualitative data collection. If not, a coordinator for that portion<br />
<strong>of</strong> <strong>the</strong> assessment should be selected and should work closely with <strong>the</strong> overall assessment<br />
coordinator. No activities should occur before an assessment coordinator is selected.<br />
Note: If <strong>the</strong> assessment coordinator will also supervise and conduct qualitative research, he/<br />
she will also have <strong>the</strong> responsibilities listed below for <strong>the</strong> qualitative data coordinator.<br />
Responsibilities<br />
• Discuss <strong>the</strong> assessment with health authorities, local partners, and<br />
community leaders<br />
• Select assessment sites<br />
• Select site supervisors, interviewers, and laboratorians<br />
• Ensure procurement <strong>of</strong> assessment equipment and supplies (See modules for list)<br />
• Organize and manage <strong>the</strong> training <strong>of</strong> site supervisors, interviewers, and<br />
laboratorians<br />
• Collect data from facility assessments and health-care worker observations<br />
• Establish quality control and supervisory mechanisms in each assessment site<br />
• Troubleshoot and make adjustments as needed<br />
• Ensure appropriate analysis and report results from <strong>the</strong> rapid assessment,<br />
in conjunction with assessment coordinator <strong>of</strong> <strong>the</strong> qualitative component,<br />
if different<br />
Requirements<br />
• Have experience working in or have links with <strong>the</strong> health system<br />
• Be familiar with <strong>the</strong> local health system and health divisions<br />
• Have experience conducting facility- and community-based surveys<br />
• Have some technical knowledge in <strong>the</strong> areas <strong>of</strong> reproductive health<br />
and malaria (optimal)<br />
• Be able to troubleshoot and adjust accordingly<br />
• If possible, have experience administering, budgeting, managing public<br />
health programs<br />
14 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Qualitative Data Coordinator<br />
Responsibilities<br />
• Discuss <strong>the</strong> assessment with health authorities, local partners, and<br />
community leaders<br />
• Select interviewers, facilitators, recorders<br />
• Organize and manage training <strong>of</strong> interviewers, facilitators, and recorders<br />
• Revise interview guides as necessary<br />
• Supervise interviewers and data management<br />
• Communicate with facilities before <strong>the</strong> site visits to organize interviews so as to not<br />
disrupt patient care, select key informants, select focus group venues<br />
• Ensure procurement <strong>of</strong> assessment equipment and supplies (See modules)<br />
• Establish quality control and supervisory mechanisms<br />
• Ensure appropriate analysis and report results from <strong>the</strong> rapid assessment<br />
Requirements<br />
• Have experience working in/have links with <strong>the</strong> health system<br />
• Be familiar with <strong>the</strong> local health system and health divisions<br />
• Have knowledge <strong>of</strong> qualitative methodology (including differences between<br />
individual and focus group interviews)<br />
• Understand elements <strong>of</strong> qualitative debriefings (See 3.7 and Modules 6, 7, 9, 10)<br />
• Have experience conducting qualitative assessments<br />
• Have skills in qualitative data management (working knowledge <strong>of</strong> computer<br />
programs such as Word, Excel; production <strong>of</strong> field notes; ability to track data<br />
across facilities)<br />
• Have reasonable technical knowledge <strong>of</strong> reproductive health and malaria (optimal)<br />
• Be able to troubleshoot and adjust accordingly<br />
Laboratory Component Supervisor<br />
A laboratory component supervisor is critical for an assessment that conducts antenatal clinic<br />
and/or delivery unit surveys.<br />
Responsibilities<br />
• Ensure control <strong>of</strong> laboratory procedures in all assessment sites<br />
• Oversee all laboratorians working on <strong>the</strong> assessment<br />
Requirements<br />
• Have experience working in/have links with <strong>the</strong> public health system<br />
• Have technical expertise in malaria microscopy (optimally, has several years’<br />
experience reading thick and thin blood films)<br />
• Has been trained to read placental blood smears by <strong>the</strong> time <strong>the</strong> study starts<br />
• Be competent in <strong>the</strong> training and management <strong>of</strong> laboratorians<br />
<strong>The</strong> Manual<br />
15
Site Supervisors, Interviewers, and Laboratorians<br />
Site supervisors, interviewers, and laboratorians should be selected carefully by <strong>the</strong> persons<br />
organizing <strong>the</strong> assessment. <strong>The</strong>se team members are essential to <strong>the</strong> success <strong>of</strong> <strong>the</strong> rapid<br />
assessment. It is important that <strong>the</strong>y be well trained.<br />
Responsibilities<br />
Site supervisors:<br />
Interviewers:<br />
Laboratorians:<br />
• Ensure assessment quality (See 3.7)<br />
• May also assist in administering <strong>the</strong> questionnaires and in conducting<br />
clinical procedures<br />
• Troubleshoot, in consultation with <strong>the</strong> assessment supervisor<br />
• Administer questionnaires and conduct all clinical procedures<br />
• Conduct all laboratory procedures<br />
Data Management Coordinator<br />
Responsibilities<br />
• Ensure that data are kept securely<br />
• Assist in data analysis<br />
3.3.2 Staffing Approaches for <strong>the</strong> <strong>Assessment</strong><br />
Quantitative Component<br />
Depending on which tools are selected for <strong>the</strong> rapid assessment, <strong>the</strong> assessment coordinator<br />
could use ei<strong>the</strong>r or both <strong>of</strong> <strong>the</strong> following approaches to select assessment team members for<br />
<strong>the</strong> quantitative portion <strong>of</strong> <strong>the</strong> assessment (e.g., antenatal clinic survey, delivery unit survey,<br />
severe disease surveillance, client exit interview, health-care worker observation, health<br />
facility assessment):<br />
• Hire new staff<br />
• Use existing antenatal clinic and delivery staff.<br />
New staff hired specifically for <strong>the</strong> quantitative portion <strong>of</strong> <strong>the</strong> assessment should be organized<br />
by teams, with each team composed ei<strong>the</strong>r <strong>of</strong> one laboratorian and three interviewers or one<br />
laboratorian, two interviewers, and one site supervisor. If existing antenatal clinic and delivery<br />
unit staff are used, one <strong>of</strong> <strong>the</strong> staff members at each antenatal clinic or delivery unit should be<br />
designated as <strong>the</strong> site supervisor.<br />
<strong>The</strong> antenatal clinic teams can rotate between antenatal clinics included in <strong>the</strong> assessment<br />
until <strong>the</strong> desired sample size is obtained. Ideally, for <strong>the</strong> delivery unit survey one team member<br />
will be available 24 hours per day in <strong>the</strong> delivery unit to promptly process placental samples.<br />
It may be helpful to include an additional interviewer for this purpose. If this is not possible, a<br />
cooler and icepacks should be available so that placentas can be stored.<br />
16 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Advantages and Disadvantages <strong>of</strong> Staffing Approaches<br />
Staffing<br />
Approach<br />
Hire new<br />
staff<br />
Use existing<br />
health staff<br />
Advantages<br />
• <strong>Assessment</strong> is staff’s priority<br />
• Payment is simple<br />
• <strong>Rapid</strong> assessment does not<br />
compromise delivery <strong>of</strong><br />
clinical care<br />
• Builds capacity<br />
• Facilitates enrollment<br />
• Facilitates clinical treatment<br />
when indicated<br />
• Builds morale<br />
• Ownership <strong>of</strong> assessment<br />
• Buy-in for future<br />
interventions<br />
Disadvantages<br />
• No capacity building <strong>of</strong> existing staff<br />
• Existing staff may resent outsiders if<br />
effective linkages to clinic staff not made<br />
• May be more expensive<br />
• May compromise assessment quality if<br />
nonmedical staff do not have sufficient<br />
training<br />
• May be more difficult to ensure treatment<br />
<strong>of</strong> women with anemia or malaria<br />
• MoH may feel less invested in <strong>the</strong><br />
assessment<br />
• May overburden busy staff<br />
• <strong>Assessment</strong> work (if paid) may take<br />
priority over regular work<br />
• Payment issues are delicate<br />
• Staff may think that any work requires<br />
extra payment<br />
• May compromise quality <strong>of</strong> assessment<br />
in busy settings<br />
• May be competing with projects going<br />
on simultaneously<br />
<strong>The</strong> choice <strong>of</strong> whe<strong>the</strong>r or not to hire new staff should be guided by<br />
• Consideration <strong>of</strong> personnel available and able to conduct <strong>the</strong>se activities<br />
• Financial constraints. <strong>The</strong> project budget may make it difficult to hire outside staff,<br />
which is <strong>the</strong> more expensive option.<br />
If existing staff members make up <strong>the</strong> assessment team, <strong>the</strong> following could help show<br />
appreciation for <strong>the</strong>ir assistance in assuming additional responsibilities outside <strong>the</strong>ir normal<br />
workload:<br />
• Improve <strong>the</strong> working environment by supplying equipment, books, and/or teaching<br />
materials or by improving <strong>the</strong> facility (for example, buying teapot and tea supplies,<br />
painting walls)<br />
• Invite staff to dissemination activities/presentation <strong>of</strong> results at <strong>the</strong> end <strong>of</strong><br />
<strong>the</strong> assessment<br />
• Pay a “per diem” for attending assessment training, but not for conducting<br />
<strong>the</strong> assessment<br />
• Provide payment (an “incentive”) for <strong>the</strong> extra work <strong>the</strong> staff does as part<br />
<strong>of</strong> <strong>the</strong> assessment<br />
• Provide certificate <strong>of</strong> participation in study.<br />
See Modules 1-10 for a list <strong>of</strong> specific personnel needed to conduct each tool.<br />
<strong>The</strong> Manual<br />
17
Qualitative Component<br />
If <strong>the</strong> assessment includes a qualitative portion, it is important to consider <strong>the</strong> approach that<br />
will be used for managing data collected from individual and focus group interviews (see<br />
4.2). Each approach has implications for <strong>the</strong> personnel and s<strong>of</strong>tware needed to manage and<br />
analyze <strong>the</strong> data. New staff may need to be hired (current staff is unlikely to be trained in this<br />
type <strong>of</strong> research), or a university or ano<strong>the</strong>r institution with expertise in qualitative research<br />
may be involved. However, if insufficient resources and opportunities exist, current staff can<br />
be provided intensive training. This can be an excellent opportunity to build local/national<br />
capacity to conduct qualitative studies. See Resource 2.<br />
Six to eight people are needed to conduct <strong>the</strong> qualitative portion <strong>of</strong> <strong>the</strong> assessment. For<br />
individual interviews, <strong>the</strong> number <strong>of</strong> staff needed depends on staff experience. An experienced<br />
staff member could both interview and record; if more junior or inexperienced staff members<br />
are used, individual interviews will require one person to interview and ano<strong>the</strong>r to record.<br />
Focus groups require one person to facilitate (i.e., ask questions) and at least two people to<br />
record, if at all possible.<br />
3.4 Selecting <strong>Assessment</strong> Areas, Sites, and Sample Sizes<br />
3.4.1 <strong>Assessment</strong> Areas<br />
<strong>The</strong> objective(s) <strong>of</strong> <strong>the</strong> rapid assessment will guide <strong>the</strong> selection <strong>of</strong> <strong>the</strong> assessment area<br />
or areas. For example, a country may wish to obtain information on <strong>the</strong> problem and<br />
interventions countrywide, or in one or more geographic regions, or in one or more districts,<br />
or in urban versus rural areas.<br />
Whe<strong>the</strong>r <strong>the</strong> assessment focuses on an entire country or only one region <strong>of</strong> a country, <strong>the</strong><br />
most important selection criterion is <strong>the</strong> transmission pattern <strong>of</strong> malaria. If <strong>the</strong> transmission<br />
pattern differs markedly within <strong>the</strong> area <strong>of</strong> interest, an attempt should be made to collect<br />
information from subareas with different transmission patterns. <strong>The</strong> chief concern should be<br />
to obtain representative data from <strong>the</strong> area <strong>of</strong> interest. Although an ideal assessment might involve<br />
sampling a variety <strong>of</strong> sites within <strong>the</strong> country, resources <strong>of</strong>ten dictate choosing one site,<br />
or a number <strong>of</strong> sites in a well-defined geographic area such as a district, which are likely to be<br />
representative <strong>of</strong> <strong>the</strong> general situation <strong>of</strong> malaria during pregnancy.<br />
18 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
3.4.2 <strong>Assessment</strong> Sites<br />
Quantitative Component<br />
Within <strong>the</strong> country, region, or district <strong>of</strong> interest, <strong>the</strong> following criteria can be used to select<br />
specific sites for facility-based surveys, observations, and interviews:<br />
• A sufficiently high volume <strong>of</strong> antenatal clinic clients (antenatal clinic survey) or facilitybased<br />
deliveries (delivery unit survey) to ensure that numbers are adequate to reach <strong>the</strong><br />
desired sample size most expeditiously and within <strong>the</strong> allotted time for <strong>the</strong> study<br />
• Facilities with both an antenatal clinic and a delivery unit (for <strong>the</strong> sake <strong>of</strong> efficiency in<br />
conducting <strong>the</strong> assessment)<br />
• Ability to gain access to antenatal clinics and delivery units during <strong>the</strong> assessment<br />
• Representativeness <strong>of</strong> <strong>the</strong> facility population (in terms <strong>of</strong> ethnicity, urban/rural<br />
residence, socioeconomic status)<br />
• Geographic area to ensure coverage from different geographic areas. This may be<br />
difficult to achieve in reality, as previously noted.<br />
<strong>The</strong> more facilities involved, <strong>the</strong> more representative <strong>the</strong> data. However, <strong>the</strong> larger <strong>the</strong><br />
number <strong>of</strong> facilities selected, <strong>the</strong> more resources (human, financial, logistic) will be<br />
required to conduct <strong>the</strong> assessment. Thus, those selecting sites should balance <strong>the</strong> need for<br />
representativeness <strong>of</strong> data with <strong>the</strong> availability <strong>of</strong> resources.<br />
Experience with rapid assessments shows that a total <strong>of</strong> two delivery units and four antenatal<br />
clinics from a selected district or region is feasible and reasonably efficient for assessment<br />
<strong>of</strong> burden <strong>of</strong> disease, but <strong>the</strong>se are not “magic” numbers. <strong>The</strong> needed sample size and client<br />
volume in <strong>the</strong> assessment area may affect <strong>the</strong> number <strong>of</strong> sites selected per region or district.<br />
See modules.<br />
Qualitative Component<br />
Participants can be selected from <strong>the</strong> chosen health facility catchment areas or from a larger<br />
number <strong>of</strong> districts or regions, depending on <strong>the</strong> budget. If participants are chosen from a<br />
broader number <strong>of</strong> districts or regions, <strong>the</strong>y should be chosen in much <strong>the</strong> same way that<br />
districts or regions selected for <strong>the</strong> quantitative surveys have been chosen.<br />
Focus groups and individual interviews can be held in health facilities, homes, and community<br />
venues, depending on who is being interviewed.<br />
<strong>The</strong> Manual<br />
19
3.4.3 Sample Sizes<br />
Sample sizes for antenatal clinic and delivery unit surveys depend largely on point estimates<br />
<strong>of</strong> key indicators <strong>of</strong> burden and desired level <strong>of</strong> accuracy. Sample sizes recommended for<br />
o<strong>the</strong>r tools derive from experience conducting assessments. Modules 1 and 2 contain more<br />
information on how to calculate sample sizes for antenatal clinic and delivery unit surveys.<br />
Summary <strong>of</strong> Required Sample Sizes, by Tool<br />
<strong>Assessment</strong> Tool<br />
1. Antenatal clinic<br />
surveys<br />
2. Delivery unit<br />
surveys<br />
3. Hospital surveillance<br />
<strong>of</strong> malaria disease<br />
4. Antenatal clinic<br />
facility assessment<br />
<strong>Assessment</strong> Tool<br />
5. Health-care worker<br />
observation<br />
6. Focus groups<br />
and individual<br />
interviews with<br />
health-care workers<br />
7. Focus groups<br />
and individual<br />
interviews with<br />
midwives and<br />
traditional birth<br />
attendants<br />
8. Antenatal clinic<br />
client exit interview<br />
9. Focus groups<br />
and individual<br />
interviews with<br />
pregnant women<br />
10. Individual<br />
interviews with<br />
key informants<br />
Sample Size/Notes<br />
Sample size will depend on <strong>the</strong> coordinator’s estimate <strong>of</strong><br />
peripheral parasitemia and 3 rd trimester anemia, as well as <strong>the</strong><br />
margin <strong>of</strong> error <strong>the</strong> coordinator thinks acceptable. See Module 1<br />
for more detail.<br />
Sample size will depend on <strong>the</strong> coordinator’s estimate <strong>of</strong><br />
placental parasitemia and LBW, as well as <strong>the</strong> margin <strong>of</strong> error <strong>the</strong><br />
coordinator thinks acceptable. See Module 2 for more detail.<br />
All ill women admitted to <strong>the</strong> hospital during <strong>the</strong> time data are<br />
being collected during <strong>the</strong> antenatal clinic and delivery unit<br />
surveys.<br />
Each <strong>of</strong> <strong>the</strong> antenatal clinics selected for an antenatal clinic survey<br />
(and may be expanded if this sample is believed to be too small).<br />
Sample Size/Notes<br />
Observation <strong>of</strong> approximately 20-25 health-care worker/patient<br />
encounters per each antenatal clinic selected for an antenatal<br />
clinic survey.<br />
Individual interviews are preferable if timing is not an issue.<br />
Could interview as many health-care workers as feasible during<br />
<strong>the</strong> assessment period, probably no more than 5-10 per facility,<br />
but sometimes as few as 1-2 is all that is possible.<br />
At least one focus group with 5 to 15 participants per facility<br />
area. May wish to conduct interviews as well, depending on <strong>the</strong><br />
available pool <strong>of</strong> potential participants.<br />
Approximately 15 per site. Note: Women selected for interviews<br />
should be different from <strong>the</strong> women selected for <strong>the</strong> antenatal<br />
clinic surveys.<br />
At least one focus group with 5 to 15 participants per facility. Four<br />
to five individual interviews per facility.<br />
Individual interviews with 2-4 key informants per facility area.<br />
20 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
3.5 Adapting, Translating, and Preparing<br />
<strong>Assessment</strong> Materials<br />
Once <strong>the</strong> assessment teams have been formed, assessment instruments (questionnaires,<br />
information sheets/informed consent forms, observation forms, interview guides) and<br />
logbooks will need to be prepared. Each module in this packet contains sample survey<br />
materials, which will likely need to be tailored for use in <strong>the</strong> particular local context. For<br />
example, changes may need to be made to reflect <strong>the</strong> drugs and <strong>the</strong> drug trade names used in<br />
a particular country. Additional questions may need to be added to obtain o<strong>the</strong>r variables <strong>of</strong><br />
interest, for example, such socioeconomic and demographic variables as caste, ethnic group,<br />
or family income. One country may wish to exclude pregnant women younger than 15; o<strong>the</strong>rs<br />
may have no lower age limit.<br />
<strong>The</strong> materials should be reviewed, pretested, and adapted as much as possible prior to<br />
assessment training and <strong>the</strong>n again during <strong>the</strong> training sessions, at which time <strong>the</strong>y may<br />
require additional adjustment.<br />
Focus groups<br />
and individual<br />
interviews can<br />
be held in health<br />
facilities, homes,<br />
and community<br />
venues, depending<br />
on who is being<br />
interviewed.<br />
After <strong>the</strong> survey instruments are adapted, <strong>the</strong>y and <strong>the</strong> information sheet (or informed<br />
consent form if used) should be translated into <strong>the</strong> national language and <strong>the</strong> primary<br />
language spoken by women in <strong>the</strong> assessment area, if different. This initial translation<br />
should be followed by a back-translation (by individuals who did not produce <strong>the</strong> original<br />
translation) into <strong>the</strong> national language to check <strong>the</strong> accuracy <strong>of</strong> <strong>the</strong> translation.<br />
If <strong>the</strong> primary language is not a written language, it will be important to work to achieve<br />
correct, consistent phrasing <strong>of</strong> survey questions and information on <strong>the</strong> information sheet<br />
(or informed consent form). It is important to hold a discussion with all interviewers present<br />
to agree on phrasing and to give <strong>the</strong> interviewers an opportunity to practice. Each participant<br />
should still receive a copy <strong>of</strong> <strong>the</strong> information sheet.<br />
It is critical to maintain participants’ confidentiality according to <strong>the</strong> laws <strong>of</strong> <strong>the</strong> country or<br />
jurisdiction. If appropriate to <strong>the</strong> local situation, questionnaires can be designed with a tear<strong>of</strong>f<br />
identifier page, which can be removed once data entry and validation are complete. <strong>The</strong><br />
removal <strong>of</strong> <strong>the</strong> identifier page ensures that recorded data cannot be linked to <strong>the</strong> participant.<br />
3.6 Conducting <strong>Assessment</strong> Training<br />
Whe<strong>the</strong>r or not <strong>the</strong> qualitative and quantitative components are conducted simultaneously<br />
largely depends on <strong>the</strong> tools selected and <strong>the</strong> availability <strong>of</strong> assessment team members.<br />
In turn, <strong>the</strong> timing <strong>of</strong> <strong>the</strong>se components may help determine how and when training is<br />
conducted, although ideally training should be done within a few days before <strong>the</strong> start <strong>of</strong> <strong>the</strong><br />
assessment. Training <strong>of</strong> <strong>the</strong> teams can occur after <strong>the</strong> preassessment activities described in<br />
<strong>the</strong> previous section and will take approximately 4-5 days.<br />
If training for both will occur during <strong>the</strong> same time period, <strong>the</strong> quantitative and qualitative<br />
teams should meet <strong>the</strong> first day <strong>of</strong> <strong>the</strong> training session to receive an overview <strong>of</strong> <strong>the</strong> entire<br />
assessment. Some topics are relevant to both teams, including providing information/<br />
obtaining informed consent, general information on <strong>the</strong> effect <strong>of</strong> malaria infection during<br />
pregnancy, politics <strong>of</strong> and sensitivities to conducting an assessment in health-care facilities<br />
(if assessment staff is hired from outside <strong>the</strong> system), and approaching potential participants.<br />
<strong>The</strong> teams can <strong>the</strong>n separate to learn <strong>the</strong>ir specific tasks. <strong>The</strong> training period can also be used<br />
<strong>The</strong> Manual<br />
21
to ensure that <strong>the</strong> assessment tools are linguistically and culturally consistent. After this,<br />
ideally, <strong>the</strong> entire team should be brought back toge<strong>the</strong>r to review assessment timing, learn<br />
who will work at each facility, and review who will assume supervisory roles. Regardless <strong>of</strong><br />
when training is conducted, each team should understand what <strong>the</strong> o<strong>the</strong>r teams are doing, <strong>the</strong><br />
types <strong>of</strong> data that <strong>the</strong>y are ga<strong>the</strong>ring, and <strong>the</strong> methods <strong>the</strong>y are using. <strong>The</strong> entire team should<br />
be prepared to answer questions about <strong>the</strong> assessment as a whole.<br />
Quantitative Component<br />
During training, each question on <strong>the</strong> questionnaire should be reviewed, and team members<br />
should be given a chance to practice conducting <strong>the</strong> questionnaire with o<strong>the</strong>r team members<br />
and <strong>the</strong>n with clients in local antenatal clinics. Team members should become familiar<br />
with how to fill out logbooks. <strong>The</strong> coordinator should explain why an information sheet (or<br />
informed consent) is necessary (see 3.8).<br />
Training will also focus on ensuring that team members can perform <strong>the</strong> needed clinical<br />
procedures including collecting blood using fingersticks, preparing slides, and weighing a<br />
newborn. <strong>The</strong>y should practice <strong>the</strong>se skills in a working facility. Because women in <strong>the</strong> surveys<br />
should receive treatment according to national policy, if <strong>the</strong>y are found to be anemic or are<br />
suspected or confirmed to have malaria infection, interviewers should be prepared to ensure<br />
that women and neonates receive proper treatment. Laboratorians should be trained in how<br />
to read peripheral, placental, and umbilical cord blood films. See each module for additional<br />
information about training.<br />
Note: Because many countries may choose to conduct both an antenatal clinic and<br />
delivery unit survey and because it is more efficient to conduct training for <strong>the</strong>se two<br />
simultaneously, this manual describes combined training in Modules 1 and 2, which<br />
can be modified, if necessary.<br />
Qualitative Component<br />
During training, qualitative teams should focus on learning and practicing how to interview,<br />
as well as how to record notes during an interview. Ideally, several days should be allowed for<br />
training. <strong>The</strong> coordinator or facilitator should review <strong>the</strong> essential elements <strong>of</strong> interviewing,<br />
particularly recording (i.e., taking notes on) interviews. Recording individual interviews or<br />
focus groups, while not difficult, must be done well, as it determines <strong>the</strong> quality <strong>of</strong> <strong>the</strong> data.<br />
Team members should be observed role playing and giving mock interviews with people who<br />
are not members <strong>of</strong> <strong>the</strong> assessment teams. Teams can <strong>of</strong>ten practice in local clinics where<br />
<strong>the</strong> assessment will not be conducted to assess <strong>the</strong> individual team members’ strengths and<br />
weaknesses. Practice might show that one person is a better focus group facilitator than an<br />
interviewer, for example. Team members’ positions should closely match <strong>the</strong>ir strengths.<br />
Consult <strong>the</strong> Sample Interviewer Training Manual in Resource 2 for additional information<br />
about training.<br />
22 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
3.7 Assuring <strong>Assessment</strong> Quality<br />
A quality assurance mechanism for data collection, transport, and storage should be<br />
established to ensure that data are <strong>of</strong> high quality. To oversee quality control, a supervisory<br />
system should be in place that ensures that questions, concerns, and technical issues are<br />
addressed in a timely manner.<br />
Quantitative Component<br />
<strong>The</strong> site supervisor (one per team) is responsible for <strong>the</strong> following:<br />
• Reviewing all questionnaires, enrollment, laboratory, and treatment logbooks<br />
(and written consent forms, if used) each day for accuracy and completeness<br />
• Maintaining a daily logbook that shows <strong>the</strong> identification (ID) numbers <strong>of</strong> <strong>the</strong><br />
interviews that were completed during that day, in which facility <strong>the</strong>y were<br />
completed, date <strong>of</strong> interview, and name <strong>of</strong> interviewer<br />
• Ensuring that each consecutive page <strong>of</strong> <strong>the</strong> interview has an ID number in case<br />
<strong>the</strong> pages become separated<br />
• Giving feedback to interviewers regarding accuracy and completeness <strong>of</strong><br />
questionnaires and logbooks<br />
• Discussing issues and concerns and developing solutions (e.g., completeness<br />
<strong>of</strong> logbooks, inconsistent completion <strong>of</strong> questionnaires, patient flow, lack <strong>of</strong> supplies,<br />
equipment failures)<br />
To oversee<br />
quality control, a<br />
supervisory system<br />
should be in place<br />
that ensures<br />
that questions,<br />
concerns, and<br />
technical issues<br />
are addressed in a<br />
timely manner.<br />
<strong>The</strong> laboratory component supervisor is responsible for:<br />
<br />
<br />
• Ensuring that adequate reagents and o<strong>the</strong>r needed materials are available<br />
• Reviewing laboratory logbooks and ensuring that <strong>the</strong>y are accurate and complete<br />
• Reread a sample (for example, 10%) <strong>of</strong> all assessment blood films weekly for<br />
accurate diagnosis<br />
• Evaluating quality <strong>of</strong> slides (both blood film preparation and staining), and<br />
providing technical support when needed for slide reading<br />
<strong>The</strong> assessment coordinator also plays an important role in ensuring <strong>the</strong> quality <strong>of</strong> <strong>the</strong> entire<br />
rapid assessment by:<br />
<br />
<br />
<br />
• Making at least weekly visits to review all logbooks and questionnaires from all<br />
assessment teams and giving feedback to site supervisors and <strong>the</strong> microscopy<br />
supervisor as appropriate. <strong>The</strong> coordinator should transport completed forms and<br />
blood films to a secure central location on a weekly basis.<br />
• Establishing a mechanism to distribute and re-stock assessment supplies. During<br />
<strong>the</strong> assessment start-up, <strong>the</strong> assessment coordinator is responsible for assuring<br />
that each assessment site has adequate equipment and supplies for at least 2 weeks<br />
<strong>of</strong> data collection. During <strong>the</strong> assessment, site supervisors are responsible for<br />
inventory <strong>of</strong> all supplies and equipment throughout <strong>the</strong> assessment period at each<br />
assessment site to assure that data collection is not interrupted.<br />
• Ensuring that adequate copies <strong>of</strong> antenatal clinic and delivery unit questionnaires<br />
are available at each assessment site. During <strong>the</strong> assessment start-up, <strong>the</strong><br />
assessment coordinator is responsible for assuring that each assessment site has<br />
adequate copies <strong>of</strong> antenatal clinic and delivery unit questionnaires and informed<br />
consent forms (or information sheets) for at least 2 weeks <strong>of</strong> data collection. During<br />
<strong>the</strong> assessment, site supervisors are responsible for inventory <strong>of</strong> questionnaires<br />
throughout <strong>the</strong> assessment period and at each assessment site to assure that data<br />
collection is not interrupted.<br />
• Ensuring adequate numbers <strong>of</strong> focus group and interview guides are available.<br />
• Ensuring participant confidentiality.<br />
<strong>The</strong> Manual<br />
23
Qualitative Component<br />
<strong>The</strong> coordinator for <strong>the</strong> qualitative part <strong>of</strong> <strong>the</strong> assessment (individual and focus group<br />
interviews), if different from <strong>the</strong> overall assessment coordinator, has primary responsibility<br />
for that portion <strong>of</strong> <strong>the</strong> assessment but should work closely with <strong>the</strong> overall assessment<br />
coordinator.<br />
<strong>The</strong> qualitative assessment coordinator is responsible for<br />
<br />
<br />
<br />
• Observing groups and interviews periodically to ensure that <strong>the</strong> facilitators and<br />
interviewers are using proper technique, e.g., that <strong>the</strong>y are using questions in <strong>the</strong><br />
guide but adapting <strong>the</strong>m as necessary in order to elicit <strong>the</strong> intended responses<br />
• Reviewing all recorded interviews for completeness and accuracy <strong>of</strong> recording<br />
• Ensuring accurate and consistent use <strong>of</strong> traditional terms for illnesses, symptoms,<br />
and prevention and treatment strategies, including usage and spelling.<br />
• Ensuring that <strong>the</strong> needed information is being obtained by reviewing recorded<br />
interviews and focus group notes and adjusting (e.g., adding new questions, making<br />
questions more specific) <strong>the</strong> interview/focus group guides accordingly.<br />
At <strong>the</strong> end <strong>of</strong> <strong>the</strong> interview before <strong>the</strong> respondent leaves, qualitative interviewers who also<br />
serve as recorders should examine <strong>the</strong>ir data to make sure <strong>the</strong> information is understandable.<br />
During training, <strong>the</strong>y can learn to use standard abbreviations to help <strong>the</strong>m record quickly. In<br />
addition, <strong>the</strong>y can use symbols (such as an asterisk in <strong>the</strong> column) to alert <strong>the</strong>m to a question<br />
that <strong>the</strong>y might have for <strong>the</strong> end <strong>of</strong> <strong>the</strong> interview. <strong>The</strong> interviewers should be trained to look<br />
for such symbols and to ask <strong>the</strong> respondent for clarification. Once <strong>the</strong> respondent leaves, <strong>the</strong><br />
interviewer should again review <strong>the</strong> interview, spelling out abbreviations and making sure <strong>the</strong><br />
handwriting is legible. If both an interviewer and recorder are involved in <strong>the</strong> interview, both<br />
need to review <strong>the</strong> data toge<strong>the</strong>r.<br />
Supervisors should also check interviews at <strong>the</strong> end <strong>of</strong> <strong>the</strong> day, as well as hold a “debriefing.”<br />
A debriefing helps determine: 1) whe<strong>the</strong>r <strong>the</strong> questions are adequate to obtain <strong>the</strong> needed<br />
data (qualitative methods are iterative; thus, questions can be changed as needed during<br />
<strong>the</strong> assessment), 2) whe<strong>the</strong>r people have understood <strong>the</strong> question (for example: is <strong>the</strong><br />
misunderstanding a sentence structure, content, or a translation problem?), 3) whe<strong>the</strong>r data<br />
are similar across facilities or show wide variability, which might require adding questions<br />
to understand <strong>the</strong> variability, and 4) whe<strong>the</strong>r expressions in <strong>the</strong> local language are being<br />
translated appropriately. <strong>The</strong> debriefing should be led by <strong>the</strong> coordinator or ano<strong>the</strong>r facilitator.<br />
<strong>The</strong> team listens to what each interviewer has learned, identifies what is common or different,<br />
and mutually agrees on what local expressions mean (particularly important when <strong>the</strong> team<br />
is trying to understand local beliefs about malaria and/or drugs during pregnancy). During<br />
<strong>the</strong> debriefings, <strong>the</strong> coordinator or facilitator should keep notes on <strong>the</strong> outcomes <strong>of</strong> each<br />
debriefing, explanations for trends seen in <strong>the</strong> data, and local language terms, as well as <strong>the</strong><br />
agreed-upon translations.<br />
<strong>The</strong> supervisor should ensure that each consecutive page <strong>of</strong> <strong>the</strong> interview has an ID number in<br />
case <strong>the</strong> pages become separated. <strong>The</strong> supervisor should also have a logbook for each day that<br />
shows <strong>the</strong> ID numbers <strong>of</strong> <strong>the</strong> interviews that were completed during that day, in which facility<br />
<strong>the</strong>y were completed, date <strong>of</strong> interview, and name <strong>of</strong> interviewer.<br />
24 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
3.8 Providing Information about <strong>the</strong> Survey<br />
and Obtaining Informed Consent<br />
Each country’s human subjects requirements should be followed in <strong>the</strong> conduct <strong>of</strong> <strong>the</strong> rapid<br />
assessment. Some countries may require that a participant give informed consent and sign a<br />
form; o<strong>the</strong>rs may require that each prospective participant simply be given information. <strong>The</strong><br />
assessment described here is usually classified as program evaluation ra<strong>the</strong>r than research<br />
and as such, may not require formal institutional review board (IRB) or ethics committee<br />
review. However, depending on <strong>the</strong> modifications to <strong>the</strong> assessment tools and local rules<br />
and regulations, <strong>the</strong> assessment may require such formal IRB or ethics committee review<br />
and approval. Generally, if blood will be collected and stored or kept longer than <strong>the</strong> local<br />
guidelines suggest, documentation <strong>of</strong> informed consent will probably be required.<br />
Each country’s<br />
human subjects<br />
requirements<br />
should be followed<br />
in <strong>the</strong> conduct<br />
<strong>of</strong> <strong>the</strong> rapid<br />
assessment.<br />
If it is decided that participants should be given an information sheet, it should be written in<br />
<strong>the</strong>ir primary language and include <strong>the</strong> following information, if applicable:<br />
• Purpose<br />
• Procedures<br />
• Alternatives to participation<br />
• Risks and discomforts<br />
• Potential benefits<br />
• Provisions <strong>of</strong> confidentiality<br />
• Voluntary participation and right to discontinue without penalty<br />
• Contacts for questions/additional information<br />
• Any o<strong>the</strong>r relevant information (e.g., who is conducting <strong>the</strong> survey, how many people<br />
will participate)<br />
If <strong>the</strong> participants cannot read or <strong>the</strong>y have low literacy skills, <strong>the</strong> information on <strong>the</strong> sheet<br />
can be read to <strong>the</strong>m. <strong>The</strong> sheet would <strong>the</strong>n serve as a script for <strong>the</strong> interviewer. In ei<strong>the</strong>r<br />
case, <strong>the</strong> participants should be given a copy. If true informed consent is being obtained, <strong>the</strong>n<br />
<strong>the</strong>re should be a witness present for those persons who cannot sign and whose consent to<br />
participate will be documented with a thumb print. Both <strong>the</strong> copy retained and <strong>the</strong> copy given<br />
to <strong>the</strong> participant should be signed. <strong>The</strong> supervisors should keep a record <strong>of</strong> <strong>the</strong> number <strong>of</strong><br />
refusals and <strong>the</strong> reasons for refusal. For example, <strong>of</strong>ten <strong>the</strong> women in antenatal clinic do not<br />
want to participate in an interview because it would extend <strong>the</strong> length <strong>of</strong> <strong>the</strong>ir visit.<br />
3.9 Providing Treatment for <strong>Malaria</strong> and Anemia<br />
In addition to ga<strong>the</strong>ring information about a pregnant woman’s experience and practices with<br />
regard to malaria, <strong>the</strong> antenatal clinic survey will also ga<strong>the</strong>r information on <strong>the</strong> proportion<br />
<strong>of</strong> women with anemia and malaria. Blood slides for women who are currently or recently<br />
(as defined by country guidelines, e.g., within <strong>the</strong> previous 7 days) febrile should be read<br />
promptly. Ideally, such slides would be read <strong>the</strong> same day. <strong>The</strong>se women should wait to receive<br />
<strong>the</strong>ir blood results before leaving clinic that day. If <strong>the</strong> slides are positive, <strong>the</strong>y should receive<br />
treatment with <strong>the</strong> appropriate antimalarial drug, according to national policy. If women are<br />
found to be anemic, <strong>the</strong>y should also receive appropriate treatment, according to national<br />
policy. If it is determined that a neonate has malaria infection, that neonate should also be<br />
treated as outlined in national policy.<br />
<strong>The</strong> Manual<br />
25
4. Data Management and Analysis<br />
This chapter is devoted to <strong>the</strong> management and analysis <strong>of</strong> data ga<strong>the</strong>red from <strong>the</strong><br />
assessment; individual modules contain fur<strong>the</strong>r guidance.<br />
4.1 Data Management<br />
Quantitative Component<br />
A statistical computer package should be used to enter and analyze <strong>the</strong> quantitative data from<br />
<strong>the</strong> assessment. Epi Info is available free <strong>of</strong> charge and has been included in this package<br />
(Resource 4). It is also available from <strong>the</strong> U.S. Centers for Disease Control and Prevention<br />
(CDC) Web site (www.cdc.gov/epiinfo). O<strong>the</strong>r packages such as SAS or SPSS may also be used,<br />
although <strong>the</strong>y are not available free; thus, <strong>the</strong>ir cost should be included in <strong>the</strong> budget for <strong>the</strong><br />
assessment.<br />
Ideally two computers should be available for data entry. Since all data should be entered<br />
twice to ensure accuracy, two computers could speed <strong>the</strong> process by allowing simultaneous<br />
entry.<br />
Before <strong>the</strong> rapid assessment begins, <strong>the</strong> assessment coordinator should identify a data<br />
management coordinator with experience in using statistical computer s<strong>of</strong>tware and<br />
managing data entry and analysis activities (see 3.3). Possible candidates for this position<br />
include<br />
• <strong>Assessment</strong> coordinator<br />
• Local program data manager or o<strong>the</strong>r local program staff<br />
• National-level program staff<br />
• Outside consultant, if necessary (one <strong>of</strong> <strong>the</strong> intended outcomes <strong>of</strong> <strong>the</strong> assessment is to<br />
develop national capacity; <strong>the</strong>refore, use <strong>of</strong> an outside consultant is not ideal).<br />
Step 1: Modify (or create) data entry programs<br />
Epi Info can be used to create data entry files for <strong>the</strong> assessment instruments. Epi Info’s<br />
data entry files consist <strong>of</strong> questionnaire (.QES), checking (.CHK), and record (.REC) files. <strong>The</strong><br />
checking file (.CHK) should specify valid (allowed) variables for each question as well as skip<br />
patterns, which could be defined as sequences <strong>of</strong> questions asked and omitted in a survey<br />
instrument.<br />
Note: Data entry files for Tools 1, 2, and 3 are included in this package in Resource 4. <strong>The</strong>y<br />
should be modified to reflect any changes made to <strong>the</strong> surveys that reflect <strong>the</strong> local situation<br />
or concerns. <strong>The</strong>se Micros<strong>of</strong>t Access–based .MDB files contain essentially all information that<br />
would be contained in <strong>the</strong> .QES, CHK, and .REC files mentioned in <strong>the</strong> next paragraph and can<br />
be opened by Epi Info 2000 and higher.<br />
26 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Step 2: Test programs<br />
<strong>The</strong> assessment coordinator should test <strong>the</strong> data entry files for each questionnaire by entering<br />
data from pilot or initial questionnaires. Each file should be tested several times and reviewed<br />
to ensure that <strong>the</strong> data entry files are working correctly.<br />
Step 3: Identify and train data management staff<br />
It is recommended that two people be identified to enter data and trained by <strong>the</strong> assessment<br />
coordinator or data manager; <strong>the</strong> training should not take more than a few hours.<br />
Step 4: Enter and store data<br />
It is critical<br />
to maintain<br />
participants’<br />
confidentiality<br />
according to <strong>the</strong><br />
laws <strong>of</strong> <strong>the</strong><br />
country/<br />
jurisdiction.<br />
Data can be entered throughout <strong>the</strong> data collection period or all at once at <strong>the</strong> end <strong>of</strong> data<br />
collection. It is strongly recommended that data be entered throughout <strong>the</strong> time data are being<br />
collected. During <strong>the</strong> process <strong>of</strong> data entry, problems in questionnaire design or completion can<br />
be revealed and corrected. <strong>The</strong> assessment coordinator is responsible for determining which<br />
method is best suited to <strong>the</strong> setting.<br />
<strong>The</strong> following suggestions may help improve <strong>the</strong> process <strong>of</strong> data entry:<br />
• Find an appropriate pace for data entry. If data entry is attempted too quickly, errors<br />
are more likely to occur.<br />
• Enter data from all questionnaires <strong>of</strong> one type sequentially (e.g., all antenatal clinic<br />
questionnaires).<br />
• If Epi Info6 is used, <strong>the</strong> program will assign a record number. Write that number on<br />
<strong>the</strong> questionnaire.<br />
• Mark each questionnaire with a check or cross after data entry <strong>of</strong> questionnaire<br />
information to indicate that data entry has been completed. Make sure that after <strong>the</strong><br />
data are double entered, <strong>the</strong> questionnaires have two checks or crosses.<br />
• Encourage data entry clerks to mark items that appear erroneous with a<br />
“post-it” note. Data entry clerks <strong>of</strong>ten uncover logical errors in questionnaire design<br />
which can be corrected early on. However, data clerks should be encouraged to note<br />
errors or problems <strong>the</strong>y encounter throughout data entry<br />
and notify <strong>the</strong> assessment coordinator.<br />
• Back up all data files regularly on a diskette or o<strong>the</strong>r storage device such as a zip<br />
disk or flash card, both during data entry and at <strong>the</strong> end <strong>of</strong> <strong>the</strong> day.<br />
• File questionnaires by type <strong>of</strong> questionnaire and enrollee’s number.<br />
To ensure that all data have been entered accurately, <strong>the</strong> data management coordinator<br />
(or assessment coordinator) should<br />
• Run <strong>the</strong> data validation program in Epi Info to uncover possible data entry<br />
errors. This needs to be done at <strong>the</strong> end <strong>of</strong> data entry. Note that questionnaires will<br />
need to be available for review during <strong>the</strong> validation process in order to reconcile<br />
discrepancies.<br />
• If .REC files are used, review <strong>the</strong> file for each questionnaire by running frequencies<br />
for each variable, identifying inconsistencies, and investigating possible errors (and<br />
<strong>the</strong>n correcting <strong>the</strong> data file based on <strong>the</strong> hard copies <strong>of</strong> <strong>the</strong> questionnaires). This is<br />
best done at <strong>the</strong> end <strong>of</strong> data entry.<br />
• Supervise data entry and periodically check quality <strong>of</strong> data entry by randomly<br />
selecting questionnaires for review.<br />
<strong>The</strong> Manual<br />
27
To store data safely<br />
• Store questionnaires (and backed-up data files) in a locked cabinet available only<br />
to <strong>the</strong> assessment coordinator and data management team to ensure participants’<br />
confidentiality.<br />
• If <strong>the</strong> questionnaire was designed with a tear-<strong>of</strong>f identifier page, <strong>the</strong> page with<br />
information identifying <strong>the</strong> participant should be removed once data entry and<br />
validation are complete.<br />
It is critical to maintain participants’ confidentiality according to <strong>the</strong> laws <strong>of</strong> <strong>the</strong><br />
country/jurisdiction.<br />
Qualitative Component<br />
Some decisions about <strong>the</strong> management <strong>of</strong> qualitative data will need to be made.<br />
• Will <strong>the</strong> interviews be tape recorded?<br />
• Will <strong>the</strong> recorders’ field notes be expanded to a full transcript <strong>of</strong> <strong>the</strong> interviews?<br />
• Will <strong>the</strong> qualitative data be entered into a computer for analysis?<br />
• What types <strong>of</strong> s<strong>of</strong>tware are likely to be useful?<br />
<strong>The</strong> assessment team may consider at least three approaches for managing data collected<br />
from individual and focus group interviews. All have implications for <strong>the</strong> personnel and<br />
s<strong>of</strong>tware needed to manage and analyze <strong>the</strong> data. Choosing between <strong>the</strong> options will<br />
involve a trade-<strong>of</strong>f for <strong>the</strong> level <strong>of</strong> detail.<br />
• <strong>The</strong> simplest approach is to record short open-ended responses directly on <strong>the</strong><br />
interview forms. <strong>The</strong> responses can later be grouped by hand or coded using<br />
relatively limited qualitative analysis s<strong>of</strong>tware such as CDC EZ - Text (http://www.<br />
cdc.gov/hiv/s<strong>of</strong>tware/ez-text.htm). This approach gleans <strong>the</strong> least detail but may<br />
be appropriate when experienced qualitative researchers and data collectors are not<br />
available.<br />
• A second approach would be to have <strong>the</strong> data recorders expand <strong>the</strong> notes taken<br />
during <strong>the</strong> interview into a structured report <strong>of</strong> <strong>the</strong> responses.<br />
• A third would be to tape record 5 <strong>the</strong> interview and <strong>the</strong>n have it transcribed word<br />
for word.<br />
Expanded field notes and interview transcripts can be managed by a more experienced<br />
qualitative researcher and will contain far more detail. However, data in <strong>the</strong>se formats will<br />
require much more time for coding and analysis. <strong>The</strong> analysis can be completed by hand, but<br />
when a large number <strong>of</strong> data are generated, s<strong>of</strong>tware products like NUDIST, <strong>the</strong> Ethnograph, or<br />
ATLAS.ti can be helpful.<br />
Choosing among <strong>the</strong>se approaches, or choosing ano<strong>the</strong>r alternative, should be left to <strong>the</strong><br />
individual responsible for coordinating and analyzing <strong>the</strong> qualitative data and needs to be<br />
decided prior to recruiting and training data collectors.<br />
5 Although tape recorders can capture everything that is said, <strong>the</strong> tape recorder may malfunction without its<br />
being realized, and all data will be lost. Transcribing a 1-hour tape takes 2-3 hours. In addition, if <strong>the</strong> interviews<br />
are held outdoors (which occurs in many facility and home interviews), <strong>the</strong> tape <strong>of</strong>ten picks up ambient<br />
noises, which obscure what is said. Focus groups interviews are difficult to listen to, as <strong>of</strong>ten, more than one<br />
person is speaking at a time. <strong>The</strong> cost <strong>of</strong> <strong>the</strong> tape recorders, tapes, and transcription also need to be considered.<br />
For <strong>the</strong>se reasons, it is <strong>of</strong>ten preferable to record <strong>the</strong> interviews and focus groups by hand.<br />
28 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
4.2 Data Analysis<br />
Quantitative Component<br />
<strong>The</strong> assessment coordinator should work with <strong>the</strong> assessment and data management teams<br />
to develop an analysis plan before <strong>the</strong> survey begins. This plan should include key indicators<br />
that will affect policy and program.<br />
For each quantitative tool included in <strong>the</strong> package, its respective module specifies outcome<br />
variables and samples <strong>of</strong> tables that are critical for analysis. Additional indicators could<br />
be selected and fur<strong>the</strong>r analyses could be done, but this may not be essential for action.<br />
Whatever indicators are selected, <strong>the</strong>re must be a plan for how that information can be used<br />
to affect <strong>the</strong> policy and program.<br />
Two months should be sufficient to enter and analyze data, write <strong>the</strong> report, and disseminate<br />
<strong>the</strong> results.<br />
A s<strong>of</strong>tware program can be used to run <strong>the</strong> analysis on quantitative data to determine<br />
• Point estimates <strong>of</strong> <strong>the</strong> proportion <strong>of</strong> women who have peripheral parasitemia, anemia,<br />
placental parasitemia, and LBW (as well as <strong>the</strong>ir 95% confidence intervals)<br />
• Estimated gravidity-specific parasitemia, anemia, and LBW rates<br />
• Frequencies <strong>of</strong> key variables collected from <strong>the</strong> facility assessment and<br />
antenatal clinic health-care worker observation.<br />
It is useful to generate a table summarizing basic sociodemographic variables. If <strong>the</strong><br />
assessment involves more than one site, it may be useful to present data by site, with one site<br />
per column. Alternatively, if sites are similar, data may be aggregated. Data from antenatal<br />
clinics and delivery units should be presented separately.<br />
It is also generally useful to analyze parasitemia, anemia, and LBW by gravidity, using <strong>the</strong>se<br />
categories: primigravidae, secundigravidae, and multigravidae.<br />
If <strong>the</strong>re is a functioning malaria prevention program, it may be useful to analyze <strong>the</strong> data<br />
by degree <strong>of</strong> self-reported adherence to <strong>the</strong> intervention (e.g., chemoprophylaxis or IPTp).<br />
Categories <strong>of</strong> adherence might be complete, incomplete, or none.<br />
Limitations<br />
<strong>The</strong> limitations <strong>of</strong> <strong>the</strong> antenatal clinic and delivery unit data will affect interpretation <strong>of</strong><br />
results. Both antenatal clinic and delivery unit surveys use a convenience sample, not a<br />
randomly selected sample. <strong>The</strong>refore, women attending antenatal clinics and delivering<br />
in delivery units are not completely representative <strong>of</strong> all pregnant women. In countries<br />
with high antenatal clinic coverage, <strong>the</strong> pregnant women surveyed are likely to be more<br />
representative <strong>of</strong> <strong>the</strong> general population <strong>of</strong> pregnant women. As is <strong>of</strong>ten <strong>the</strong> case, more<br />
women visit antenatal clinics during <strong>the</strong>ir pregnancies than deliver in facilities, and so women<br />
in <strong>the</strong> delivery units are usually less representative <strong>of</strong> all pregnant women. In countries with<br />
low coverage, a facility-based rapid assessment will not give a very accurate picture <strong>of</strong> <strong>the</strong><br />
burden <strong>of</strong> malaria in pregnancy nationwide.<br />
<strong>The</strong> Manual<br />
29
Qualitative Component<br />
Regardless <strong>of</strong> <strong>the</strong> approach used to record and manage data, analysis <strong>of</strong> qualitative data ideally<br />
begins at <strong>the</strong> start <strong>of</strong> data collection, and <strong>the</strong> supervisor should begin reviewing data as <strong>the</strong>y<br />
are collected in order to identify <strong>the</strong> need to expand or revise <strong>the</strong> interview/focus group<br />
guides to capture detail that might not have been anticipated. Daily debriefing sessions can<br />
be used to identify and track <strong>the</strong>mes as <strong>the</strong>y emerge. See 3.7 and Modules 6, 7, 9, and 10 for<br />
fur<strong>the</strong>r discussion <strong>of</strong> debriefing.<br />
Content analysis <strong>of</strong> completed qualitative data can be performed by hand or using one <strong>of</strong><br />
several s<strong>of</strong>tware tools (see 4.1). Usually one person or several will review all <strong>of</strong> <strong>the</strong> data and<br />
assign codes to <strong>the</strong> passages <strong>of</strong> text that contain each <strong>the</strong>me.<br />
Content analysis can be performed on qualitative data, with data aggregated into general<br />
<strong>the</strong>mes to reflect <strong>the</strong> consensus <strong>of</strong> <strong>the</strong> participants. For example, a question might focus on<br />
barriers to care. Responses might include “distance,” “need to farm,” “lack <strong>of</strong> money during<br />
planting season,” “bad relationships with health-care facility staff,” “no drugs available at<br />
<strong>the</strong> health-care facility,” “being mocked at <strong>the</strong> facility for being poor or not dressing well,”<br />
and “need to obtain permission from family.” <strong>The</strong>se responses could <strong>the</strong>n be grouped into<br />
higher level codes, for example those reflecting facility issues (lack <strong>of</strong> equipment/drugs, poor<br />
provider-patient relationships), financial concerns (need to maintain income, seasonal income<br />
sources), and statements about <strong>the</strong> locus <strong>of</strong> power within households (need permission). It is<br />
<strong>of</strong>ten <strong>the</strong> case that ideas for new codes will occur to researchers while <strong>the</strong> analysis is under<br />
way. <strong>The</strong> process <strong>of</strong> qualitative analysis can accommodate this by incorporating new ideas<br />
and codes as <strong>the</strong>y emerge. If more than one person is involved in coding text-based data, it is<br />
important that <strong>the</strong> coders apply a common approach and work toge<strong>the</strong>r closely to ensure that<br />
<strong>the</strong> codes are applied consistently and newly identified <strong>the</strong>mes are incorporated as <strong>the</strong>y are<br />
identified.<br />
Generally, qualitative findings are presented in terms <strong>of</strong> <strong>the</strong> most typical responses.<br />
Occasionally <strong>the</strong> statements <strong>of</strong> participants with exceptional views are useful as well. Direct<br />
quotes from participants can be a powerful way to illustrate <strong>the</strong> key <strong>the</strong>mes identified in<br />
qualitative studies. It is frequently helpful to quantify some qualitative data to indicate which<br />
<strong>the</strong>mes or opinions were stated most frequently. For example, responses to <strong>the</strong> question “If<br />
you are sick during pregnancy, from whom would you seek advice?” might include husband,<br />
traditional?? birth attendants, mo<strong>the</strong>rs-in-law, elders. Frequency counts can illustrate which<br />
categories were mentioned most <strong>of</strong>ten. Frequencies derived from qualitative data are purely<br />
illustrative and cannot be subjected to statistical tests. If a population-based frequency is<br />
desired (e.g., to compare care-seeking preferences across study sites or sub-populations),<br />
quantitative surveys are usually a more appropriate approach.<br />
30 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
5. Report Preparation and Use <strong>of</strong> Results<br />
Once data analysis is complete, a report should be promptly drafted, finalized, and<br />
disseminated to key stakeholders. It is important that <strong>the</strong> report reach <strong>the</strong> appropriate<br />
<strong>of</strong>ficials and decision makers in <strong>the</strong> areas <strong>of</strong> malaria and reproductive health so that <strong>the</strong><br />
findings <strong>of</strong> <strong>the</strong> rapid assessment can promptly be used for action. <strong>The</strong> presentation and use <strong>of</strong><br />
results greatly depend on <strong>the</strong> focus <strong>of</strong> <strong>the</strong> assessment. Communications about an assessment<br />
designed to determine <strong>the</strong> burden <strong>of</strong> malaria during pregnancy would probably be quite<br />
different from an assessment designed to determine program impact.<br />
Results <strong>of</strong> <strong>the</strong> assessment can be used to provide:<br />
► Information to guide decisions about whe<strong>the</strong>r to recommend IPTp<br />
Although <strong>the</strong>re is agreement that in areas <strong>of</strong> stable (or high) transmission, <strong>the</strong> control<br />
package for malaria in pregnancy should include IPTp, <strong>the</strong>re is less agreement about whe<strong>the</strong>r<br />
IPTp belongs in <strong>the</strong> control package in areas <strong>of</strong> unstable (or low) transmission or areas that<br />
are epidemic-prone.<br />
One commonly asked question is at (or above) what level <strong>of</strong> transmission IPTp should be<br />
recommended and at (or below) what level IPTp should not be recommended. To date, <strong>the</strong>re<br />
has not been a formal cost-effectiveness or cost-benefit analysis to guide policy in this regard,<br />
but several factors could be taken into account in decision-making:<br />
It is important<br />
that <strong>the</strong> report<br />
reach <strong>the</strong><br />
appropriate<br />
<strong>of</strong>ficials and<br />
decision makers<br />
in <strong>the</strong> areas <strong>of</strong><br />
malaria and<br />
reproductive<br />
health so that <strong>the</strong><br />
findings <strong>of</strong> <strong>the</strong><br />
rapid assessment<br />
can promptly be<br />
used for action.<br />
Prevalence <strong>of</strong> P. falciparum malaria parasitemia. Studies show that if malaria prevalence<br />
is high, IPTp will help prevent malaria’s ill effects on <strong>the</strong> health <strong>of</strong> pregnant women<br />
and babies, and a policy <strong>of</strong> IPTp should be recommended. However, <strong>the</strong>re have been no<br />
studies that have examined <strong>the</strong> effects <strong>of</strong> IPTp in areas <strong>of</strong> low or unstable transmission. If<br />
malaria prevalence is low and IPTp were recommended for all pregnant women, it would<br />
be given to many women who, because <strong>the</strong>y were not infected, would not benefit. As <strong>the</strong><br />
prevalence <strong>of</strong> parasitemia decreases, it becomes less compelling to recommend IPTp.<br />
For example, consistent use <strong>of</strong> IPTp has been shown to bring prevalence rates down<br />
to about 5% – 10% in <strong>the</strong> high and moderate transmission areas where studies have<br />
been conducted. One might <strong>the</strong>n argue that a cut-<strong>of</strong>f prevalence <strong>of</strong> 10% could be used.<br />
However, if <strong>the</strong> prevalence rate was 10% and all women were given IPTp, 90% would<br />
receive a drug <strong>the</strong>y did not need. <strong>The</strong> malaria community needs to address what cut-<strong>of</strong>f<br />
to recommend in areas <strong>of</strong> low prevalence.<br />
<strong>The</strong> Manual<br />
31
Effect <strong>of</strong> malaria parasitemia: A rapid assessment conducted in Ethiopia found that<br />
women in low or unstable or epidemic-prone areas had relatively low rates <strong>of</strong> peripheral<br />
parasitemia (1.8%) and low rates <strong>of</strong> placental parasitemia (2.5%), but that placental<br />
parasitemia was associated with prematurity and a 7-fold increased risk <strong>of</strong> stillbirths.<br />
<strong>The</strong>se findings suggested that routine use <strong>of</strong> IPTp may be inappropriate given <strong>the</strong> low<br />
prevalence <strong>of</strong> peripheral and placental parasitemia, but given <strong>the</strong> strong association<br />
with adverse outcomes, malaria had <strong>the</strong> potential to contribute substantially to <strong>the</strong><br />
population-attributable risk <strong>of</strong> <strong>the</strong>se adverse outcomes if disease prevalence increased,<br />
for example, during an epidemic. In this situation, <strong>the</strong> researchers concluded that <strong>the</strong><br />
situation should be evaluated during an epidemic to examine prevention and intervention<br />
opportunities [20].<br />
Presence <strong>of</strong> symptomatic malaria: In areas <strong>of</strong> high transmission, pregnant women<br />
who become infected are generally assumed not to have symptoms because <strong>the</strong>y have<br />
developed some level <strong>of</strong> immunity, even though this immunity is somewhat compromised<br />
by pregnancy. Despite being asymptomatic, <strong>the</strong>se women and <strong>the</strong>ir babies can still<br />
be adversely affected by <strong>the</strong> infection. <strong>The</strong>refore, IPTp was developed as a preventive<br />
intervention to be given to all women. In areas <strong>of</strong> low transmission or epidemic-prone<br />
areas, pregnant women have little or no immunity and may experience symptoms <strong>of</strong><br />
malaria infection and become ill. In <strong>the</strong>se areas, IPTp would not necessarily keep a<br />
woman parasite-free throughout gestation and thus women could still become very ill,<br />
causing harm to <strong>the</strong>mselves and <strong>the</strong>ir infants. <strong>The</strong>refore, in areas <strong>of</strong> lower transmission<br />
where women may develop severe malaria during pregnancy, IPTp will not prevent<br />
severe disease, and prompt and effective case management is still critical. In <strong>the</strong>se<br />
settings, <strong>the</strong> role <strong>of</strong> case management based on proactive screening for malaria infection<br />
<strong>of</strong> women attending ANC, compared to preventive approaches with IPTp or ITNs remains<br />
to be established.<br />
► Advocacy for policy development and change. <strong>The</strong> information ga<strong>the</strong>red can<br />
also be used to advocate for resources to change or implement a new policy<br />
► Suggestions for improving ANC attendance. <strong>The</strong> assessment may discover multiple barriers<br />
to women’s decisions to attend an antenatal clinic during pregnancy. To address this, more<br />
effective information, education, and communication (IEC) campaigns need to be planned<br />
and conducted, or structural factors, such as price <strong>of</strong> care, may need to be addressed.<br />
► Suggestions for improving service delivery. Results may indicate, for example, that more<br />
focused health-care worker training needs to be provided or that adequate supplies <strong>of</strong><br />
medications and ITNs need to be made accessible and affordable.<br />
► A snapshot <strong>of</strong> <strong>the</strong> impact <strong>of</strong> current interventions. <strong>The</strong> country may never have evaluated<br />
its policy and program, or an evaluation may not have been done recently. <strong>The</strong>refore, a<br />
rapid assessment may point to <strong>the</strong> need for routinely <strong>of</strong>fering a different intervention. For<br />
example, a rapid assessment in Burkina Faso showed that high coverage with chloroquine<br />
chemoprophylaxis (as opposed to IPTp) did not decrease <strong>the</strong> adverse effects <strong>of</strong> malaria<br />
during pregnancy and that IPTp was needed.<br />
► Directions for fur<strong>the</strong>r study. A rapid assessment may have equivocal findings. For example,<br />
a rapid assessment conducted in Ethiopia found that women in low or unstable or<br />
epidemic-prone areas had relatively low rates <strong>of</strong> peripheral parasitemia (1.8%) and low<br />
rates <strong>of</strong> placental parasitemia (2.5%), but that placental parasitemia was associated with<br />
prematurity and a 7-fold increased risk <strong>of</strong> stillbirths. <strong>The</strong>se findings suggested that routine<br />
use <strong>of</strong> IPTp may be inappropriate given <strong>the</strong> low prevalence <strong>of</strong> peripheral and placental<br />
parasitemia, but given <strong>the</strong> association with adverse outcomes, <strong>the</strong> magnitude <strong>of</strong> <strong>the</strong><br />
burden <strong>of</strong> malaria during pregnancy should be evaluated during an epidemic to examine<br />
prevention and intervention opportunities.<br />
32 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
References<br />
1. Desai, M., et al., Epidemiology and burden <strong>of</strong> malaria in pregnancy. Lancet Infect Dis,<br />
2007. 7(2): p. 93-104.<br />
2. WHO, A Strategic Framework for <strong>Malaria</strong> Prevention and Control During Pregnancy in<br />
<strong>the</strong> African Region. 2004, Brazzaville: WHO Regional Office for Africa.<br />
3. Steketee, R.W., et al., <strong>The</strong> burden <strong>of</strong> malaria in pregnancy in malaria-endemic areas.<br />
American Journal <strong>of</strong> Tropical Medicine & Hygiene, 2001. 64(1-2 Suppl): p. 28-35.<br />
4. Brabin, B., An assessment <strong>of</strong> low birthweight risk in primiparae as an indicator <strong>of</strong><br />
malaria control in pregnancy. International Journal <strong>of</strong> Epidemiology, 1991. 20(1):<br />
p. 276-83.<br />
5. Jelliffe, E.F., Low birth-weight and malarial infection <strong>of</strong> <strong>the</strong> placenta. Bulletin <strong>of</strong> <strong>the</strong><br />
World Health Organization, 1968. 38(1): p. 69-78.<br />
6. McGregor, I.A., M.E. Wilson, and W.Z. Billewicz, <strong>Malaria</strong> infection <strong>of</strong> <strong>the</strong> placenta in<br />
<strong>The</strong> Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and<br />
placental weight. Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene,<br />
1983. 77(2): p. 232-44.<br />
7. Menendez, C., <strong>Malaria</strong> during pregnancy: a priority area <strong>of</strong> malaria research and<br />
control. Parasitology Today, 1995. 11(5): p. 178-183.<br />
8. Steketee, R.W., et al., <strong>The</strong> problem <strong>of</strong> malaria and malaria control in pregnancy in<br />
sub-Saharan Africa. American Journal <strong>of</strong> Tropical Medicine & Hygiene, 1996. 55<br />
(1 Suppl): p. 2-7.<br />
9. Guyatt, H.L. and R.W. Snow, <strong>The</strong> epidemiology and burden <strong>of</strong> Plasmodium falciparumrelated<br />
anemia among pregnant women in sub-Saharan Africa. American Journal <strong>of</strong><br />
Tropical Medicine & Hygiene, 2001. 64(1-2 Suppl): p. 36-44.<br />
10. Bloland, P., et al., Rates and risk factors for mortality during <strong>the</strong> first two years <strong>of</strong> life in<br />
rural Malawi. American Journal <strong>of</strong> Tropical Medicine & Hygiene, 1996. 55<br />
(1 Suppl): p. 82-6.<br />
11. McCormick, M.C., <strong>The</strong> contribution <strong>of</strong> low birth weight to infant mortality and<br />
childhood morbidity. New England Journal <strong>of</strong> Medicine, 1985. 312(2): p. 82-90.<br />
12. Kramer, M.S., Determinants <strong>of</strong> low birth weight: methodological assessment and metaanalysis.<br />
Bulletin <strong>of</strong> <strong>the</strong> World Health Organization, 1987. 65(5): p. 663-737.<br />
13. Steketee, R.W., J.J. Wirima, and C.C. Campbell, Developing effective strategies for<br />
malaria prevention programs for pregnant African women. American Journal <strong>of</strong><br />
Tropical Medicine & Hygiene, 1996. 55(1): p. 95-100.<br />
14. Guyatt, H. and R.W. Snow, Impact <strong>of</strong> malaria during pregnancy on low birth weight in<br />
sub-Saharan Africa. Clin Microbiol Rev, 2004(17): p. 760-9.<br />
15. Brabin, B.J., M. Hakimi, and D. Pelletier, An analysis <strong>of</strong> anemia and pregnancy-related<br />
maternal mortality. Journal <strong>of</strong> Nutrition, 2001. 131(2S-2): p. 604S-614S; discussion<br />
614S-615S.<br />
16. Memórias do Instituto Oswaldo Cruz. Volume 99, Issue 1: p. 19-21<br />
17. Nosten, F., et al., Effects <strong>of</strong> Plasmodium vivax malaria in pregnancy. Lancet, 1999.<br />
354(9178): p. 546-9.<br />
18. McGready, R., et al., <strong>The</strong> effects <strong>of</strong> Plasmodium falciparum and P. vivax infections on<br />
placental histopathology in an area <strong>of</strong> low malaria transmission. Am J Trop Med Hyg,<br />
2004. 70(4): p. 398-407.<br />
19. ter Kuile, F.O., et al., <strong>The</strong> burden <strong>of</strong> co-infection with human immunodeficiency virus<br />
type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg,<br />
2004. 71(2 Suppl): p. 41-54.<br />
20. Newman, R.D., et al., <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy in Areas <strong>of</strong> Stable and<br />
Unstable Transmission in Ethiopia during a Nonepidemic Year. J Infect Dis, 2003.<br />
187(11): p. 1765-72.<br />
<strong>The</strong> Manual<br />
33
Glossary<br />
Anemia and severe anemia: Conditions in which hemoglobin is less than 11 and 7 grams/<br />
deciliter, respectively.<br />
Case management refers to treatment <strong>of</strong> malaria illness. Case management requires<br />
proper diagnosis and prompt access to antimalarial drugs to treat <strong>the</strong> illness.<br />
Chemoprophylaxis: <strong>The</strong> prevention <strong>of</strong> an infectious disease by <strong>the</strong> use <strong>of</strong> chemical agents at<br />
sub<strong>the</strong>rapeutic doses. Weekly chemoprophylaxis is no longer recommended as <strong>the</strong> preferred<br />
malaria prevention strategy for pregnant women in areas <strong>of</strong> stable (high) P. falciparum<br />
transmission.<br />
Fetal loss: Expulsion or delivery <strong>of</strong> a fetus without evidence <strong>of</strong> cardiac or respiratory effort,<br />
regardless <strong>of</strong> number <strong>of</strong> weeks’ gestation.<br />
Fever: An axillary temperature >37.5 o C.<br />
Insecticide-treated mosquito net (ITN): Mosquito nets treated with an effective insecticide<br />
to repel or kill mosquitoes.<br />
Intermittent preventive treatment (IPT): <strong>The</strong> administration <strong>of</strong> full, curative treatment<br />
doses <strong>of</strong> an effective antimalarial drug during pregnancy in order to reduce placental malaria<br />
infection, low birth weight babies, and maternal anemia. WHO no longer recommends weekly<br />
chemoprophylaxis (administration <strong>of</strong> an antimalarial drug in sub<strong>the</strong>rapeutic doses) for several<br />
reasons, including poor adherence with a weekly or daily regimen and increasing resistance to<br />
<strong>the</strong> most popular antimalarial drug used in chemoprophylaxis, chloroquine.<br />
Low birth weight: Infants weighing less than 2,500 grams at birth.<br />
<strong>Malaria</strong> infection: A woman or baby is considered to have a malaria infection if any asexual<br />
blood stage parasites are seen on a thick blood smear.<br />
Neonatal death: Death <strong>of</strong> a live-born infant during <strong>the</strong> first 28 days <strong>of</strong> life.<br />
Parasitemia (in peripheral, placental, or umbilical cord blood): A condition in which <strong>the</strong><br />
blood contains asexual stage malaria parasites.<br />
Premature: Assessed as less than 37 weeks gestation at birth by <strong>the</strong><br />
Ballard examination.<br />
Small-for-gestational-age (SGA) newborn: Weight for gestational age at birth can be<br />
used to categorize infants as having normal or subnormal growth in utero. A newborn can<br />
be considered small for gestational age if <strong>the</strong> birth weight is less than <strong>the</strong> 10 th percentile <strong>of</strong><br />
weight for gestational age. However, for most rapid assessments, it is not necessary to make<br />
this determination. Note: Existing data on weight for gestational age are from industrialized<br />
countries.<br />
34 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Module 1: Conducting an Antenatal Clinic Survey<br />
An Antenatal Clinic (ANC) Survey is designed to determine <strong>the</strong><br />
magnitude <strong>of</strong> <strong>the</strong> burden <strong>of</strong> malaria during pregnancy, specifically:<br />
• What is <strong>the</strong> prevalence <strong>of</strong> peripheral parasitemia in<br />
pregnant women?<br />
• What is <strong>the</strong> prevalence <strong>of</strong> maternal anemia?<br />
• Does <strong>the</strong> prevalence <strong>of</strong> peripheral parasitemia vary by<br />
gravidity or locale?<br />
This module contains sample materials for an Antenatal Clinic Survey (and in some<br />
cases for <strong>the</strong> Delivery Unit Survey also). <strong>The</strong>se materials can and should be adapted<br />
to suit local needs. General guidance for conducting an Antenatal Clinic Survey<br />
and managing data can be found in Chapters 3-4 <strong>of</strong> <strong>the</strong> manual. See Resource 3 for<br />
presentations that address some <strong>of</strong> <strong>the</strong> topics below.<br />
A. Antenatal Clinic Survey Timetable<br />
B. Selecting Sample Sizes<br />
C. Eligibility Criteria<br />
D. List <strong>of</strong> Supplies and Equipment<br />
E. <strong>Assessment</strong> Teams<br />
F. <strong>Assessment</strong> Team Training<br />
Contents<br />
G. Supervisor’s Check List for <strong>Assessment</strong> Start-Up<br />
H. <br />
I. <br />
Supervisor’s Guide to Conducting Antenatal Clinic and Delivery<br />
Unit Surveys<br />
Supervisor’s Guide to Data Management for Antenatal Clinic and Delivery<br />
Unit Surveys<br />
J. Sample Logbooks: Enrollment and Laboratory<br />
K. Handbook for <strong>Assessment</strong> Teams<br />
L. <br />
Blood Test Procedures: HemoCue for Determination <strong>of</strong> Hemoglobin Level<br />
M. Blood Test Procedures: Thick and Thin Films for Microscopic Diagnosis <strong>of</strong><br />
<strong>Malaria</strong> Infection/Finger-Stick Blood Collection<br />
N. Antenatal Clinic Survey Information Sheet<br />
O. Analysis <strong>of</strong> Antenatal Clinic Data<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
1
A. Antenatal Clinic Survey Timetable<br />
This timetable outlines key steps in planning for and conducting Antenatal Clinic and<br />
Delivery Unit Surveys and <strong>the</strong> approximate length <strong>of</strong> time to allow. Many key steps will<br />
require advance planning.<br />
Planning <strong>the</strong><br />
assessment<br />
Period Time Activities<br />
2-4<br />
weeks<br />
Preassessment 2-3<br />
weeks<br />
• Determine what assessment components, if any, need to<br />
be conducted<br />
• Determine what approvals (ethical, scientific, o<strong>the</strong>r<br />
ministerial) are needed and initiate approval process<br />
• Secure funding<br />
• Select site(s)<br />
• Explain <strong>the</strong> assessment to <strong>the</strong> community<br />
• Procure assessment equipment and supplies<br />
• Hire assessment team and/or identify<br />
existing staff<br />
• Adapt and translate questionnaires<br />
• Pretest questionnaires<br />
• Identify site for training<br />
• Identify responsible persons for all presentations that<br />
will be given during training (See Resource 3 for sample<br />
presentations)<br />
• Manage logistics <strong>of</strong> training, including per diem,<br />
transportation, meals, and lodging<br />
• Arrange for on-site training in delivery units and<br />
antenatal clinics<br />
<strong>Assessment</strong> training 1 week • Conduct training course (4-5 days)<br />
• Finalize questionnaires based on pretest and make adequate<br />
copies for final day <strong>of</strong> training<br />
• Meet with supervisors to coordinate assessment start-up in<br />
clinical facilities<br />
Start-up <strong>of</strong> assessment 2 weeks • Make adequate copies <strong>of</strong> antenatal clinic and delivery<br />
unit questionnaires, enrollment logbooks, and laboratory<br />
logbooks, and ensure questionnaires are at assessment sites<br />
• Distribute supplies to each assessment site<br />
and ensure a system <strong>of</strong> re-stocking supplies is in place<br />
• Establish quality control mechanism for data collection,<br />
including clinical and laboratory procedures, transport,<br />
and storage<br />
• Establish a supervisory system that addresses logistics<br />
(staffing, supplies), quality <strong>of</strong> interviewing, quality <strong>of</strong> data<br />
collected on questionnaires, quality <strong>of</strong> obtaining specimens,<br />
laboratory quality (slide and staining, HemoCue calibration),<br />
logbook maintenance<br />
<strong>Assessment</strong> 8-9<br />
weeks<br />
• Enroll women and collect data<br />
• Ensure supervisory system and quality control mechanisms<br />
are functioning<br />
• Ensure adequate supplies and equipment<br />
are available and functioning at each assessment site<br />
Postassessment 8 weeks Conduct data entry, cleaning, and analysis<br />
Write final report<br />
Disseminate results<br />
Initiate policy discussions<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
B. Selecting Sample Sizes<br />
<strong>The</strong> sample size needed for <strong>the</strong> Antenatal Clinic Survey depends on<br />
1. <strong>the</strong> estimated prevalence <strong>of</strong> women with parasitemia and with anemia,<br />
2. <strong>the</strong> acceptable margin <strong>of</strong> error, AND<br />
3. <strong>the</strong> design effect<br />
<strong>The</strong> sample size required to measure each <strong>of</strong> <strong>the</strong> survey’s main indicators (peripheral<br />
parasitemia and anemia) can be calculated by using Statcalc in EPI-INFO. <strong>The</strong> EPI-INFO<br />
calculation should include an adjustment (i.e., design effect [see note at end <strong>of</strong> this section,<br />
Selecting Sample Sizes]) for <strong>the</strong> fact that <strong>the</strong> survey uses cluster sampling, ra<strong>the</strong>r than<br />
random sampling.<br />
If <strong>the</strong> sample size required to measure one indicator is larger than <strong>the</strong> sample size<br />
required for <strong>the</strong> o<strong>the</strong>r indicator, <strong>the</strong> larger <strong>of</strong> <strong>the</strong> two sample sizes should be selected. <strong>The</strong><br />
sample size may need to be modified to account for o<strong>the</strong>r factors (see example below).<br />
<strong>The</strong> sample size for <strong>the</strong> Antenatal Clinic Survey can be determined using<br />
1. Point estimates <strong>of</strong> <strong>the</strong> proportion <strong>of</strong> women with peripheral parasitemia and <strong>the</strong><br />
proportion with anemia. Because hemoglobin levels change throughout pregnancy,<br />
<strong>the</strong> prevalence <strong>of</strong> anemia should be estimated for women in <strong>the</strong> same trimester<br />
(e.g., third). If no estimates are available from <strong>the</strong> district or region where <strong>the</strong><br />
survey is being conducted, data from a neighboring area or national data could be<br />
used.<br />
2. Level <strong>of</strong> accuracy desired, for example + 10%.<br />
3. <strong>The</strong> design effect.<br />
Antenatal Clinic Survey Sample Size Calculation: An Example<br />
Point estimates: In this example, <strong>the</strong> assessment coordinator estimates <strong>the</strong> prevalence<br />
<strong>of</strong> peripheral parasitemia in <strong>the</strong> area to be 35%, on <strong>the</strong> basis <strong>of</strong> a previous study done in<br />
<strong>the</strong> area. <strong>The</strong> prevalence <strong>of</strong> anemia (Hgb
Peripheral<br />
parasitemia<br />
Third<br />
trimester<br />
anemia<br />
Total<br />
sample<br />
size<br />
Estimated<br />
prevalence*<br />
Margin<br />
<strong>of</strong> error<br />
Needed sample<br />
size (from<br />
Statcalc)<br />
O<strong>the</strong>r<br />
factors<br />
35% 10% 174 --- 174<br />
50% 10% 192<br />
% women<br />
attending<br />
antenatal<br />
clinic<br />
during third<br />
trimester:<br />
50%<br />
Sample<br />
size (after<br />
adjusting<br />
for o<strong>the</strong>r<br />
factors)<br />
384<br />
384<br />
* If <strong>the</strong> prevalence <strong>of</strong> peripheral parasitemia during <strong>the</strong> high transmission season is unknown,<br />
assume a level <strong>of</strong> 50% for calculating sample size. This level is <strong>the</strong> most conservative estimate,<br />
as it yields <strong>the</strong> largest required sample size.<br />
If <strong>the</strong> assessment is being used as a baseline that will be repeated after an intervention<br />
in order to demonstrate impact, <strong>the</strong> sample required will be larger and <strong>the</strong> sample size<br />
calculations more complex. It is advisable to consult a statistician for fur<strong>the</strong>r guidance.<br />
Note on design effect:<br />
Large surveys are <strong>of</strong>ten conducted using cluster surveys, meaning that <strong>the</strong> population is<br />
divided into clusters and sampled accordingly. Clusters are selected by random sampling and<br />
<strong>the</strong>n random samples are taken within <strong>the</strong> selected clusters. <strong>The</strong> benefits <strong>of</strong> cluster sampling<br />
are that it is <strong>of</strong>ten easier and less expensive to conduct than simple random sampling as <strong>the</strong><br />
needed sample size is smaller. However, its disadvantage is that <strong>the</strong>re is a loss <strong>of</strong> precision<br />
because <strong>the</strong> elements within <strong>the</strong> cluster are generally more correlated (similar) than those<br />
between <strong>the</strong> clusters. Selecting an additional member from <strong>the</strong> same cluster adds less<br />
new information than would a completely independent selection. As <strong>the</strong> cluster size and<br />
intracluster correlation increase, cluster variances increase more than one would find in a<br />
simple random sample. <strong>The</strong> benefits <strong>of</strong> cluster sampling <strong>of</strong>ten outweigh <strong>the</strong> disadvantage <strong>of</strong><br />
<strong>the</strong> loss in precision.<br />
Because cluster sampling results in a loss <strong>of</strong> precision and a smaller sample size, an<br />
adjustment called <strong>the</strong> design effect should be used to determine survey sample size when<br />
clustering is involved. <strong>The</strong> design effect is basically <strong>the</strong> ratio <strong>of</strong> <strong>the</strong> actual variance 1 , under <strong>the</strong><br />
sampling method actually used, to <strong>the</strong> variance computed under <strong>the</strong> assumption <strong>of</strong> simple<br />
random sampling. <strong>The</strong> main components <strong>of</strong> <strong>the</strong> design effect are <strong>the</strong> intraclass correlation and<br />
<strong>the</strong> cluster sample sizes. <strong>The</strong> design effect is calculated as follows:<br />
DEFF = 1 + ρ (n – 1),<br />
where Deff is <strong>the</strong> design effect, ρ is <strong>the</strong> intraclass correlation for <strong>the</strong> statistic in question, and<br />
n is <strong>the</strong> average size <strong>of</strong> <strong>the</strong> cluster. <strong>The</strong> interpretation <strong>of</strong> a value <strong>of</strong> DEFF <strong>of</strong>, say, 3.0 is that <strong>the</strong><br />
sample variance is 3 times bigger than it would be if <strong>the</strong> survey were based on <strong>the</strong> same<br />
1 Variation measured in a set <strong>of</strong> data for one variable, defined as <strong>the</strong> sum <strong>of</strong> squares <strong>of</strong> <strong>the</strong> deviation <strong>of</strong> each<br />
data point from <strong>the</strong> mean for <strong>the</strong> data, divided by <strong>the</strong> degrees <strong>of</strong> freedom (sample observation – 1).<br />
4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
sample size but selected randomly. It can be seen that <strong>the</strong> design effect increases as <strong>the</strong> cluster<br />
sizes increase, and as <strong>the</strong> intraclass correlation increases. <strong>The</strong> square root <strong>of</strong> <strong>the</strong> design effect<br />
shows how much <strong>the</strong> sample standard error, and consequently <strong>the</strong> confidence intervals,<br />
will increase because <strong>of</strong> <strong>the</strong> clustering. <strong>The</strong> intraclass correlation represents <strong>the</strong> likelihood<br />
that two elements in <strong>the</strong> same cluster have <strong>the</strong> same value, for a given statistic, relative to<br />
two elements chosen completely at random in <strong>the</strong> population. A value <strong>of</strong> 0.10 is interpreted,<br />
<strong>the</strong>refore, to mean that <strong>the</strong> elements in <strong>the</strong> cluster are about 10% more likely to have <strong>the</strong> same<br />
value than if <strong>the</strong> two elements were chosen at random in <strong>the</strong> survey.<br />
Design effects vary from survey to survey and even within <strong>the</strong> same survey will vary from<br />
question to question. In summary, using a cluster sample generally requires ei<strong>the</strong>r a larger<br />
sample size than a simple random sample or a wider confidence interval. <strong>The</strong> design effect<br />
is used to determine how much larger <strong>the</strong> sample size or confidence interval needs to be.<br />
In general, for a well-designed study, <strong>the</strong> design effect usually ranges from 1 to 3. It is not<br />
uncommon, however, for <strong>the</strong> design effect to be much larger.<br />
<strong>The</strong> survey methodology recommended for both <strong>the</strong> Antenatal Clinic Surveys and <strong>the</strong> Delivery<br />
Unit surveys use cluster sample methodology and thus require that a design effect be used.<br />
C. Eligibility Criteria<br />
• Women who participate in <strong>the</strong> assessment should be as representative as possible<br />
<strong>of</strong> all women attending <strong>the</strong> antenatal clinic.<br />
Women are eligible for <strong>the</strong> survey if <strong>the</strong>y meet <strong>the</strong> following requirements:<br />
Stage <strong>of</strong> Gestation: Women who have experienced “quickening” (i.e., <strong>the</strong> recognition <strong>of</strong> fetal<br />
movement).<br />
Gravidity: All gravidities. Although primigravidae and secundigravidae are typically most<br />
affected in high transmission areas, women <strong>of</strong> all gravidities should be eligible so that <strong>the</strong> local<br />
situation can be confirmed.<br />
Age: <strong>The</strong> youngest age at which women are eligible to participate should be <strong>the</strong> age at which<br />
most women in <strong>the</strong> assessment area have <strong>the</strong>ir first child. This is to ensure that primigravidae<br />
and secundigravidae (<strong>the</strong> groups at highest risk) are included in <strong>the</strong> assessment. <strong>The</strong> age <strong>of</strong><br />
<strong>the</strong> youngest participants may well be less than <strong>the</strong> age <strong>of</strong> majority and should be consistent<br />
with any country policy or norm regarding this type <strong>of</strong> survey. Many countries consider a<br />
woman with a child and her own household to be an emancipated minor regardless <strong>of</strong> age.<br />
However, 15 years is <strong>of</strong>ten chosen as a minimum age.<br />
Note: Women who have not yet experienced quickening should not be included in <strong>the</strong> survey.<br />
This exclusion criterion helps avoid use <strong>of</strong> drugs in <strong>the</strong> first trimester o<strong>the</strong>r than what would<br />
be recommended in <strong>the</strong> national policy. For example, in this survey, women may be treated for<br />
asymptomatic parasitemia, but would not o<strong>the</strong>rwise, according to national policy.<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
5
D. List <strong>of</strong> Supplies and Equipment<br />
Make sure that each antenatal clinic has <strong>the</strong> necessary supplies and equipment<br />
before <strong>the</strong> start <strong>of</strong> <strong>the</strong> survey.<br />
Item<br />
Quantity per<br />
ANC<br />
Comments/Use<br />
# in<br />
stock/<br />
Balance<br />
needed<br />
Date<br />
Ordered<br />
Screening &<br />
Clinical Evaluation<br />
Electronic<br />
<strong>the</strong>rmometers<br />
Laboratory<br />
2<br />
Temperature<br />
measurement;<br />
if electronic<br />
<strong>the</strong>rmometers are<br />
unavailable, mercury<br />
glass <strong>the</strong>rmometers<br />
are an acceptable<br />
alternative.<br />
Count-down timer 1 For laboratory use.<br />
Slides 1/participant Allow extras for waste.<br />
Lancets 1/participant Allow extras for waste.<br />
Isopropyl alcohol<br />
Enough to<br />
clean 1 finger/<br />
participant<br />
Premoistened alcohol<br />
wipes are an acceptable<br />
alternative.<br />
Cotton wool or<br />
gauze<br />
Giemsa stain<br />
Toilet paper (or<br />
slide boxes)<br />
Container for used<br />
lancets<br />
Staining jars<br />
Slide drying rack<br />
Enough to<br />
clean 1 finger/<br />
participant<br />
Sufficient<br />
to wrap (or<br />
store) all<br />
slides from<br />
assessment<br />
2/site<br />
2/lab<br />
1/lab<br />
Based upon sample size.<br />
In addition to Giemsa<br />
powder, need all o<strong>the</strong>r<br />
materials to mix stain,<br />
including distilled<br />
water, buffer, glycerol,<br />
and glassware to mix<br />
and store.<br />
Sharps container;<br />
should only be used<br />
for lancets (or o<strong>the</strong>r<br />
sharps), microcuvettes,<br />
and microhematocrit<br />
tubes.<br />
6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Item<br />
Quantity per<br />
ANC<br />
Comments/Use<br />
# in<br />
stock/<br />
Balance<br />
needed<br />
Date<br />
Ordered<br />
Basin/bleach<br />
1 basin<br />
Bleach for disinfecting<br />
and cleaning spreader<br />
slides if using thin films.<br />
Hair dryer<br />
1/lab<br />
May be needed,<br />
depending on climate.<br />
Optional.<br />
Microhematocrit<br />
tubes<br />
1/participant<br />
Centrifuge for<br />
microhematocrit<br />
tubes<br />
1<br />
HemoCue machine and<br />
microcuvettes may<br />
be substituted when<br />
available.<br />
Microscope<br />
1/lab<br />
Spare light bulbs<br />
for microscope<br />
3/lab<br />
Immersion oil<br />
3 tubes/lab<br />
Lens cleaner<br />
1 bottle/lab<br />
Lens cleaning<br />
tissue<br />
2 sheets/day<br />
<strong>of</strong> survey<br />
Sharpie markers<br />
(ultra fine)<br />
3/team/site<br />
Examination gloves<br />
1 pair/<br />
participant<br />
Extra for breakage,<br />
extra for lab personnel.<br />
Trash can/trash<br />
bags<br />
1 can and bags<br />
as needed<br />
For non-sharp waste<br />
(gloves, cotton, etc.).<br />
Tally counters<br />
2/laboratory<br />
If using 2-channel<br />
counter, 1 is sufficient.<br />
Computer 1-2<br />
2 is ideal, 1 is adequate;<br />
with at least Windows<br />
2000.<br />
Epi-Info or ano<strong>the</strong>r<br />
statistical s<strong>of</strong>tware<br />
package (Epi Info is<br />
preferred)<br />
Office Supplies<br />
1-2<br />
Installed on each<br />
computer.<br />
AA batteries<br />
If using HemoCue.<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
7
Item<br />
Quantity per<br />
ANC<br />
Comments/Use<br />
# in<br />
stock/<br />
Balance<br />
needed<br />
Date<br />
Ordered<br />
Clipboards<br />
1/interviewer<br />
Pencils<br />
1/interviewer<br />
Only if preparing thin<br />
films.<br />
Pencil sharpener<br />
1/interviewer<br />
Only if preparing thin<br />
films.<br />
Pens<br />
2/interviewer<br />
Stapler 1<br />
Staples<br />
2 boxes<br />
Ink pad/Ink<br />
1/site<br />
For fingerprinting<br />
women if signature<br />
needed and woman<br />
cannot sign.<br />
Logbooks<br />
Drug Supplies<br />
Antimalarials for<br />
IPTp (if IPTp is <strong>the</strong><br />
policy); should be<br />
available as part<br />
<strong>of</strong> routine ANC<br />
supplies<br />
2/clinical site<br />
and 1/lab<br />
Should be bound books,<br />
not spiral-bound or<br />
perforated. 2 in clinical<br />
site: 1 for register, 1 for<br />
hemoglobin. 1 in lab for<br />
slide results.<br />
Antimalarial for<br />
treatment<br />
Iron and folate<br />
8 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
E. <strong>Assessment</strong> Teams<br />
<strong>The</strong> number <strong>of</strong> assessment teams depends on <strong>the</strong> number<br />
<strong>of</strong> antenatal clinics used.<br />
<strong>The</strong> following example assumes that 4 antenatal clinics will be surveyed.<br />
Title<br />
Number needed<br />
<strong>Assessment</strong> coordinator 1<br />
Laboratorian supervisor 1<br />
Site supervisors<br />
4 (1 per site)<br />
Interviewers<br />
8 (2 per site)<br />
Laboratorians<br />
4 (1 per site)<br />
Data management coordinator 1<br />
Data entry clerks 2<br />
<strong>The</strong>re is no magic formula for how to staff <strong>the</strong> assessment. If <strong>the</strong> antenatal clinic sites<br />
see patients every day, it may be advantageous to staff <strong>the</strong>m continuously, and <strong>the</strong>refore have a<br />
complete team at each site. If <strong>the</strong>re are antenatal clinic sites that are not open daily, <strong>the</strong>n it may<br />
be more efficient to have a team <strong>of</strong> newly hired staff who rotate among two or more sites.<br />
F. <strong>Assessment</strong> Team Training<br />
<strong>The</strong> training for site supervisors, interviewers, and laboratorians should be held after<br />
preassessment activities. Training will take approximately 4-5 days.<br />
<strong>The</strong> text below explains how to conduct <strong>the</strong> training. A sample schedule follows <strong>the</strong><br />
explanation.<br />
Note: If both Antenatal Clinic and Delivery Unit Surveys will be conducted, it is more<br />
efficient to conduct training for both surveys simultaneously. <strong>The</strong>refore, this module<br />
describes simultaneous training. If only one <strong>of</strong> <strong>the</strong> surveys is conducted,<br />
this module will need to be modified accordingly.<br />
Note: If qualitative studies will be conducted about <strong>the</strong> same time as <strong>the</strong> quantitative<br />
studies, it would be beneficial to conduct <strong>the</strong> training simultaneously. Consult <strong>the</strong><br />
qualitative training manual (or <strong>the</strong> modules that accompany <strong>the</strong> qualitative surveys)<br />
for guidance on how to combine <strong>the</strong> two.<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
9
Day 1:<br />
Morning: <strong>The</strong> assessment coordinator should present background information on malaria<br />
during pregnancy and assessment objectives. (See Resource 3 for sample presentations)<br />
Afternoon: <strong>The</strong> assessment coordinator reviews antenatal clinic and delivery unit policies and<br />
procedures located in <strong>the</strong> assessment team member’s handbook (see K in this Module). This<br />
provides a general overview <strong>of</strong> <strong>the</strong> assessment. Once <strong>the</strong> overview is complete, <strong>the</strong> assessment<br />
coordinator should split <strong>the</strong> interviewers into teams. Each team will rotate through antenatal<br />
clinic and delivery unit clinical procedures. Depending on <strong>the</strong> size <strong>of</strong> <strong>the</strong> assessment team,<br />
<strong>the</strong> logistics can be varied. In a small team, everyone might work toge<strong>the</strong>r to go through all<br />
procedures. In a large team with a sufficient number <strong>of</strong> facilitators, it may be worthwhile to<br />
divide teams into groups that rotate around a series <strong>of</strong> workstations. <strong>The</strong> important thing is<br />
that each staff member has <strong>the</strong> opportunity to learn and practice each procedure that he/she<br />
will be conducting.<br />
Antenatal clinic procedures include: 2<br />
<br />
<br />
• Exercise universal precaution for handling blood (prior to this exercise,<br />
presentation on lab safety [see Resources] could be shown)<br />
• Take and read axillary temperature<br />
• Collect blood samples (fingersticks) from each o<strong>the</strong>r<br />
• Prepare slide (recording date and ID number on slide) (see M)<br />
• Prepare thick films (and thin films in an area with substantial P. vivax<br />
transmission) (see M)<br />
• Collect blood on cuvette and use HemoCue machine to perform <strong>the</strong> Hb<br />
reading (see L)<br />
Delivery unit procedures include: 2<br />
<br />
• Take woman’s temperature<br />
• Measure woman’s mid-upper arm circumference<br />
• Measure woman’s height<br />
• Prepare slides—peripheral, placental, and cord blood<br />
• Weigh newborn using scale<br />
• Conduct <strong>the</strong> Ballard examination and apply <strong>the</strong> scoring system (See Resource<br />
3 for Ballard video; see also Module 2 for Ballard check list)<br />
Day 2:<br />
Morning: <strong>The</strong> assessment coordinator arranges for interviewers to visit a delivery unit site<br />
for practice <strong>of</strong> delivery unit procedures. At <strong>the</strong> same time, <strong>the</strong> laboratorian supervisor trains<br />
assessment laboratorians on how to read peripheral, placental and cord films.<br />
Afternoon: In a group setting, <strong>the</strong> assessment coordinator reviews each question on antenatal<br />
clinic and delivery unit questionnaires and <strong>the</strong> information sheet (or consent form), depending<br />
on which is being used. <strong>The</strong> coordinator also describes why <strong>the</strong>re is a consent form if a consent<br />
form has been determined necessary. Interviewers should be encouraged to ask questions and<br />
<strong>of</strong>fer suggestions. After reviewing each questionnaire, <strong>the</strong> interviewers should break into small<br />
groups and practice each questionnaire one-on-one using copies <strong>of</strong> actual antenatal clinic<br />
2 In some circumstances it may be possible to conduct polymerase chain reaction (PCR) on filter paper samples<br />
or to examine tissue specimens preserved in formalin. However, in many settings <strong>the</strong>se are nei<strong>the</strong>r possible<br />
nor necessary.<br />
10 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
cards from <strong>the</strong> clinic. It is important that <strong>the</strong> antenatal clinic cards have had all identifiers<br />
removed. Any discrepancies regarding data extraction from antenatal clinic cards should be<br />
addressed with <strong>the</strong> assessment coordinator, and questionnaires revised as necessary.<br />
Day 3:<br />
Morning: After <strong>the</strong> survey instruments are adapted, <strong>the</strong> survey instruments, as well as <strong>the</strong><br />
information sheet (or informed consent form if used), should be translated into <strong>the</strong> national<br />
language and <strong>the</strong> primary language spoken by women in <strong>the</strong> assessment area, if different.<br />
This initial translation should be followed by a back-translation (by individuals who did not<br />
produce <strong>the</strong> original translation) into <strong>the</strong> national language to check <strong>the</strong> adequacy <strong>of</strong> <strong>the</strong><br />
translation. Once <strong>the</strong> translation is complete, pretesting can begin. While <strong>the</strong> surveys are being<br />
pretested, laboratorians could practice film reading.<br />
Note: If <strong>the</strong> primary language is not a written language, it will be important to use correct,<br />
consistent phrasing <strong>of</strong> survey questions and information on <strong>the</strong> information sheet (or<br />
informed consent form) so that questions are asked in a standardized manner. All interviewers<br />
should work toge<strong>the</strong>r to achieve correct, consistent phrasing <strong>of</strong> <strong>the</strong> questions and have <strong>the</strong><br />
opportunity to practice.<br />
Afternoon: <strong>The</strong> assessment coordinator arranges for interviewers to visit two antenatal clinic<br />
sites to practice <strong>the</strong> antenatal clinic questionnaire with clients.<br />
NOTE: <strong>The</strong> delivery unit questionnaire is very similar to <strong>the</strong> antenatal clinic<br />
questionnaire, which will have been pretested. Because <strong>of</strong> this, it is not necessary to<br />
pretest <strong>the</strong> delivery unit questionnaire. This avoids <strong>the</strong> need to ask women who may be<br />
in physical discomfort to practice interviews.<br />
Divide <strong>the</strong> interviewers into two teams. Each team should visit one <strong>of</strong> <strong>the</strong> selected sites to<br />
pretest <strong>the</strong> antenatal clinic questionnaires with at least 15 clients (total, not per interviewer)<br />
in each facility.<br />
Day 4:<br />
Morning: <strong>The</strong> assessment coordinator will explain <strong>the</strong> purpose <strong>of</strong> antenatal clinic and delivery<br />
unit enrollment and laboratory logbooks. <strong>The</strong>n, <strong>the</strong> coordinator should demonstrate and<br />
review <strong>the</strong>se log books. It is important that all assessment team members understand that<br />
<strong>the</strong> enrollment logbooks are used to record everyone who is enrolled in <strong>the</strong> assessment as<br />
well as those who are excluded for any reason. <strong>The</strong> interviewers should be divided into pairs<br />
to continue practicing <strong>the</strong> revised questionnaires. <strong>The</strong> rest <strong>of</strong> <strong>the</strong> morning should be used to<br />
resolve outstanding issues, and conclude <strong>the</strong> training.<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
11
Day 5:<br />
If <strong>the</strong> training is scheduled for 5 days, Day 5 can be reserved for work on any remaining issues.<br />
Sample Training Schedule<br />
Day 1 Day 2 Day 3 Day 4<br />
Introduction/<br />
Overview<br />
Delivery<br />
Unit Clinical<br />
Procedures<br />
Pretest<br />
questionnaires<br />
Wrap-up<br />
Morning<br />
-Welcome<br />
-Training objectives<br />
-<strong>Malaria</strong> situation in<br />
country<br />
-Epidemiology <strong>of</strong><br />
malaria during<br />
pregnancy<br />
-<strong>Rapid</strong> assessment<br />
objectives<br />
See Resource 3 for<br />
sample presentations<br />
Microscopy training<br />
for laboratorians<br />
On site delivery<br />
unit clinical<br />
procedures training<br />
and practice for<br />
interviewers<br />
Practice<br />
questionnaires<br />
and consent form<br />
administration in<br />
local language(s)<br />
with translator<br />
Practice<br />
questionnaires<br />
and consent form<br />
administration in<br />
local language(s) in<br />
small groups<br />
Introduce enrollment<br />
and laboratory registers<br />
Practice questionnaires<br />
in pairs (using<br />
antenatal clinic cards<br />
and antenatal clinic and<br />
delivery unit registers).<br />
Conclusion <strong>of</strong> training<br />
Afternoon<br />
Policy and procedures<br />
in antenatal clinic and<br />
delivery unit (worker’s<br />
handbook)<br />
Practice clinical<br />
procedures for<br />
antenatal clinic and<br />
delivery unit (show<br />
video <strong>of</strong> Ballard)<br />
if available. Live<br />
demonstrations<br />
using an adult model<br />
before practicing on<br />
live newborns can be<br />
useful.<br />
Review antenatal<br />
clinic and delivery<br />
unit questionnaires<br />
and consent forms<br />
Practice<br />
questionnaires<br />
in pairs (using<br />
antenatal clinic<br />
cards). Resolve<br />
discrepancies<br />
regarding data<br />
extraction from<br />
antenatal clinic<br />
cards.<br />
Pretest<br />
questionnaires on<br />
site in antenatal<br />
clinic facilities<br />
Meet with supervisors<br />
to discuss assessment<br />
start-up:<br />
-Make copies <strong>of</strong><br />
antenatal clinic<br />
and delivery unit<br />
questionnaires<br />
-Ensure antenatal clinic<br />
and delivery unit log<br />
books are at each<br />
assessment site<br />
-Distribute supplies to<br />
each assessment site<br />
-Establish quality<br />
control mechanism<br />
-Establish a supervisory<br />
system<br />
Evening<br />
Team members to read<br />
questionnaires and<br />
consent forms<br />
<strong>Assessment</strong><br />
coordinator finalizes<br />
both questionnaires<br />
based on pretests.<br />
12 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
G. Supervisor’s Check List for <strong>Assessment</strong> Start-Up<br />
<strong>The</strong> following guide contains worksheets to assist <strong>the</strong> supervisor during <strong>the</strong><br />
start-up phase <strong>of</strong> <strong>the</strong> assessment.<br />
Note: This list pertains to both Antenatal Clinic and Delivery Unit Surveys, as most likely<br />
both will be conducted. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, <strong>the</strong> list will need to be<br />
modified accordingly.<br />
Explain <strong>the</strong> purpose <strong>of</strong> <strong>the</strong> assessment to <strong>the</strong> “community,” through direct communication<br />
where possible, and also through <strong>the</strong> display <strong>of</strong> malaria posters in <strong>the</strong> clinic, and any o<strong>the</strong>r<br />
communication means.<br />
Set up <strong>the</strong> supply management system:<br />
• Verify that all supplies on <strong>the</strong> list are available.<br />
• Provide <strong>the</strong> delivery unit, antenatal clinic unit, and <strong>the</strong> lab each with a set <strong>of</strong> supplies<br />
(papers, laboratory materials, examination materials, antimalarial drugs and<br />
hematinics) to last at least one week.<br />
• If supply shortages (batteries, slides, etc.) are noticed, find a solution to continue <strong>the</strong><br />
assessment uninterrupted.<br />
• Keep spare supplies in a safe place, preferably a locked cupboard or box.<br />
• Keep a record <strong>of</strong> available stocks.<br />
Have planning meeting with <strong>the</strong> assessment team:<br />
• Make sure every person understands what is expected <strong>of</strong> him/her.<br />
• Draw up a time and duty schedule for each team member, aiming for 8 hrs/day<br />
antenatal clinic presence, and 24 hrs/day delivery room presence.<br />
• Rehearse every team member’s interviewer number, and go over <strong>the</strong> patient number<br />
system once more.<br />
Also:<br />
• Instruct <strong>the</strong> night staff <strong>of</strong> <strong>the</strong> delivery room to routinely store ALL placentas for <strong>the</strong><br />
assessment in individually marked plastic bags in <strong>the</strong> ice box if no assessment team<br />
member happens to be present<br />
• Assign responsibility for <strong>the</strong> ice box and for replacing <strong>the</strong> ice packs to an assessment<br />
team member<br />
• Arrange additional laboratory support, if needed<br />
• Identify possible translators for local languages among <strong>the</strong> hospital staff. Where<br />
possible, make <strong>the</strong>m familiar with <strong>the</strong> questionnaire beforehand.<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
13
Set up instruments:<br />
• Set up measuring tape, scales and Ballard chart in <strong>the</strong> delivery room<br />
• Set up HemoCue instructions in <strong>the</strong> antenatal clinic room, if using HemoCue. Set up<br />
<strong>the</strong> HemoCue and calibrate. Recalibrate daily.<br />
• Find a safe and stable place for <strong>the</strong> infant weighing scale. Make sure that it is never<br />
lifted by <strong>the</strong> cradle, as this will damage it.<br />
• Keep instrument instructions in a safe place for future reference.<br />
Set up data management system:<br />
• Provide staff with enough information sheets (or consent forms, if used) and<br />
questionnaires for at least one week.<br />
• Make <strong>the</strong> arrangements for daily review <strong>of</strong> assessment results by <strong>the</strong> supervisor<br />
toge<strong>the</strong>r with <strong>the</strong> antenatal clinic and delivery unit staff.<br />
• Make arrangements for daily storing <strong>of</strong> papers and slides (and filter papers and test<br />
tubes, if being used).<br />
• Make arrangements for weekly storing <strong>of</strong> papers and slides (and filter papers and<br />
test tubes, if being used).<br />
• Go through <strong>the</strong> data management system with <strong>the</strong> team members.<br />
Set up assessment logs:<br />
• Antenatal clinic logbook, delivery unit logbook, laboratory logbooks<br />
(one for malaria, one for hemoglobin results)<br />
14 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
H. Supervisor’s Guide for Conducting Antenatal Clinic<br />
and Delivery Unit Surveys<br />
<strong>The</strong> following guide contains worksheets to assist <strong>the</strong> supervisor in noting <strong>the</strong> progress<br />
<strong>of</strong> <strong>the</strong> survey, reminding <strong>the</strong> supervisor <strong>of</strong> important tasks (e.g., calibrating <strong>the</strong> HemoCue<br />
machine daily), and guiding <strong>the</strong> supervisor in reviewing questionnaires.<br />
<strong>The</strong>se worksheets should be filled out on a regular basis, as determined by <strong>the</strong> supervisor.<br />
Note: <strong>The</strong> worksheets pertain to both Antenatal Clinic and Delivery Unit Surveys, as most<br />
likely both will be conducted. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, <strong>the</strong> forms will need to<br />
be modified accordingly.<br />
Site: _______________________________________________________________________________________________________<br />
Date: __ __ /__ __ /__ __<br />
1. Enrollment and rates <strong>of</strong> positivity<br />
Antenatal clinic enrolled to date (No): ________________________________________________________________<br />
Number positive: ________________________________________________________________________________________<br />
Last antenatal clinic ID number used: _________________________________________________________________<br />
Delivery enrolled to date (No): _________________________________________________________________________<br />
Number positive (Mo<strong>the</strong>r): _____________________________________________________________________________<br />
Number positive (Placenta): ___________________________________________________________________________<br />
Number positive (Cord): ________________________________________________________________________________<br />
Last delivery ID number used:__ __ /__ __ /__ __<br />
2. Staff, supplies and samples<br />
Have any staff left <strong>the</strong> assessment?_____________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
Are all nights on <strong>the</strong> delivery unit being covered by <strong>the</strong> assessment team? ________________________<br />
If this is not possible, are sufficient coolers (with icepacks) available for placental storage? ____<br />
Using <strong>the</strong> supply list above, note if supplies are adequate.<br />
YES =1 NO = 2<br />
Any o<strong>the</strong>r missing supplies: ____________________________________________________________________________<br />
If any supplies are needed, what is <strong>the</strong> plan for restocking?_ ________________________________________<br />
Are questionnaires and samples well organized and in a safe place?_______________________________<br />
____________________________________________________________________________________________________________<br />
If not, plan to improve situation:_______________________________________________________________________<br />
Samples and questionnaires taken to central location<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
15
ANC:<br />
Questionnaire numbers __ __ - __ __ __ to __ __ - __ __ __<br />
Slide numbers: to Delivery __ __ - __ __ __ to __ __ - __ __ __<br />
Questionnaire numbers __ __ - __ __ __ to __ __ - __ __ __<br />
Slide numbers (M,P,C):__ __ - __ __ __ to __ __ - __ __ __<br />
Tissue sample numbers, if collected: __ __ - __ __ __ to __ __ - __ __ __<br />
Filter paper numbers (M,P), if collected: __ __ - __ __ __ to __ __ - __ __ __<br />
3. Antenatal Care Survey<br />
Is <strong>the</strong> HemoCue machine being calibrated daily?_____________________________________________________<br />
Check calibration today: ________________________________________________________________________________<br />
Examine <strong>the</strong> logbooks. Are <strong>the</strong>y being filled out correctly? __________________________________________<br />
(Note: Enrollment logbook should contain all patients, whe<strong>the</strong>r or not enrolled in<br />
assessment.]<br />
Note any problems with logbooks: ____________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
What is <strong>the</strong> plan to correct any problems with logbooks? ___________________________________________<br />
____________________________________________________________________________________________________________<br />
What is <strong>the</strong> average enrollment per day? (look at last 10 days): ____________________________________<br />
If it is too high or too low, examine reasons, and make a plan for correction: ______________________<br />
____________________________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
Examine at least 5 questionnaires per assessment team member. Note any problems, and<br />
discuss with that person. Pay particular attention to whe<strong>the</strong>r hemoglobin, temperature, and<br />
blood smear results are completed.<br />
Note any important problems and what measures were taken to fix <strong>the</strong>m: ________________________<br />
____________________________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
Are women with anemia receiving iron? ______________________________________________________________<br />
If not, why not? __________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
Are women with positive blood smears receiving treatment for malaria?_________<br />
If not, why not? __________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
If consent forms are used, examine. Have women signed <strong>the</strong>m in accordance with assessment/<br />
country policy? Is <strong>the</strong> name <strong>of</strong> a contact person for questions written in as instructed? _ ________<br />
____________________________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
16 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
4. Delivery Unit Survey<br />
Examine logbooks. Are <strong>the</strong>y being filled out correctly?_______________________________________________<br />
(Note: Enrollment logbook should contain all women who deliver, whe<strong>the</strong>r or not enrolled<br />
in assessment)<br />
Note any problems with logbook: ______________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
What is <strong>the</strong> plan to correct any problems with <strong>the</strong> logbook: ________________________________________<br />
____________________________________________________________________________________________________________<br />
What is <strong>the</strong> average enrollment per day? (look at last 10 days): ____________________________________<br />
____________________________________________________________________________________________________________<br />
If it seems very low, examine reasons, and make a plan for correction: _ ___________________________<br />
____________________________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
Are enrollments evenly spaced throughout <strong>the</strong> day (i.e., not all in <strong>the</strong> a.m. or p.m.)?______________<br />
____________________________________________________________________________________________________________<br />
Examine at least 5 questionnaires per assessment team member. Note any problems, and<br />
discuss with that person. Pay particular attention to ensure that <strong>the</strong> following are completed:<br />
height, arm circumference, baby weight, Ballard gestational age, blood smear results and<br />
treatment.<br />
Note any specific problems and what measures were taken to fix <strong>the</strong>m: ___________________________<br />
____________________________________________________________________________________________________________<br />
Is <strong>the</strong> baby’s sex being documented on <strong>the</strong> Delivery Unit questionnaire?__________________________<br />
Are women with positive blood smears receiving treatment for malaria? _ ________________________<br />
If not, why not? __________________________________________________________________________________________<br />
If consent forms are used, examine. Have women signed <strong>the</strong>m in accordance with assessment/<br />
country policy? Is <strong>the</strong> name <strong>of</strong> a contact person for questions written in<br />
as instructed? ____________________________________________________________________________________________<br />
Are sample sets complete for each delivery patient (that is, do <strong>the</strong>y contain a questionnaire, 3<br />
slides (M, P, C), and, if collected, 2 filter papers (M, P), and a tissue sample? ______________________<br />
If not, why not? __________________________________________________________________________________________<br />
5. Laboratory (Supervisor may need assistance from Laboratory Supervisor on first few<br />
items below.)<br />
Examine <strong>the</strong> results books. Are <strong>the</strong> books being completed correctly? _____________________________<br />
If problems are found, document here, and make a plan for correction: ___________________________<br />
____________________________________________________________________________________________________________<br />
Are <strong>the</strong> results for mo<strong>the</strong>rs from antenatal clinic with fever, and mo<strong>the</strong>rs and babies from<br />
delivery, being given promptly to assessment team? _________________________________________________<br />
If not, what steps can be taken to improve <strong>the</strong> speed <strong>of</strong> obtaining results? ________________________<br />
____________________________________________________________________________________________________________<br />
Reread 10% <strong>of</strong> <strong>the</strong> slides <strong>of</strong> each type (ANC, Delivery M, Delivery P, Delivery C).<br />
Rate <strong>the</strong> accuracy <strong>of</strong> slides:<br />
Thick: (1 to 5, 5 is highly accurate): ___________________________________________________________________<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
17
Thin: (1 to 5, 5 is highly accurate): _____________________________________________________________________<br />
If quality is poor, examine reasons (e.g., smears badly done, thick specimen is fixed, or stain<br />
coloration is bad), and try to find a solution to <strong>the</strong> problem: ________________________________________<br />
____________________________________________________________________________________________________________<br />
Are slides being stored in a good manner (in slide boxes or, if slide boxes cannot be obtained,<br />
rolled in tissue paper)?: ________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
If not, plan for correction: ______________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
Does <strong>the</strong> laboratory have adequate supplies? ________________________________________________________<br />
If not, plan to correct <strong>the</strong> problem: ____________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
6. Data Entry<br />
Review at least 5 questionnaires that have been entered in <strong>the</strong> computer.<br />
Number <strong>of</strong> errors found in 5 ANC: _____________________________________________________________________<br />
Number <strong>of</strong> errors found in 5 Delivery: ________________________________________________________________<br />
Is <strong>the</strong> record number being written at <strong>the</strong> top <strong>of</strong> each questionnaire on each page?______________<br />
____________________________________________________________________________________________________________<br />
O<strong>the</strong>r comments, observations or problems not mentioned above____________________________<br />
____________________________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
18 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
I. Supervisor’s Guide to Data Management for Antenatal Clinic<br />
and Delivery Unit Surveys<br />
<strong>The</strong> following guide contains worksheets to assist <strong>the</strong> supervisor in managing and collecting<br />
data. Worksheets outline tasks for assessment team members, as well as <strong>the</strong> supervisor.<br />
Note: <strong>The</strong> worksheets pertain to both Antenatal Clinic and Delivery Unit Surveys,<br />
as most likely both will be conducted. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, <strong>the</strong> forms can<br />
be modified accordingly.<br />
1. Enrollment targets:<br />
List for each site:<br />
Desired # <strong>of</strong> antenatal clinic visits: _____ at least x/day<br />
Desired # <strong>of</strong> deliveries: _____ at least x/day<br />
2. Target data collection period:<br />
ANC<br />
Deliveries<br />
List months during which to collect <strong>the</strong>se data<br />
List months during which to collect <strong>the</strong>se data<br />
3. Assigning an ID number<br />
1 st digit: assessment site<br />
Site #1 1<br />
Site #2 2<br />
Site #3 3<br />
Site #4 4<br />
2 nd digit: type <strong>of</strong> health service<br />
ANC A<br />
Delivery D<br />
3 rd – 5 th digit: consecutive number identifying each patient<br />
Example: 35 th antenatal clinic woman in Site#3 = 3A – 035<br />
46 th delivery in Site#1 = 1D – 046<br />
Note: If <strong>the</strong> woman has been assigned an ID number but enrollment has to be abandoned for<br />
whatever reason, file all related papers and test results, and assign <strong>the</strong> next woman <strong>the</strong> next<br />
number. ID numbers should only be used once. All ID numbers should be accounted for at <strong>the</strong><br />
final data analysis.<br />
• All data must be entered in computer<br />
• All data items must be returned to designated location for re-entering into computer<br />
(for double data entry) and quality control <strong>of</strong> slide readings<br />
Mark ID NUMBERS on each item and each page!!<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
19
4. Assigning an interviewer number<br />
<strong>The</strong> supervisor should assign each interviewer a unique number to be used throughout<br />
assessment.<br />
For example:<br />
Site #1 01 – 20<br />
Site #2 21 – 40<br />
Site #3 41 – 60<br />
Site #4 61 – 80<br />
5. Hints to provide interviewers for filling out questionnaires<br />
<br />
<br />
<br />
• Keep all pages <strong>of</strong> <strong>the</strong> consent forms (if used) and <strong>of</strong> <strong>the</strong> questionnaires stapled toge<strong>the</strong>r<br />
• Number all pages immediately with <strong>the</strong> ID number<br />
• Write clearly<br />
• ………….. is a connecting line<br />
• ________ is a line to write on<br />
<br />
• Feel free to make notes in <strong>the</strong> margin <strong>of</strong> <strong>the</strong> questionnaire form if <strong>the</strong> answer<br />
you received was not very clear or if you have doubts. <strong>The</strong> more information<br />
<strong>the</strong> better.<br />
• If it states “check all that apply,” please do not enter dashes for negative. Just leave those<br />
spaces blank. O<strong>the</strong>rwise it may confuse <strong>the</strong> data entry.<br />
<br />
• Make sure to write <strong>the</strong> right information in <strong>the</strong> right places: Some information comes from<br />
asking <strong>the</strong> woman, some from <strong>the</strong> antenatal clinic card, and some from <strong>the</strong> examination<br />
done for <strong>the</strong> assessment.<br />
• Completed consent forms (if used), questionnaires, slides, filter papers (if used), placenta<br />
tubes (if used), and logbooks should be guarded very carefully: Any missing or mislabeled<br />
items will compromise <strong>the</strong> final interpretation <strong>of</strong> <strong>the</strong> assessment.<br />
20 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Antenatal Clinic Survey<br />
Each antenatal clinic enrollment will have at least 2 loose pieces <strong>of</strong> information<br />
• Signed consent form, if used<br />
• Completed questionnaire (…pages)<br />
• 1 blood slide (thick and thin)<br />
Data management tasks <strong>of</strong> antenatal clinic staff:<br />
Each enrollment:<br />
• Mark ID number clearly on each item and each page<br />
• Mark ID number clearly on blood slide result from <strong>the</strong> lab<br />
Before woman leaves:<br />
During <strong>the</strong> day:<br />
• Verify that questionnaire is completed, and iron/folate given as indicated<br />
•If woman is febrile or had a fever recently: Ensure that lab results are returned<br />
as soon as possible. If <strong>the</strong> slide was positive, treat <strong>the</strong> woman with appropriate<br />
antimalarial drug as per national policy before she leaves that clinic that day (or<br />
when you visit <strong>the</strong> woman at home with results.)<br />
• Obtain lab results from all o<strong>the</strong>r women and if any were positive, prepare for treatment<br />
when <strong>the</strong> woman returns that afternoon or <strong>the</strong> next day<br />
Data management tasks <strong>of</strong> supervisor:<br />
At <strong>the</strong> end <strong>of</strong> each day:<br />
Each week:<br />
• Keep antenatal clinic log <strong>of</strong> enrollment and refusals up to date<br />
• Collect and review for completeness all data items<br />
• File all forms toge<strong>the</strong>r each day<br />
• Store all papers chronologically by assessment number<br />
• Store all slides chronologically by assessment number<br />
• Mark patient number range on each set <strong>of</strong> items, e.g.: 41.001 – 41.035<br />
• Put all items aside in a safe place<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
21
Delivery Unit Survey<br />
Each delivery will have at least 4 and as many as 8 loose pieces <strong>of</strong> information<br />
• Signed consent form, if used<br />
• Completed questionnaire (…pages)<br />
• 3 blood slides:<br />
Mo<strong>the</strong>r (thick and thin)<br />
Placenta (thick and thin)<br />
Cord (thick and thin)<br />
• 2 filter papers:, if used:<br />
Mo<strong>the</strong>r<br />
Placenta<br />
• Placenta tissue in tube, if used:<br />
Data management tasks <strong>of</strong> delivery unit staff:<br />
Each enrollment:<br />
• Mark patient number clearly on each item and each page<br />
• Mark M or P or C clearly on blood slides and filter papers, if used<br />
• Mark patient number + M or P or C in <strong>the</strong> laboratory logbook<br />
Before woman leaves:<br />
• Verify that questionnaire is completed<br />
• Verify that M and C slide results are back from laboratory, and treat her if positive<br />
Data management tasks <strong>of</strong> supervisor:<br />
At <strong>the</strong> end <strong>of</strong> each day:<br />
Each week:<br />
• Keep delivery log <strong>of</strong> enrollment and refusals up to date<br />
• Collect and review all data items for completeness<br />
• File all forms toge<strong>the</strong>r each day<br />
• Store all papers chronologically by assessment number<br />
• Store all slides chronologically by assessment number<br />
• Mark patient number range on each set <strong>of</strong> items, e.g.: 42.001 – 42.035<br />
• Put all items aside in a safe place<br />
22 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
J. Sample Logbooks: Enrollment and Laboratory<br />
• Enrollment logbook: Records a list, by facility, <strong>of</strong> <strong>the</strong> pregnant women visiting <strong>the</strong> site<br />
each day <strong>of</strong> <strong>the</strong> survey, her antenatal clinic number, and whe<strong>the</strong>r or not she was enrolled<br />
(and if not, why not).<br />
• Laboratory logbooks (two): One records information about <strong>the</strong> malaria blood films <strong>of</strong><br />
enrolled women and <strong>the</strong> o<strong>the</strong>r records information about enrolled women’s hemoglobin<br />
or hematocrit, by facility.<br />
During <strong>the</strong> assessment start-up, <strong>the</strong> assessment coordinator is responsible for ensuring that<br />
each site has prepared enrollment and laboratory logbooks.<br />
During <strong>the</strong> assessment, site supervisors are responsible for monitoring <strong>the</strong> use <strong>of</strong> <strong>the</strong> logbooks<br />
and preparing additional books as necessary.<br />
<strong>Malaria</strong> During Pregnancy <strong>Rapid</strong> <strong>Assessment</strong> - Enrollment Antenatal Clinic Logbook<br />
Facility: __________________________________________________________________________________________________<br />
District/Region: ________________________________________________________________________________________<br />
Date<br />
Woman’s<br />
antenatal<br />
clinic<br />
number<br />
Name <strong>of</strong><br />
Woman<br />
Age<br />
G/P*<br />
Mo<strong>the</strong>r<br />
tongue<br />
Enrolled?<br />
Yes/No<br />
Woman’s<br />
ID<br />
number<br />
Comments**<br />
*Gravidity/parity<br />
**It may be helpful to make a list <strong>of</strong> reasons for nonenrollment, along with a code number for each<br />
reason, and place it on <strong>the</strong> face page <strong>of</strong> <strong>the</strong> logbook. For example, if <strong>the</strong> first reason on <strong>the</strong> list was<br />
“woman refused to participate” and <strong>the</strong> code for that reason was “1,” “1” could be written in <strong>the</strong><br />
comments column above.<br />
<strong>Malaria</strong> During Pregnancy <strong>Rapid</strong> <strong>Assessment</strong> – Laboratory Antenatal Clinic Logbook for<br />
<strong>Malaria</strong> Facility: ________________________________________________________________________________________<br />
District/Region:________________________________________________________________________________________<br />
Date<br />
Woman’s<br />
ID<br />
number<br />
Blood<br />
smear<br />
+/-<br />
Species* Density Comments<br />
*In some settings may need a column for malaria species.<br />
<strong>Malaria</strong> During Pregnancy <strong>Rapid</strong> <strong>Assessment</strong> – Laboratory Antenatal Clinic Logbook for<br />
Hemoglobin Facility: _ _________________________________________________________________________________<br />
District/Region: ________________________________________________________________________________________<br />
Date<br />
Woman’s ID<br />
number<br />
Hb<br />
Comments<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
23
K. Handbook for <strong>Assessment</strong> Teams<br />
Each member <strong>of</strong> <strong>the</strong> assessment team should receive a handbook during<br />
assessment training.<br />
<strong>The</strong> handbook briefly describes <strong>the</strong> enrollment procedure and postenrollment activities,<br />
including <strong>the</strong> questionnaire, measurements and laboratory specimens, medications, and<br />
follow-up activities.<br />
Note: <strong>The</strong> team member’s handbook has space for including <strong>the</strong> number <strong>of</strong> women to be<br />
enrolled each day.<br />
HANDBOOK FOR ASSESSMENT TEAMS<br />
Antenatal Clinic Survey<br />
Contents<br />
I. Enrollment<br />
Identification <strong>of</strong> eligible women<br />
Inclusion criteria<br />
Exclusion criteria<br />
Provision <strong>of</strong> information or consent (if necessary)<br />
II. Postenrollment<br />
Questionnaire<br />
Measurements and laboratory specimens<br />
Medications<br />
Follow-up<br />
(Throughout woman’s stay at antenatal clinic unit: follow normal procedures to ensure safety <strong>of</strong><br />
mo<strong>the</strong>r and baby. Ensure proper medical care.)<br />
Goal: Enroll ____ women/day<br />
24 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Procedures<br />
Comments<br />
Enrollment<br />
1. Identify eligible women.<br />
Check antenatal clinic card<br />
Confirm information with woman<br />
Note regarding gravidity: All pregnancies count, not just live<br />
births. Inquire if <strong>the</strong> woman has had any pregnancies end in<br />
death <strong>of</strong> <strong>the</strong> fetus for completeness <strong>of</strong> gravidity history.<br />
Not previously enrolled in this assessment<br />
All pregnancies; have experienced quickening.<br />
Note: Record for all women attending antenatal<br />
clinic in <strong>the</strong> enrollment logbook:<br />
Date<br />
Woman’s antenatal clinic number<br />
Name<br />
Age<br />
Gravidity/parity<br />
Mo<strong>the</strong>r tongue<br />
Whe<strong>the</strong>r or not enrolled<br />
Woman’s ID number<br />
Reasons for nonenrollment:<br />
• refused to participate, already enrolled, not<br />
selected, etc.<br />
2. Ask every eligible woman to participate. Note: If antenatal clinic volume is high, it may be<br />
necessary to select every o<strong>the</strong>r eligible woman to<br />
avoid selection bias. It is not a good idea to select<br />
<strong>the</strong> first 10 women for example, as those who come<br />
early for antenatal clinic may be different from<br />
women who come later in <strong>the</strong> day.<br />
3. Verify criteria. Exclusion criteria:<br />
Gestational age before quickening<br />
Age
L. Blood Test Procedures: HemoCue for Determination <strong>of</strong><br />
Hemoglobin Level<br />
<strong>The</strong> following describes how to take a blood sample for use in a HemoCue machine.<br />
Note: Not all countries and sites routinely use <strong>the</strong> HemoCue method and so should use <strong>the</strong><br />
method currently used. However, if a choice exists, use <strong>of</strong> <strong>the</strong> HemoCue system is preferable<br />
as it allows a quick assessment <strong>of</strong> hemoglobin level that can be easily compared across<br />
countries and sites.<br />
• Organize <strong>the</strong> supplies you need:<br />
gloves<br />
cotton<br />
disinfectant swab<br />
lancet<br />
HemoCue<br />
HemoCue cuvette<br />
sharps disposal container<br />
hospital waste basket<br />
slide marker<br />
• Take one HemoCue cuvette from <strong>the</strong> container and close <strong>the</strong> lid again.<br />
• Switch HemoCue ON and open cuvette holder to loading position.<br />
• Put on gloves.<br />
• Use <strong>the</strong> third or fourth finger for sampling. Clean puncture site with disinfectant and<br />
allow to dry.<br />
• Use your thumb to lightly press <strong>the</strong> finger from top <strong>of</strong> <strong>the</strong> knuckle to <strong>the</strong> tip (to increase<br />
blood flow).<br />
• Using disposable lancet, prick <strong>the</strong> side <strong>of</strong> <strong>the</strong> fingertip. (See steps 1-3 in Figure A-1 in <strong>the</strong><br />
next section.) Immediately dispose <strong>of</strong> <strong>the</strong> lancet in a sharps container.<br />
• Wipe away <strong>the</strong> first 2-3 drops <strong>of</strong> blood. If necessary, apply light pressure again, until<br />
ano<strong>the</strong>r drop <strong>of</strong> blood appears. Avoid “milking.”<br />
• Fill HemoCue cuvette in one continuous process. Wipe <strong>of</strong>f excess blood on outside <strong>of</strong><br />
cuvette tip. Place in cuvette holder. Push HemoCue cuvette holder into <strong>the</strong> measuring<br />
position.<br />
• Wipe and clean puncture site.<br />
• Note Hb value (within 10 minutes <strong>of</strong> reading).<br />
• Take cuvette out <strong>of</strong> holder and throw away.<br />
• Clean up and be careful with sharps.<br />
• Switch HemoCue OFF.<br />
26 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
M. Blood Test Procedures: Thick and Thin Films for <strong>the</strong> Microscopic<br />
Diagnosis <strong>of</strong> <strong>Malaria</strong> Infection 3<br />
<strong>The</strong> following describes how to make thick and thin films for <strong>the</strong> determination <strong>of</strong> malaria<br />
infection. If <strong>the</strong>re are a substantial number <strong>of</strong> non–Plasmodium falciparum infections in <strong>the</strong><br />
area, both thick and thin films should be made. O<strong>the</strong>rwise, thick films are generally adequate.<br />
Note: <strong>Rapid</strong> tests are available that can detect <strong>the</strong> presence <strong>of</strong> malaria parasites in peripheral<br />
blood. <strong>The</strong>se tests, although expensive, perform well when conducted by trained personnel.<br />
<strong>The</strong>y show decreased sensitivity in persons/settings with low parasite load. <strong>The</strong>re are<br />
currently not enough data to recommend <strong>the</strong> use <strong>of</strong> rapid Organize <strong>the</strong> supplies you need:<br />
lab coat<br />
gloves<br />
cotton<br />
disinfectant swab<br />
2 slides (labeled slide & swipe slide)<br />
lancet<br />
sharps disposal container<br />
hospital waste basket<br />
slide marker<br />
Thick blood films are more sensitive in detecting malaria parasites because <strong>the</strong> blood is<br />
concentrated, allowing a greater volume <strong>of</strong> blood to be examined. However, thick films are<br />
difficult to read. Thick films are stained unfixed after drying.<br />
Thin films should be used if <strong>the</strong>re are a substantial number <strong>of</strong> non—P. falciparum infections in<br />
<strong>the</strong> area, as thin films make it easier to identify species. <strong>The</strong> thin film should be air-dried, fixed<br />
with methanol, and allowed to dry before staining.<br />
For best results, both thick and thin films should be stained with a 3% Giemsa solution (pH <strong>of</strong><br />
7.2) for 30--45 minutes. A Wright-Giemsa stain can also indicate malaria parasites but does<br />
not demonstrate Schüffner’s dots as reliably as Giemsa.<br />
Plasmodium parasites are always intracellular, and <strong>the</strong>y demonstrate, if stained correctly, blue<br />
cytoplasm with a red chromatin dot. Common errors in reading malaria films are caused by<br />
platelets overlying a red blood cell and <strong>the</strong> misreading <strong>of</strong> artifacts as parasites.<br />
Thick blood films are more sensitive in detecting malaria parasites because <strong>the</strong> blood is<br />
concentrated, allowing a greater volume <strong>of</strong> blood to be examined. WHO recommends that<br />
at least 100 fields, each containing approximately 20 white blood cells (WBCs), be screened<br />
before calling a thick smear negative.<br />
To quantify malaria parasites against WBCs (i.e., determine parasite density) on <strong>the</strong> thick<br />
smear: Tally <strong>the</strong> parasites against <strong>the</strong> WBCs, until you have counted 500 parasites or 1,000<br />
WBC, whichever comes first. Express <strong>the</strong> results as parasites per microliter <strong>of</strong> blood, using <strong>the</strong><br />
WBC count if known, or o<strong>the</strong>rwise assuming 8,000 WBCs per microliter blood.<br />
3 We have slightly adapted <strong>the</strong> following article for this section: Shah S, Filler S, Causer L et al. MMWR.<br />
Surveillance Summary. <strong>Malaria</strong> surveillance --- United States, 2002. April 30, 2004. 53 (SS01); 21-34.<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
27
Parasites/microliter blood = (parasites/WBCs) x WBC count per microliter (or 8,000).<br />
Thin smears are useful for species identification <strong>of</strong> parasites already detected on thick smears.<br />
<strong>The</strong>y are also useful for screening for parasites if adequate thick smear are not available and as<br />
a rapid screen while <strong>the</strong> thick smear is still drying.<br />
To quantify parasites (i.e., determine parasite density) against red blood cells (RBCs) on thin<br />
smear: Count <strong>the</strong> parasitized RBCs among 500-2,000 RBCs on <strong>the</strong> thin smear and express <strong>the</strong><br />
results as % parasitemia.<br />
% parasitemia = (parasitized RBCs/total RBCs) x 100. If <strong>the</strong> parasitemia is high (>10%)<br />
examine 500 BBCs; if it is low (
Figure A-1<br />
Figure A-2<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
29
N. Antenatal Clinic Survey Information Sheet 4<br />
<strong>The</strong> following information sheet should be given to each potential survey participant.<br />
If <strong>the</strong> potential survey participant cannot read or has low literacy skills, <strong>the</strong><br />
information should be read aloud to her. All potential participants should receive a<br />
copy <strong>of</strong> <strong>the</strong> information sheet to take home.<br />
Note to Interviewer: If <strong>the</strong> potential survey participant cannot read or if she has<br />
low literacy skills, read this information aloud to her. Give each potential survey<br />
participant a copy <strong>of</strong> this information sheet to take home.<br />
Introduction<br />
<strong>The</strong> [Ministry <strong>of</strong> Health] is doing an assessment to find out how many pregnant women in this<br />
[assessment area] have malaria. This will help us find <strong>the</strong> best ways to prevent <strong>the</strong> effects <strong>of</strong><br />
malaria on pregnant women and <strong>the</strong>ir babies. As you know, sometimes you may get malaria<br />
and feel sick. What you may not know is that sometimes you may have malaria without<br />
feeling sick. <strong>The</strong> only way for us to know how many women may have this problem is to check<br />
women’s blood. We plan to assess this problem in about _____ women in antenatal clinics in <strong>the</strong><br />
[assessment area].<br />
Purpose <strong>of</strong> <strong>the</strong> Survey<br />
We plan to check women’s blood for malaria to know how many women in <strong>the</strong> [assessment<br />
area] are infected. This will help us plan and measure <strong>the</strong> effects <strong>of</strong> programs to decrease<br />
malaria in pregnant women.<br />
Procedures<br />
If you agree to participate in this survey, we will ask you some questions about yourself and<br />
your health since you have been pregnant. We will not be telling anyone about your individual<br />
answers to <strong>the</strong> questions, and we will keep all assessment information about you safe and<br />
secure. You also do not need to answer any questions on <strong>the</strong> survey forms that you do not<br />
want to. We will review your clinic card and take your temperature. We will take a few drops <strong>of</strong><br />
blood from a finger stick to check your blood for anemia and malaria. You will still go through<br />
<strong>the</strong> usual clinic exam by <strong>the</strong> clinic staff. If we find that you have malaria, we will treat you<br />
with a drug called ___________ (enter appropriate drug name). If we find you need treatment for<br />
anemia, we will inform <strong>the</strong> clinic staff so <strong>the</strong>y will be sure to give you treatment for it. If you<br />
participate in <strong>the</strong> survey, it will take about x number <strong>of</strong> minutes more than if you did not.<br />
If you do not wish to participate in this survey, it will not affect <strong>the</strong> care given to you by <strong>the</strong><br />
clinic. If you have questions later, please feel free to ask. You can ask me today or if you have<br />
questions later, you can ask _________________ (responsible assessment team member).<br />
4 It is very important that <strong>the</strong> country’s human subjects or ethics requirements be followed with regard to<br />
whe<strong>the</strong>r provision <strong>of</strong> information only is sufficient or documentation <strong>of</strong> participant’s informed consent is<br />
necessary. It may also be required to obtain consent <strong>of</strong> <strong>the</strong> baby’s fa<strong>the</strong>r.<br />
30 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Risks or discomforts<br />
You will feel a “pinch” that lasts for a few seconds when <strong>the</strong> finger stick is done to take blood<br />
from your finger.<br />
Benefits<br />
One <strong>of</strong> <strong>the</strong> benefits to you <strong>of</strong> participating in this survey is that if we find that you have malaria,<br />
we will give you___________ (enter appropriate drug name) to cure it. If you have anemia, you’ll<br />
receive treatment for it.<br />
Treatment<br />
__________ (enter appropriate drug name) works very well to treat malaria. Studies have shown<br />
that this drug is very safe for you to take while you are pregnant and that it will not harm your<br />
baby. We believe that treating you for <strong>the</strong> malaria and recent fever outweighs any risk from <strong>the</strong><br />
drug.<br />
We are always concerned that abnormal events may occur when you are pregnant that might<br />
affect <strong>the</strong> baby inside <strong>of</strong> you. You may have seen babies that were born with some defects.<br />
Most <strong>of</strong> <strong>the</strong>se we cannot do anything about and it was no fault <strong>of</strong> <strong>the</strong> woman or clinic workers.<br />
If we treat you with any drug, we would only use one that we think is very safe and would not<br />
cause any <strong>of</strong> <strong>the</strong>se problems. If you have any questions about this, please ask now, or you can<br />
ask _______ (assessment team member) at <strong>the</strong> clinic at any time during <strong>the</strong> assessment. (Be sure<br />
to give enough information so that <strong>the</strong> woman can find <strong>the</strong>m.) If you have any questions about<br />
your rights as a survey participant, you may contact _________ (name and address to be filled in).<br />
Thank you very much for your time. Would you like to participate?<br />
Please keep this information sheet in case you have questions later on.<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
31
O. Analysis <strong>of</strong> Antenatal Clinic Data: Key Indicators<br />
and Summary Tables<br />
Below are key indicators for <strong>the</strong> Antenatal Clinic Survey and summary tables <strong>of</strong> survey<br />
results. Fur<strong>the</strong>r data analysis may be helpful, but it is generally not necessary for decision<br />
making.<br />
Tables can be useful for showing relationships between outcome variables.<br />
• Table 1 shows how representative <strong>the</strong> women in <strong>the</strong> survey are <strong>of</strong> <strong>the</strong> women in <strong>the</strong><br />
country.<br />
• Table 2 shows women’s reported use <strong>of</strong> prevention and control measures, such as IPTp,<br />
ITNs, and antimalarial drugs for treatment <strong>of</strong> illness.<br />
• Table 3 focuses on parasitemia, fever, and anemia by use <strong>of</strong> antenatal clinics and malaria<br />
prevention interventions.<br />
• Table 4 looks at <strong>the</strong> relationship between peripheral parasitemia, fever, and anemia.<br />
Note: <strong>The</strong> tables can also break down <strong>the</strong> numbers and percentages by locale (e.g., region,<br />
site, urban vs. rural).<br />
32 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Outcome Variables<br />
No. Outcome Variable (%) Numerator/Denominator<br />
1 Pregnant women with peripheral<br />
parasitemia<br />
Number <strong>of</strong> pregnant women with positive<br />
peripheral parasitemia blood films/<br />
Number <strong>of</strong> women with valid blood films<br />
2 Pregnant women with anemia<br />
(Hb
Table 1. Characteristics <strong>of</strong> Women in <strong>the</strong> Antenatal Clinic Survey and Women<br />
Country-Wide<br />
Characteristic<br />
Median age in years [range]<br />
Median gravidity [range]<br />
Antenatal clinic visits, median no. [range]<br />
Able to read<br />
Attended school (any)<br />
Married<br />
Owns own home<br />
Owns moped<br />
Owns bike<br />
Owns radio<br />
Works for cash<br />
Grows cash crops<br />
TOTAL<br />
Women in Antenatal<br />
Clinic Survey* (n= # )<br />
Women in national<br />
DHS**<br />
*Data are % <strong>of</strong> participants unless o<strong>the</strong>rwise indicated.<br />
**If available, national data (e.g., from Demographic and Health Surveys) can be used to<br />
compare how similar women in <strong>the</strong> assessment are to women nationally.<br />
34 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Table 2. Use <strong>of</strong> Prevention and Control Measures by Women in <strong>the</strong> Antenatal<br />
Clinic Survey<br />
Treatment and Prevention Measures<br />
(#sites) (#women)<br />
Gestational age at 1 st antenatal clinic visit<br />
Owns insecticide-treated bed net (ITN)<br />
Uses ITN<br />
Slept under ITN previous night<br />
Used antimalarial drug during pregnancy for prevention (IPTp)<br />
Used antimalarial drug during pregnancy for treatment <strong>of</strong> malaria<br />
illness<br />
Module 1: Conducting an Antenatal Clinic Survey<br />
35
Table 3. Status <strong>of</strong> Peripheral Parasitemia, Fever, and Anemia among<br />
Women in <strong>the</strong> Antenatal Clinic Survey<br />
All<br />
women<br />
(n=#)<br />
Women<br />
with no<br />
prior<br />
ANC<br />
(n=#)<br />
Women<br />
with at<br />
least 1<br />
prior<br />
antenatal<br />
clinic visit<br />
(n=#)<br />
Slept<br />
under<br />
bednet<br />
previous<br />
night<br />
(n=#)<br />
Use <strong>of</strong> antimalarial drug for IPTp<br />
during pregnancy among women<br />
with at least 1 prior antenatal<br />
clinic visit (n=#)<br />
Complete Incomplete None<br />
Parasitemia<br />
Overall<br />
Primigravidae<br />
Secundigravidae<br />
Multigravidae<br />
(>3 pregnancies)<br />
Fever<br />
Reported<br />
fever or<br />
malaria during<br />
pregnancy and<br />
took antimalarial<br />
drug<br />
Reported fever<br />
within 7 days <strong>of</strong><br />
enrollment<br />
Fever (>37.5ºC)<br />
at visit<br />
Anemia<br />
(Hb3 pregnancies)<br />
Moderate to<br />
severe anemia<br />
(Hb
Table 4. Relationship between Peripheral Parasitemia, Fever, and Anemia<br />
among Women in <strong>the</strong> Antenatal Clinic Survey<br />
Characteristic<br />
Reported fever<br />
within week before<br />
enrollment<br />
Parasitemic<br />
(n=#)<br />
Aparasitemic<br />
(n=#)<br />
Risk<br />
ratio<br />
95%<br />
Confidence<br />
interval<br />
P<br />
Anemia (Hb
38 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Woman’s full name:____________________________________________________________________________________<br />
ID #_____A________<br />
Tool 1: Antenatal Clinic Questionnaire<br />
Today’s date: ______/_______/______<br />
Day/Month/Year<br />
ID number: ___ _1__ -- ___ ___ ___<br />
Digit 1 = facility number Digit 2 = A (for antenatal clinic)<br />
Digits 3, 4 & 5 = woman’s consecutive number<br />
SCREENING QUESTION<br />
Interviewer number _______<br />
1. Age (years):: [ ]<br />
(If <strong>the</strong> mo<strong>the</strong>r does not know her age, <strong>the</strong>n estimate her age using <strong>the</strong> categories below)<br />
less than 15 years [ ] 30-34 years [ ]<br />
15-19 years [ ] 35-39 years [ ]<br />
20-24 years [ ] 40-44 years [ ]<br />
25-29 years [ ] more than 44 years [ ]<br />
If <strong>the</strong> woman is less than an age deemed appropriate, thank her for her time and<br />
DO NOT enroll her in this survey.<br />
2. Have you felt <strong>the</strong> baby move inside you? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
If <strong>the</strong> woman has not experienced quickening, thank her for her time, and<br />
DO NOT enroll her in this survey.<br />
DEMOGRAPHIC INFORMATION<br />
3. Village/town: ____________________________________________<br />
Interviewer: Skip <strong>the</strong> next question; it will be coded later so that it is done uniformly.<br />
4. Is this a rural or urban area? [ ]<br />
Urban = 1<br />
Rural = 2<br />
Periurban = 3<br />
Unknown = 9<br />
5. What language do you usually speak with family members at home? [ ]<br />
Language a = 1<br />
Language b = 2<br />
Language c = 3<br />
O<strong>the</strong>r = 8 (specify) ______________________________________<br />
6. Are you married? [ ]<br />
yes, married and living with husband = 1<br />
yes, married but do not live with husband = 2<br />
not married but living with a man = 3<br />
separated or divorced = 4<br />
widow <strong>of</strong> <strong>the</strong> fa<strong>the</strong>r <strong>of</strong> this baby = 5<br />
never married or lived with a man = 6<br />
<br />
Tool 1: Antenatal Clinical Questionnaire<br />
1
EDUCATION<br />
7. What is <strong>the</strong> highest level <strong>of</strong> school you attended? [ ]<br />
Primary = 1<br />
Secondary = 2<br />
Higher = 3<br />
Never attended = 4<br />
Unknown = 9<br />
8. Can you read? [ ]<br />
YES = 1<br />
NO = 2<br />
SOCIOECONOMIC INDICATORS<br />
9. What is <strong>the</strong> ro<strong>of</strong> <strong>of</strong> your house made <strong>of</strong>? [ ]<br />
corrugated iron = 1<br />
cement or concrete = 2<br />
wood and mud = 3<br />
thatch or grass = 4<br />
reed or bamboo = 5<br />
plastic sheet = 6<br />
mobile ro<strong>of</strong>s <strong>of</strong> nomads = 7<br />
o<strong>the</strong>r = 8 (specify) ________________________________<br />
10. What kind <strong>of</strong> floor does your house have? [ ]<br />
earth or sand = 1<br />
dung = 2<br />
wood planks = 3<br />
reed or bamboo = 4<br />
vinyl tiles or carpet = 5<br />
cement = 6<br />
cement tiles or brick = 7<br />
o<strong>the</strong>r = 8 (specify) ________________________________<br />
11. What is <strong>the</strong> main job <strong>of</strong> <strong>the</strong> head <strong>of</strong> household/husband? [ ]<br />
job a = 1<br />
job b = 2<br />
job c = 3<br />
job d = 4<br />
12. What is <strong>the</strong> monthly household income for your family? [ ]<br />
income bracket a = 1<br />
income bracket b= 2<br />
income bracket c=3<br />
FOR THE NEXT QUESTION, PLEASE ENTER A 1 OR 2 FOR EACH LINE<br />
13. Do you or any member <strong>of</strong> your family living in <strong>the</strong> same compound own:<br />
YES = 1<br />
NO = 2<br />
A bicycle/scooter/moped? [ ]<br />
A radio? [ ]<br />
A TV? [ ]<br />
Own <strong>the</strong> house you are living in? [ ]<br />
Own crop land? [ ]<br />
Grow cash crops? [ ]<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
REPRODUCTIVE AND CLINICAL HISTORY<br />
14. How many times have you become pregnant? [ ]<br />
(including this one and all o<strong>the</strong>r pregnancies, including abortions and miscarriages)<br />
14a. How many pregnancies with a live-born child? [ ]<br />
14b. How many pregnancies with loss <strong>of</strong> <strong>the</strong> fetus? [ ]<br />
MALARIA PREVENTION<br />
15. Did you take malaria medicine during this pregnancy to prevent/protect from malaria to keep illness from coming into<br />
<strong>the</strong> body when you did not have symptoms?<br />
(NOTE: This question does NOT concern treatment for malaria illness.) [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
If NO OR UNKNOWN, skip to question 16<br />
If YES:<br />
15a. What type <strong>of</strong> medicine did you take?<br />
Chloroquine [ ]<br />
Sulfadoxine-Pyrimethamine (SP, Fansidar) [ ]<br />
Proguanil [ ]<br />
O<strong>the</strong>r [ ]<br />
(specify): ______________________________<br />
Unknown [ ]<br />
15b. When you started taking <strong>the</strong> medicine, how many months pregnant were you? [ ]<br />
15c. For <strong>the</strong> first time you took <strong>the</strong> medicine, how many total tablets did you take? [ ]<br />
15d. How many times in a week did you take <strong>the</strong> medicine? [ ]<br />
15e. How many tablets did you take each time? [ ]<br />
15f. After <strong>the</strong> first dose, how <strong>of</strong>ten did you take this medicine? [ ]<br />
Every week = 1<br />
Almost every week = 2<br />
Some weeks = 3<br />
Monthly = 4<br />
Rarely = 5<br />
Do not know = 6<br />
16. Did you sleep under a bed net during this pregnancy? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
If no, skip to question 17<br />
16a. If yes, how frequently? [ ]<br />
all <strong>the</strong> time = 1<br />
most <strong>of</strong> <strong>the</strong> time = 2<br />
sometimes = 3<br />
rarely = 4<br />
16b. Did you sleep under <strong>the</strong> net last night? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
Tool 1: Antenatal Clinical Questionnaire<br />
3
16c. Has this net ever been treated with insecticide? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
16d. If yes, has <strong>the</strong> net been treated with insecticide in <strong>the</strong> past one year? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
16e. Is <strong>the</strong> net a long-lasting insecticide-treated net (LLN)? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
HISTORY OF FEVER OR MALARIA<br />
17. Have you had a fever that you thought was malaria during this pregnancy? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
If NO, skip to question 18<br />
17a. Did you get a convulsion with fever/malaria? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
17b. Did you stay in hospital overnight for treatment <strong>of</strong> fever/malaria? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
17c. Did you get a blood transfusion? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
17d. Did you take iron and folic acid tablets? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
17e. Have you taken a medication to treat malaria or fever during this pregnancy? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
17f. Type <strong>of</strong> medication taken (check all that apply)<br />
Chloroquine [ ]<br />
Sulfadoxine-Pyrimethamine (SP) [ ]<br />
Quinine [ ]<br />
Antipyretics [ ]<br />
Coartem [ ]<br />
O<strong>the</strong>r [ ]<br />
(specify):_________________________________<br />
Unknown [ ]<br />
18. Have you had a fever that you thought was malaria during <strong>the</strong> past week? [ ]<br />
(IF yes, perform a rapid diagnostic test and treat accordingly.)<br />
ANTENATAL RECORD INFORMATION<br />
(Copy <strong>the</strong> following information from <strong>the</strong> antenatal record)<br />
19. ANTENATAL CLINIC VISITS<br />
19a. Total number <strong>of</strong> visits (including this one) [ ]<br />
19b. Timing <strong>of</strong> visits:<br />
Date <strong>of</strong> visit______________Gestational age______________Fundal______________ (weeks)______________height______________<br />
first visit: ___ ___ / ___ ___ / ___ ___ [ ] [ ]<br />
this visit: ___ ___ / ___ ___ / ___ ___ [ ] [ ]<br />
19c. Last menstrual period (LMP)(if recorded)… ___ __/_____/____<br />
TODAY’S EXAMINATION BY ASSESSMENT TEAM<br />
20. Hemoglobin (g/dl): _____ _____ . _____<br />
If Hgb < 11, ensure that treatment for anemia is given<br />
If Hgb < 7, ensure that treatment for severe anemia given and refer to ANC staff<br />
21. Temperature ____ ____.____ (Celsius)<br />
(If temperature >37.5, do a rapid diagnostic test.)<br />
22. <strong>Rapid</strong> diagnostic test result [ ]<br />
Positive = 1<br />
Negative = 2<br />
Result available and examined, but undetermined = 9<br />
23. Blood film result [ ]<br />
Positive = 1<br />
Negative = 2<br />
Result available and examined, but undetermined = 9<br />
(If febrile, or history <strong>of</strong> fever in past 7 days with negative RDT, <strong>the</strong>n read <strong>the</strong> slide in <strong>the</strong> clinic immediately.)<br />
24. <strong>Malaria</strong> species. Check all that apply.<br />
Plasmodium falciparum = 1 [ ]<br />
P. vivax = 2 [ ]<br />
P. malariae = 3 [ ]<br />
P. ovale = 4 [ ]<br />
Undetermined = 9 [ ]<br />
25. Parasite density [ ]<br />
Tool 1: Antenatal Clinical Questionnaire<br />
5
26. Antimalarial drug given? [ ]<br />
YES = 1<br />
NO = 2<br />
If NO, skip to Q27<br />
26a. If YES, what type [ ]<br />
Chloroquine = 1<br />
Sulfadoxine-pyrimethamine (SP) = 2<br />
Chloroquine and SP = 3<br />
Quinine = 4<br />
Coartem = 5<br />
O<strong>the</strong>r = 8 (specify and explain): ____________________________________________________________<br />
26b. Date administered: ___ ___ / ___ ___ / ___ ___<br />
26c. Name <strong>of</strong> person administering antimalarial drugs _________________________________________<br />
27. Treatment given for anemia, according to national policy? [ ]<br />
YES = 1<br />
NO = 2 (If no, go to end <strong>of</strong> questionnaire)<br />
27a. What was <strong>the</strong> dose? _________<br />
27b. Was she given <strong>the</strong> appropriate amount to take home and complete her<br />
anemia treatment?<br />
Note to Interviewer: If a woman is currently febrile or reports having had a fever in <strong>the</strong> last 7 days, she should<br />
wait to receive her blood smear results prior to leaving clinic that day, and her blood slides should be promptly<br />
read. If <strong>the</strong> slide is positive, she should receive treatment with <strong>the</strong> appropriate antimalarial drug. If a woman<br />
is currently afebrile, with no history <strong>of</strong> fever in <strong>the</strong> past week, she need not wait for smear results but can<br />
return for <strong>the</strong>m <strong>the</strong> following day. If a woman is anemic or severely anemic, she should receive appropriate<br />
treatment.<br />
OR<br />
If above differs from <strong>the</strong> country’s national policy, follow national policy.<br />
PLEASE CHECK OVER THE QUESTIONNAIRE NOW TO MAKE SURE THAT ALL QUESTIONS HAVE BEEN ANSWERED, THEN<br />
CHECK THIS BOX [ ]<br />
Thank <strong>the</strong> woman for her time.<br />
28. QUALITY CONTROL<br />
Site supervisor should check all questionnaires for completeness every day at <strong>the</strong> end <strong>of</strong> all interviews.<br />
Data entry clerks should initial at <strong>the</strong> end <strong>of</strong> every entry.<br />
Person Name/Signature Date<br />
28a Site Supervisor<br />
28b Data Entry Clerk 1<br />
28c Data Entry Clerk 2<br />
28d <strong>Assessment</strong> Coordinator<br />
6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Module 2: Conducting a Delivery Unit Survey<br />
A Delivery Unit Survey is designed to determine <strong>the</strong> magnitude<br />
<strong>of</strong> <strong>the</strong> problem <strong>of</strong> malaria, specifically:<br />
• What is <strong>the</strong> prevalence <strong>of</strong> peripheral, placental, and umbilical cord<br />
parasitemia in pregnant women?<br />
• What is <strong>the</strong> prevalence <strong>of</strong> low birth weight and premature delivery?<br />
• Is <strong>the</strong>re a relationship between parasitemia and low birth weight or<br />
premature delivery?<br />
• Does <strong>the</strong> prevalence <strong>of</strong> placental parasitemia vary by gravidity or locale?<br />
This module contains sample materials for a Delivery Unit Survey. <strong>The</strong>se<br />
materials can and should be adapted to suit local needs. General guidance for<br />
conducting a Delivery Unit Survey and managing data can be found in Chapters<br />
3 and 4 <strong>of</strong> <strong>the</strong> manual.<br />
Contents<br />
Consult Resource 3 for presentations that address some <strong>of</strong> <strong>the</strong><br />
topics below.<br />
A. Delivery Unit Survey Timetable<br />
B. Selecting Sample Sizes<br />
C. Eligibility Criteria<br />
D. List <strong>of</strong> Supplies and Equipment<br />
E. <strong>Assessment</strong> Teams<br />
F. <strong>Assessment</strong> Team Training (Resource 3)<br />
G. Supervisor’s Check List for <strong>Assessment</strong> Start-Up<br />
H. Supervisor’s Guide to Conducting Antenatal Clinic<br />
and Delivery Unit Surveys<br />
I. Supervisor’s Guide to Data Management for Antenatal Clinic and<br />
Delivery Unit Surveys<br />
J. Sample Logbooks: Enrollment and Laboratory<br />
K. Handbook for <strong>Assessment</strong> Teams<br />
L. Guide for Night-time Admissions to <strong>the</strong> Delivery Unit<br />
M. Ballard Score Sheet for Determining Gestational Age<br />
(see also Resource 3)<br />
N. Blood Test Procedures: Making Thick and Thin Films for <strong>the</strong> Microscopic<br />
Detection <strong>of</strong> <strong>Malaria</strong> Infection<br />
O. Taking Blood Samples from a Finger, Placenta,<br />
and Umbilical Cord<br />
P. Making a Placental Impression Smear<br />
Q. Information Sheet<br />
R. Analysis <strong>of</strong> Delivery Unit Survey Data<br />
Module 2: Delivery Unit Survey<br />
1
A. Delivery Unit Survey Timetable<br />
<strong>The</strong> timetable below outlines key steps in planning for and conducting Delivery Unit (and<br />
antenatal clinic) survey activities and <strong>the</strong> approximate length <strong>of</strong> time to allow for <strong>the</strong>se steps.<br />
Note that this timetable is <strong>the</strong> same as that for <strong>the</strong> ANC survey and that <strong>the</strong>se preparations and<br />
activities should be undertaken simultaneously.<br />
Period Time Activities<br />
Planning <strong>the</strong><br />
assessment<br />
2-4 weeks •Determine what assessment components, if any, need<br />
to be conducted<br />
• Determine what approvals (ethical, scientific, o<strong>the</strong>r<br />
ministerial) are needed and initiate approval process<br />
Preassessment 2-3 weeks • Select Site(s)<br />
• Explain <strong>the</strong> assessment to <strong>the</strong> community<br />
• Procure assessment equipment and supplies<br />
• Hire assessment team and/or identify existing staff<br />
• Adapt and translate questionnaires<br />
• Pretest questionnaires<br />
• Identify site for training<br />
• Identify responsible persons for all presentations<br />
(See Resource 3 for sample presentations)<br />
• Manage logistics <strong>of</strong> training, including per diem,<br />
transportation, meals, and lodging<br />
• Arrange for on-site training in DUs and in ANCs<br />
<strong>Assessment</strong><br />
training<br />
Start-up <strong>of</strong><br />
assessment<br />
1 week • Conduct training course<br />
• Finalize questionnaires based on pretest and make<br />
adequate copies for final day <strong>of</strong> training<br />
• Meet with supervisors to coordinate assessment<br />
start-up in clinical facilities<br />
2 weeks • Make adequate copies <strong>of</strong> ANC and Delivery Unit<br />
questionnaires, enrollment logbooks, and laboratory<br />
logbooks, and ensure questionnaires are at assessment<br />
sites<br />
• Distribute supplies to each assessment site and ensure<br />
a system <strong>of</strong> re-stocking supplies is in place<br />
• Establish quality control mechanism for data collection,<br />
including clinical and laboratory procedures,<br />
transport, and storage<br />
• Establish a supervisory system that addresses logistics<br />
(staffing, supplies), quality <strong>of</strong> interviewing, quality<br />
<strong>of</strong> questionnaires, quality <strong>of</strong> obtaining specimens,<br />
laboratory quality (slide and staining, Hemocue<br />
calibration), logbook maintenance<br />
<strong>Assessment</strong> 8-9 weeks • Enroll women and collect data<br />
• Ensure supervisory system and quality control<br />
mechanisms are functioning<br />
• Ensure adequate supplies and equipment are available<br />
and functioning at each assessment site<br />
Postassessment 8 weeks • Conduct data entry, cleaning, and analysis<br />
• Write final report<br />
• Disseminate results<br />
• Initiate policy discussions<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
B. Selecting Sample Sizes<br />
<strong>The</strong> sample size needed for <strong>the</strong> Delivery Unit Survey depends on<br />
1) <strong>the</strong> estimated prevalence <strong>of</strong> women with placental parasitemia and <strong>of</strong> LBW babies,<br />
2) <strong>the</strong> acceptable margin <strong>of</strong> error, and<br />
3) <strong>the</strong> design effect<br />
<strong>The</strong> sample size required to measure each <strong>of</strong> <strong>the</strong> survey’s main indicators (placental<br />
parasitemia and low-birth-weight babies) can be calculated by using Statcalc in EPI-INFO. <strong>The</strong><br />
EPI-INFO calculation should include an adjustment (i.e., design effect [see note at end <strong>of</strong> this<br />
section, Selecting Sample Sizes]) for <strong>the</strong> fact that <strong>the</strong> survey uses cluster sampling, ra<strong>the</strong>r than<br />
random sampling.<br />
If <strong>the</strong> sample size required to measure one indicator is larger than <strong>the</strong> sample size required for<br />
<strong>the</strong> o<strong>the</strong>r indicator, <strong>the</strong> larger <strong>of</strong> <strong>the</strong> two sample sizes should be selected. <strong>The</strong> sample size may<br />
need to be modified to account for o<strong>the</strong>r factors (see example below).<br />
Determination <strong>of</strong> <strong>the</strong> sample size for <strong>the</strong> Delivery Unit Survey begins with<br />
1. Point estimates <strong>of</strong> <strong>the</strong> proportion <strong>of</strong> women with placental parasitemia and<br />
<strong>the</strong> proportion <strong>of</strong> babies with LBW<br />
2. <strong>The</strong> level <strong>of</strong> accuracy desired, for example + 10%, and<br />
3. <strong>The</strong> design effect<br />
Delivery Unit Survey Sample Size Calculation: An Example<br />
Point estimates: <strong>The</strong> prevalence <strong>of</strong> placental parasitemia during high transmission season<br />
among women <strong>of</strong> all gravidities is estimated at 35%, and <strong>the</strong> prevalence <strong>of</strong> LBW is estimated to<br />
be 14%.<br />
Level <strong>of</strong> accuracy: <strong>The</strong> assessment coordinator determines that it is acceptable if <strong>the</strong> survey<br />
can estimate <strong>the</strong> prevalence <strong>of</strong> placental parasitemia within 10% (that is, <strong>the</strong> prevalence <strong>of</strong><br />
parasitemia could be between 25% and 45%) and <strong>the</strong> prevalence <strong>of</strong> low birth weight within<br />
5% [that is, low birth weight could be between 9% and 19%].<br />
<strong>The</strong>se numbers are <strong>the</strong>n entered in Statcalc, with a design effect=2 (to correct for <strong>the</strong> fact that<br />
this is not a random community sample) for each indicator. <strong>The</strong> design effect <strong>of</strong> 2 is chosen on<br />
<strong>the</strong> basis <strong>of</strong> previous similar studies. EPI-INFO <strong>the</strong>n calculates sample sizes: 174 for placental<br />
parasitemia and 370 for LBW. <strong>The</strong> larger <strong>of</strong> <strong>the</strong>se two is 370, and thus this is <strong>the</strong> sample size<br />
for <strong>the</strong> Delivery Unit Survey.<br />
Estimated<br />
prevalence<br />
Margin <strong>of</strong><br />
error<br />
Needed<br />
sample size<br />
(from Statcalc)<br />
O<strong>the</strong>r<br />
factors<br />
Placental 35% 10% 174 --- 174<br />
parasitemia<br />
during high<br />
transmission<br />
season<br />
LBW 14% 5% 370 --- 370<br />
Total<br />
delivery unit<br />
Sample size<br />
(after adjusting<br />
for o<strong>the</strong>r factors)<br />
Note: If <strong>the</strong> prevalence <strong>of</strong> placental parasitemia during high transmission season is unknown,<br />
assume a level <strong>of</strong> 50% for calculating sample size. This level is <strong>the</strong> most conservative estimate,<br />
as it yields <strong>the</strong> largest required sample size. If <strong>the</strong> prevalence <strong>of</strong> LBW is unknown, countries<br />
could use <strong>the</strong> following estimates from UNICEF and WHO to calculate sample sizes:<br />
East Africa, 13.5%; Middle Africa, 12.3%; Sou<strong>the</strong>rn Africa, 14.6%; and Western Africa, 15.4%.<br />
370<br />
Module 2: Delivery Unit Survey<br />
3
Note: If <strong>the</strong> assessment is being used as a baseline that will be repeated after an intervention<br />
in order to demonstrate impact, <strong>the</strong> sample required will be larger and <strong>the</strong> sample size calculations<br />
more complex. It is advisable to consult a statistician for fur<strong>the</strong>r guidance.<br />
Note on design effect:<br />
Large surveys are <strong>of</strong>ten conducted using cluster surveys, meaning that <strong>the</strong> population is<br />
divided into clusters and sampled accordingly. Clusters are selected by random sampling and<br />
<strong>the</strong>n random samples are taken within <strong>the</strong> selected clusters. <strong>The</strong> benefits <strong>of</strong> cluster sampling<br />
are that it is <strong>of</strong>ten easier and less expensive to conduct than simple random sampling as <strong>the</strong><br />
needed sample size is smaller. However, its disadvantage is that <strong>the</strong>re is a loss <strong>of</strong> precision<br />
because <strong>the</strong> elements within <strong>the</strong> cluster are generally more correlated (similar) than those<br />
between <strong>the</strong> clusters. Selecting an additional member from <strong>the</strong> same cluster adds less<br />
new information than would a completely independent selection. As <strong>the</strong> cluster size and<br />
intracluster correlation increase, cluster variances increase more than one would find in a<br />
simple random sample. <strong>The</strong> benefits <strong>of</strong> cluster sampling <strong>of</strong>ten outweigh <strong>the</strong> disadvantage <strong>of</strong><br />
<strong>the</strong> loss in precision.<br />
Because cluster sampling results in a loss <strong>of</strong> precision and a smaller sample size, an<br />
adjustment called <strong>the</strong> design effect should be used to determine survey sample size when<br />
clustering is involved. <strong>The</strong> design effect is basically <strong>the</strong> ratio <strong>of</strong> <strong>the</strong> actual variance , under <strong>the</strong><br />
sampling method actually used, to <strong>the</strong> variance computed under <strong>the</strong> assumption <strong>of</strong> simple<br />
random sampling. <strong>The</strong> main components <strong>of</strong> <strong>the</strong> design effect are <strong>the</strong> intraclass correlation and<br />
<strong>the</strong> cluster sample sizes. <strong>The</strong> design effect is calculated as follows:<br />
DEFF = 1 + þ (n – 1),<br />
where Deff is <strong>the</strong> design effect, þ is <strong>the</strong> intraclass correlation for <strong>the</strong> statistic in question, and<br />
n is <strong>the</strong> average size <strong>of</strong> <strong>the</strong> cluster. <strong>The</strong> interpretation <strong>of</strong> a value <strong>of</strong> DEFF <strong>of</strong>, say, 3.0 is that<br />
<strong>the</strong> sample variance is 3 times bigger than it would be if <strong>the</strong> survey were based on <strong>the</strong> same<br />
sample size but selected randomly. It can be seen that <strong>the</strong> design effect increases as <strong>the</strong> cluster<br />
sizes increase, and as <strong>the</strong> intraclass correlation increases. <strong>The</strong> square root <strong>of</strong> <strong>the</strong> design effect<br />
shows how much <strong>the</strong> sample standard error, and consequently <strong>the</strong> confidence intervals,<br />
will increase because <strong>of</strong> <strong>the</strong> clustering. <strong>The</strong> intraclass correlation represents <strong>the</strong> likelihood<br />
that two elements in <strong>the</strong> same cluster have <strong>the</strong> same value, for a given statistic, relative to<br />
two elements chosen completely at random in <strong>the</strong> population. A value <strong>of</strong> 0.10 is interpreted,<br />
<strong>the</strong>refore, to mean that <strong>the</strong> elements in <strong>the</strong> cluster are about 10% more likely to have <strong>the</strong> same<br />
value than if <strong>the</strong> two elements were chosen at random in <strong>the</strong> survey.<br />
4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Design effects vary from survey to survey and even within <strong>the</strong> same survey will vary from<br />
question to question. In summary, using a cluster sample generally requires ei<strong>the</strong>r a larger<br />
sample size than a simple random sample or a wider confidence interval. <strong>The</strong> design effect<br />
is used to determine how much larger <strong>the</strong> sample size or confidence interval needs to be.<br />
In general, for a well-designed study, <strong>the</strong> design effect usually ranges from 1 to 3. It is not<br />
uncommon, however, for <strong>the</strong> design effect to be much larger.<br />
<strong>The</strong> survey methodology recommended for both <strong>the</strong> antenatal clinic surveys and <strong>the</strong> Delivery<br />
Unit Surveys use cluster sample methodology and thus require that a design effect be used.<br />
C. Eligibility Criteria<br />
All women who are delivering babies should be asked to participate in <strong>the</strong> survey.<br />
Women are eligible for <strong>the</strong> survey if <strong>the</strong>y meet <strong>the</strong> following requirements:<br />
Gravidity: All gravidities. Although primigravidae and secundigravidae are <strong>the</strong> groups<br />
typically most affected in high transmission areas, women <strong>of</strong> all gravidities should be eligible<br />
so that <strong>the</strong> burden <strong>of</strong> malaria during pregnancy can be estimated for all pregnant women.<br />
Age: <strong>The</strong> youngest age at which women are eligible to participate should be <strong>the</strong> age at which<br />
most women in <strong>the</strong> assessment area have <strong>the</strong>ir first child. This is to ensure that primigravidae<br />
and secundigravidae (<strong>the</strong> groups at highest risk) are included in <strong>the</strong> assessment. <strong>The</strong> usual<br />
minimum age is 15 years. <strong>The</strong> age <strong>of</strong> <strong>the</strong> youngest participants may well be less than <strong>the</strong> age<br />
<strong>of</strong> majority and should be consistent with any country policy or norm regarding this type <strong>of</strong><br />
survey.<br />
Notes: Women who participated in <strong>the</strong> ANC survey are eligible to also participate in <strong>the</strong><br />
Delivery Unit Survey, but should not be selected for <strong>the</strong> Client Exit Interview.<br />
Module 2: Delivery Unit Survey<br />
5
D. List <strong>of</strong> Supplies and Equipment<br />
Make sure that each delivery unit has <strong>the</strong> necessary supplies and equipment before <strong>the</strong><br />
start <strong>of</strong> <strong>the</strong> survey.<br />
Item Quantity Comments/Use # in<br />
stock/<br />
Balance<br />
needed<br />
Screening<br />
& Clinical<br />
Evaluation<br />
Electronic<br />
<strong>the</strong>rmometers<br />
2 Temperature collection; if electronic<br />
<strong>the</strong>rmometers are unavailable,<br />
mercury glass <strong>the</strong>rmometers are an<br />
acceptable alternative.<br />
Baby scale 1 Ideally, an electronic digital scale.<br />
A well-calibrated balance scale is<br />
also acceptable.<br />
Tape measure 1 Mo<strong>the</strong>r’s mid-upper arm<br />
circumference.<br />
Height stick 1 Can make height measuring area on<br />
wall <strong>of</strong> DU.<br />
Laboratory<br />
Count-down 1 For laboratory use.<br />
timer<br />
Slides 3/participant Allow extras for waste<br />
Lancets 2/participant Allow extras for waste;<br />
1 for peripheral blood film and 1 to<br />
pierce <strong>the</strong> umbilical cord.<br />
Isopropyl<br />
alcohol<br />
Cotton wool<br />
or gauze<br />
Giemsa stain<br />
Toilet paper<br />
(or slide boxes)<br />
Container for<br />
used lancets<br />
Staining jars<br />
Slide drying rack<br />
Enough<br />
to clean<br />
1 finger/<br />
participant<br />
Enough<br />
to clean<br />
1 finger/<br />
participant<br />
Premoistened alcohol wipes are an<br />
acceptable alternative.<br />
Gauze is preferable to wool as it<br />
leaves fewer fibers on <strong>the</strong> placenta<br />
and <strong>the</strong>refore on <strong>the</strong> slide.<br />
Based upon sample size. In addition<br />
to Giemsa powder, need all<br />
o<strong>the</strong>r materials to mix stain, including<br />
distilled water, buffer, glycerol,<br />
and glassware to mix and store.<br />
Sufficient to wrap (or store) all<br />
slides from assessment<br />
1 Sharps container<br />
2/lab<br />
1/lab<br />
Hair dryer 1/lab May be needed, depending on<br />
climate. Optional.<br />
Microscope 1/lab<br />
Surgical scissors 6 pairs/site<br />
Forceps<br />
6/site<br />
Date<br />
Ordered<br />
6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Item Quantity Comments/Use # in<br />
stock/<br />
Balance<br />
needed<br />
Date<br />
Ordered<br />
Wooden<br />
applicator sticks<br />
or plastic<br />
transfer pipettes<br />
1/participant<br />
To transfer placental blood to slide<br />
Spare light bulbs<br />
for microscope<br />
Immersion oil<br />
Lens cleaner<br />
Lens cleaning<br />
tissue<br />
Sharpie markers<br />
(ultra fine)<br />
Examination<br />
gloves<br />
1/lab<br />
3 tubes/lab<br />
3 pairs/<br />
participant<br />
Need 1 pair for peripheral film<br />
and 2 pairs for placental sampling.<br />
Need extra for laboratory and extra<br />
for breakage<br />
Tally counters 2/laboratory<br />
Computer 1-2 2 is ideal, 1 is adequate<br />
(with at least<br />
Windows 2000)<br />
Epi-Info or ano<strong>the</strong>r<br />
1-2 Installed on each computer<br />
statistical<br />
s<strong>of</strong>tware package<br />
(Epi Info is<br />
preferred)<br />
Goggles 2 pairs/site For use when handling placenta to<br />
prevent splashes to eyes.<br />
Tray<br />
1/site<br />
Tissue paper<br />
Filter paper<br />
Bleach<br />
Beaker and 1/site<br />
basin<br />
Office Supplies<br />
AA batteries<br />
If using digital baby scale.<br />
Clipboards 1/interviewer<br />
Pencils<br />
1/interviewer<br />
Only if preparing thin films.<br />
Pencil sharpener 1/interviewer<br />
Only if preparing thin films.<br />
Pens<br />
2/interviewer<br />
Stapler 1<br />
Staples<br />
2 boxes<br />
Ink pad/Ink 1/site For fingerprinting women if signature<br />
needed and woman cannot<br />
sign. Should be bound books, not<br />
spiral-bound or perforated.<br />
Logbooks 1/site and 1/<br />
lab<br />
Module 2: Delivery Unit Survey<br />
7
E. <strong>Assessment</strong> Teams<br />
<strong>The</strong> number <strong>of</strong> assessment teams depends on <strong>the</strong> number <strong>of</strong> delivery units used.<br />
<strong>The</strong> following example assumes that 4 delivery units will be used.<br />
Title<br />
Number needed<br />
<strong>Assessment</strong> coordinator 1<br />
Laboratorian supervisor 1<br />
Site supervisors<br />
Interviewers<br />
Laboratorians<br />
Data management coordinator 1<br />
Data entry clerks 2<br />
4 (1 per site)<br />
8 (2 per site)<br />
4 (1 per site)<br />
Note: At least one assessment team member should be available 24 hours per day to enroll all<br />
women who are delivering and promptly process placentas. If this is not possible, a cooler and<br />
icepacks should be available in order to store placentas.<br />
F. <strong>Assessment</strong> Team Training<br />
<strong>The</strong> training for site supervisors, interviewers, and laboratorians should be held after<br />
preassessment activities. Training will take approximately 4-5 days.<br />
Below is a detailed explanation <strong>of</strong> how to conduct <strong>the</strong> training. A sample schedule follows <strong>the</strong><br />
explanation.<br />
Note: If both antenatal clinic (ANC) and Delivery Unit (DU) surveys will be conducted, it is<br />
more efficient to conduct training for both surveys simultaneously. <strong>The</strong>refore, this module<br />
describes simultaneous training. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, this module will need<br />
to be modified accordingly.<br />
Note: If qualitative studies will be conducted about <strong>the</strong> same time as <strong>the</strong> quantitative studies,<br />
it would be beneficial to conduct <strong>the</strong> training simultaneously. Consult <strong>the</strong> qualitative training<br />
manual (or <strong>the</strong> modules that accompany <strong>the</strong> qualitative surveys) for guidance on how to<br />
combine <strong>the</strong> two.<br />
Day 1:<br />
Morning: <strong>The</strong> assessment coordinator should present background information on malaria<br />
during pregnancy and assessment objectives. (See Resource 3 for sample presentations)<br />
Afternoon: <strong>The</strong> assessment coordinator reviews ANC policies and procedures located in<br />
<strong>the</strong> assessment team member’s handbook (see K in this Module). This provides a general<br />
overview <strong>of</strong> <strong>the</strong> assessment. Once <strong>the</strong> overview is complete, <strong>the</strong> assessment coordinator<br />
should split <strong>the</strong> interviewers into teams. Each team will rotate through ANC and delivery unit<br />
clinical procedures. Depending on <strong>the</strong> size <strong>of</strong> <strong>the</strong> assessment team, <strong>the</strong> logistics can be varied.<br />
In a small team, everyone might work toge<strong>the</strong>r to go through all procedures. In a large team<br />
with a sufficient number <strong>of</strong> facilitators, it may be worthwhile to divide teams into groups that<br />
rotate around a series <strong>of</strong> workstations. <strong>The</strong> important thing is that each staff member have <strong>the</strong><br />
opportunity to learn and practice each procedure that he/she will be conducting.<br />
8 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
ANC procedures include 1 :<br />
• Exercise universal precaution for handling blood<br />
Take and read axillary temperature<br />
• Collect blood samples (fingersticks) from each o<strong>the</strong>r<br />
Prepare slide (recording date and ID number on slide)<br />
• Prepare thick films (and thin films in an area with substantial P. vivax transmission)<br />
• Prepare Hemocue cuvette for hemoglobin reading; or Measure Hb or Hct by methods<br />
used in that clinic<br />
Delivery unit procedures include:<br />
• Measure women’s mid-upper arm circumference<br />
• Measure woman’s height<br />
• Prepare slides—peripheral, placental, and cord blood<br />
• Weigh newborn using scale<br />
• Conduct <strong>the</strong> Ballard examination and apply <strong>the</strong> scoring system<br />
(See Resource 3 for Ballard video)<br />
Day 2:<br />
Morning: <strong>The</strong> assessment coordinator arranges for interviewers to visit a delivery unit site<br />
for practice <strong>of</strong> delivery unit procedures. At <strong>the</strong> same time, <strong>the</strong> laboratorian supervisor trains<br />
assessment laboratorians on how to read peripheral, placental and cord films. (See N and O in<br />
this module)<br />
Afternoon: In a group setting, <strong>the</strong> assessment coordinator reviews each question on ANC and<br />
delivery unit questionnaires and <strong>the</strong> information sheet (or consent form), depending on which<br />
is being used. <strong>The</strong> coordinator also describes why <strong>the</strong>re is a consent form if a consent form<br />
has been determined necessary. Interviewers should be encouraged to ask questions and <strong>of</strong>fer<br />
suggestions. After reviewing each questionnaire, <strong>the</strong> interviewers should break into small<br />
groups and practice each questionnaire one-on-one using copies <strong>of</strong> actual ANC cards from <strong>the</strong><br />
clinic. Any discrepancies regarding data extraction from ANC cards should be addressed with<br />
<strong>the</strong> assessment coordinator, and questionnaires revised as necessary.<br />
Day 3:<br />
Morning: After <strong>the</strong> survey instruments are adapted, <strong>the</strong> survey instruments, as well as <strong>the</strong><br />
information sheet (or informed consent form if used), should be translated into <strong>the</strong> national<br />
language and <strong>the</strong> primary language spoken by women in <strong>the</strong> assessment area, if different.<br />
This initial translation should be followed by a back-translation (by individuals who did not<br />
produce <strong>the</strong> original translation) into <strong>the</strong> national language to check <strong>the</strong> adequacy <strong>of</strong> <strong>the</strong><br />
translation. Once <strong>the</strong> translation is complete, pretesting can begin. While <strong>the</strong> surveys are<br />
being pretested, laboratorians could practice film reading.<br />
Note: If <strong>the</strong> primary language is not a written language, it will be important to use correct,<br />
consistent phrasing <strong>of</strong> survey questions and information on <strong>the</strong> information sheet (or<br />
informed consent form) so that questions are asked in a standardized manner. All<br />
interviewers should work toge<strong>the</strong>r to achieve correct, consistent phrasing <strong>of</strong> <strong>the</strong> questions<br />
and have <strong>the</strong> opportunity to practice.<br />
Afternoon: <strong>The</strong> assessment coordinator arranges for interviewers to visit two ANC sites to<br />
practice <strong>the</strong> ANC questionnaire with clients. NOTE: Since <strong>the</strong> delivery unit questionnaire<br />
is very similar to <strong>the</strong> ANC questionnaire, it is not necessary to pretest <strong>the</strong> delivery unit<br />
questionnaire due to ethical considerations related to practicing interviewing women in labor<br />
without <strong>the</strong>ir being enrolled in <strong>the</strong> assessment.<br />
Divide <strong>the</strong> interviewers into two teams. Each team should visit one <strong>of</strong> <strong>the</strong> selected sites to pretest<br />
<strong>the</strong> ANC questionnaires with at least 15 clients (total, not per interviewer) in each facility.<br />
1 In some circumstances it may be possible to conduct polymerase chain reaction (PCR) on filter paper<br />
samples or to examine tissue specimens preserved in formalin. However, in many settings <strong>the</strong>se are nei<strong>the</strong>r<br />
possible nor necessary.<br />
Module 2: Delivery Unit Survey<br />
9
Day 4:<br />
Morning: <strong>The</strong> assessment coordinator will explain <strong>the</strong> purpose <strong>of</strong> ANC and delivery unit<br />
enrollment and laboratory logbooks. <strong>The</strong>n, <strong>the</strong> coordinator should demonstrate and review<br />
<strong>the</strong>se logbooks. Many people may not understand that <strong>the</strong> logbooks are used to record<br />
everyone who is enrolled in <strong>the</strong> assessment as well as those who are excluded for any reason.<br />
<strong>The</strong> interviewers should be divided into pairs to practice <strong>the</strong> revised questionnaires. <strong>The</strong> rest<br />
<strong>of</strong> <strong>the</strong> morning should be used to resolve outstanding issues, and conclude <strong>the</strong> training.<br />
Day 5:<br />
If training is scheduled for 5 days, Day 5 can be reserved for work on any remaining issues.<br />
Sample Training Schedule<br />
Day 1 Day 2 Day 3 Day 4<br />
Introduction/ Overview<br />
Delivery Unit Clinical<br />
Procedures<br />
Pretest<br />
questionnaires<br />
Wrap-up<br />
Morning<br />
• Welcome<br />
• Training objectives<br />
• <strong>Malaria</strong> situation in<br />
country<br />
• Epidemiology <strong>of</strong><br />
malaria during<br />
pregnancy<br />
• <strong>Rapid</strong> assessment<br />
objectives<br />
See Resource 3 for<br />
sample presentations.<br />
Microscopy training<br />
for laboratorians<br />
On site delivery unit<br />
clinical procedures<br />
training and practice<br />
for interviewers<br />
Practice<br />
questionnaires<br />
and consent form<br />
administration in<br />
local language(s)<br />
with translator<br />
Practice<br />
questionnaires<br />
and consent form<br />
administration in<br />
local language(s) in<br />
small groups<br />
Introduce enrollment and<br />
laboratory registers<br />
Practice questionnaires<br />
in pairs (using ANC cards<br />
and ANC and delivery unit<br />
registers).<br />
Conclusion <strong>of</strong> training<br />
Afternoon<br />
Policy and procedures<br />
in ANC and delivery unit<br />
(worker’s handbook)<br />
Practice clinical<br />
procedures for ANC and<br />
delivery unit (video <strong>of</strong><br />
Ballard) if available.<br />
Use live demonstrations<br />
using an adult model<br />
before practicing on live<br />
newborns.<br />
Review ANC and<br />
delivery unit<br />
questionnaires and<br />
consent forms<br />
Practice<br />
questionnaires in<br />
pairs (using ANC<br />
cards). Resolve<br />
discrepancies<br />
regarding data<br />
extraction from ANC<br />
cards.<br />
Pretest<br />
questionnaires on<br />
site in ANC facilities<br />
• Meet with supervisors<br />
to discuss assessment<br />
start-up:<br />
• Make copies <strong>of</strong> ANC<br />
and delivery unit<br />
questionnaires<br />
• Ensure ANC and<br />
delivery unit log books<br />
are at each assessment<br />
site<br />
• Distribute supplies to<br />
each assessment site<br />
• Establish quality control<br />
mechanism<br />
• Establish a supervisory<br />
system<br />
Evening<br />
Read questionnaires<br />
and consent forms<br />
<strong>Assessment</strong><br />
coordinator<br />
finalizes ANC<br />
and delivery unit<br />
questionnaires<br />
based on pretests.<br />
10 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
G. Supervisor’s Check List for <strong>Assessment</strong> Start-Up<br />
<strong>The</strong> following contains worksheets to assist <strong>the</strong> supervisor during <strong>the</strong> start-up phase <strong>of</strong> <strong>the</strong><br />
assessment. <strong>The</strong>se sheets pertain to both Antenatal Clinic and Delivery Unit Surveys, as most<br />
likely both will be conducted. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, <strong>the</strong> list will need to be<br />
modified accordingly.<br />
Explain <strong>the</strong> purpose <strong>of</strong> <strong>the</strong> assessment to <strong>the</strong> “community,” through direct communication<br />
where possible, and also through <strong>the</strong> display <strong>of</strong> malaria posters in <strong>the</strong> clinic, and any o<strong>the</strong>r<br />
communication means.<br />
Set up <strong>the</strong> supply management system:<br />
• Verify that all supplies on <strong>the</strong> list are available.<br />
• Provide <strong>the</strong> delivery unit, antenatal clinic unit, and <strong>the</strong> lab each with a set <strong>of</strong> supplies<br />
(papers, laboratory materials, examination materials, antimalarial drugs and hematinics)<br />
to last at least one week.<br />
• If supply shortages (batteries, slides, etc.) are noticed, find a solution to continue <strong>the</strong><br />
assessment uninterrupted.<br />
• Keep spare supplies in a safe place, preferably a locked cupboard or box.<br />
• Keep <strong>the</strong> record <strong>of</strong> available stocks.<br />
Have planning meeting with <strong>the</strong> assessment team:<br />
• Make sure every person understands what is expected <strong>of</strong> him/her.<br />
• Draw up a time and duty schedule for each team member, aiming for 8 hrs/day antenatal<br />
clinic presence, and 24 hrs/day delivery room presence.<br />
• Rehearse every team member’s interviewer number, and go over <strong>the</strong> patient number<br />
system once more.<br />
Also:<br />
• Instruct <strong>the</strong> night staff <strong>of</strong> <strong>the</strong> delivery room to routinely store ALL placentas for <strong>the</strong><br />
assessment in individually marked plastic bags in <strong>the</strong> ice box if no assessment team<br />
member happens to be present<br />
• Assign responsibility for <strong>the</strong> ice box and for replacing <strong>the</strong> ice packs to an assessment<br />
team member<br />
• Arrange additional laboratory support, if needed<br />
• Identify possible translators for local languages among <strong>the</strong> hospital staff. Where<br />
possible, make <strong>the</strong>m familiar with <strong>the</strong> questionnaire beforehand.<br />
Module 2: Delivery Unit Survey<br />
11
Set up instruments:<br />
• Set up measuring tape, scales and Ballard chart in <strong>the</strong> delivery room<br />
• Set up Hemocue instructions in <strong>the</strong> antenatal clinic room, if using Hemocue. Set up <strong>the</strong><br />
Hemocue and calibrate. Recalibrate daily.<br />
• Find a safe and stable place for <strong>the</strong> infant weighing scale. Make sure that it is never lifted<br />
by <strong>the</strong> cradle, as this will damage it.<br />
• Keep instrument instructions in a safe place for future reference.<br />
Set up data management system:<br />
• Provide staff with enough information sheets (or consent forms, if used) and<br />
questionnaires for at least one week.<br />
• Make <strong>the</strong> arrangements for daily review <strong>of</strong> assessment results by <strong>the</strong> supervisor toge<strong>the</strong>r<br />
with <strong>the</strong> antenatal clinic and delivery unit staff.<br />
• Make arrangements for daily storing <strong>of</strong> papers and slides (and filter papers and test<br />
tubes, if being used).<br />
• Make arrangements for weekly storing <strong>of</strong> papers and slides (and filter papers and test<br />
tubes, if being used).<br />
• Go through <strong>the</strong> data management system with <strong>the</strong> team members.<br />
Set up assessment logs:<br />
• Antenatal clinic logbook, delivery unit logbook, laboratory logbooks<br />
(one for malaria, one for anemia)<br />
12 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
H. Supervisor’s Guide to Conducting Antenatal Clinic<br />
and Delivery Unit Surveys<br />
<strong>The</strong> following guide contains worksheets to assist <strong>the</strong> supervisor in noting <strong>the</strong> progress <strong>of</strong> <strong>the</strong><br />
survey, reminding <strong>the</strong> supervisor <strong>of</strong> important tasks (e.g., calibrating <strong>the</strong> Hemocue machine<br />
daily), and guiding <strong>the</strong> supervisor in reviewing questionnaires.<br />
<strong>The</strong>se worksheets should be filled out on a regular basis, as determined by <strong>the</strong> supervisor.<br />
Note: <strong>The</strong> worksheets pertain to both Antenatal Clinic and Delivery Unit Surveys, as most likely<br />
both will be conducted. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, <strong>the</strong> forms can be modified<br />
accordingly.<br />
Site: ______________________________<br />
Date: ___ ___ / ___ ___ / ___ ___<br />
1. Enrollment and rates <strong>of</strong> positivity<br />
Antenatal clinic enrolled to date (No): ___________ Number positive: __________<br />
Last antenatal clinic ID number used: ___ ___ - ___ ___ ___<br />
Delivery enrolled to date (No):___________<br />
Number positive (Placental): __________<br />
Number positive (Maternal): __________<br />
Number positive (Cord): __________<br />
Last delivery ID number used: ___ ___ - ___ ___ ___<br />
2. Staff, supplies and samples<br />
Have any staff left <strong>the</strong> assessment?<br />
Are all nights on <strong>the</strong> delivery unit being covered by <strong>the</strong> assessment team? ______<br />
If this is not possible, are sufficient coolers (with icepacks) available for placental storage? ____<br />
____________________________________________________________________________________________________________<br />
Using <strong>the</strong> supply list above, note if supplies are adequate.<br />
YES =1 NO = 2<br />
Any o<strong>the</strong>r missing supplies: ______________________________________<br />
If any supplies are needed, what is <strong>the</strong> plan for restocking? _________________________________________<br />
____________________________________________________________________________________________________________<br />
Are questionnaires and samples well organized and in a safe place?_______________________________<br />
____________________________________________________________________________________________________________<br />
If not, plan to improve situation:_______________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
Samples and questionnaires taken to central location:<br />
Module 2: Delivery Unit Survey<br />
13
ANC:<br />
Questionnaire numbers<br />
Slide numbers:<br />
___ ___ - ___ ___ ___ to ___ ___ - ___ ___ ___<br />
___ ___ - ___ ___ ___ to ___ ___ - ___ ___ ___<br />
Delivery<br />
Questionnaire numbers<br />
Slide numbers (M,P,C):<br />
Tissue sample numbers, if collected:<br />
Filter paper numbers (M,P), if collected:<br />
___ ___ - ___ ___ ___ to ___ ___ - ___ ___ ___<br />
___ ___ - ___ ___ ___ to ___ ___ - ___ ___ ___<br />
___ ___ - ___ ___ ___ to ___ ___ - ___ ___ ___<br />
___ ___ - ___ ___ ___ to ___ ___ - ___ ___ ___<br />
3. Antenatal Care<br />
Is <strong>the</strong> Hemocue machine being calibrated daily?______________________________________________________<br />
____________________________________________________________________________________________________________<br />
Check calibration today: ________________________________________________________________________________<br />
Examine <strong>the</strong> logbooks. Are <strong>the</strong>y being filled out correctly? __________________________________________<br />
(Note: Enrollment logbooks should contain all patients, whe<strong>the</strong>r or not enrolled in<br />
assessment]<br />
Note any problems with logbooks:_____________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
What is <strong>the</strong> plan to correct any problems with logbooks? ___________________________________________<br />
____________________________________________________________________________________________________________<br />
What is <strong>the</strong> average enrollment per day? (look at last 10 days): ____________________________________<br />
If it is too high or too low, examine reasons, and make a plan for correction:______________________<br />
____________________________________________________________________________________________________________<br />
Are enrollments evenly spaced throughout <strong>the</strong> day (i.e., not all in <strong>the</strong> a.m. or p.m.)? _____________<br />
Examine at least 5 questionnaires per assessment team member. Note any problems, and<br />
discuss with that person. Pay particular attention to whe<strong>the</strong>r hemoglobin, temperature, and<br />
blood smear results are completed.<br />
Note any important problems and what measures were taken to fix <strong>the</strong>m:<br />
Are women with anemia receiving iron or iron/folate? ________<br />
If not, why not? ______________________________________________________________________<br />
Are women with positive blood smears receiving treatment for malaria?__________________________<br />
If not, why not?__________________________________________________________________________________________<br />
If consent forms are used, examine. Have women signed <strong>the</strong>m in accordance with assessment/<br />
country policy? Is <strong>the</strong> name <strong>of</strong> a contact person for questions written in as instructed?__________<br />
____________________________________________________________________________________________________________<br />
14 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
4. Delivery Unit<br />
Examine logbooks. Are <strong>the</strong>y being filled out correctly? ______________________________________________<br />
(Note: Enrollment logbook should contain all deliveries, whe<strong>the</strong>r or not enrolled in<br />
assessment)<br />
Note any problems with logbook: ______________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
What is <strong>the</strong> plan to correct any problems with <strong>the</strong> logbook: ________________________________________<br />
___________________________________________________________________________<br />
What is <strong>the</strong> average enrollment per day? (look at last 10 days): __________<br />
If it seems very low, examine reasons, and make a plan for correction:<br />
___________________________________________________________________________<br />
___________________________________________________________________________<br />
Examine at least 5 questionnaires per assessment team member. Note any problems, and<br />
discuss with that person. Pay particular attention to ensure that <strong>the</strong> following are completed:<br />
height, arm circumference, baby weight, Ballard gestational age, blood smear results and<br />
treatment.<br />
Note any specific problems and what measures were taken to fix <strong>the</strong>m:___________________________<br />
____________________________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
Is <strong>the</strong> baby’s sex being documented on <strong>the</strong> Delivery Unit questionnaire ?__________________________<br />
Are women with positive blood smears receiving treatment for malaria?__________________________<br />
If not, why not?__________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
If consent forms are used, examine. Have women signed <strong>the</strong>m in accordance with assessment/<br />
country policy? Is <strong>the</strong> name <strong>of</strong> a contact person for questions written in as instructed?__________<br />
____________________________________________________________________________________________________________<br />
Are sample sets complete for each delivery patient (that is, do <strong>the</strong>y contain a questionnaire, 3<br />
slides (M, P, C), and, if collected, 2 filter papers (M, P), and a tissue sample? ______________________<br />
____________________________________________________________________________________________________________<br />
If not, why not? __________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
Module 2: Delivery Unit Survey<br />
15
5. Laboratory<br />
Examine <strong>the</strong> results books. Are <strong>the</strong> books being completed correctly?_____________________________<br />
If problems are found, document here, and make a plan for correction: ___________________________<br />
____________________________________________________________________________________________________________<br />
Are <strong>the</strong> results for mo<strong>the</strong>rs from antenatal clinic with fever, and mo<strong>the</strong>rs and babies from<br />
delivery, being given promptly to assessment team? _________________________________________________<br />
____________________________________________________________________________________________________________<br />
If not, what steps can be taken to improve <strong>the</strong> speed <strong>of</strong> obtaining results? ________________________<br />
____________________________________________________________________________________________________________<br />
Reread 10% <strong>of</strong> <strong>the</strong> slides <strong>of</strong> each type (ANC, Delivery M, Delivery P, Delivery C).<br />
Rate <strong>the</strong> accuracy <strong>of</strong> slides:<br />
Thick: (1 to 5, 5 is highly accurate):_______________<br />
Thin: (1 to 5, 5 is highly accurate): _______________<br />
If quality is poor, examine reasons (e.g., smears badly done, thick specimen is fixed, or stain<br />
coloration is bad), and try to find a solution to <strong>the</strong> problem: ________________________________________<br />
____________________________________________________________________________________________________________<br />
Are slides being stored in a good manner (in slide boxes or, if slide boxes cannot be obtained,<br />
rolled in tissue paper)?: ________________________________________________________________________________<br />
If not, plan for correction: ______________________________________________________________________________<br />
Does <strong>the</strong> laboratory have adequate supplies?_________________________________________________________<br />
If not, plan to correct <strong>the</strong> problem: ____________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
7. Data Entry<br />
Review at least 5 questionnaires that have been entered in <strong>the</strong> computer.<br />
Number <strong>of</strong> errors found in 5 ANC: _____________________________________________________________________<br />
Number <strong>of</strong> errors found in 5 Delivery:_________________________________________________________________<br />
Is <strong>the</strong> record number being written at <strong>the</strong> top <strong>of</strong> each questionnaire on each page? ______________<br />
O<strong>the</strong>r comments, observations or problems not mentioned above_________________________________<br />
____________________________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
____________________________________________________________________________________________________________<br />
16 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
I. Supervisor’s Guide to Data Management for Antenatal Clinic<br />
and Delivery Unit Surveys<br />
<strong>The</strong> following guide contains worksheets to assist <strong>the</strong> supervisor in managing and collecting<br />
data. Worksheets outline tasks for assessment team members, as well as <strong>the</strong> supervisor.<br />
Note: <strong>The</strong> worksheets pertain to both Antenatal Clinic and Delivery Unit Surveys, as most<br />
likely both will be conducted. If only one <strong>of</strong> <strong>the</strong> surveys is conducted, <strong>the</strong> forms will need to be<br />
modified accordingly.<br />
Enrollment targets:<br />
• List for each site:<br />
Desired # <strong>of</strong> antenatal clinic visits: at least x/day<br />
Desired # <strong>of</strong> deliveries:<br />
at least x/day<br />
Target data collection period:<br />
• ANC<br />
• Deliveries<br />
Assigning an ID number:<br />
List months during which to collect <strong>the</strong>se data<br />
List months during which to collect <strong>the</strong>se data<br />
1st digit: assessment site<br />
Site #1 1<br />
Site #2 2<br />
Site #3 3<br />
Site #4 4<br />
2nd digit: type <strong>of</strong> health service<br />
ANC<br />
Delivery<br />
A<br />
D<br />
3rd – 5th digit: consecutive number identifying each patient<br />
Example: 35th antenatal clinic woman in Site#3 = 3A – 035<br />
46th delivery in Site#1 = 1D – 046<br />
Note: If <strong>the</strong> woman has been assigned an ID number but enrollment has to be abandoned for<br />
whatever reason, file all related papers and test results, and assign <strong>the</strong> next woman <strong>the</strong> next<br />
number. ID numbers should only be used once. All ID numbers should be accounted for at <strong>the</strong><br />
final data analysis.<br />
• All data must be entered in computer<br />
• All data items must be returned to designated location for re-entering into computer (for<br />
double data entry) and quality control <strong>of</strong> slide readings<br />
Mark ID NUMBERS on each item and each page!!<br />
Module 2: Delivery Unit Survey<br />
17
Assigning an interviewer number:<br />
<strong>The</strong> supervisor should assign each interviewer a unique number to be used throughout<br />
assessment.<br />
For example:<br />
Site #1 01 – 20<br />
Site #2 21 – 40<br />
Site #3 41 – 60<br />
Site #4 61 – 80<br />
Hints to provide interviewers for filling out questionnaires:<br />
• Keep all pages <strong>of</strong> <strong>the</strong> consent forms (if used) and <strong>of</strong> <strong>the</strong> questionnaires stapled toge<strong>the</strong>r<br />
• Number all pages immediately with <strong>the</strong> ID number<br />
• Write clearly<br />
•………….. is a connecting line<br />
•________ is a line to write on<br />
• Feel free to make notes in <strong>the</strong> margin <strong>of</strong> <strong>the</strong> questionnaire form if <strong>the</strong> answer you<br />
got was not very clear or if you have doubts. <strong>The</strong> more information <strong>the</strong> better.<br />
• If it states “check all that apply,” please do not enter dashes for negative. Just leave<br />
those spaces blank. O<strong>the</strong>rwise it may confuse <strong>the</strong> data entry.<br />
• Make sure to get <strong>the</strong> right information in <strong>the</strong> right places: Some information comes<br />
from asking <strong>the</strong> woman, some from <strong>the</strong> antenatal clinic card, and some from <strong>the</strong><br />
examination done for <strong>the</strong> assessment.<br />
Completed consent forms (if used), questionnaires, slides, filter papers (if used), placenta<br />
tubes (if used), and logbooks should be guarded very carefully: Any missing or<br />
mislabeled items will compromise <strong>the</strong> final interpretation <strong>of</strong> <strong>the</strong> assessment.<br />
Antenatal Clinic Survey<br />
Each antenatal clinic enrollment will have at least 2 loose pieces <strong>of</strong> information<br />
• Signed consent form, if used<br />
• Completed questionnaire (…pages)<br />
• 1 blood slide (thick and thin)<br />
Data management tasks <strong>of</strong> antenatal clinic staff:<br />
Each enrollment:<br />
• Mark patient number clearly on each item and each page<br />
• Mark patient number clearly on blood slide result from <strong>the</strong> lab<br />
Before woman leaves:<br />
• Verify that questionnaire is completed, and iron/folate given as indicated<br />
• If woman is febrile or had a fever recently: Ensure that lab results are returned as soon as<br />
possible and treat <strong>the</strong> woman with appropriate antimalarial drug as per national policy<br />
before she leaves <strong>the</strong> clinic that day (Monica has a question here) if <strong>the</strong> slide was positive<br />
During <strong>the</strong> day:<br />
• Obtain lab results from all o<strong>the</strong>r women and if any were positive, prepare for treatment<br />
when <strong>the</strong> woman returns that afternoon or <strong>the</strong> next day<br />
18 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Data management tasks <strong>of</strong> supervisor:<br />
At <strong>the</strong> end <strong>of</strong> each day:<br />
• Keep antenatal clinic log <strong>of</strong> enrollment and refusals up to date<br />
• Collect and review for completeness all data items<br />
• File all forms toge<strong>the</strong>r each day<br />
Each week:<br />
• Store all papers chronologically by assessment number<br />
• Store all slides chronologically by assessment number<br />
• Mark patient number range on each set <strong>of</strong> items, e.g.: 41.001 – 41.035<br />
• Put all items aside in a safe place<br />
Delivery Unit Survey<br />
Each delivery will have at least 4 and as many as 8 loose pieces <strong>of</strong> information<br />
• Signed consent form, if used<br />
• completed questionnaire (…pages)<br />
• 3 blood slides:<br />
• Mo<strong>the</strong>r (thick and thin)<br />
• Placenta (thick and thin)<br />
• Cord (thick and thin)<br />
• 2 filter papers:, if used:<br />
• Mo<strong>the</strong>r<br />
• Placenta<br />
• Placenta tissue in tube, if used:<br />
Data management tasks <strong>of</strong> delivery unit staff:<br />
Each enrollment:<br />
• Mark patient number clearly on each item and each page<br />
• Mark M or P or C clearly on blood slides and filter papers, if used<br />
• Mark patient number + M or P or C in <strong>the</strong> laboratory logbook<br />
Before woman leaves:<br />
• Verify that questionnaire is completed<br />
• Verify that M and C slide results are back from laboratory, and treat her if positive<br />
Data management tasks <strong>of</strong> supervisor:<br />
At <strong>the</strong> end <strong>of</strong> each day:<br />
• Keep delivery log <strong>of</strong> enrollment and refusals up to date<br />
• Collect and review all data items for completeness<br />
• File all forms toge<strong>the</strong>r each day<br />
Each week:<br />
• Store all papers chronologically by assessment number<br />
• Store all slides chronologically by assessment number<br />
• Mark patient number range on each set <strong>of</strong> items, e.g.: 41.001 – 41.035<br />
• Put all items aside in a safe place<br />
Module 2: Delivery Unit Survey<br />
19
J. Sample Logbooks: Enrollment and Laboratory<br />
• Enrollment logbook: Records a list, by facility, <strong>of</strong> <strong>the</strong> pregnant women visiting <strong>the</strong> site<br />
each day <strong>of</strong> <strong>the</strong> survey, her survey number, and whe<strong>the</strong>r or not she was enrolled (and if<br />
not, why not).<br />
• Laboratory logbooks: One records information about enrolled women’s malaria blood<br />
films, and <strong>the</strong> o<strong>the</strong>r records information about enrolled women’s hemoglobin or<br />
hematocrit, by facility.<br />
During <strong>the</strong> assessment start-up, <strong>the</strong> assessment coordinator is responsible for ensuring that<br />
each site has prepared enrollment and laboratory logbooks. During <strong>the</strong> assessment, site<br />
supervisors are responsible for monitoring <strong>the</strong> use <strong>of</strong> <strong>the</strong> logbooks and preparing additional<br />
books as necessary.<br />
<strong>Malaria</strong> During Pregnancy <strong>Rapid</strong> <strong>Assessment</strong> - Enrollment Delivery Unit Logbook<br />
Facility: __________________________________________________________________________________________________<br />
District/Region:________________________________________________________________________________________<br />
Date<br />
Woman’s<br />
DU<br />
number<br />
Name <strong>of</strong><br />
Woman<br />
Age G/P* Mo<strong>the</strong>r<br />
tongue<br />
Enrolled?<br />
Yes/No<br />
Woman’s<br />
ID number<br />
Comments**<br />
*Gravidity/parity<br />
**It may be helpful to make a list <strong>of</strong> reasons for nonenrollment, along with a code number for<br />
each reason, and place it on <strong>the</strong> face page <strong>of</strong> <strong>the</strong> logbook. For example, if <strong>the</strong> first reason on<br />
<strong>the</strong> list was “woman refused to participate” and <strong>the</strong> code for that reason was “1,” “1” could be<br />
written in <strong>the</strong> comments column above.<br />
<strong>Malaria</strong> During Pregnancy <strong>Rapid</strong> <strong>Assessment</strong> –<br />
Laboratory Delivery Unit Logbook for <strong>Malaria</strong><br />
Facility: __________________________________________________________________________________________________<br />
District/Region:________________________________________________________________________________________<br />
Date<br />
Woman’s<br />
ID number<br />
Blood<br />
smear<br />
+/-<br />
Maternal:<br />
Placenta:<br />
Cord:<br />
M:<br />
P:<br />
C:<br />
Species*<br />
Density (only<br />
for maternal<br />
sample)<br />
*Some settings may need a column for malaria species.<br />
Pigment<br />
Comments<br />
20 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
K. Handbook for <strong>Assessment</strong> Teams<br />
Each member <strong>of</strong> <strong>the</strong> assessment team should receive a handbook during assessment training.<br />
<strong>The</strong> handbook briefly describes <strong>the</strong> enrollment procedure and postenrollment activities,<br />
including <strong>the</strong> questionnaire, measurements and laboratory specimens, medications, and<br />
follow-up activities.<br />
Note: <strong>The</strong> team member’s handbook has space for including <strong>the</strong> number <strong>of</strong> women to be<br />
enrolled each day.<br />
Throughout woman’s stay at delivery unit: Follow normal procedures to ensure safety<br />
<strong>of</strong> mo<strong>the</strong>r and baby. Ensure proper medical care.<br />
Ensure that ei<strong>the</strong>r an interviewer is available 24 hours/day in <strong>the</strong> delivery unit to enroll<br />
all women and process placentas OR that an ice pack and cooler is available for storage<br />
and <strong>the</strong> interviewer arriving in <strong>the</strong> morning can retrospectively enroll women who<br />
arrived during <strong>the</strong> night.<br />
Procedures<br />
Enrollment<br />
1. Identify eligible women.<br />
• Confirm information with woman<br />
Note: Enroll all women at delivery, even<br />
those who may have participated in <strong>the</strong><br />
ANC survey.<br />
Comments<br />
All deliveries<br />
Mo<strong>the</strong>rs at least 15 years old<br />
(or minimum age limit)<br />
Note: Record for all women attending delivery<br />
unit in <strong>the</strong> enrollment logbook:<br />
Date<br />
Woman’s delivery unit number<br />
Name<br />
Age<br />
Gravidity/parity<br />
Mo<strong>the</strong>r tongue<br />
Whe<strong>the</strong>r or not enrolled<br />
Woman’s ID number<br />
Reasons for no enrollment:<br />
• Refused to participate, placenta not available,<br />
left delivery unit without being enrolled, less<br />
than minimum age.<br />
2. Verify criteria. Exclusion criteria:<br />
• Allergic to antimalarial drugs being used or<br />
related drugs<br />
• Age
Postenrollment<br />
Mo<strong>the</strong>r<br />
4. Complete <strong>the</strong> questionnaire, collecting<br />
information on <strong>the</strong> current pregnancy.<br />
Note: Peripheral blood samples are taken<br />
before and after delivery. Parasitemia<br />
<strong>of</strong>ten clears quickly after delivery.<br />
Baby<br />
5. Examine <strong>the</strong> baby within 24 hours <strong>of</strong><br />
delivery.<br />
Note: Nonlive births should be enrolled, if<br />
feasible and culturally appropriate.<br />
• Administer questionnaire.<br />
• Mark <strong>the</strong> thick film slide with <strong>the</strong> date, woman’s<br />
enrollment number, and <strong>the</strong> letter “M” to<br />
indicate that slide is mo<strong>the</strong>r’s peripheral blood<br />
film.<br />
• Take mo<strong>the</strong>r’s height and midupper arm circumference<br />
If live birth:<br />
• Determine sex<br />
• Weigh (in grams)<br />
• Assign a Ballard score (see directions later in<br />
this module)<br />
• Determine gestation age in weeks<br />
• Note any physical abnormalities<br />
If nonlive birth:<br />
• Take placental and umbilical cord samples<br />
• Weigh<br />
• Record probable cause <strong>of</strong> death<br />
Placenta<br />
6. Take placenta samples<br />
(see directions later in this module)<br />
7. Give treatment to <strong>the</strong> mo<strong>the</strong>r if she has<br />
a positive peripheral blood film and<br />
to <strong>the</strong> baby if <strong>the</strong> baby has a positive<br />
umbilical cord film.<br />
Note re: night-time deliveries: Ideally, interviewers<br />
will be available 24 hours/day to enroll<br />
women who deliver at night and to promptly<br />
process placentas. If not, ensure that ice packs<br />
and coolers are available for placenta storage.<br />
Mark two separate slides with <strong>the</strong> following<br />
information:<br />
• Mark <strong>the</strong> placental thick film slide with <strong>the</strong><br />
date, woman’s enrollment number, and <strong>the</strong> letter<br />
“P” to indicate that this slide is <strong>the</strong> mo<strong>the</strong>r’s<br />
placental film.<br />
• Mark <strong>the</strong> umbilical cord thick film slide with<br />
<strong>the</strong> date, woman’s enrollment number, and <strong>the</strong><br />
letter “C” to indicate slide as cord film.<br />
• Provide treatment according to <strong>the</strong><br />
country policy<br />
• A thin blood film may be required in areas with high prevalence <strong>of</strong> mixed or pure non—P.<br />
falciparum species.<br />
22 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
L. Guide for Night-Time Admissions to <strong>the</strong> Delivery Unit<br />
Ideally, interviewers will be available 24 hours per day to enroll women who deliver at<br />
night and to promptly process placentas, but this is not always possible. Coolers (with<br />
ice packs) should be available for storing placentas.<br />
<strong>The</strong> following describes how to handle enrollment and placenta samples for women<br />
who are admitted during <strong>the</strong> night if no interviewer is present.<br />
At night if no team member is present:<br />
•Store all placentas in individual bags in <strong>the</strong> cooler (outfitted with ice packs). Mark patient<br />
name and hospital registration number on <strong>the</strong> bag.<br />
• Enter patient data in <strong>the</strong> hospital’s delivery ward admissions book.<br />
• Encourage women to stay in <strong>the</strong> hospital until <strong>the</strong> assessment team arrives in <strong>the</strong> morning.<br />
In <strong>the</strong> morning on arrival <strong>of</strong> <strong>the</strong> assessment team member:<br />
• Check hospital’s delivery ward admissions book for deliveries, copy into assessment log.<br />
• Check placenta box to see if all are <strong>the</strong>re.<br />
• See if mo<strong>the</strong>rs and newborns are still on <strong>the</strong> ward.<br />
• Enroll patients for whom placentas are available. Do questionnaire, obtain Mo<strong>the</strong>r’s thick<br />
and thin blood smear and examine mo<strong>the</strong>r and child. Encourage mo<strong>the</strong>r to wait for slide<br />
results from <strong>the</strong> laboratory. Submit M slide with priority to <strong>the</strong> laboratory.<br />
• Once all questionnaires and clinical examinations are done, take <strong>the</strong> placenta samples.<br />
Batch placenta testing toge<strong>the</strong>r, submit C slide with priority to <strong>the</strong> laboratory.<br />
• Get lab results back and treat mo<strong>the</strong>r and newborn if slides were positive.<br />
Note: Leave <strong>the</strong> placenta tests for after you have finished with <strong>the</strong> mo<strong>the</strong>r and baby.<br />
<strong>The</strong> placentas will stay in <strong>the</strong> ice box, but <strong>the</strong> mo<strong>the</strong>r might o<strong>the</strong>rwise leave <strong>the</strong> hospital.<br />
Module 2: Delivery Unit Survey<br />
23
M. Ballard Score Sheet for Determining Gestational Age<br />
<strong>The</strong> Ballard score sheet can be used to determine gestational age. A video that<br />
describes <strong>the</strong> Ballard method is included on <strong>the</strong> accompanying CD-ROM, with <strong>the</strong> kind<br />
permission <strong>of</strong> Dr. Jeanne Ballard.<br />
Some researchers have proposed a modification <strong>of</strong> <strong>the</strong> Ballard examination in<br />
which only <strong>the</strong> external criteria are evaluated and <strong>the</strong> neurologic examination is not<br />
performed [Verhoeff FH, Milligan P, Brabin BJ, Mlanga S, Nakoma N. 1997. Gestational<br />
age assessment by nurses in a developing country using <strong>the</strong> Ballard method, external<br />
criteria only. Annals <strong>of</strong> Tropical Paediatrics, 1997. 17: 333-342]. <strong>The</strong> resulting score is<br />
<strong>the</strong>n doubled to arrive at a total Ballard score with which an estimated gestational age<br />
may be correlated. This modification can be useful for stillbirths. While <strong>the</strong> results<br />
from <strong>the</strong>se researchers suggest that <strong>the</strong> approach compares favorably with o<strong>the</strong>r<br />
approaches for estimating gestational age, <strong>the</strong>re is less experience with <strong>the</strong> Ballard<br />
external-only method than <strong>the</strong>re is with <strong>the</strong> standard Ballard examination.<br />
Note: If several or many interviewers are working on <strong>the</strong> rapid assessment in one<br />
site, <strong>the</strong> Ballard score results should be assessed by a smaller subset <strong>of</strong> interviewers.<br />
This would help improve consistency <strong>of</strong> <strong>the</strong> results by reducing <strong>the</strong> possibility <strong>of</strong><br />
interpersonal differences. In addition, those who are assigned <strong>the</strong> responsibility <strong>of</strong><br />
determining gestational age will gain substantial experience. <strong>The</strong> supervisor should<br />
check to make sure that age is being assessed consistently.<br />
24 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Physical Maturity<br />
Skin<br />
Sticky, friable,<br />
transparent<br />
Gelatinous,<br />
red,<br />
translucent<br />
Smooth,<br />
pink;<br />
visible<br />
veins<br />
Superficial<br />
peeling and/<br />
or rash; few<br />
veins<br />
Cracking,<br />
pale<br />
areas; rare<br />
veins<br />
Parchment,<br />
deep<br />
cracking; no<br />
vessels<br />
Lanugo None Sparse Abundant Thinning Bald areas Mostly bald<br />
Plantar<br />
surface<br />
Heel-toe<br />
40-50 mm:-1<br />
50 mm;<br />
no crease<br />
Breast Imperceptible Barely<br />
perceptible<br />
Eye/Ear<br />
Genitals<br />
(male)<br />
Genitals<br />
(female)<br />
Lids fused<br />
loosely: -1<br />
Tightly: -2<br />
Scrotum flat,<br />
smooth<br />
Clitoris<br />
prominent,<br />
labia flat<br />
Lids open;<br />
pinna<br />
flat: stays<br />
folded<br />
Scrotum<br />
empty, faint<br />
rugae<br />
Clitoris<br />
prominent,<br />
small labia<br />
minora<br />
Faint red<br />
marks<br />
Flat areola,<br />
no bud<br />
Slightly<br />
curved<br />
pinna: s<strong>of</strong>t;<br />
slow recoil<br />
Testes<br />
in upper<br />
canal, rare<br />
rugae<br />
Clitoris<br />
prominent,<br />
enlarging<br />
minora<br />
Anterior<br />
transverse<br />
crease only<br />
Stippled<br />
areola, 1-2<br />
mm bud<br />
Well-curved<br />
pinna: s<strong>of</strong>t but<br />
ready recoil<br />
Testes<br />
descending,<br />
few rugae<br />
Majora and<br />
minora equally<br />
prominent<br />
Creases<br />
anterior<br />
2/3<br />
Raised<br />
areola, 3-4<br />
mm bud<br />
Formed<br />
and firm,<br />
instant<br />
recoil<br />
Testes<br />
down,<br />
good<br />
rugae<br />
Majora<br />
large,<br />
minora<br />
small<br />
Creases<br />
over entire<br />
sole<br />
Full areola,<br />
5-10 mm<br />
bud<br />
Thick<br />
cartilage, ear<br />
stiff<br />
Testes<br />
pendulous,<br />
deep rugae<br />
Majora cover<br />
clitoris and<br />
minora<br />
Lea<strong>the</strong>ry,<br />
cracked,<br />
wrinkled<br />
Score<br />
Maturity<br />
Rating<br />
-10 20<br />
-5 22<br />
0 24<br />
5 26<br />
10 28<br />
15 30<br />
20 32<br />
25 34<br />
30 36<br />
35 38<br />
40 40<br />
45 42<br />
50 44<br />
Weeks<br />
Module 2: Delivery Unit Survey<br />
25
N. Blood Test Procedures: Making Thick and Thin Films for <strong>the</strong><br />
Microscopic Diagnosis <strong>of</strong> <strong>Malaria</strong> Infection<br />
<strong>The</strong> following describes how to make thick and thin films for <strong>the</strong> determination <strong>of</strong><br />
malaria infection. If <strong>the</strong>re are a substantial number <strong>of</strong> non–Plasmodium falciparum<br />
infections in <strong>the</strong> area, both thick and thin films should be made. O<strong>the</strong>rwise, thick films<br />
are generally adequate.<br />
Note: <strong>Rapid</strong> tests are available that can detect <strong>the</strong> presence <strong>of</strong> malaria parasites in<br />
peripheral blood. <strong>The</strong>se tests, although expensive, perform well when conducted by<br />
trained personnel. <strong>The</strong>y show decreased sensitivity in persons/settings with low<br />
parasite load. <strong>The</strong>re are currently not enough data to recommend <strong>the</strong> use <strong>of</strong> rapid tests<br />
to detect malaria infection in placental blood.<br />
Organize <strong>the</strong> supplies you need:<br />
lab coat<br />
gloves<br />
cotton<br />
disinfectant swab<br />
2 slides (labeled slide & swipe slide)<br />
lancet<br />
sharps disposal container<br />
hospital waste basket<br />
slide marker<br />
Thick blood films are more sensitive in detecting malaria parasites because <strong>the</strong> blood is<br />
concentrated, allowing a greater volume <strong>of</strong> blood to be examined. However, thick films are<br />
difficult to read. Thick films are stained unfixed after drying.<br />
Thin films should be used if <strong>the</strong>re are a substantial number <strong>of</strong> non—P. falciparum infections in<br />
<strong>the</strong> area, as thin films make it easier to identify species. <strong>The</strong> thin film should be air-dried, fixed<br />
with methanol, and allowed to dry before staining.<br />
For best results, both thick and thin films should be stained with a 3% Giemsa solution (pH <strong>of</strong><br />
7.2) for 30--45 minutes. A Wright-Giemsa stain can also indicate malaria parasites but does<br />
not demonstrate Schüffner’s dots as reliably as Giemsa.<br />
Plasmodium parasites are always intracellular, and <strong>the</strong>y demonstrate, if stained correctly, blue<br />
cytoplasm with a red chromatin dot. Common errors in reading malaria films are caused by<br />
platelets overlying a red blood cell and <strong>the</strong> misreading <strong>of</strong> artifacts as parasites.<br />
Thick blood films are more sensitive in detecting malaria parasites because <strong>the</strong> blood is<br />
concentrated, allowing a greater volume <strong>of</strong> blood to be examined. WHO recommends that<br />
at least 100 fields, each containing approximately 20 white blood cells (WBCs), be screened<br />
before calling a thick smear negative.<br />
To quantify malaria parasites against WBCs (i.e., determine parasite density) on <strong>the</strong> thick<br />
smear: Tally <strong>the</strong> parasites against <strong>the</strong> WBCs, until you have counted 500 parasites or 1,000<br />
WBC, whichever comes first. Express <strong>the</strong> results as parasites per microliter <strong>of</strong> blood, using <strong>the</strong><br />
WBC count if known, or o<strong>the</strong>rwise assuming 8,000 WBCs per microliter blood.<br />
26 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Parasites/microliter blood = (parasites/WBCs) x WBC count per microliter (or 8,000).<br />
Thin smears are useful for species identification <strong>of</strong> parasites already detected on thick smears.<br />
<strong>The</strong>y are also useful for screening for parasites if adequate thick smear are not available and<br />
as a rapid screen while <strong>the</strong> thick smear is still drying.<br />
To quantify parasites (i.e., determine parasite density) against red blood cells (RBCs) on thin<br />
smear: Count <strong>the</strong> parasitized RBCs among 500-2,000 RBCs on <strong>the</strong> thin smear and express <strong>the</strong><br />
results as % parasitemia.<br />
% parasitemia = (parasitized RBCs/total RBCs) x 100. If <strong>the</strong> parasitemia is high (>10%)<br />
examine 500 RBCs; if it is low (
O. How to Take Blood Samples from a Finger, Placenta,<br />
and Umbilical Cord<br />
Finger Prick:<br />
Organize <strong>the</strong> supplies you will need:<br />
gloves<br />
cotton gauze<br />
2 slides per finger-stick (1 labeled M for maternal peripheral blood and 1 swipe slide)<br />
lancet<br />
sharps disposal container<br />
<strong>The</strong> figure below shows how blood may be obtained by pricking <strong>the</strong> patient’s finger.<br />
* In Figure A-1, <strong>the</strong> hands are illustrated ungloved to better indicate <strong>the</strong>ir placement during <strong>the</strong> procedures. However,<br />
wearing gloves while processing blood specimens is recommended to prevent transmission <strong>of</strong> bloodborne pathogens<br />
(MMWR 1988;37:377--82, 387--8 and MMWR 1987;36[No. S2]).<br />
Placenta and Umbilical Cord:<br />
Organize <strong>the</strong> supplies you need:<br />
gloves<br />
cotton gauze<br />
3 slides per placenta (1 labeled P for placenta, 1 labeled C for cord, and 1 swipe slide)<br />
tweezers<br />
scissors<br />
lancet<br />
sharps disposal container<br />
basin with disinfectant for tweezers, scissors<br />
1. Label all slides with ID number, date, and site obtained (i.e., P or C)<br />
2. Put on gloves<br />
3. Keep placentas in plastic bags whenever possible<br />
4. Wipe cord<br />
5. Use lancet to puncture cord<br />
6. Obtain cord slide by touching from above, make thick and thin film<br />
7. Turn placenta over and find maternal side<br />
8. Wipe <strong>of</strong>f placenta<br />
9. Make placenta thick and thin film<br />
10. Clean up and be careful with sharps<br />
If more than one placenta is done at once: Be careful not to cross-contaminate. Change<br />
gloves and instruments after sampling each placenta.<br />
28 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
P. Making a Placental Impression Smear<br />
Although both impression smears and thick smears require taking blood samples,<br />
impression smears require more manipulation <strong>of</strong> <strong>the</strong> placenta than do thick smears.<br />
Thus, <strong>the</strong> benefit <strong>of</strong> <strong>the</strong> additional information gained from an impression smear needs<br />
to be balanced against <strong>the</strong> potential risk incurred.<br />
Materials and equipment needed to collect <strong>the</strong> sample:<br />
Tray<br />
Blunt-ended scissors<br />
Forceps with blunt tips<br />
Scissors/scalpel knife<br />
Gloves<br />
Marking pen<br />
Absorbent material such as paper towel<br />
Safety cover or transparent disposable plastic face shield to cover <strong>the</strong> face to protect against<br />
any blood splash<br />
Beaker containing 10% bleach<br />
How to make a smear:<br />
1. Label <strong>the</strong> slide with a marking pen, include <strong>the</strong> sample/placenta number and date.<br />
2. Place <strong>the</strong> whole placenta in <strong>the</strong> tray.<br />
3. Open up <strong>the</strong> membranes covering <strong>the</strong> maternal side <strong>of</strong> <strong>the</strong> placenta and move <strong>the</strong>m aside.<br />
4. Holding <strong>the</strong> piece <strong>of</strong> placenta with forceps, cut a small (about 5mm3) piece with scissors<br />
or a scalpel knife.<br />
5. Absorb <strong>the</strong> excess blood with absorbent material.<br />
6. Blot several times on a piece <strong>of</strong> absorbent material.<br />
7. Make 3 to 6 impressions <strong>of</strong> <strong>the</strong> tissue along one long edge <strong>of</strong> <strong>the</strong> slide by gently dabbing<br />
<strong>the</strong> tissue. <strong>The</strong> blood impression should be no thicker than a thin smear.<br />
8. For increased surface area for smear reading, make smears along <strong>the</strong> o<strong>the</strong>r long edge <strong>of</strong><br />
<strong>the</strong> slide using short, diagonal strokes.<br />
9. Place <strong>the</strong> forceps and scissors/scalpel knife in <strong>the</strong> beaker containing 10% bleach.<br />
10. Allow <strong>the</strong> slide to dry.<br />
11. Process as for thin blood smears.<br />
For an impression smear, <strong>the</strong> level <strong>of</strong> infection should be reported as percent parasitemia<br />
ra<strong>the</strong>r than number <strong>of</strong> parasites/ul <strong>of</strong> blood.<br />
Module 2: Delivery Unit Survey<br />
29
Q. Delivery Unit Survey Information Sheet 2<br />
<strong>The</strong> following information sheet should be given to each potential survey participant.<br />
If <strong>the</strong> potential survey participant cannot read or has low literacy skills, <strong>the</strong> information<br />
should be read aloud to her. All potential participants should receive a copy <strong>of</strong> <strong>the</strong><br />
information sheet to take home.<br />
Note to Interviewer: If <strong>the</strong> potential survey participant cannot read or has low literacy<br />
skills, read this information aloud to her. Give all potential participants a copy <strong>of</strong> this<br />
information sheet to take home.<br />
Introduction<br />
<strong>The</strong> [Ministry <strong>of</strong> Health] is doing an assessment to find out how many pregnant women in this<br />
[assessment area] have malaria. This will help us find <strong>the</strong> best ways to prevent <strong>the</strong> effects <strong>of</strong><br />
malaria on pregnant women and <strong>the</strong>ir babies. As you know, sometimes you may get malaria<br />
and feel sick. What you may not know is that sometimes you may have malaria without feeling<br />
sick. When you are pregnant and you have malaria, <strong>the</strong> baby can be born small and weak, even<br />
if you have not felt sick. <strong>The</strong> only way for us to know how many women may have this problem<br />
is to check blood from <strong>the</strong> placenta (afterbirth) after <strong>the</strong> woman gives birth. We plan to assess<br />
this problem in about ________ women in <strong>the</strong> [assessment area].<br />
Purpose <strong>of</strong> <strong>the</strong> Survey<br />
We plan to check blood from <strong>the</strong> placenta for malaria to know how many women in <strong>the</strong><br />
[assessment area] are infected. This will help us plan and measure <strong>the</strong> effects <strong>of</strong> programs<br />
to decrease malaria in pregnant women.<br />
Procedures<br />
If you agree to be in this assessment, we will ask you some questions about yourself and<br />
your health since you have been pregnant. We will not be telling anyone about your individual<br />
answers to <strong>the</strong> questions, and we will keep all assessment information about you safe and<br />
secure. You also do not need to answer any questions on <strong>the</strong> survey forms that you do not<br />
want to. We will review your clinic card. You will be measured for height and have a<br />
measurement done <strong>of</strong> <strong>the</strong> width <strong>of</strong> your arm. Before you have <strong>the</strong> baby, we will take a few<br />
drops <strong>of</strong> blood from a finger stick to check your blood for malaria. After you give birth, we<br />
will weigh and examine your baby. We will also take ano<strong>the</strong>r finger stick to look for malaria,<br />
and we’ll also be looking for malaria in <strong>the</strong> placenta and in <strong>the</strong> cord that goes to <strong>the</strong> baby after<br />
you have <strong>the</strong> baby.<br />
2 It is very important that <strong>the</strong> country’s human subjects or ethics requirements be followed with regard to<br />
provision <strong>of</strong> information and documentation <strong>of</strong> participant’s consent.<br />
30 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
[Note: <strong>The</strong> two paragraphs that follow have been used in assessments in areas <strong>of</strong> high<br />
transmission; <strong>the</strong>y should be adapted to reflect policy and practice in <strong>the</strong> country where <strong>the</strong><br />
assessment is being conducted. ] If we find malaria in your blood before you give birth, we will<br />
treat you with _____________ (enter appropriate drug name).<br />
We rarely find malaria in <strong>the</strong> cord that goes to <strong>the</strong> baby but, if we do, we will treat <strong>the</strong> baby<br />
with____________ (enter appropriate drug name).<br />
If you join <strong>the</strong> assessment, it will probably take about x number <strong>of</strong> minutes more than if you<br />
didn’t join <strong>the</strong> assessment. How much extra time will depend on if we find malaria in your<br />
blood or <strong>the</strong> cord that goes to your baby.<br />
If you do not wish to join in <strong>the</strong> assessment, you and your baby will still get <strong>the</strong> best possible<br />
care from <strong>the</strong> hospital. If you join <strong>the</strong> assessment, but <strong>the</strong>n decide you don't want to be in <strong>the</strong><br />
assessment, you can withdraw yourself from <strong>the</strong> assessment at any time. This will not affect<br />
<strong>the</strong> health care you get here.<br />
Risks or discomforts<br />
You will feel a “pinch” that lasts for a few seconds when <strong>the</strong> finger stick is done to take blood.<br />
Benefits<br />
You and/or your baby will be treated if you or <strong>the</strong> baby has malaria after birth. <strong>The</strong><br />
information we get from <strong>the</strong> assessment will help us know how best to prevent malaria in<br />
pregnant women in this [assessment area].<br />
Treatment<br />
_________ (enter appropriate drug name) works well to treat malaria and has been used safely to<br />
treat malaria in adults and in children. If you or <strong>the</strong> baby has any side effect which you think<br />
might be due to _________ (enter appropriate drug name), please come back to <strong>the</strong> hospital right<br />
away to be checked and treated by one <strong>of</strong> <strong>the</strong> doctors.<br />
If you join <strong>the</strong> assessment and have questions later, please feel free to ask. You can ask me<br />
today or if you have questions later, you can ask _________________ (responsible assessment team<br />
member).<br />
Thank you very much for your time. Would you like to join in <strong>the</strong> assessment?<br />
Please keep this information sheet in case you have questions later.<br />
Module 2: Delivery Unit Survey<br />
31
R. Analysis <strong>of</strong> Delivery Unit Survey Data<br />
Below are outcome variables for <strong>the</strong> Delivery Unit Survey and summary tables <strong>of</strong> survey<br />
results. Fur<strong>the</strong>r data analysis may be helpful, but is not necessary for decision making.<br />
Tables can be useful for showing relationships between outcome variables.<br />
• Table 1 shows how representative <strong>the</strong> women in <strong>the</strong> survey are <strong>of</strong> <strong>the</strong> women in <strong>the</strong><br />
country.<br />
• Table 2 shows women’s reported use <strong>of</strong> prevention and control measures, such as<br />
IPTpp, ITNs, and antimalarial drugs for treatment <strong>of</strong> illness.<br />
• Table 3 focuses on prevalence <strong>of</strong> parasitemia and fever among pregnant women and<br />
low birth weight, and prematurity among <strong>the</strong>ir babies.<br />
• Table 4 looks at <strong>the</strong> relationship between placental and peripheral malaria<br />
parasitemia, low birth weight, and premature delivery.<br />
No. Outcome Variable Numerator/Denominator<br />
1. Women with peripheral<br />
parasitemia<br />
2. Women with placental<br />
parasitemia<br />
Number <strong>of</strong> pregnant women with a positive result <strong>of</strong><br />
peripheral blood film/ Total number <strong>of</strong> pregnant women<br />
with peripheral blood films<br />
Number <strong>of</strong> pregnant women with a positive result <strong>of</strong><br />
placental blood film/ Total number <strong>of</strong> pregnant women<br />
with placental blood film<br />
3. Infants with umbilical cord parasitemia Number <strong>of</strong> infants with positive result <strong>of</strong> umbilical cord<br />
blood film/ Total number <strong>of</strong> infants with umbilical cord<br />
blood film<br />
4. Infants with low birth weight (
Table 1. Characteristics <strong>of</strong> Women in <strong>the</strong> Delivery Unit Survey and Women Country-Wide<br />
Characteristic<br />
Median age in years [range]<br />
Median gravidity [range]<br />
ANC visits, median no. [range]<br />
Able to read<br />
Attended school (any)<br />
Married<br />
Owns own home<br />
Owns moped<br />
Owns bike<br />
Owns radio<br />
Works for cash<br />
Grows cash crops<br />
TOTAL<br />
Women in Delivery<br />
Unit Survey* (n= # )<br />
Women in national<br />
DHS**<br />
*Data are % <strong>of</strong> participants unless o<strong>the</strong>rwise indicated.<br />
**If available, national data (e.g., Demographic and Health Surveys) can be used to compare<br />
how similar women in <strong>the</strong> assessment are to women nationally.<br />
Table 2. Use <strong>of</strong> Prevention and Control Measures by Women in <strong>the</strong> Delivery Unit Survey<br />
Treatment and Prevention Measures<br />
Gestational age at 1st ANC visit<br />
Owns insecticide-treated bed net (ITN)<br />
Uses ITN<br />
Slept under ITN previous night<br />
Used antimalarial drug during pregnancy for prevention (IPTpp)<br />
Used antimalarial drug during pregnancy for treatment <strong>of</strong> malaria<br />
illness<br />
Used <strong>the</strong> correct dose <strong>of</strong> antimalarial drug for treatment<br />
(#sites) (#women)<br />
Module 2: Delivery Unit Survey<br />
33
Table 3. Rates <strong>of</strong> Peripheral and Placental Parasitemia, Reported Fever, Low Birth<br />
Weight, and Prematurity among Delivering Women<br />
Characteristic All women (n= ) Use <strong>of</strong> IPTp or Chemoprophylaxis P<br />
Peripheral parasitemia<br />
Overall<br />
Primigravidae<br />
Secundigravidae<br />
Multigravidae<br />
Placental parasitemia<br />
Overall<br />
Primigravidae<br />
Secundigravidae<br />
Multigravidae<br />
Umbilical cord parasitemia<br />
Fever during pregnancy<br />
Self-reported use <strong>of</strong> an<br />
antimalarial for treatment<br />
during pregnancy<br />
Fever within week before<br />
enrollment<br />
Singleton live-born birth<br />
weight (g) ± SD<br />
Low birth weight (liveborn<br />
singletons
Table 4. Relationship between Placental <strong>Malaria</strong> Parasitemia and Peripheral <strong>Malaria</strong><br />
Parasitemia, Low Birth Weight, and Premature Delivery among Delivering Women<br />
Characteristic<br />
Positive result <strong>of</strong><br />
peripheral blood film<br />
Low birth weight<br />
(
36 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Woman’s full name:<br />
ID #_____A________<br />
Tool 2: Delivery Unit Questionnaire<br />
Today’s date: ______/_______/______<br />
Day/Month/Year<br />
ID number: ___ _1__ -- ___ ___ ___<br />
Digit 1 = facility number Digit 2 = D (for Delivery Unit)<br />
Digits 3, 4 & 5 = woman’s consecutive number<br />
SCREENING QUESTION<br />
Interviewer number _______<br />
1. Age (years): [ ]<br />
If <strong>the</strong> mo<strong>the</strong>r does not know her age, estimate her age using <strong>the</strong> categories below.<br />
less than 15 years [ ] 30-34 years [ ]<br />
15-19 years [ ] 35-39 years [ ]<br />
20-24 years [ ] 40-44 years [ ]<br />
25-29 years [ ] more than 44 years [ ]<br />
If <strong>the</strong> woman is less than an age deemed appropriate, thank her for her time and<br />
DO NOT enroll her in this survey.<br />
DEMOGRAPHIC INFORMATION<br />
<br />
2. Village/town: ____________________________________________<br />
Interviewer: Skip <strong>the</strong> next question; it will be coded later so that it is done uniformly.<br />
3. Is this a rural or urban area? [ ]<br />
Urban = 1<br />
Rural = 2<br />
Periurban = 3<br />
Unknown = 9<br />
4. What language do you usually speak with family members at home? [ ]<br />
Language a = 1<br />
Language b = 2<br />
Language c = 3<br />
O<strong>the</strong>r = 8 (specify) ______________________________________<br />
5. Are you married? [ ]<br />
yes, married and living with husband = 1<br />
yes, married but do not live with husband = 2<br />
not married but living with a man = 3<br />
separated or divorced = 4<br />
widow <strong>of</strong> <strong>the</strong> fa<strong>the</strong>r <strong>of</strong> this baby = 5<br />
never married or lived with a man = 6<br />
Tool 2: Delivery Unit Questionnaire<br />
1
EDUCATION<br />
6. What is <strong>the</strong> highest level <strong>of</strong> school that you attended?..[ ]<br />
Primary = 1<br />
Secondary = 2<br />
Higher = 3<br />
Never attended = 4<br />
Unknown = 9<br />
7. Can you read [ ]<br />
YES = 1 NO = 2<br />
SOCIOECONOMIC INDICATORS<br />
8. What is <strong>the</strong> ro<strong>of</strong> <strong>of</strong> your house made <strong>of</strong>? [ ]<br />
corrugated iron = 1<br />
cement or concrete = 2<br />
wood and mud = 3<br />
thatch or grass = 4<br />
reed or bamboo = 5<br />
plastic sheet = 6<br />
mobile ro<strong>of</strong>s <strong>of</strong> nomads = 7<br />
o<strong>the</strong>r = 8 (specify) __________________________________<br />
9. What kind <strong>of</strong> floor does your house have? [ ]<br />
earth or sand = 1<br />
dung = 2<br />
wood planks = 3<br />
reed or bamboo = 4<br />
vinyl tiles or carpet = 5<br />
cement = 6<br />
cement tiles or brick = 7<br />
o<strong>the</strong>r = 8 (specify) ___________________________________<br />
10. What is <strong>the</strong> main job <strong>of</strong> <strong>the</strong> head <strong>of</strong> household/husband? [ ]<br />
job a = 1<br />
job b = 2<br />
job c = 3<br />
job d = 4<br />
11. What is <strong>the</strong> monthly household income for your family? [ ]<br />
income bracket a = 1<br />
income bracket b= 2<br />
income bracket c=3<br />
(FOR THE NEXT QUESTION, PLEASE ENTER A 1 OR 2 FOR EACH LINE)<br />
12. Do you or any member <strong>of</strong> your family living in <strong>the</strong> same compound:<br />
YES = 1 NO = 2<br />
Own a bicycle/scooter/moped? [ ]<br />
Own a radio? [ ]<br />
Own a TV? [ ]<br />
Own <strong>the</strong> house you are living in? [ ]<br />
Own crop land? [ ]<br />
Grow cash crops? [ ]<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
REPRODUCTIVE AND CLINICAL HISTORY<br />
13. How many times have you become pregnant? [ ]<br />
(including this one and all o<strong>the</strong>r pregnancies, including abortions and miscarriages)<br />
13a. How many pregnancies with a live-born child?<br />
13b. How many pregnancies with loss <strong>of</strong> <strong>the</strong> fetus?<br />
MALARIA PREVENTION<br />
14. Did you take medicine during pregnancy to protect you from malaria and keep illness from coming into <strong>the</strong> body when<br />
you did not have symptoms? [ ]<br />
(NOTE, NOT treatment for malaria illness)<br />
YES = 1<br />
NO = 2 If NO, skip to question 16<br />
UNKNOWN = 9<br />
If YES:<br />
14a. What type <strong>of</strong> medicine did you take?<br />
Chloroquine [ ]<br />
Sulfadoxine-Pyrimethamine (SP, Fansidar) [ ]<br />
Proguanil [ ]<br />
O<strong>the</strong>r [ ]<br />
(specify): ______________________________<br />
Unknown [ ]<br />
14b. When you started taking <strong>the</strong> medicine, how many months pregnant were you? [ ]<br />
14c. For <strong>the</strong> first time you took <strong>the</strong> medicine, howmany total tablets did you take? [ ]<br />
14d. How many times in a week did you take <strong>the</strong> medicine? [ ]<br />
14e. How many tablets did you take each time? [ ]<br />
14f. After <strong>the</strong> first dose, how <strong>of</strong>ten did you take this medicine? [ ]<br />
Every week=1<br />
Almost every week=2<br />
Some weeks=3<br />
Monthly=4<br />
Rarely=5<br />
Do not know=6<br />
15. Did you sleep under a bed net during this pregnancy? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
If no, skip to question 17<br />
15a. If yes, how frequently? [ ]<br />
all <strong>the</strong> time = 1<br />
most <strong>of</strong> <strong>the</strong> time = 2<br />
sometimes = 3<br />
rarely = 4<br />
15b. Did you sleep under <strong>the</strong> net last night? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
Tool 2: Delivery Unit Questionnaire<br />
3
15c. Has this net ever been treated with insecticide? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
15d. If yes, has <strong>the</strong> net been treated with insecticide in <strong>the</strong> past one year? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
15e. Is <strong>the</strong> net a long-lasting insecticide-treated net (LLN)? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
HISTORY OF FEVER OR MALARIA (DURING THE PRESENT PREGNANCY)<br />
16. Have you had a fever or malaria during this pregnancy? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
If NO, skip to question 17<br />
16a. Did you get a convulsion with fever/malaria? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
16b. Did you stay in hospital overnight for treatment <strong>of</strong> fever/malaria? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
16c. Did you get a blood transfusion: [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
16d. Did you take iron and folic acid tablets? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
16e. Have you taken a medication to treat malaria or fever during this pregnancy? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
16f. Type <strong>of</strong> medication taken (check all that apply)<br />
Chloroquine [ ]<br />
Sulfadoxine-Pyrimethamine (SP) [ ]<br />
Quinine [ ]<br />
Antipyretics [ ]<br />
O<strong>the</strong>r [ ]<br />
(specify):______________________________________<br />
Unknown [ ]<br />
4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
ANTENATAL CARE CLINIC VISITS AND ANC CARD DETAILS<br />
17. Have you previously attended antenatal clinic for this pregnancy? [ ]<br />
YES = 1 NO = 2<br />
18. Did you bring your ANC card today? [ ]<br />
YES = 1 NO = 2<br />
If yes, RECORD THE INFORMATION BELOW FROM THE ANC CLINIC CARD.<br />
19. Total number <strong>of</strong> ANC visits [ ]<br />
20. Timing <strong>of</strong> visits:<br />
Date <strong>of</strong> visit Gestational age Fundal<br />
(weeks) height<br />
first visit: ___ ___ / ___ ___ / ___ ___ [ ] [ ]<br />
most recent visit: ___ ___ / ___ ___ / ___ ___ [ ] [ ]<br />
21. Last menstrual period (LMP) if recorded: ________/___/____<br />
22. Estimated date <strong>of</strong> delivery ___ ___ / ___ ___ / ___ ___<br />
23. Risk factors during <strong>the</strong> current pregnancy:<br />
(Check if any <strong>of</strong> <strong>the</strong> following are written in <strong>the</strong> antenatal record –<br />
Please put a 1 or 2 for each risk factor)<br />
YES = 1 NO = 2<br />
Anemia (Hb < 7 g/dl) [ ]<br />
BP > 140/90 [ ]<br />
Pre-eclampsia [ ]<br />
Gestational diabetes [ ]<br />
APH (antepartum hemorrhage) [ ]<br />
Malpresentation [ ]<br />
O<strong>the</strong>r [ ]<br />
(specify) ____________________________<br />
RECENT MALARIA MORBIDITY HISTORY<br />
24. Have you had a fever or malaria during <strong>the</strong> past week? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
If NO, skip to question 25<br />
24a. If YES, Have you received any treatment for this illness? [ ]<br />
YES = 1<br />
NO = 2<br />
24b. If YES, check treatments received (check all that apply)<br />
Chloroquine [ ]<br />
Sulfadoxine-Pyrimethamine (Fansidar) [ ]<br />
Quinine [ ]<br />
Artemisinin-combination <strong>the</strong>rapy (ACT) [ ]<br />
If an ACT, specify : ___________________________<br />
O<strong>the</strong>r [ ]<br />
(Specify): _____________________________________<br />
Not known [ ]<br />
Tool 2: Delivery Unit Questionnaire<br />
5
DELIVERY DATA (from hospital records and observation <strong>of</strong> present delivery)<br />
25. Date <strong>of</strong> Delivery ____ / ____ / ____<br />
26. Type <strong>of</strong> Delivery: [ ]<br />
Spontaneous vaginal delivery = 1<br />
Caesarian section = 2<br />
Forceps/vacuum = 3<br />
O<strong>the</strong>r = 8 Specify: _____________________________________<br />
27. Number <strong>of</strong> babies delivered [ ]<br />
1 = singleton (1 baby)<br />
2 = twins<br />
3 = more than two<br />
27a. If singleton (1 baby), please describe if <strong>the</strong> baby was<br />
1 = born alive, left hospital alive (Skip to Q. 30)<br />
2 = born alive, died before leaving hospital (Skip to Q. 27c)<br />
3 = born dead/stillbirth (Skip to Q. 27b)<br />
9 = unknown (Skip to Q. 30)<br />
27b. (For all singletons), did <strong>the</strong> baby move arms and legs after birth? [ ]<br />
YES = 1 NO = 2 (If NO, skip to Q. 27d)<br />
27c. (For singletons) If <strong>the</strong> baby was born alive but died before leaving hospital, what was <strong>the</strong> cause <strong>of</strong> death?<br />
(Answer this question and <strong>the</strong>n skip to Q. 30)<br />
____________________________________________________________________________________________<br />
27d. (For singletons born dead) If <strong>the</strong> baby was born dead, what was <strong>the</strong> estimated gestational age?<br />
________________weeks<br />
28. If <strong>the</strong> singleton child was born dead, check all possible causes<br />
[ ] <strong>Malaria</strong><br />
[ ] Fever<br />
[ ] Spontaneous without explanation<br />
[ ] Infection (septic)<br />
[ ] Trauma<br />
[ ] Intentional<br />
[ ] Cephalopelvic disproportion (head too big, baby got stuck)<br />
[ ] Weak expulsion<br />
[ ] Prolonged labor<br />
[ ] Fetal distress<br />
[ ] Asphyxia<br />
[ ] Nuchal cord<br />
[ ] Placental abruption<br />
[ ] Chorioamnionitis<br />
[ ] Hydrops fetalis<br />
[ ] Not known<br />
[ ] O<strong>the</strong>r (specify): _____________________________________<br />
29. If <strong>the</strong> singleton was born dead, was <strong>the</strong> fetus:<br />
Fresh? = 1<br />
Macerated? = 2<br />
Not known = 9<br />
6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
EXAMINATION: BEFORE DELIVERY<br />
30. Mo<strong>the</strong>r’s axillary temperature _____._____ degrees C<br />
31. Mo<strong>the</strong>r's height (centimeters): ____ ____ ____<br />
32. Mo<strong>the</strong>r’s mid-upper arm circumference (centimeters) ____ ____<br />
34. Was a rapid diagnostic test (RDT) for malaria done? [ ]<br />
YES = 1<br />
NO = 2 (If “no” or “unknown” skip to Q36.<br />
UNKNOWN = 9<br />
35. RDT result [ ]<br />
Positive = 1<br />
Negative = 2<br />
Result available, examined, but undetermined = 9<br />
36. Was a blood sample taken from a prick <strong>of</strong> <strong>the</strong> mo<strong>the</strong>r’s finger? [ ]<br />
YES = 1<br />
NO = 2 (If “no” or “unknown” skip to Q39.<br />
UNKNOWN = 9<br />
37. Blood smear result [ ]<br />
Positive = 1<br />
Negative = 2<br />
Result available, examined, but undetermined = 9<br />
38. <strong>Malaria</strong> species. Check all that apply .[ ]<br />
Plasmodium falciparum = 1 [ ]<br />
P. vivax = 2 [ ]<br />
P. malariae = 3 [ ]<br />
P. ovale = 4 [ ]<br />
Undetermined = 9<br />
39. If ei<strong>the</strong>r <strong>of</strong> <strong>the</strong> tests above was positive, was an antimalarial given? [ ]<br />
YES = 1 NO = 2<br />
39a. If YES, what type [ ]<br />
Chloroquine = 1<br />
Sulfadoxine-pyrimethamine (SP) = 2<br />
Chloroquine and SP = 4<br />
Quinine = 3<br />
Coartem = 4<br />
O<strong>the</strong>r = 8 (specify and explain): ______________________<br />
39b. Date administered: ___ ___ / ___ ___ / ___ ___<br />
39c. Name <strong>of</strong> person administering antimalarials:______________________________________<br />
Note: All women who are currently febrile or report having had a fever in <strong>the</strong> last 7 days should wait to receive <strong>the</strong>ir<br />
blood smear results prior to leaving clinic that day. <strong>The</strong>ir blood slides should be promptly read. If positive, <strong>the</strong>y will<br />
receive treatment with appropriate antimalarial drug. Women who are presently afebrile with no history <strong>of</strong> fever in<br />
<strong>the</strong> past week need not wait for smear results but can return for <strong>the</strong> results <strong>the</strong> following day.<br />
OR<br />
If above differs from <strong>the</strong> country’s national policy, follow national policy.<br />
Tool 2: Delivery Unit Questionnaire<br />
7
EXAMINATION OF LIVE-BORN SINGLETON BABY<br />
40. Weight <strong>of</strong> baby (g) ____ . ____ ____<br />
FROM SCALE, NOT FROM DELIVERY RECORD<br />
41. Sex <strong>of</strong> baby [ ]<br />
Male = 1<br />
Female = 2<br />
42. Ballard score ____ ____<br />
43. Gestational age (weeks) by Ballard score………………..[ ]<br />
44. Physical abnormalities? [ ]<br />
YES = 1 NO = 2<br />
If yes, list any abnormalities__________________________________<br />
MATERNAL OUTCOMES<br />
45. Maternal death [ ]<br />
YES = 1<br />
NO = 2<br />
If maternal death, list cause: ______________________________<br />
If not known, please state: “Unknown”<br />
46. Were <strong>the</strong>re any o<strong>the</strong>r complications <strong>of</strong> labor? [ ]<br />
0 = No o<strong>the</strong>r complications<br />
1 = Puerperal sepsis<br />
2 = Pre-eclampsia<br />
3 = Eclampsia<br />
4 = Obstructed labor<br />
5 = Breech delivery<br />
6 = Antepartum hemorrhage<br />
7 = Postpartum hemorrhage<br />
8 = Uterine rupture<br />
9 = O<strong>the</strong>r (specify) _______________________________________<br />
PLEASE CHECK OVER THE QUESTIONNAIRE NOW TO MAKE SURE THAT ALL QUESTIONS HAVE BEEN ANSWERED, THEN<br />
CHECK THIS BOX [ ]<br />
Thank <strong>the</strong> woman for her time.<br />
47. QUALITY CONTROL<br />
Site supervisor should check all questionnaires for completeness every day at <strong>the</strong> end <strong>of</strong> all interviews.<br />
Data entry clerks should initial at <strong>the</strong> end <strong>of</strong> every entry.<br />
Person Name/Signature Date<br />
47a Site Supervisor<br />
47b Data Entry Clerk 1<br />
47c Data Entry Clerk 2<br />
47d <strong>Assessment</strong><br />
Coordinator<br />
8 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Module 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong><br />
Disease: Data Abstraction Form<br />
Ga<strong>the</strong>ring information about malaria disease among all hospitalized women can<br />
provide descriptive information about whe<strong>the</strong>r or not pregnant women have<br />
more malaria illness, which in turn can be used to determine if intermittent<br />
preventive treatment (IPTp) should be recommended or if <strong>the</strong> focus should be on<br />
case management and use <strong>of</strong> insecticide-treated bed nets (ITNs).<br />
A data abstraction form is used to collect <strong>the</strong> following information about all<br />
hospitalized women: history <strong>of</strong> illness and treatment, admission and discharge<br />
diagnoses, laboratory results <strong>of</strong> tests for malaria, and indicators related to severe<br />
malaria, treatment, and clinical outcome for <strong>the</strong> mo<strong>the</strong>r and fetus.<br />
This module contains sample materials for hospital surveillance <strong>of</strong> malaria<br />
disease. <strong>The</strong>se materials can and should be adapted to suit local needs. General<br />
guidance for conducting assessment surveys and managing data can be found in<br />
Chapters 3 and 4.<br />
A. Eligibility Criteria<br />
Contents<br />
B. Surveillance Team<br />
C. Notes for <strong>Assessment</strong> Team<br />
D. Sample Logbook<br />
E. Severe Plasmodium falciparum <strong>Malaria</strong> in Adults: WHO’s List <strong>of</strong> Clinical<br />
Manifestations and Laboratory Findings<br />
F. Analysis <strong>of</strong> Data<br />
1<br />
Module 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease: Data Abstraction Form 1
A. Eligibility Criteria<br />
Women and units/wards: All women (both pregnant and nonpregnant) admitted to <strong>the</strong>se<br />
hospital units/wards: women’s internal medicine unit, gynecology, or delivery. <strong>The</strong> choice<br />
<strong>of</strong> units/wards should be individualized to <strong>the</strong> local situation so as to capture as many<br />
admissions by women---both pregnant and nonpregnant---as possible. <strong>The</strong> hospital may be<br />
operated by <strong>the</strong> government or by private concerns.<br />
Note: If <strong>the</strong> surveillance is conducted only in maternity units, it will not provide data on <strong>the</strong><br />
difference between how many pregnant and nonpregnant women become ill with malaria.<br />
B. Surveillance Team<br />
<strong>The</strong> abstraction form involves interpretation <strong>of</strong> medical records as well as making clinical<br />
judgments; <strong>the</strong>refore, <strong>the</strong> surveillance team should be made up <strong>of</strong> persons with clinical<br />
training, e.g., physicians, nurses, midwives.<br />
C. Notes for <strong>Assessment</strong> Team<br />
A record will need to be kept <strong>of</strong> all women who are admitted, pregnant or nonpregnant, with<br />
or without malaria or anemia. Data abstraction forms need to be filled out only for those with<br />
malaria.<br />
It is important to ask about last menstrual period in order not to omit women early in <strong>the</strong>ir<br />
pregnancy.<br />
Questions 7 and 19 should be adapted to reflect <strong>the</strong> medications that are available and used in<br />
<strong>the</strong> country. It might be helpful to list both generic and trade names.<br />
Questions 10-18 (Laboratory Results) should also be adapted to reflect laboratory tests used<br />
in <strong>the</strong> country.<br />
Note that <strong>the</strong> laboratory results recorded in Q. 10-18 may serve to validate symptoms and<br />
conditions noted in Q.9.<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
D. Sample Logbook<br />
Date Ward Newly<br />
admitted<br />
women<br />
(total #)<br />
<strong>Malaria</strong> and anemia admissions—<br />
women only<br />
Number<br />
<strong>of</strong> forms<br />
completed<br />
Comments<br />
Day/mo/yr<br />
Day/mo/yr<br />
Int<br />
Gyn<br />
Delivery<br />
Int<br />
Gyn<br />
Delivery<br />
Total Preg Nonpreg<br />
E. Severe Plasmodium falciparum <strong>Malaria</strong> in Adults: WHO’s List <strong>of</strong><br />
Clinical Manifestations and Laboratory Findings<br />
Clinical manifestations and laboratory findings <strong>of</strong> severe P. falciparum in adults<br />
include:*<br />
Prostration<br />
Impaired consciousness<br />
Respiratory distress (acidotic breathing)<br />
Multiple convulsions<br />
Circulatory collapse<br />
Pulmonary edema (radiological)<br />
Abnormal bleeding<br />
Jaundice<br />
Hemoglobinuria<br />
Severe anemia<br />
*Adapted from: World Health Organization. Severe falciparum malaria. Royal Society <strong>of</strong><br />
Tropical Medicine and Hygiene, 2000. 94 (1 Suppl): p. 2.<br />
F. Analysis <strong>of</strong> Data<br />
Important outcome variables include:<br />
• Percentage <strong>of</strong> women admitted to <strong>the</strong> hospital with malaria, anemia, or severe malaria<br />
who were pregnant,<br />
by level <strong>of</strong> transmission (if surveillance is conducted in areas <strong>of</strong> both stable and unstable<br />
malaria)<br />
• Percentage <strong>of</strong> pregnancies with a fatal outcome for <strong>the</strong> fetus or for <strong>the</strong> mo<strong>the</strong>r<br />
Module 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease: Data Abstraction Form<br />
3
4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Woman’s full name:________________________________________________________________ ID #_____A________<br />
Tool 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease<br />
Data Abstraction Form<br />
NOTE: Abstract data only from forms <strong>of</strong> women who are <strong>of</strong> reproductive age.<br />
Abstracter name ____________________<br />
Today’s date ____/____/_____<br />
Day Month Year<br />
Interviewer number _______<br />
Patient record ID# (or patient hospital file #): ______________________<br />
Type <strong>of</strong> facility_____________________________________<br />
PATIENT DETAILS<br />
1. Age <strong>of</strong> patient (years): [ ]<br />
<br />
2. Last menstrual period<br />
Not applicable [ ]<br />
Date <strong>of</strong> last menstrual period ____ ___ / ___ ___ / ___ ___<br />
if UNKNOWN, mark this box [ ]<br />
3. Pregnant [ ]<br />
YES = 1, NO = 2, UNKNOWN = 3<br />
3a. If YES, what is <strong>the</strong> gestational age (weeks) [ ]<br />
3b. If NO, has she ever been pregnant? [ ]<br />
YES = 1, NO = 2, UNKNOWN = 3<br />
3c. If YES, what is <strong>the</strong> date <strong>of</strong> <strong>the</strong> last delivery ____ ___ / ___ ___ / ___<br />
If UNKNOWN, mark this box [ ]<br />
4. Patient’s village/town/district_________________________<br />
Tool 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease: Data Abstraction Form<br />
1
HISTORY OF CURRENT ILLNESS AND TREATMENT<br />
5. How long has <strong>the</strong> patient been ill?[days]<br />
6. Prior to admission, did <strong>the</strong> patient have<br />
YES = 1, NO = 2, UNKNOWN = 3<br />
a. Convulsions [ ]<br />
b. Decreased consciousness [ ]<br />
c. Coma [ ]<br />
7. Did patient receive any antimalarial treatment in <strong>the</strong> 7 days before admission [ ]<br />
YES = 1, NO = 2, UNKNOWN = 3<br />
If YES, mark all that apply<br />
Chloroquine [ ]<br />
Sulfadoxine-Pyrimethamine (SP) [ ]<br />
Quinine [ ]<br />
Artesunate [ ]<br />
O<strong>the</strong>r [ ]<br />
(specify and explain): ________________________<br />
ADMISSION DATA<br />
8. Admitting diagnosis: (mark all that apply)<br />
malaria = 1 [ ]<br />
severe malaria = 2 [ ]<br />
cerebral malaria = 3 [ ]<br />
anemia = 4 [ ]<br />
o<strong>the</strong>r = 5 (specify): ____________________________________________<br />
9. Any manifestations <strong>of</strong> severe or cerebral malaria (mark all that apply)<br />
Prostration [ ]<br />
Respiratory distress (acidotic breathing) [ ]<br />
Multiple convulsions [ ]<br />
Circulatory collapse (shock) [ ]<br />
Pulmonary oedema (radiological) [ ]<br />
Abnormal bleeding [ ]<br />
Jaundice [ ]<br />
Haemoglobinuria [ ]<br />
Severe anemia [ ]<br />
Impaired consciousness [ ]<br />
Hypoglycemia [ ]<br />
Decreased consciousness [ ]<br />
Coma [ ]<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
LABORATORY RESULTS (provide if available)<br />
10. <strong>Malaria</strong> blood film done [ ]<br />
YES = 1, NO = 2<br />
10a. If YES, result [ ]<br />
Positive = 1<br />
Negative = 2<br />
Result available, examined, but undetermined = 9<br />
10b. If positive, parasite count: __________<br />
10c. If positive, species (mark all that apply) [ ]<br />
Plasmodium falciparum = 1 [ ]<br />
P. vivax = 2 [ ]<br />
P. malariae = 3 [ ]<br />
P. ovale = 4 [ ]<br />
Not determined = 5 [ ]<br />
11. Hemoglobin/Hematocrit (lowest) ____ ____<br />
12. Glucose (lowest) _______________<br />
13. Creatinine (highest) _______________<br />
14. Bilirubin (highest) _______________<br />
15. Plasma bicarbonate ________________<br />
16. Mean cell volume ________________<br />
17. Lumbar puncture<br />
Glucose_________<br />
Protein__________<br />
Cell Count<br />
RBC: _______ WBC: _______ WBC differential: _______<br />
18. O<strong>the</strong>r [ ]<br />
(specify): ___________________________________<br />
Tool 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease Data Abstraction Form<br />
3
TREATMENT<br />
19. Antimalarial medications given (mark all that apply)<br />
Chloroquine [ ]<br />
Sulfadoxine-pyrimethamine (SP) [ ]<br />
Quinine [ ]<br />
Artesunate [ ]<br />
Primaquine [ ]<br />
Proguanil [ ]<br />
Artemisinin-containing combination <strong>the</strong>rapy (ACT) [ ]<br />
If ACT, specify __________________________________<br />
O<strong>the</strong>r [ ]<br />
(specify and explain): _________________________<br />
20. O<strong>the</strong>r <strong>the</strong>rapy given (mark all that apply)<br />
Anticonvulsant [ ]<br />
Transfusion <strong>of</strong> whole blood / packed RBC [ ]<br />
Glucose [ ]<br />
Furosemide (or o<strong>the</strong>r diuretic) [ ]<br />
Oxygen [ ]<br />
Vitamin K [ ]<br />
O<strong>the</strong>r [ ]<br />
(specify): ___________________________________<br />
DISCHARGE INFORMATION<br />
21. Woman’s outcome [ ]<br />
Full recovery = 1<br />
Recovered with some residual disability = 2<br />
Died = 3<br />
Unknown = 9<br />
4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
22. Pregnancy outcome (for pregnant women only):<br />
Did woman deliver [ ]<br />
YES = 1, NO = 2, UNKNOWN = 3<br />
22a. If YES, outcome [ ]<br />
alive = 1<br />
fetal loss = 2<br />
22b. If NO, outcome [ ]<br />
no labor = 1<br />
false labor = 2<br />
23. Discharge diagnosis: (mark all that apply)<br />
uncomplicated malaria = 1 [ ]<br />
severe malaria = 2 [ ]<br />
anemia = 3 [ ]<br />
o<strong>the</strong>r = 4 [ ]<br />
(specify):_________________________________<br />
24. Additional comments:<br />
_______________________________________________________________________________________________________<br />
_______________________________________________________________________________________________________<br />
25. QUALITY CONTROL<br />
Site supervisor should check all questionnaires for completeness every day at <strong>the</strong> end<br />
<strong>of</strong> all interviews.<br />
Data entry clerks should initial at <strong>the</strong> end <strong>of</strong> every entry.<br />
Person Name/Signature Date<br />
25a Site Supervisor<br />
25b Data Entry Clerk 1<br />
25c Data Entry Clerk 2<br />
25d <strong>Assessment</strong> Coordinator<br />
Tool 3: Hospital Surveillance <strong>of</strong> <strong>Malaria</strong> Disease Data Abstraction Form<br />
5
6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Module 4: Conducting an Antenatal Clinic<br />
Facility <strong>Assessment</strong><br />
<strong>The</strong> antenatal clinic facility assessment is designed to determine<br />
• Antental clinic services provided<br />
• Stockouts <strong>of</strong> medicine/vaccine/laboratory supplies<br />
• Facility staffing and equipment<br />
• Cost <strong>of</strong> services<br />
This module contains sample materials for an antenatal clinic facility assessment.<br />
<strong>The</strong>se materials can and should be adapted to suit local needs. General guidance for<br />
conducting assessment tools survey and managing data can be found in Chapters 3-4.<br />
Contents<br />
A. Antenatal Clinic Facility <strong>Assessment</strong> Timetable<br />
B. Sample Size<br />
C. <strong>Assessment</strong> Team<br />
D. Data Analysis<br />
Module 4: Conducting an Antenatal Clinic Facility <strong>Assessment</strong><br />
1
A. Antenatal Clinic Facility <strong>Assessment</strong> Timetable<br />
<strong>The</strong> Antenatal Clinic Facility <strong>Assessment</strong> can be conducted before, during, or after <strong>the</strong><br />
Antenatal Clinic Surveys take place.<br />
B. Sample Size<br />
An Antenatal Clinic Facility <strong>Assessment</strong> should be conducted with <strong>the</strong> manager, or his/<br />
her designee, <strong>of</strong> each antenatal clinic in which an Antenatal Clinic Survey is conducted.<br />
C. <strong>Assessment</strong> Team<br />
<strong>The</strong> site supervisor or his or her designee should serve as <strong>the</strong> interviewer.<br />
D. Data Analysis<br />
Outcome Variables<br />
No. Outcome Variable<br />
1 Proportion <strong>of</strong> facilities with a written protocol on malaria during pregnancy<br />
2 Proportion <strong>of</strong> facilities reporting stock-out <strong>of</strong> antimalarial drugs in<br />
antenatal clinic within <strong>the</strong> last calendar month<br />
3 Proportion <strong>of</strong> facilities that distribute/sell insecticide treated nets (ITNs)<br />
Summary Tables<br />
Table 1. Services provided to women in antenatal clinics by site or region,<br />
by percentage <strong>of</strong> clinics.<br />
Service Region X (%) Region Y (%)<br />
IPTp<br />
Counseling on use<br />
<strong>of</strong> ITNs<br />
Hemoglobin test<br />
Iron<br />
Folate<br />
Iron and folate<br />
combined<br />
Blood films<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Table 2. Availability <strong>of</strong> medication and supplies by site or region,<br />
by percentage <strong>of</strong> clinics<br />
Item Region X (%) Region Y (%)<br />
Iron<br />
Folate<br />
Iron and folate combined<br />
Chloroquine<br />
Proguanil<br />
Quinine<br />
SP<br />
Hemoglobin tests<br />
Materials for blood films<br />
<strong>The</strong>rmometer<br />
Alcohol<br />
Gloves<br />
Glass slides<br />
Lancets<br />
Microscope<br />
Giemsa and staining equipment<br />
Hemoglobin measuring supplies<br />
Clean water<br />
Cups to drink from<br />
Module 4: Conducting an Antenatal Clinic Facility <strong>Assessment</strong><br />
3
4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Name <strong>of</strong> person interviewed: ________________________<br />
Facility number:_______________<br />
TOOL 4: ANTENATAL CLINIC FACILITY ASSESSMENT<br />
Interviewer name ___________________________________________<br />
Interviewer number __________<br />
Facility number: ____________________________<br />
Facility name:________________________________<br />
Today’s Date: ____/_____/_______<br />
Day Month Year<br />
Instructions for <strong>the</strong> interviewer: Please administer this assessment to <strong>the</strong> manager <strong>of</strong> <strong>the</strong> health facility. Respond<br />
to each question as completely as possible and add all comments in <strong>the</strong> space provided at <strong>the</strong> end <strong>of</strong> <strong>the</strong> assessment.<br />
Please read <strong>the</strong> following paragraph to <strong>the</strong> respondent before beginning <strong>the</strong> interview:<br />
I am here today to conduct an assessment <strong>of</strong> antenatal care facilities to learn more information regarding malaria<br />
during pregnancy. We would like to ask you several questions about <strong>the</strong> prevention <strong>of</strong> malaria during pregnancy in<br />
your facility. <strong>The</strong> information ga<strong>the</strong>red will be used to ______________________. Your participation in this process is very<br />
important. Your responses will be kept confidential. No institution or individual will be identified by name in <strong>the</strong> final<br />
report. This assessment will not last more than 30 minutes.<br />
We ask you to respond to each question to <strong>the</strong> best <strong>of</strong> your ability. If you have questions at any moment during <strong>the</strong><br />
interview, do not hesitate to ask. Do you agree to participate in this assessment?<br />
Instructions to <strong>the</strong> interviewer: If <strong>the</strong> respondent agrees to participate in <strong>the</strong> assessment, place an « X » in <strong>the</strong><br />
following box.<br />
<strong>The</strong> respondent agreed to participate in <strong>the</strong> assessment.<br />
<br />
Tool 4: Antenatal Clinic Facility <strong>Assessment</strong><br />
1
BACKGROUND<br />
1. Name <strong>of</strong> <strong>the</strong> facility:______________________________________________<br />
2. Type <strong>of</strong> facility: [ ]<br />
Regional hospital = 1<br />
District hospital = 2<br />
Health center = 3<br />
Health dispensary = 4<br />
O<strong>the</strong>r = 9 (specify) _____________________________________________<br />
3. District: _______________________________________________________<br />
4. Region: ________________________________________________________<br />
5. Title <strong>of</strong> <strong>the</strong> respondent: __________________________________________<br />
6. Number <strong>of</strong> years <strong>of</strong> service in <strong>the</strong> facility: [ ] Years<br />
7. Training <strong>of</strong> <strong>the</strong> respondent: [ ]<br />
Doctor = 1<br />
Nurse = 2<br />
Midwife = 3<br />
O<strong>the</strong>r = 9 (specify) ______________________________________<br />
ASSESSMENT OF ANC SERVICES<br />
8. Are ANC cards used in this facility? [ ]<br />
Yes = 1<br />
No = 2 (SKIP TO Q11)<br />
Don’t know = 98 (SKIP TO Q11)<br />
If yes, are ANC cards provided free by <strong>the</strong> facility or are women required to purchase <strong>the</strong>m? [ ]<br />
Provided by <strong>the</strong> clinic for free = 1<br />
Provided by <strong>the</strong> clinic for a fee = 2<br />
Used at <strong>the</strong> clinic, but woman must provide = 3<br />
Don’t know = 98<br />
9. Do <strong>the</strong>se cards have a place to record antimalarial drug use?<br />
Yes = 1<br />
No = 2<br />
Don’t know = 98<br />
If yes, do <strong>the</strong> cards have a place to record (check all that apply)<br />
Treatment <strong>of</strong> malaria illness ________<br />
Intermittent preventive treatment (IPTp)_________<br />
Chemoprophylaxis__________<br />
10. If yes, Interviewer should examine at least 20 ANC cards <strong>of</strong> women making second or greater ANC visit and<br />
note how many cards have any information recorded on antimalarial drug use 1 [ ]<br />
All have antimalarial drug use information recorded = 1<br />
Half have antimalarial drug use information recorded = 2<br />
Fewer than half have antimalarial drug use information = 3<br />
O<strong>the</strong>r = 9 (specify): ____________________________________________<br />
Don’t know = 98<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
11. How many ANC visits are recommended in your clinic?<br />
11a. Number <strong>of</strong> recommended visits: [ ]<br />
11b. Average gestational age at first ANC visit (weeks) [ ] weeks<br />
11c. Number <strong>of</strong> visits per trimester<br />
First [ ]<br />
Second [ ]<br />
Third [ ]<br />
12. Actual practices in ANC services:<br />
Interviewer: Read each practice to respondent and record appropriate response.<br />
PRACTICE<br />
12a. Intermittent preventive<br />
treatment<br />
12b. Counseling on<br />
use <strong>of</strong> ITNs<br />
12c. Hemoglobin test<br />
12d. Iron<br />
12e. Folate<br />
12f. Iron and folate<br />
(combined tablet)<br />
12g. Blood films<br />
NEVER<br />
PROVIDED<br />
PROVIDED TO<br />
ALL WOMEN<br />
PROVIDED TO<br />
CERTAIN WOMEN<br />
If provided to certain<br />
women, reason why<br />
13. Are health education sessions held during ANC visits? [ ]<br />
Yes = 1<br />
No = 2 (SKIP TO Q15)<br />
Don’t know = 98 (SKIP TO Q15)<br />
If Yes,<br />
13a. Number <strong>of</strong> days with health education sessions/week: [ ]<br />
13b. Is <strong>the</strong> location for <strong>the</strong>se sessions adequate? [ ]<br />
Women can sit down = 1<br />
Certain women remain standing = 2<br />
All women are standing, but can fit in <strong>the</strong> room = 3<br />
<strong>The</strong> room is too full and women cannot enter into <strong>the</strong> room = 4<br />
O<strong>the</strong>r = 9 (specify): ___________________________________<br />
13c. <strong>The</strong>mes covered that are relevant to malaria: ______________________________________________<br />
__________________________________<br />
14. Are visual aids used during <strong>the</strong>se sessions? [ ]<br />
Yes = 1<br />
No = 2<br />
Don’t know = 98<br />
14a. If Yes,<br />
Are <strong>the</strong>re materials that women can take home with <strong>the</strong>m? [ ]<br />
Yes = 1 No = 2 Don’t know = 98<br />
Tool 4: Antenatal Clinic Facility <strong>Assessment</strong><br />
3
15. Are <strong>the</strong>re any job aids related to malaria during pregnancy<br />
available for <strong>the</strong> health-care workers (for example, wall posters, laminated sheets)? [ ]<br />
Yes = 1<br />
If yes, specify:___________________________________________________<br />
No = 2<br />
Don’t know = 98<br />
16. How do <strong>the</strong> women usually obtain <strong>the</strong>ir antimalarial drugs? [ ]<br />
Directly from <strong>the</strong> ANC (by <strong>the</strong> health provider) = 1<br />
From <strong>the</strong> pharmacy on site at <strong>the</strong> ANC after getting<br />
a prescription from <strong>the</strong> provider = 2<br />
Having a prescription filled elsewhere = 3<br />
O<strong>the</strong>r = 9 (SPECIFY)________________<br />
Don’t know = 98<br />
17. Quantities <strong>of</strong> medicines available at facility:<br />
Note <strong>the</strong> estimated number <strong>of</strong> boxes <strong>of</strong> pills or containers present. (If pregnant women’s medicines are<br />
stored toge<strong>the</strong>r with medicines for all o<strong>the</strong>r patients, note <strong>the</strong> total number. If pregnant women’s medicines are<br />
stored separately, note <strong>the</strong> number set aside for pregnant women.)<br />
Number <strong>of</strong> boxes <strong>of</strong> pills, containers<br />
17a. Chloroquine [ ]<br />
17b. Paracetamol [ ]<br />
17c. Sulfadoxine-Pyrimethamine [ ]<br />
17d. Quinine [ ]<br />
17e. Iron sulfate [ ]<br />
17f. Folate [ ]<br />
17g. Iron/folate [ ]<br />
18. Number <strong>of</strong> stock-outs: (Collect <strong>the</strong> following information from facility records)<br />
Medicine/vaccines/laboratory<br />
18a. Iron<br />
18b. Folate<br />
18c. Iron/folate<br />
18d. Chloroquine<br />
18e. Proguanil<br />
18f. Quinine<br />
18g. Sulfadoxine-pyrimethamine (SP)<br />
18h. Hemoglobin tests<br />
18i. Materials for blood films<br />
18j. O<strong>the</strong>r (specify): ___________________<br />
___________________________<br />
Number Total number Not available<br />
<strong>of</strong> stock- outs in <strong>the</strong><br />
last 6 months*<br />
*If 6 months is not feasible, could specify 3 months.<br />
<strong>of</strong> days with stockouts<br />
in <strong>the</strong> last 6<br />
months*<br />
4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
19. Facility Equipment:<br />
Present and working =1<br />
Present but not working = 2<br />
Not present = 3<br />
19a. <strong>The</strong>rmometer [ ]<br />
19b. Alcohol [ ]<br />
19c. Gloves [ ]<br />
19d. Cotton [ ]<br />
19e. Glass slides [ ]<br />
19f. Lancets [ ]<br />
19g. Microscope [ ]<br />
19h. Giemsa and staining equipment [ ]<br />
19i. Hemoglobin measuring supplies [ ]<br />
19j. Clean water [ ]<br />
19k. Cups to drink from [ ]<br />
MALARIA DURING PREGNANCY<br />
20. If malaria prophylaxis is recommended, does <strong>the</strong> clinic have a written copy <strong>of</strong> <strong>the</strong> national protocol? [ ]<br />
Yes = 1<br />
No = 2 (SKIP TO Q21)<br />
Don’t know = 98 (SKIP TO Q21)<br />
If yes,<br />
20a. Can <strong>the</strong> respondent show you <strong>the</strong> written protocol? [ ]<br />
Yes = 1 No = 2 Don’t know = 98<br />
20b. Treatment recommended in <strong>the</strong> protocol: [ ]<br />
Chloroquine treatment dose <strong>the</strong>n once per week = 1<br />
Two doses <strong>of</strong> SP = 2<br />
None = 3<br />
O<strong>the</strong>r = 9 (specify): _______________________________________<br />
21. Are insecticide-treated mosquito nets (ITNs) available for distribution or sale in your facility? [ ]<br />
Yes = 1<br />
No = 2 (SKIP TO Q22)<br />
Don’t know = 98 (SKIP TO Q22)<br />
If Yes:<br />
21a. Approximate cost to <strong>the</strong> ANC client <strong>of</strong> one ITN ___________________<br />
21b. Average number <strong>of</strong> ITNs distributed/sold per month: [ ]<br />
22. Are re-impregnation kits available for distribution or sale in your facility? [ ]<br />
Yes =1<br />
No = 2 (SKIP TO Q23)<br />
Don’t know = 98 (SKIP TO Q23)<br />
If yes<br />
22a. Approximate cost <strong>of</strong> one re-impregnation kit (to <strong>the</strong> ANC client)?: ___________________<br />
22b. Average number <strong>of</strong> kits distributed/sold per month [ ]<br />
Tool 4: Antenatal Clinic Facility <strong>Assessment</strong><br />
5
23. If ITNs are not available directly for sale, are vouchers/coupons distributed to women?<br />
Yes=1 No=2 Don’t know=98<br />
If Yes:<br />
23a. How much is <strong>the</strong> voucher/coupon worth? ____________<br />
COSTS OF ANC SERVICES<br />
24. Do women pay for ANC services? [ ]<br />
Yes = 1<br />
No = 2 (SKIP TO Q26)<br />
Don’t know = 98 (SKIP TO Q26)<br />
24a. If women pay for ANC services, what is <strong>the</strong> schedule <strong>of</strong> payments? [ ]<br />
Pay each visit = 1<br />
One payment for all ANC services = 2<br />
One payment for ANC and childbirth services = 3<br />
O<strong>the</strong>r = 9 (specify): ______________________________________________<br />
24b. How much do <strong>the</strong>y pay? ___________ per _____________<br />
25. Please indicate in <strong>the</strong> table below what women pay for each <strong>of</strong> <strong>the</strong> following medications:<br />
Medicines/Vaccinations/ Laboratory<br />
25a. Iron<br />
25b. Folate<br />
25c. Iron/Folate<br />
25c. Chloroquine (treatment)<br />
25d. Chloroquine (chemoprophylaxis)<br />
25e. SP (treatment)<br />
25f. SP (IPTp)<br />
25g. O<strong>the</strong>r antimalarial drug for<br />
treatment (specify): ___________________<br />
25h. O<strong>the</strong>r antimalarial drug for<br />
prevention (specify):__________________<br />
Cost to <strong>the</strong> woman<br />
Free = 0<br />
Included in cost <strong>of</strong> ANC services = 1<br />
Purchase at pharmacy part <strong>of</strong> <strong>the</strong><br />
facility = 2<br />
Purchase elsewhere = 3<br />
Not available = 4<br />
If purchased at <strong>the</strong> facility, cost<br />
(per quantity) (For example, 10<br />
packets for US$1)<br />
26. Which <strong>of</strong> <strong>the</strong> following information is routinely collected each month and forwarded on to <strong>the</strong> district health<br />
management team? (Check all that apply)<br />
26a. Number <strong>of</strong> first antenatal clinic consultations _______<br />
26b. Number <strong>of</strong> repeat antenatal clinic consultations _______<br />
26c. Number <strong>of</strong> tetanus toxoid vaccinations delivered _______<br />
26d. Number <strong>of</strong> 1st dose <strong>of</strong> IPTp delivered _______<br />
26e. Number <strong>of</strong> 2nd dose <strong>of</strong> IPTp delivered _______<br />
26f. Number <strong>of</strong> chemoprophylaxis doses delivered _______<br />
26g. Number <strong>of</strong> ITNs sold and distributed _______<br />
Thank <strong>the</strong> respondent for his or her time!<br />
6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
INTERVIEWER COMMENTS:<br />
(Please note any additional observations in <strong>the</strong> following space):<br />
Tool 4: Antenatal Clinic Facility <strong>Assessment</strong><br />
7
8 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Module 5: Conducting a Health-Care Worker<br />
Observation<br />
<strong>The</strong> health-care worker observation is designed to<br />
• Determine whe<strong>the</strong>r health-care workers are providing <strong>the</strong> needed healthcare<br />
services, specifically whe<strong>the</strong>r health-care workers are providing IPTp ,<br />
antimalarial drugs for a febrile illness, and tetanus toxoid<br />
This module contains sample materials for a health-care worker observation.<br />
<strong>The</strong>se materials can and should be adapted to suit local needs. General guidance for<br />
conducting assessment tools survey and managing data can be found in Chapters 3<br />
and 4 <strong>of</strong> <strong>the</strong> manual.<br />
A. Sample Size<br />
B. <strong>Assessment</strong> Team Members<br />
C. Data Analysis<br />
Contents<br />
A. Sample Size<br />
Approximately 20-25 health-care worker/patient encounters per each ANC clinic<br />
selected for an ANC survey should be observed and recorded.<br />
B. <strong>Assessment</strong> Team Members<br />
<strong>The</strong> health-care worker observations can be done by <strong>the</strong> assistant coordinator or his or<br />
her designee.<br />
C. Data Analysis<br />
No.<br />
Outcome variables<br />
1 Proportion <strong>of</strong> health providers who universally prescribed/distributed<br />
iron/folate during <strong>the</strong> ANC visit<br />
2 Proportion <strong>of</strong> health providers who universally prescribed/distributed<br />
antimalarial drug during <strong>the</strong> ANC visit<br />
3 Proportion <strong>of</strong> health providers who performed at least 90% <strong>of</strong> ANC<br />
services correctly<br />
Module 5: Conducting a Health-Care Worker Observation<br />
1
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Provider’s name: ________________<br />
Observation ID #____________________________<br />
TOOL 5: HEALTH-CARE WORKER OBSERVATION<br />
Observer name _____________________________________________________ Today’s date: ____/____/____<br />
Observer number _______<br />
Day Month Year<br />
Observation ID number: ___ -- ___ ___ ___<br />
Digit 1 = facility number<br />
Digits 2, 3 & 4 = provider’s consecutive number<br />
1. Woman’s arrival time: ___:___ AM/PM<br />
<br />
2. Training <strong>of</strong> health care worker [ ]<br />
Physician = 1<br />
Health Officer = 2<br />
Midwife = 3<br />
Nurse = 4<br />
Health assistant = 5<br />
Sanitarian = 6<br />
O<strong>the</strong>r = 9 (specify) ___________________________<br />
3. Number <strong>of</strong> ANC visits during this pregnancy (including this one) [ ]<br />
Obtain information from ANC card. If no ANC card is available, skip this question.<br />
3a. Check this box if woman’s first ANC visit<br />
4. Observation <strong>of</strong> health care worker with woman (check if behavior was performed<br />
by any <strong>of</strong> <strong>the</strong> clinic staff):<br />
YES NO<br />
___ ___ Checks if has ANC card<br />
___ ___ Takes history (during 1st ANC visit):<br />
___ ___ Age<br />
___ ___ Gravidity<br />
___<br />
___ Last menstrual period<br />
YES NO<br />
___ ___ Pregnancy symptoms<br />
___ ___ Contraceptive history<br />
___ ___ Reproductive history - prior deliveries/outcomes; complications<br />
___ ___ Medical history<br />
___ ___ Asks woman about HIV status<br />
___ ___ Counsels women about HIV/AIDS during pregnancy, childbirth, postpartum<br />
Tool 5: Health-Care Worker Observation<br />
1
Physical examination (during each ANC visit):<br />
___ ___ Measures blood pressure<br />
___ ___ Measures fundal height (abdominal exam)<br />
___ ___ Listens to fetal heart<br />
___ ___ Screens for anemia (physical signs)<br />
___ ___ Prescribes or dispenses iron/folate<br />
___ ___ Prescribes or dispenses antimalarial prophylaxis<br />
___ ___ Administers tetanus toxoid if needed<br />
Laboratory examination:<br />
___ ___ Orders urine test<br />
___ ___ Orders hemoglobin<br />
___ ___ Orders syphilis test<br />
___ ___ Treats for syphilis, if positive ____<br />
___ ___ Arranges partner follow up, if syphilis (+) ____<br />
Procedure related to problems:<br />
___ ___ Checks temperature, if reports fever ____<br />
___ ___ Refer for blood smear, if reports fever and malaria is suspected ____<br />
___ ___ Prescribes/dispenses antimalarial, if reports fever___<br />
General care during each ANC visit:<br />
___ ___ Social history & support<br />
___ ___ Assesses for woman’s complaints<br />
___ ___ Asks woman if has questions<br />
___ ___ Answers questions, if woman has questions<br />
___ ___ Discusses individualized birth plan<br />
(including clean and safe delivery)<br />
___ ___ Gives individual health education (specify) ________________<br />
___ ___ Washes hands before touching patient<br />
___ ___ Uses gloves if genital examination performed, disposes <strong>of</strong><br />
gloves properly<br />
___ ___ Fills out ANC card<br />
___ ___ Marks next visit<br />
___ ___ Reminds woman <strong>of</strong> next visit<br />
___ ___ O<strong>the</strong>r (specify) ______________________________________<br />
5. Time spent with woman for exam (minutes) _____<br />
6. Time seen by health-care worker (minutes) _____<br />
7. Time woman leaves clinic ___:___AM/PM<br />
8. Total time (minutes) _____<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Module 6: Conducting Individual Interviews and<br />
Focus Groups with Health-Care Workers<br />
Individual interviews and focus groups with health-care workers are designed<br />
to determine<br />
• <strong>The</strong> health-care workers’ knowledge <strong>of</strong> <strong>the</strong> problem <strong>of</strong> malaria<br />
• Role <strong>of</strong> health-care workers in influencing pregnant women’s behavior in<br />
seeking antenatal care at health facilities<br />
• What types <strong>of</strong> preventive and treatment measures <strong>the</strong>y currently<br />
recommend and provide<br />
• Factors that motivate or inhibit women from using antenatal care<br />
• Best methods for promoting health education messages to pregnant women<br />
This module contains sample materials relevant to conducting a focus group or an<br />
individual interview. <strong>The</strong>se materials can and should be adapted to meet <strong>the</strong> needs <strong>of</strong><br />
<strong>the</strong> local situation.<br />
Contents<br />
A. Interview/Focus Group Timetable<br />
B. Focus Group or Individual Interview or Both?<br />
C. Number <strong>of</strong> Individual Interviews/Focus Group Size<br />
D. Eligibility Criteria<br />
E. Venues and Equipment<br />
F. <strong>Assessment</strong> Team Members<br />
G. <strong>Assessment</strong> Team Training<br />
H. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />
I. Information Sheet<br />
J. Debriefing<br />
K. Focus Group/Interview Analysis<br />
In addition, please see Resource 2, which includes a Sample Interviewer Training<br />
Manual and a Resource List.<br />
Module 6: Conducting Individual Interviews and Focus Groups with Health-Care Workers<br />
1
A. Focus Group/Interview Timetable<br />
To prepare for focus groups or individual interviews, it is important to alert health facilities<br />
and community leaders well in advance (ideally, 2 weeks) <strong>of</strong> <strong>the</strong> qualitative team’s visits to <strong>the</strong><br />
facilities so that potential participants know that this activity will be occurring and that <strong>the</strong>y<br />
will be asked to participate. In addition, advance notice is needed so that community and/<br />
or facility focus groups can be established and that arrangements can be made for interview<br />
venues. It is helpful to follow up a week before <strong>the</strong> assigned meeting times.<br />
After planning for <strong>the</strong> focus groups and interviews, selecting sites, and training interviewers,<br />
<strong>the</strong> focus groups/interviews can begin.<br />
B. Focus Group or Individual Interview or Both?<br />
It may not always be possible to conduct both focus groups and individual interviews and<br />
thus “triangulate” <strong>the</strong> data. If both cannot be done, <strong>the</strong> more appropriate technique should be<br />
chosen based on <strong>the</strong> local situation.<br />
• Individual interviews are a better choice when individual variability within communities<br />
is <strong>of</strong> interest.<br />
• Focus group interviews elicit community norms.<br />
• Focus group interviews might help stimulate thinking and expose conflicting feelings–<br />
<strong>the</strong>y can ‘remind’ people <strong>of</strong> events or things that any one individual might have forgotten.<br />
Focus groups are best at helping participants express opinions and perceptions <strong>of</strong> which<br />
<strong>the</strong>y might individually be unaware or not <strong>of</strong>ten think about.<br />
• Individual interviews are <strong>of</strong>ten better if a topic is contentious or associated with strong<br />
individual opinions or emotions.<br />
• Focus group interviews are better for a small number <strong>of</strong> issues.<br />
• Individual interviews lend <strong>the</strong>mselves to a larger number <strong>of</strong> issues.<br />
• Focus group interviews may be more efficient when resources—time, distance (e.g.,<br />
vehicles), and money—are limited.<br />
C. Number <strong>of</strong> Individual Interviews/Focus Group Size<br />
Individual interviews are preferable if timing is not an issue. Could interview as many healthcare<br />
workers as feasible during <strong>the</strong> assessment period, probably no more than 5-10 per<br />
facility, but sometimes only 1 or 2 is all that is possible.<br />
D. Eligibility Criteria<br />
HCWs who routinely provide antenatal care or care for sick pregnant women who<br />
have malaria.<br />
E. Venues and Equipment<br />
<strong>The</strong> focus group will ideally be held in a quiet space in a health facility or within a village.<br />
Writing materials/stationery to record notes <strong>of</strong> <strong>the</strong> focus group will be needed, as will a tape<br />
recorder if <strong>the</strong> decision to use one has been made.<br />
Sufficient seating is needed for <strong>the</strong> members <strong>of</strong> <strong>the</strong> group, as well as for <strong>the</strong> facilitator and<br />
<strong>the</strong> persons who serve as recorders. Because a focus group may draw a crowd <strong>of</strong> interested<br />
people, ask that a member <strong>of</strong> <strong>the</strong> health-care facility or a community member politely dismiss<br />
<strong>the</strong> crowd, with a brief explanation <strong>of</strong> what is occurring.<br />
Individual interviews can also be conducted at health facilities.<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
<strong>The</strong> decision about how to record what is said (and whe<strong>the</strong>r to use a tape recorder) should<br />
have been made before interviewers are selected and trained (see 4.1 in <strong>the</strong> Manual). Note<br />
that for focus group interviews, it is wise to have at least 2 people recording <strong>the</strong> session, even<br />
if a tape recorder is used.<br />
F. <strong>Assessment</strong> Team Members<br />
For each focus group, a facilitator and a recorder are needed. Sometimes tape recorders are<br />
used to record <strong>the</strong> group’s discussion. <strong>The</strong> facilitator/recorder should write up <strong>the</strong> summary<br />
<strong>of</strong> findings.<br />
An interviewer who can speak <strong>the</strong> woman’s mo<strong>the</strong>r tongue will be needed to conduct<br />
interviews.<br />
G. <strong>Assessment</strong> Team Training<br />
<strong>The</strong> training can be conducted concurrently, but separately, with training for Antenatal Clinic<br />
and Delivery Unit Surveys.<br />
Training can include <strong>the</strong> following subjects:<br />
• an overview <strong>of</strong> <strong>the</strong> local malaria program implementation plan<br />
• a review <strong>of</strong> malaria (transmission cycle, symptoms, diagnosis, prophylaxis and<br />
treatment, epidemiology <strong>of</strong> malaria, consequences <strong>of</strong> malaria during pregnancy, and<br />
local beliefs related to malaria)<br />
• differences between qualitative and quantitative studies<br />
• interviewing techniques<br />
• data recording techniques<br />
• differences between individual and focus group interviews<br />
For most <strong>of</strong> <strong>the</strong> training, <strong>the</strong> team conducting focus groups and individual interviews team<br />
can train alone, although both assessment teams can meet toge<strong>the</strong>r for <strong>the</strong> training related<br />
to proper interviewing techniques. Practice sessions can include role-playing <strong>of</strong> interview<br />
sessions.<br />
To assist in building capacity in qualitative research methodologies, all team members can be<br />
given information on qualitative assessments and methodology, as well as written handouts on<br />
interviewing techniques.<br />
<strong>The</strong> training period can also be used to ensure that <strong>the</strong> interview instruments are linguistically<br />
consistent. In addition, using <strong>the</strong> team members as community experts, each interview guide<br />
should be reviewed to ensure that questions are relevant to <strong>the</strong> context <strong>of</strong> this district, and<br />
minor modifications in <strong>the</strong> interview guides can be made.<br />
H. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />
Both <strong>the</strong> focus group facilitator and <strong>the</strong> recorder should have a copy <strong>of</strong> <strong>the</strong> guide. <strong>The</strong> guide<br />
will serve as a script for <strong>the</strong> facilitator and will help familiarize <strong>the</strong> recorder with <strong>the</strong> questions<br />
that will be discussed.<br />
<strong>The</strong> interviewer will need a copy <strong>of</strong> <strong>the</strong> guide.<br />
It is important that <strong>the</strong> guide be flexible. If <strong>the</strong> questions as written in <strong>the</strong> guide do not elicit<br />
<strong>the</strong> intended responses, <strong>the</strong>y should be adapted as necessary. See J below, Debriefing.<br />
Note that <strong>the</strong> guide included in this package may need to be adapted depending on whe<strong>the</strong>r it<br />
is used for a focus group or an individual interview.<br />
Module 6: Conducting Individual Interviews and Focus Groups with Health-Care Workers<br />
3
I. Information Sheet<br />
<strong>The</strong> following information sheet should be given to each potential interview participant. If <strong>the</strong><br />
person cannot read or has low literacy skills, <strong>the</strong> information should be read aloud to her. All<br />
potential participants should receive a copy <strong>of</strong> <strong>the</strong> information sheet to take home.<br />
Notes to interviewer:<br />
• Explain everything in <strong>the</strong> local language or language <strong>of</strong> choice <strong>of</strong> <strong>the</strong> participant. Use<br />
words that are easily understood and tailor your explanations to <strong>the</strong> level <strong>of</strong> education <strong>of</strong><br />
<strong>the</strong> participant.<br />
• Do not force <strong>the</strong> person to agree to participate. You may need to explain <strong>the</strong> survey in<br />
several different ways if <strong>the</strong> person does not seem to understand. If <strong>the</strong> person looks<br />
confused or scared, try to clarify <strong>the</strong>ir concerns.<br />
• If participant refuses to participate, please remember that this was an INVITATION to<br />
participate. Thank <strong>the</strong> person for <strong>the</strong>ir time and trouble and go onto <strong>the</strong> next person.<br />
• KEEP A RECORD <strong>of</strong> <strong>the</strong> number <strong>of</strong> participants who accept and refuse. For those that<br />
refuse, keep a record <strong>of</strong> <strong>the</strong>ir reason for refusing, if possible.<br />
Introduction<br />
<strong>The</strong> Ministry <strong>of</strong> Health is trying to find out <strong>the</strong> best ways prevent <strong>the</strong> effects <strong>of</strong> malaria on<br />
pregnant women and <strong>the</strong>ir babies. To do this, we need to know what women know about<br />
malaria and its effects on pregnant women. We also need to know <strong>the</strong> places that women<br />
seek health care when <strong>the</strong>y are pregnant and what sorts <strong>of</strong> things <strong>the</strong>y do to prevent malaria<br />
when <strong>the</strong>y are pregnant. We plan to talk to ____________ (describe about how many women and<br />
o<strong>the</strong>rs will be involved in this component <strong>of</strong> <strong>the</strong> assessment).<br />
Purpose<br />
What we learn about women’s ideas and actions about malaria and what <strong>the</strong>y do when <strong>the</strong>y<br />
are pregnant will help us plan programs to decrease malaria in pregnant women.<br />
Procedures<br />
Being part <strong>of</strong> this individual interview/focus group is up to you. If you agree to participate/<br />
be part <strong>of</strong> this interview/focus group, we will ask you some questions about what you think<br />
and do about malaria, and about where you get help and information about malaria. You also<br />
do not need to answer any questions that we ask that you do not want to. If you agree to<br />
participate and during <strong>the</strong> interview/focus group, decide that you do not want to continue, you<br />
can withdraw at any time. We will not be asking for any blood or urine samples.<br />
Benefits<br />
Although what we learn might not help you directly, it will help us know how best to prevent<br />
malaria in pregnant women in this district.<br />
Risks or discomforts<br />
We will not be telling anyone about your individual answers to <strong>the</strong> questions.<br />
Would you like to participate?<br />
Thank you very much for your time.<br />
Please be sure to give this information sheet to <strong>the</strong> person with whom you spoke.<br />
4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
J. Debriefing<br />
Daily debriefings are an essential element <strong>of</strong> good qualitative work. At <strong>the</strong> end <strong>of</strong> each day that<br />
focus groups or individual interviews are conducted, it is useful for <strong>the</strong> assessment team to<br />
hold a debriefing session lasting approximately 1 - 1.5 hours. <strong>The</strong> debriefing should be led by<br />
<strong>the</strong> coordinator or ano<strong>the</strong>r facilitator.<br />
Debriefings are a method to determine if a) <strong>the</strong> questions are adequate to obtain <strong>the</strong> needed<br />
data (qualitative methods are iterative, thus, you can change questions as needed as you<br />
conduct <strong>the</strong> assessment), b) if people have understood <strong>the</strong> question (for example: is it a<br />
sentence structure, content or a translation problem?), if c) data are similar across facilities or<br />
show wide variability, which might require adding questions to understand <strong>the</strong> variability, and<br />
if d) expressions in <strong>the</strong> local language are being translated appropriately.<br />
<strong>The</strong> team listens to what each interviewer has learned (aggregate summary <strong>of</strong> <strong>the</strong> data <strong>the</strong>y<br />
collected that day), identifies what is common, what is different, and mutually agrees on what<br />
local expressions mean. This is particularly important when <strong>the</strong> team is trying to understand<br />
local beliefs, including taboos, about malaria and/or drugs during pregnancy. Debriefings<br />
tend to be difficult as <strong>the</strong> team is tired and <strong>the</strong> process can be tedious, but having high-quality,<br />
clearly understandable data when analysis begins rewards <strong>the</strong> time spent in daily debriefings.<br />
During <strong>the</strong> debriefings, <strong>the</strong> coordinator or facilitator should keep notes on <strong>the</strong> outcomes <strong>of</strong><br />
each debriefing, explanations for trends seen in <strong>the</strong> data, and local language terms (using <strong>the</strong><br />
local language), as well as <strong>the</strong> agreed-upon translations.<br />
During this time, all recorded interviews can be reviewed for completeness and accuracy <strong>of</strong><br />
<strong>the</strong> recording. In addition, concepts can be clarified, traditional terms used for prevention<br />
and treatment strategies can be reviewed for linguistic accuracy and consistency, and<br />
understanding <strong>of</strong> local pregnancy taboos can be discussed.<br />
<strong>The</strong>se types <strong>of</strong> surveys can require <strong>the</strong> addition <strong>of</strong> new questions or probes to <strong>the</strong> survey tool<br />
during <strong>the</strong> survey period in order to make <strong>the</strong> questions wider, narrower, or more specific in<br />
order to obtain <strong>the</strong> needed information.<br />
K. Focus Group/Interview Analysis<br />
Recording and analyzing information for a focus group is somewhat different from recording<br />
and analyzing information for an individual interview.<br />
For focus groups:<br />
• <strong>The</strong> recorder must be able to record general <strong>the</strong>mes during <strong>the</strong> interview and fill in <strong>the</strong><br />
details afterwards.<br />
• Counting <strong>the</strong> number <strong>of</strong> responses is not important, but noting that most or many<br />
participants felt <strong>the</strong> same way is.<br />
• It is important to note if one person in <strong>the</strong> focus group has thoughts or behaviors very<br />
different from those <strong>of</strong> <strong>the</strong> rest <strong>of</strong> <strong>the</strong> group. This person is called an “outlier.”<br />
• Names should not be used in recording <strong>the</strong>mes, although speakers can be identified by<br />
<strong>the</strong>ir job description (for example, “<strong>the</strong> nurses felt…”) or o<strong>the</strong>r pertinent descriptors.<br />
When <strong>the</strong>re is a good quote in <strong>the</strong> local language, make sure it is written as it is said in <strong>the</strong><br />
local language and <strong>the</strong>n reach consensus (perhaps during debriefing) on what it means in <strong>the</strong><br />
primary language used in <strong>the</strong> rapid assessment, if different.<br />
Module 6: Conducting Individual Interviews and Focus Groups with Health-Care Workers<br />
5
6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
TOOL 6: INDIVIDUAL INTERVIEW/FOCUS GROUP GUIDE FOR<br />
HEALTH-CARE WORKERS<br />
This guide can be adapted to be used as a guide for conducting ei<strong>the</strong>r focus groups or individual interviews.<br />
Region_______________________________<br />
Name <strong>of</strong> facility/facility area_______________<br />
Date: ____/____/____<br />
Month Day Year<br />
Time_________________________<br />
Interviewer_____________________<br />
Recorder_______________________<br />
INTRODUCTION: Introduce yourself and team members, describe your roles, and obtain agreement to<br />
participate (or informed consent if required). Tell <strong>the</strong> participant(s) <strong>the</strong> goal <strong>of</strong> <strong>the</strong> focus group.<br />
A. Demographics:<br />
Age:<br />
Level <strong>of</strong> education: Highest level <strong>of</strong> school attended (primary, secondary, higher, unknown)<br />
Job description at health facility:<br />
<br />
B. Topical area: Prevailing health problems and malaria in pregnancy<br />
1. What are <strong>the</strong> 3 most serious health problems among pregnant women in this area?<br />
List <strong>the</strong>m in order <strong>of</strong> how serious <strong>the</strong>y are.<br />
2. (Ask if malaria is not mentioned in Question 1) Is malaria a serious or common health problem among<br />
pregnant women in this community?<br />
C. Topical area: Signs and symptoms <strong>of</strong> fever and malaria during pregnancy<br />
1. What are <strong>the</strong> common signs and symptoms <strong>of</strong> malaria among pregnant women?<br />
D. Topical area: Causes and consequences <strong>of</strong> malaria in pregnancy<br />
1. What effect does malaria have on pregnant women? On <strong>the</strong> fetus? On <strong>the</strong> neonate?<br />
2. Are pregnant women more susceptible to malaria? Do pregnant women with malaria get more severely<br />
ill than o<strong>the</strong>r people?<br />
Tool 6: Individual Interview/ Focus Group Guide for Health-Care Workers<br />
1
E. Topical area: Sources <strong>of</strong> advice for malaria prevention/treatment during pregnancy<br />
1. From whom do women seek advice regarding malaria or pregnancy issues in general?<br />
2. Who influences women <strong>the</strong> most when <strong>the</strong>y need information about pregnancy or malaria? For example, someone<br />
at <strong>the</strong> health facility, a traditional birth attendant, a midwife, someone else in <strong>the</strong> community (example village elder),<br />
or someone in <strong>the</strong>ir family?<br />
What is <strong>the</strong> order <strong>of</strong> seeking advice? First, second, third?<br />
3. Do husbands play a role in deciding what to do if <strong>the</strong>ir pregnant wife gets malaria?<br />
IF YES: please describe <strong>the</strong>ir role.<br />
4. What is <strong>the</strong> best (most effective) way to reach women in this community in order to provide <strong>the</strong>m malaria<br />
prevention and treatment information?<br />
F. Topical area: Preventive strategies<br />
1. In general, how do people protect <strong>the</strong>mselves in this area against malaria when <strong>the</strong>y are pregnant? (Probe for<br />
traditional remedies, use <strong>of</strong> insecticides, insecticide-treated nets or curtains, mosquito coils, dress, etc.)<br />
Are any <strong>of</strong> <strong>the</strong>se strategies harmful to a pregnant woman or her baby? Yes___No___ IF YES: Which ones?<br />
IF YES: please describe how it will hurt <strong>the</strong> woman or <strong>the</strong> baby.<br />
2. What preventive methods are provided at <strong>the</strong> clinic?<br />
3. For intermittent preventive treatment (IPTp), what drugs are given?<br />
• When are <strong>the</strong>se given? How many doses do <strong>the</strong> women get?<br />
• Do you use directly observed treatments? Yes___ No___<br />
• Are <strong>the</strong>re any times when you can not do this? (Probes: for example, no drinkable water or drug shortages, woman<br />
complains that she has not eaten?)<br />
• If you do not see <strong>the</strong> woman taking <strong>the</strong> pill, do you think most women are compliant?<br />
• How are you recording <strong>the</strong> doses? For example, do you have a written record <strong>of</strong> women receiving doses or do you<br />
only ask <strong>the</strong> women if <strong>the</strong>y have received a dose? Is it written in <strong>the</strong>ir clinic cards?<br />
• When did this facility start implementing IPT?<br />
• What has been <strong>the</strong> response <strong>of</strong> <strong>the</strong> women to <strong>the</strong> IPTp? (Probe: Do <strong>the</strong>y see it as a welcome addition to antenatal<br />
care, are <strong>the</strong>y concerned about toxic effects to <strong>the</strong> baby?)<br />
4. What has been <strong>the</strong>ir response to insecticide-treated nets/nets?<br />
• Are <strong>the</strong>se provided to pregnant women? Yes___No___<br />
• Do you think most women sleep under <strong>the</strong>se nets? Yes___No___ IF NO: who sleeps under <strong>the</strong> net in most <strong>of</strong> <strong>the</strong>se<br />
families?<br />
• What comments have you heard from <strong>the</strong> women about <strong>the</strong> nets?<br />
• How are <strong>the</strong>y provided:<br />
o given free<br />
o given as a cost-sharing mechanism (If so, how much do you charge for <strong>the</strong> net?)<br />
o If using a cost-sharing mechanism, can most women afford <strong>the</strong>m? Yes___No___<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
G. Topic area: Treatment strategies<br />
1. What treatment do you use for a pregnant woman with uncomplicated malaria? Does this vary with gestational age?<br />
2. Are <strong>the</strong>re any antimalarials you will not use in pregnant women? Why? Does this vary with gestational age?<br />
3. What concerns do most women express regarding malaria treatments during pregnancy? (Probes: Are women<br />
concerned that <strong>the</strong> medicines are too harsh for <strong>the</strong> baby? Is <strong>the</strong> medicine worse for <strong>the</strong> baby or is <strong>the</strong> malaria worse?<br />
Will taking treatments during pregnancy put a curse on <strong>the</strong> baby?)<br />
H. Topical area: Acceptance <strong>of</strong> antenatal care (from health facilities and<br />
traditional birth attendants)<br />
1. How can health-care workers work better with traditional birth attendants? With o<strong>the</strong>r community-based workers?<br />
2. In your opinion, what could be done to improve <strong>the</strong> services <strong>of</strong> <strong>the</strong> health facility?<br />
3. How could services for pregnant women regarding <strong>the</strong> prevention and treatment <strong>of</strong> malaria be improved?<br />
4. Do you feel that you have had adequate training regarding malaria during pregnancy?<br />
BE SURE TO THANK THE HEALTH CARE WORKER FOR HIS OR HER TIME, AND ASK IF HE OR SHE HAS ANY<br />
QUESTIONS FOR YOU.<br />
Tool 6: Individual Interview/ Focus Group Guide for Health-Care Workers<br />
3
4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Module 7: Conducting Individual Interviews and<br />
Focus Groups with Traditional Birth<br />
Attendants (TBAs)<br />
Individual interviews and focus groups with traditional birth attendants<br />
(TBAs) are designed to determine<br />
• Role <strong>of</strong> TBAs in influencing pregnant women’s behavior in seeking antenatal<br />
care at health facilities<br />
• What types <strong>of</strong> preventive and treatment measures are currently being<br />
recommended and used<br />
• Factors that motivate or inhibit women from using antenatal care<br />
• Best methods for promoting health education messages to pregnant women<br />
This module contains sample materials relevant to conducting a focus group or an<br />
individual interview. <strong>The</strong>se materials can and should be adapted to meet <strong>the</strong> needs <strong>of</strong><br />
<strong>the</strong> local situation.<br />
Contents<br />
A. Interview/Focus Group Timetable<br />
B. Focus Group or Individual Interview or Both?<br />
C. Number <strong>of</strong> Individual Interviews/Focus Group Size<br />
D. Eligibility Criteria<br />
E. Venues and Equipment<br />
F. <strong>Assessment</strong> Team Members<br />
G. <strong>Assessment</strong> Team Training<br />
H. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />
I. Information Sheet<br />
J. Debriefing<br />
K. Focus Group/Interview Analysis<br />
In addition, please see Resource 2, which includes a Sample Interviewer Training<br />
Manual and a Resource List.<br />
Module 7: Conducting Individual Interviews and Focus Groups with Traditional Birth Attendants (TBAs)<br />
1
A. Focus Group/Interview Timetable<br />
To prepare for focus groups or individual interviews, it is important to alert community<br />
leaders well in advance (ideally, 2 weeks) <strong>of</strong> <strong>the</strong> qualitative team’s visits so that potential<br />
participants know that this activity will be occurring and that <strong>the</strong>y will be asked to participate.<br />
In addition, advance notice is needed so that community and/or facility focus groups can be<br />
established and that arrangements can be made for interview venues. It is helpful to follow up<br />
a week before <strong>the</strong> assigned meeting times.<br />
After planning for <strong>the</strong> focus groups and interviews, selecting sites, and training interviewers,<br />
<strong>the</strong> focus groups/interviews can begin.<br />
B. Focus Group or Individual Interview or Both?<br />
It may not always be possible to conduct both focus groups and individual interviews and<br />
thus “triangulate” <strong>the</strong> data. If both cannot be done, <strong>the</strong> more appropriate technique should be<br />
chosen based on <strong>the</strong> local situation.<br />
• Individual interviews are a better choice when individual variability within communities is<br />
<strong>of</strong> interest.<br />
• Focus group interviews elicit community norms.<br />
• Focus group interviews might help stimulate thinking and expose conflicting feelings–<strong>the</strong>y<br />
can ‘remind’ people <strong>of</strong> events or things that any one individual might have forgotten.<br />
• Focus groups are best at helping participants express opinions and perceptions <strong>of</strong> which <strong>the</strong>y<br />
might individually be unaware or not <strong>of</strong>ten think about.<br />
•Individual interviews are <strong>of</strong>ten better if a topic is contentious or associated with strong<br />
individual opinions or emotions.<br />
• Focus group interviews are better for a small number <strong>of</strong> issues.<br />
• Individual interviews lend <strong>the</strong>mselves to a larger number <strong>of</strong> issues.<br />
• Focus group interviews may be more efficient when resources—time, distance (e.g.,<br />
vehicles), and money—are limited.<br />
C. Number <strong>of</strong> Individual Interviews/Focus Group Size<br />
At least one focus group with 5 to 15 participants per facility area. May wish to conduct<br />
interviews as well, depending on <strong>the</strong> available pool <strong>of</strong> potential participants.<br />
Note: Community health workers, church leaders, and primary school teachers can help<br />
identify TBAs who attend home births.<br />
D. Eligibility Criteria<br />
TBAs who attend home births and advise pregnant women are eligible.<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
E. Venues and Equipment<br />
<strong>The</strong> focus group will ideally be held in a quiet space within a village.<br />
Writing materials/stationery to record notes <strong>of</strong> <strong>the</strong> focus group will be needed, as will a<br />
tape recorder if <strong>the</strong> decision to use one has been made.<br />
Sufficient seating is needed for <strong>the</strong> members <strong>of</strong> <strong>the</strong> group, as well as for <strong>the</strong> facilitator<br />
and <strong>the</strong> persons who serve as recorders. Because a focus group may draw a crowd <strong>of</strong><br />
interested people, ask that a community member politely dismiss <strong>the</strong> crowd, with a brief<br />
explanation <strong>of</strong> what is occurring.<br />
Homes in villages near <strong>the</strong> health facilities can also serve as interview sites.<br />
<strong>The</strong> decision about how to record what is said (and whe<strong>the</strong>r to use a tape recorder) should<br />
have been made before interviewers are selected and trained (see 4.1 in <strong>the</strong> Manual). Note<br />
that for focus group interviews, it is wise to have at least 2 people recording <strong>the</strong> session, even<br />
if a tape recorder is used.<br />
F. <strong>Assessment</strong> Team Members<br />
For each focus group, a facilitator and a recorder are needed. Sometimes tape recorders<br />
are used to record <strong>the</strong> group’s discussion. <strong>The</strong> facilitator/recorder should write up <strong>the</strong><br />
summary <strong>of</strong> findings.<br />
An interviewer who can speak <strong>the</strong> woman’s mo<strong>the</strong>r tongue will be needed to conduct<br />
interviews.<br />
G. <strong>Assessment</strong> Team Training<br />
<strong>The</strong> training can be conducted concurrently, but separately, with training for Antenatal<br />
Clinic and Delivery Unit Surveys.<br />
Training can include <strong>the</strong> following subjects:<br />
• an overview <strong>of</strong> <strong>the</strong> local malaria program implementation plan<br />
• a review <strong>of</strong> malaria (transmission cycle, symptoms, diagnosis, prophylaxis and treatment,<br />
epidemiology <strong>of</strong> malaria, consequences <strong>of</strong> malaria during pregnancy, and local beliefs<br />
related to malaria)<br />
• differences between qualitative and quantitative studies<br />
• interviewing techniques<br />
• data recording techniques<br />
• differences between individual and focus group interviews<br />
For most <strong>of</strong> <strong>the</strong> training, <strong>the</strong> team conducting focus groups and individual interviews team<br />
can train alone, although both assessment teams can meet toge<strong>the</strong>r for <strong>the</strong> training related<br />
to proper interviewing techniques. Practice sessions can include role-playing <strong>of</strong> interview<br />
sessions.<br />
To assist in building capacity in qualitative research methodologies, all team members can be<br />
given information on qualitative assessments and methodology, as well as written handouts on<br />
interviewing techniques.<br />
Module 7: Conducting Individual Interviews and Focus Groups with Traditional Birth Attendants (TBAs)<br />
3
<strong>The</strong> training period can also be used to ensure that <strong>the</strong> interview instruments are linguistically<br />
consistent. In addition, using <strong>the</strong> team members as community experts, each interview guide<br />
should be reviewed to ensure that questions are relevant to <strong>the</strong> context <strong>of</strong> this district, and<br />
minor modifications in <strong>the</strong> interview guides can be made.<br />
H. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />
Both <strong>the</strong> focus group facilitator and <strong>the</strong> recorder should have a copy <strong>of</strong> <strong>the</strong> guide. <strong>The</strong><br />
guide will serve as a script for <strong>the</strong> facilitator and will help familiarize <strong>the</strong> recorder with<br />
<strong>the</strong> questions that will be discussed.<br />
<strong>The</strong> interviewer will need a copy <strong>of</strong> <strong>the</strong> guide.<br />
It is important that <strong>the</strong> guide be flexible. If <strong>the</strong> questions as written in <strong>the</strong> guide do not elicit<br />
<strong>the</strong> intended responses, <strong>the</strong>y should be adapted as necessary. See H below, Debriefing.<br />
Note that <strong>the</strong> guide included in this package may need to be adapted depending on whe<strong>the</strong>r it<br />
is used for a focus group or an individual interview.<br />
I. Information Sheet<br />
<strong>The</strong> following information sheet should be given to each potential interview participant.<br />
If <strong>the</strong> person cannot read or has low literacy skills, <strong>the</strong> information should be read<br />
aloud to her. All potential participants should receive a copy <strong>of</strong> <strong>the</strong> information sheet<br />
to take home.<br />
Notes to interviewer:<br />
• Explain everything in <strong>the</strong> local language or language <strong>of</strong> choice <strong>of</strong> <strong>the</strong> participant. Use words<br />
that are easily understood and tailor your explanations to <strong>the</strong> level <strong>of</strong> education <strong>of</strong> <strong>the</strong><br />
participant.<br />
• Do not force <strong>the</strong> person to agree to participate. You may need to explain <strong>the</strong> survey in several<br />
different ways if <strong>the</strong> person does not seem to understand. If <strong>the</strong> person looks confused or<br />
scared, try to clarify <strong>the</strong>ir concerns.<br />
• If participant refuses to participate, please remember that this was an INVITATION to<br />
participate. Thank <strong>the</strong> person for <strong>the</strong>ir time and trouble and go on to <strong>the</strong> next person.<br />
• KEEP A RECORD <strong>of</strong> <strong>the</strong> number <strong>of</strong> participants who accept and refuse. For those that refuse,<br />
keep a record <strong>of</strong> <strong>the</strong>ir reason for refusing, if possible.<br />
4 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Introduction<br />
<strong>The</strong> Ministry <strong>of</strong> Health is trying to find out <strong>the</strong> best ways prevent <strong>the</strong> effects <strong>of</strong> malaria on<br />
pregnant women and <strong>the</strong>ir babies. To do this, we need to know what women know about<br />
malaria and its effects on pregnant women. We also need to know <strong>the</strong> places that women<br />
seek health care when <strong>the</strong>y are pregnant and what sorts <strong>of</strong> things <strong>the</strong>y do to prevent malaria<br />
when <strong>the</strong>y are pregnant. We plan to talk to ____________ (describe about how many women and<br />
o<strong>the</strong>rs will be involved in this component <strong>of</strong> <strong>the</strong> assessment).<br />
Purpose<br />
What we learn about women’s ideas and actions about malaria and what <strong>the</strong>y do when <strong>the</strong>y<br />
are pregnant will help us plan programs to decrease malaria in pregnant women.<br />
Procedures<br />
Being part <strong>of</strong> this individual interview/focus group is up to you. If you agree to participate/<br />
be part <strong>of</strong> this interview/focus group, we will ask you some questions about what you think<br />
and do about malaria, and about where you get help and information about malaria. You also<br />
do not need to answer any questions that we ask that you do not want to. If you agree to<br />
participate and during <strong>the</strong> interview/focus group, decide that you do not want to continue,<br />
you can withdraw at any time. We will not be asking for any blood or urine samples.<br />
Benefits<br />
Although what we learn might not help you directly, it will help us know how best to prevent<br />
malaria in pregnant women in this district.<br />
Risks or discomforts<br />
We will not be telling anyone about your individual answers to <strong>the</strong> questions.<br />
Would you like to participate?<br />
Thank you very much for your time.<br />
Please be sure to give this information sheet to <strong>the</strong> person with whom you spoke.<br />
Module 7: Conducting Individual Interviews and Focus Groups with Traditional Birth Attendants (TBAs)<br />
5
J. Debriefing<br />
Daily debriefings are an essential element <strong>of</strong> good qualitative work. At <strong>the</strong> end <strong>of</strong> each day that<br />
focus groups or individual interviews are conducted, it is useful for <strong>the</strong> assessment team to<br />
hold a debriefing session lasting approximately 1 - 1.5 hours. <strong>The</strong> debriefing should be led by<br />
<strong>the</strong> coordinator or ano<strong>the</strong>r facilitator.<br />
Debriefings are a method to determine if a) <strong>the</strong> questions are adequate to obtain <strong>the</strong> needed<br />
data (qualitative methods are iterative, thus, you can change questions as needed as you<br />
conduct <strong>the</strong> assessment), b) if people have understood <strong>the</strong> question (for example: is it a<br />
sentence structure, content or a translation problem?), if c) data are similar across facilities or<br />
show wide variability, which might require adding questions to understand <strong>the</strong> variability, and<br />
if d) expressions in <strong>the</strong> local language are being translated appropriately.<br />
<strong>The</strong> team listens to what each interviewer has learned (aggregate summary <strong>of</strong> <strong>the</strong> data <strong>the</strong>y<br />
collected that day), identifies what is common, what is different, and mutually agrees on what<br />
local expressions mean. This is particularly important when <strong>the</strong> team is trying to understand<br />
local beliefs, including taboos, about malaria and/or drugs during pregnancy. Debriefings<br />
tend to be difficult as <strong>the</strong> team is tired and <strong>the</strong> process can be tedious, but having high-quality,<br />
clearly understandable data when analysis begins rewards <strong>the</strong> time spent in daily debriefings.<br />
During <strong>the</strong> debriefings, <strong>the</strong> coordinator or facilitator should keep notes on <strong>the</strong> outcomes <strong>of</strong><br />
each debriefing, explanations for trends seen in <strong>the</strong> data, and local language terms (using <strong>the</strong><br />
local language), as well as <strong>the</strong> agreed-upon translations.<br />
During this time, all recorded interviews can be reviewed for completeness and accuracy <strong>of</strong><br />
<strong>the</strong> recording. In addition, concepts can be clarified, traditional terms used for prevention<br />
and treatment strategies can be reviewed for linguistic accuracy and consistency, and<br />
understanding <strong>of</strong> local pregnancy taboos can be discussed.<br />
<strong>The</strong>se types <strong>of</strong> surveys can require <strong>the</strong> addition <strong>of</strong> new questions or probes to <strong>the</strong> survey tool<br />
during <strong>the</strong> survey period in order to make <strong>the</strong> questions wider, narrower, or more specific in<br />
order to obtain <strong>the</strong> needed information.<br />
K. Focus Group/Interview Analysis<br />
Recording and analyzing information for a focus group is somewhat different from recording<br />
and analyzing information for an individual interview.<br />
For focus groups:<br />
• <strong>The</strong> recorder must be able to record general <strong>the</strong>mes during <strong>the</strong> interview and fill in <strong>the</strong><br />
details afterwards.<br />
• Counting <strong>the</strong> number <strong>of</strong> responses is not important, but noting that most or many<br />
participants felt <strong>the</strong> same way is.<br />
• It is important to note if one person in <strong>the</strong> focus group has thoughts or behaviors very<br />
different from those <strong>of</strong> <strong>the</strong> rest <strong>of</strong> <strong>the</strong> group. This person is called an “outlier.”<br />
• Names should not be used in recording <strong>the</strong>mes, although speakers can be identified by <strong>the</strong>ir<br />
job description (for example, “<strong>the</strong> nurses felt…”) or o<strong>the</strong>r pertinent descriptors.<br />
When <strong>the</strong>re is a good quote in <strong>the</strong> local language, make sure it is written as it is said in <strong>the</strong><br />
local language and <strong>the</strong>n reach consensus (perhaps during debriefing) on what it means in <strong>the</strong><br />
primary language used in <strong>the</strong> rapid assessment, if different.<br />
6 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
TOOL 7: INDIVIDUAL INTERVIEW/FOCUS GROUP GUIDE FOR<br />
TRADITIONAL BIRTH ATTENDANTS<br />
This guide can be adapted to be used as a guide for conducting ei<strong>the</strong>r focus groups or individual interviews.<br />
Region_______________________________<br />
Name <strong>of</strong> facility/facility area_______________<br />
Date: ____/____/____<br />
Month Day Year<br />
Time_________________________<br />
Interviewer_____________________<br />
Recorder____________________________<br />
INTRODUCTION: Introduce yourself and team members, describe your roles, and obtain agreement to<br />
participate (or informed consent if required). Tell <strong>the</strong> participant(s) <strong>the</strong> goal <strong>of</strong> <strong>the</strong> focus group.<br />
A. Demographics: For each <strong>of</strong> <strong>the</strong> participants, record <strong>the</strong> following information:<br />
Age:<br />
Level <strong>of</strong> education: Highest level <strong>of</strong> school attended (primary, secondary, higher, unknown)<br />
For traditional birth attendants, number <strong>of</strong> years <strong>of</strong> experience as a traditional birth attendant:<br />
Ethnic group (If group is diverse):<br />
<br />
B. Topical area: Prevailing health problems and malaria in pregnancy<br />
1. What are <strong>the</strong> 3 most important health problems among pregnant women in this area?<br />
List <strong>the</strong>m in order <strong>of</strong> importance.<br />
2. (If malaria is not already mentioned in Question 1) Is malaria a serious or common health problem among pregnant<br />
women in this community?<br />
C. Topical area: Signs and symptoms <strong>of</strong> fever and malaria during pregnancy<br />
1. What are <strong>the</strong> common signs and symptoms <strong>of</strong> malaria among pregnant women?<br />
D. Topical area: Causes and consequences <strong>of</strong> malaria in pregnancy<br />
1. What effect does malaria have on pregnant women? On <strong>the</strong> fetus? On <strong>the</strong> neonate?<br />
2. Are pregnant women more susceptible to malaria? Do pregnant women with malaria get more severely ill than<br />
o<strong>the</strong>r people?<br />
E. Topical area: Sources <strong>of</strong> advice for malaria prevention/treatment during pregnancy<br />
1. From whom do women seek advice regarding malaria or pregnancy issues in general?<br />
2. Who influences women <strong>the</strong> most when <strong>the</strong>y need information about pregnancy or malaria? For example, someone<br />
at <strong>the</strong> health facility, a traditional birth attendant, someone else in <strong>the</strong> community (example village elder), or<br />
someone in <strong>the</strong>ir family?<br />
What is <strong>the</strong> order <strong>of</strong> seeking advice? First, second, third?<br />
Tool 7: Individual Interview/ Focus Group Guide for Traditional Birth Attendants<br />
1
3. Do husbands play a role in deciding what to do if <strong>the</strong>ir pregnant wife gets malaria?<br />
IF YES: please describe <strong>the</strong>ir role.<br />
4. What is <strong>the</strong> best (most effective) way to reach women in this community in order to provide <strong>the</strong>m malaria<br />
prevention and treatment information?<br />
F. Topical Area: Preventive strategies<br />
1. In general, how do women protect <strong>the</strong>mselves in this area against malaria when <strong>the</strong>y are pregnant?<br />
(Probe for traditional methods: infusions, teas, smoke, leaves for dousing <strong>the</strong> walls, going to bed earlier; and<br />
modern methods: insecticides, use <strong>of</strong> nets or treated curtains; clo<strong>the</strong>s)<br />
Are any <strong>of</strong> <strong>the</strong>se strategies harmful to a pregnant woman or <strong>the</strong> baby? Yes___No___<br />
IF YES: please describe how it will hurt <strong>the</strong> woman or <strong>the</strong> baby.<br />
2. Which preventive strategies do you think work best to prevent malaria when someone is pregnant? Please identify<br />
which method you think is most effective to use.<br />
G. Topical Area: Treatment sources<br />
1. What concerns do most women voice regarding malaria treatments during pregnancy?<br />
2. If a pregnant woman experiences a fever or malaria during pregnancy, what recommendations would you make?<br />
H. Topical Area: Acceptance <strong>of</strong> antenatal care<br />
1. When do most pregnant women in this area start to get antenatal care from a traditional birth attendant?<br />
2. How do traditional birth attendants give support and advice to pregnant women?<br />
(Probe: Do <strong>the</strong>y routinely make visits to a woman’s house?)<br />
3. Does <strong>the</strong> distance to <strong>the</strong> health care facility limit <strong>the</strong> number <strong>of</strong> women who can attend antenatal clinics in this<br />
district?<br />
4. What reasons have you heard as to why women in this community might not want to go to <strong>the</strong> health facility for<br />
antenatal care?<br />
(Probes: What types <strong>of</strong> complaints have you heard about <strong>the</strong> health facility?<br />
What have you heard about <strong>the</strong> attitudes <strong>of</strong> health care workers toward women in<br />
<strong>the</strong> clinics?)<br />
5. What could be done to improve <strong>the</strong> services <strong>of</strong> <strong>the</strong> health facility?<br />
6. What could be done to improve your services?<br />
7. What is <strong>the</strong> best way to encourage women to obtain antenatal care?<br />
(Probes: Have you seen successful strategies being used to increase <strong>the</strong> number <strong>of</strong> women who attend<br />
antenatal clinics?)<br />
I. Topical Area: Role <strong>of</strong> traditional birth attendants in influencing behaviors<br />
1. What advice do you give to pregnant women in regard to starting antenatal care? (Probe: Do you routinely make<br />
visits to a woman’s house?)<br />
2. Do you routinely refer pregnant women to antenatal care at a health facility? Yes__No__<br />
If not, why not?<br />
Under what circumstances?<br />
Do you give pregnant women cards to refer <strong>the</strong>m?<br />
3. Is <strong>the</strong>re a policy stating that traditional birth attendants should refer all pregnant women to <strong>the</strong> health care<br />
facilities?<br />
4. Do you follow up with women that you have referred to ask if <strong>the</strong>y have actually gone to <strong>the</strong> health facility after you<br />
have referred <strong>the</strong>m?<br />
5. If a pregnant woman comes to you experiencing fever/malaria during her pregnancy, what advice is routinely given<br />
to her?<br />
6. How can health care workers work better with traditional birth attendants?<br />
(Probes: Should health care workers provide any training to traditional<br />
birth attendants?)<br />
7. Do you think your own training is sufficient in <strong>the</strong> area <strong>of</strong> malaria during pregnancy?<br />
BE SURE TO THANK THE PARTICIPANTS FOR THEIR TIME, AND ASK IF THEY HAVE ANY QUESTIONS FOR YOU.<br />
2 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Module 8: Conducting an Antenatal Clinic<br />
Client Exit Interview<br />
An antenatal clinic client exit interview is designed to determine<br />
• Client’s knowledge <strong>of</strong> malaria and experience with malaria prevention<br />
and treatment methods<br />
• Services received that day in <strong>the</strong> antenatal clinic<br />
• Satisfaction with services received<br />
This module contains sample materials for an Antenatal Clinic Client Exit Interview. <strong>The</strong>se materials can<br />
and should be adapted to suit local needs, including translating <strong>the</strong> information sheet into <strong>the</strong> pregnant<br />
woman’s primary language. General guidance for conducting assessment tools survey and managing data<br />
can be found in Chapters 3-4.<br />
A. Sample Sizes<br />
B. Study Site<br />
C. Eligibility Criteria<br />
D. Information Sheet<br />
E. Data Analysis<br />
Contents<br />
Module 8: Conducting an Antenatal Clinic<br />
31
A. Sample Sizes<br />
Note that <strong>the</strong> clients participating in <strong>the</strong> client exit interviews should not be <strong>the</strong> same clients<br />
that participate in <strong>the</strong> antenatal clinic survey. Approximately 15 women per site should be<br />
selected.<br />
B. Study Site<br />
<strong>The</strong> survey should be conducted at antenatal clinics. In countries with clinics that have<br />
specific antenatal care days, it would be most appropriate to conduct this survey on those<br />
days.<br />
C. Eligibility Criteria<br />
Women who participate in <strong>the</strong> Antenatal Clinic Client Exit Interview should be as<br />
representative as possible <strong>of</strong> all women attending <strong>the</strong> antenatal clinic. <strong>The</strong> eligibility<br />
criteria are <strong>the</strong> same as those for <strong>the</strong> antenatal clinic and delivery unit surveys. However,<br />
if women have participated in <strong>the</strong> antenatal clinic survey, <strong>the</strong>y should be excluded from<br />
participating in <strong>the</strong> exit interview.<br />
Women are eligible for <strong>the</strong> survey if <strong>the</strong>y meet <strong>the</strong> following requirements :<br />
Gestation: Women who have experienced “quickening” (i.e., <strong>the</strong> recognition <strong>of</strong> fetal<br />
movement) are eligible.<br />
Gravidity: All gravidities. Although primigravidae and secundigravidae are <strong>the</strong> groups<br />
typically most affected by malaria in high transmission areas, women <strong>of</strong> all gravidities should<br />
be eligible so that <strong>the</strong> local situation can be confirmed.<br />
Age: <strong>The</strong> youngest age at which women are eligible to participate should be <strong>the</strong> age at which<br />
most women in <strong>the</strong> assessment area have <strong>the</strong>ir first child. This is to ensure that primigravidae<br />
and secundigravidae (<strong>the</strong> groups at highest risk) are included in <strong>the</strong> assessment. <strong>The</strong> age <strong>of</strong><br />
<strong>the</strong> youngest participants may well be less than <strong>the</strong> age <strong>of</strong> majority and should be consistent<br />
with any country policy or norm regarding this type <strong>of</strong> survey.<br />
Women are not eligible for <strong>the</strong> client exit interview if <strong>the</strong>y have participated in <strong>the</strong><br />
Antenatal Clinic Survey.<br />
D. Information Sheet<br />
<strong>The</strong> following information sheet should be given to each potential survey participant.<br />
If <strong>the</strong> potential survey participant cannot read or has low literacy skills, <strong>the</strong> information<br />
should be read aloud to her. All potential participants should receive a copy <strong>of</strong> <strong>the</strong><br />
information sheet to take home.<br />
Note to Interviewer: If <strong>the</strong> potential survey participant cannot read or if she has low literacy<br />
skills, read this information aloud to her. Give each potential survey participant a copy <strong>of</strong> this<br />
information sheet to take home.<br />
2<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Introduction<br />
<strong>The</strong> [Ministry <strong>of</strong> Health] is doing an assessment to find out how many pregnant women in this<br />
[assessment area] have malaria and to find out <strong>the</strong> best ways to prevent <strong>the</strong> effects <strong>of</strong> malaria<br />
on pregnant women and <strong>the</strong>ir babies. We plan to assess this problem in about _____ women in<br />
antenatal clinics in <strong>the</strong> [assessment area].<br />
Purpose <strong>of</strong> <strong>the</strong> Survey<br />
In this survey, we’d like to find out more about <strong>the</strong> services you received today in <strong>the</strong> antenatal<br />
clinic and how satisfied you are with <strong>the</strong> services you received.<br />
This will help us better plan programs to decrease malaria in pregnant women.<br />
Procedures<br />
If you agree to participate in this survey, we will ask you some questions about yourself and<br />
your antenatal care visit. We will not be telling anyone about your individual answers to <strong>the</strong><br />
questions, and we will keep all assessment information about you safe and secure. You also do<br />
not need to answer any questions on <strong>the</strong> survey forms that you do not want to. <strong>The</strong> survey will<br />
take about “x” minutes.<br />
If you do not wish to participate in this survey, it will not affect <strong>the</strong> care given to you by <strong>the</strong><br />
clinic. If you have questions later, please feel free to ask. You can ask me today or if you have<br />
questions later, you can ask _________________ (responsible assessment team member).<br />
Thank you very much for your time. Would you like to participate?<br />
Remind participant to keep this information sheet in case <strong>the</strong>re are questions later on.<br />
E. Data Analysis<br />
Antenatal Clinic Client Exit Interview results can be summarized as tables or graphs.<br />
Outcome variables include <strong>the</strong> following:<br />
Percentage <strong>of</strong> pregnant women satisfied with <strong>the</strong> services <strong>the</strong>y received<br />
Percentage <strong>of</strong> women who use antimalarial drugs for treatment and prevention <strong>of</strong> malaria<br />
Percentage <strong>of</strong> women who use ITNs<br />
Module 8: Conducting an Antenatal Clinic<br />
3
4<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Woman’s full name:<br />
ID #_____A________<br />
TOOL 8: CLIENT EXIT INTERVIEW<br />
Today’s date: _____/_____/_____<br />
Day Month Year<br />
ID number: ___ _A__ -- ___ ___ ___<br />
Digit 1 = facility number Digit 2 = A (for Antenatal Clinic)<br />
Digits 3, 4 & 5 = woman’s consecutive number<br />
SCREENING INFORMATION:<br />
Interviewer number _______<br />
1. Age (years):: [ ]<br />
(If <strong>the</strong> mo<strong>the</strong>r does not know her age, <strong>the</strong>n estimate her age using <strong>the</strong> categories below)<br />
less than 15 years [ ] 30-34 years [ ]<br />
15-19 years [ ] 35-39 years [ ]<br />
20-24 years [ ] 40-44 years [ ]<br />
25-29 years [ ] more than 44 years [ ]<br />
If <strong>the</strong> woman is less than an age deemed appropriate, thank her for her time, and DO<br />
NOT enroll her<br />
in this survey.<br />
2. Did you receive antenatal care services today? [ ]<br />
YES = 1<br />
NO = 2 (skip to end <strong>of</strong> interview)<br />
UNKNOWN = 9<br />
If <strong>the</strong> woman did not receive antenatal care services, thank her for her time, and DO<br />
NOT enroll her in this survey.<br />
3. Have you felt <strong>the</strong> baby move inside you yet? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
If <strong>the</strong> woman has not experienced quickening, thank her for her time, and<br />
DO NOT enroll her in this survey.<br />
4. What village/town do you live in? _______________________________________________________________<br />
Interviewer: skip <strong>the</strong> next question; to be coded later so that it is done uniformly.<br />
5. Is this a rural or urban area? [ ]<br />
Urban = 1<br />
Rural = 2<br />
Periurban = 3<br />
Unknown = 9<br />
6. What language do you usually speak with family members at home? [ ]<br />
Language a = 1<br />
Language b = 2<br />
Language c = 3<br />
O<strong>the</strong>r = 8 (specify) ______________________________________<br />
<br />
Tool 8: Conducting an Antenatal Clinic 1
EDUCATION<br />
7. What is <strong>the</strong> highest level <strong>of</strong> school you attended? [ ]<br />
Primary = 1<br />
Secondary = 2<br />
Higher = 3<br />
Never attended = 4<br />
Unknown = 9<br />
8. Can you read? [ ]<br />
YES = 1 NO = 2<br />
SOCIOECONOMIC INDICATORS<br />
9. What is <strong>the</strong> ro<strong>of</strong> <strong>of</strong> your house made <strong>of</strong>? [ ]<br />
corrugated iron = 1<br />
cement or concrete = 2<br />
wood and mud = 3<br />
thatch or grass = 4<br />
reed or bamboo = 5<br />
plastic sheet = 6<br />
mobile ro<strong>of</strong>s <strong>of</strong> nomads = 7<br />
o<strong>the</strong>r = 8 (specify) __________________________________<br />
10. What kind <strong>of</strong> floor does your house have? [ ]<br />
earth or sand = 1<br />
dung = 2<br />
wood planks = 3<br />
reed or bamboo = 4<br />
vinyl tiles or carpet = 5<br />
cement = 6<br />
cement tiles or brick = 7<br />
o<strong>the</strong>r = 8 (specify) ___________________________________<br />
11. What is <strong>the</strong> main job <strong>of</strong> <strong>the</strong> head <strong>of</strong> household/husband? [ ]<br />
job a = 1<br />
job b = 2<br />
job c = 3<br />
job d = 4<br />
12. What is <strong>the</strong> monthly household income for your family? [ ]<br />
income bracket a = 1<br />
income bracket b= 2<br />
income bracket c=3<br />
(FOR THE NEXT QUESTION, PLEASE ENTER A 1 OR 2 FOR EACH LINE)<br />
13. Do you or any member <strong>of</strong> your family living in <strong>the</strong> same compound:<br />
YES = 1 NO = 2<br />
Own a bicycle/scooter/moped? [ ]<br />
Own a radio? [ ]<br />
Own a TV? [ ]<br />
Own <strong>the</strong> house you are living in? [ ]<br />
Own crop land? [ ]<br />
Grow cash crops? [ ]<br />
2<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
MARITAL STATUS<br />
14. Are you married? [ ]<br />
yes, married or living with a man = 1<br />
was married or living with a man, but separated or divorced = 2<br />
widow <strong>of</strong> <strong>the</strong> fa<strong>the</strong>r <strong>of</strong> this baby = 3<br />
never married or lived with a man = 4<br />
ANTENATAL CARE<br />
Pregnancy and Antenatal Care<br />
15. How many times have you been pregnant in your life (including this one)?[ ]<br />
16. How many months pregnant are you now? [ ] (Months)<br />
Antenatal Care Received<br />
Interviewer please read to respondent: Now I am going to ask you about your visit today.<br />
17. Were you asked how you are feeling? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
18. Was <strong>the</strong> place (abdomen) where <strong>the</strong> baby is growing (fundal height) measured? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
19. Did someone listen to your baby’s heart? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
20. Was your blood pressure taken? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
21. Did someone check your urine? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
22. Did you receive counseling or health education? [ ]<br />
YES = 1<br />
NO = 2 (skip to question 23)<br />
UNKNOWN = 9 (skip to question 23)<br />
22a. If YES, what topics did <strong>the</strong> service provider discuss?<br />
______________________________________________________________<br />
______________________________________________________________<br />
______________________________________________________________<br />
Tool 8: Client Exit Interview<br />
3
23. Did someone help you make up or review your special birth plan that tells where you’ll be giving birth,<br />
who will be <strong>the</strong>re, and what you’ll need at <strong>the</strong> birth for yourself and <strong>the</strong> baby? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
24. Were you given an insecticide-treated bednet? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
24a. Is today <strong>the</strong> first time you are attending <strong>the</strong> clinic for antenatal care during this pregnancy? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
25. Were you given or prescribed any tablets or drugs? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
Medications/Tablets<br />
Instructions to interviewer: Mark down each kind <strong>of</strong> tablet provided to <strong>the</strong> client<br />
26. Please show me <strong>the</strong> medication/tablets you received today. [ ] [ ] [ ] [ ]<br />
Combined iron and folate = 1<br />
Fansidar = 2<br />
Chloroquine = 3<br />
Hookworm medications = 4<br />
STI medications = 5<br />
O<strong>the</strong>r = 9 (specify) ________________________________________________<br />
27. What is <strong>the</strong> purpose <strong>of</strong> each <strong>of</strong> <strong>the</strong> medications/ tablets that you received<br />
today? [ ] [ ] [ ] [ ]<br />
(Mark all that apply)<br />
Prevent anemia = 1<br />
Prevent malaria = 2<br />
Treat malaria = 3<br />
Prevent congenital malformations = 4<br />
Treat worms = 5<br />
Treat STIs = 6<br />
Did not receive any = 7<br />
O<strong>the</strong>r = 9 (specify) _____________________________________________<br />
Unknown = 9<br />
4<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
28. Did you receive any medications/tablets during your last antenatal care visit? [ ]<br />
Yes = 1<br />
No = 2 (skip to question 29)<br />
First antenatal care visit = 3 (skip to question 29)<br />
Unknown/can’t remember = 9 (skip to question 29)<br />
28a. If YES, did you take all <strong>the</strong> tablets you received during your last antenatal<br />
care visit? [ ]<br />
YES = 1<br />
NO = 2<br />
Don’t know/can’t remember = 9<br />
CLIENT SATISFACTION<br />
Interviewer please read to respondent: Now I am going to ask you a few questions about <strong>the</strong> services that you<br />
received today at <strong>the</strong> clinic.<br />
29. About how long did you wait between <strong>the</strong> time you first arrived at <strong>the</strong> clinic and <strong>the</strong> time you received antenatal<br />
services? [ ]<br />
Less than 15 minutes = 1<br />
16-30 minutes = 2<br />
31-45 minutes = 3<br />
46-60 minutes = 4<br />
more than 60 minutes = 5<br />
Unknown = 9<br />
30. Do you feel that your waiting time was reasonable or too long? [ ]<br />
No waiting time = 1<br />
Reasonable/short = 2<br />
Too long = 3<br />
Unknown = 9<br />
31. Did you have enough privacy during your consultation? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
32. Did you feel comfortable to ask <strong>the</strong> provider questions during your visit today? [ ]<br />
YES = 1<br />
NO =2<br />
UNKNOWN = 9<br />
33. Did <strong>the</strong> provider answer all <strong>of</strong> your questions today? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
Tool 8: Client Exit Interview<br />
5
34. Do you feel <strong>the</strong> information you shared about yourself with <strong>the</strong> provider will be kept confidential? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
35. During your visit today, how were you treated by <strong>the</strong> service provider(s)? [ ]<br />
Very well = 1<br />
Well = 2<br />
Badly = 3<br />
Very badly = 4<br />
O<strong>the</strong>r = 9 (specify) ___________________________________________<br />
Unknown = 9<br />
36. How satisfied are you, overall, with <strong>the</strong> services that you received today? [ ]<br />
Very satisfied = 1<br />
Somewhat satisfied = 2<br />
Not very satisfied = 3<br />
Completed unsatisfied = 4<br />
Unknown = 9<br />
37. Do you plan to come to ano<strong>the</strong>r visit at this clinic? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
38. Would you encourage a friend or relative <strong>of</strong> yours to come to this facility for antenatal care services? [ ]<br />
YES = 1<br />
NO = 2<br />
UNKNOWN = 9<br />
Thank respondent for her time.<br />
INTERVIEWER COMMENTS:<br />
(Please note any additional observations in <strong>the</strong> space below):<br />
6<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Module 9: Conducting Interviews and Focus<br />
Groups with Recently or Currently Pregnant Women<br />
Individual interviews or focus groups with recently/currently pregnant women are<br />
designed to determine<br />
• How pregnant women understand <strong>the</strong> problem <strong>of</strong> malaria in pregnancy<br />
• What types <strong>of</strong> preventive and treatment measures are currently being recommended and used<br />
• Factors that motivate or inhibit women from using antenatal care<br />
• Best methods for promoting health education messages to pregnant women<br />
• Acceptance and usage <strong>of</strong> antimalarials during pregnancy.<br />
This module contains sample materials relevant to conducting a focus group or an individual interview. <strong>The</strong>se<br />
materials can and should be adapted to meet <strong>the</strong> needs <strong>of</strong> <strong>the</strong> local situation.<br />
A. Focus Group/Interview Timetable<br />
Contents<br />
B. Focus Group or Individual Interview or Both?<br />
C. Number <strong>of</strong> Individual Interviews/Focus Group Size<br />
D. Eligibility Criteria<br />
E. Venues and Equipment<br />
F. <strong>Assessment</strong> Team Members<br />
G. <strong>Assessment</strong> Team Training<br />
H. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />
I. Information Sheet<br />
J. Debriefing<br />
K. Focus Group/Interview Analysis<br />
Please see Resource 2, which includes a Sample Interviewer Training Manual and a Resource List.<br />
Module 9: Conducting Interviews and Focus Groups with Recently or Currently Pregnant Women<br />
1
A. Focus Group/Interview Timetable<br />
To prepare for focus groups or individual interviews, it is important to alert health facilities<br />
and community leaders well in advance (ideally, 2 weeks) <strong>of</strong> <strong>the</strong> qualitative team’s visits to <strong>the</strong><br />
facilities so that potential participants know that this activity will be occurring and that <strong>the</strong>y<br />
will be asked to participate. In addition, advance notice is needed so that community and/<br />
or facility focus groups can be established and that arrangements can be made for interview<br />
venues. It is helpful to follow up a week before <strong>the</strong> assigned meeting times.<br />
After planning for <strong>the</strong> focus groups and interviews, selecting sites, and training interviewers,<br />
<strong>the</strong> focus groups/interviews can begin.<br />
B. Focus Group or Individual Interview or Both?<br />
It may not always be possible to conduct both focus groups and individual interviews and<br />
thus “triangulate” <strong>the</strong> data. If both cannot be done, <strong>the</strong> more appropriate technique should be<br />
chosen based on <strong>the</strong> local situation.<br />
• Individual interviews are a better choice when individual variability within communities is<br />
<strong>of</strong> interest.<br />
• Focus group interviews elicit community norms.<br />
• Focus group interviews might help stimulate thinking and expose conflicting feelings–<strong>the</strong>y<br />
can ‘remind’ people <strong>of</strong> events or things that any one individual might have forgotten.<br />
• Focus groups are best at helping participants express opinions and perceptions <strong>of</strong> which <strong>the</strong>y<br />
might individually be unaware or not <strong>of</strong>ten think about.<br />
• Individual interviews are <strong>of</strong>ten better if a topic is contentious or associated with strong<br />
individual opinions or emotions.<br />
• Focus group interviews are better for a small number <strong>of</strong> issues.<br />
• Individual interviews lend <strong>the</strong>mselves to a larger number <strong>of</strong> issues.<br />
• Focus group interviews may be more efficient when resources—time, distance (e.g.,<br />
vehicles), and money—are limited.<br />
C. Number <strong>of</strong> Individual Interviews/Focus Group Size<br />
At least one focus group with 5 to 15 participants for each facility. Four to five individual<br />
interviews per facility.<br />
D. Eligibility Criteria<br />
<strong>The</strong> only criterion is that <strong>the</strong> women who are in <strong>the</strong> focus group or who are participating in <strong>the</strong><br />
interview should ei<strong>the</strong>r be pregnant or have been recently pregnant (within <strong>the</strong> last 2 years).<br />
E. Venues and Equipment<br />
<strong>The</strong> focus group will ideally be held in a quiet space in a health facility or within a village.<br />
Writing materials/stationery to record notes <strong>of</strong> <strong>the</strong> focus group will be needed, as will a<br />
tape recorder if <strong>the</strong> decision to use one has been made.<br />
Sufficient seating is needed for <strong>the</strong> members <strong>of</strong> <strong>the</strong> group, as well as for <strong>the</strong> facilitator and<br />
<strong>the</strong> persons who serve as recorders. Because a focus group may draw a crowd <strong>of</strong> interested<br />
people, ask that a member <strong>of</strong> <strong>the</strong> health-care facility or a community member politely<br />
dismiss <strong>the</strong> crowd, with a brief explanation <strong>of</strong> what is occurring.<br />
Individual interviews can also be conducted at health facilities. Homes in villages near <strong>the</strong><br />
health facilities can also serve as interview sites.<br />
62<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
<strong>The</strong> decision about how to record what is said (and whe<strong>the</strong>r to use a tape recorder) should<br />
have been made before interviewers are selected and trained (see 4.1 in <strong>the</strong> Manual). Note<br />
that for focus group interviews, it is wise to have at least 2 people recording <strong>the</strong> session,<br />
even if a tape recorder is used.<br />
F. <strong>Assessment</strong> Team Members<br />
For each focus group, a facilitator and a recorder are needed. Sometimes tape recorders<br />
are used to record <strong>the</strong> group’s discussion. <strong>The</strong> facilitator/recorder should write up <strong>the</strong><br />
summary <strong>of</strong> findings.<br />
An interviewer who can speak <strong>the</strong> woman’s mo<strong>the</strong>r tongue will be needed to conduct<br />
interviews.<br />
G. <strong>Assessment</strong> Team Training<br />
<strong>The</strong> training can be conducted concurrently, but separately, with training for Antenatal<br />
Clinic and Delivery Unit Surveys.<br />
Training can include <strong>the</strong> following subjects:<br />
• an overview <strong>of</strong> <strong>the</strong> local malaria program implementation plan<br />
• a review <strong>of</strong> malaria (transmission cycle, symptoms, diagnosis, prophylaxis and treatment,<br />
epidemiology <strong>of</strong> malaria, consequences <strong>of</strong> malaria during pregnancy, and local beliefs<br />
related to malaria)<br />
• differences between qualitative and quantitative studies<br />
• interviewing techniques<br />
• data recording techniques<br />
• differences between individual and focus group interviews<br />
For most <strong>of</strong> <strong>the</strong> training, <strong>the</strong> team conducting focus groups and individual interviews team<br />
can train alone, although both assessment teams can meet toge<strong>the</strong>r for <strong>the</strong> training related<br />
to proper interviewing techniques. Practice sessions can include role-playing <strong>of</strong> interview<br />
sessions.<br />
To assist in building capacity in qualitative research methodologies, all team members<br />
can be given information on qualitative assessments and methodology, as well as written<br />
handouts on interviewing techniques.<br />
<strong>The</strong> training period can also be used to ensure that <strong>the</strong> interview instruments are<br />
linguistically consistent. In addition, using <strong>the</strong> team members as community experts, each<br />
interview guide should be reviewed to ensure that questions are relevant to <strong>the</strong> context <strong>of</strong><br />
this district, and minor modifications in <strong>the</strong> interview guides can be made.<br />
H. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />
Both <strong>the</strong> focus group facilitator and <strong>the</strong> recorder should have a copy <strong>of</strong> <strong>the</strong> guide.<br />
<strong>The</strong> guide will serve as a script for <strong>the</strong> facilitator and will help familiarize <strong>the</strong> recorder<br />
with <strong>the</strong> questions that will be discussed.<br />
<strong>The</strong> interviewer will need a copy <strong>of</strong> <strong>the</strong> guide.<br />
It is important that <strong>the</strong> guide be flexible. If <strong>the</strong> questions as written in <strong>the</strong> guide do not elicit<br />
<strong>the</strong> intended responses, <strong>the</strong>y should be adapted as necessary. See J below, Debriefing.<br />
Note that <strong>the</strong> guide included in this package may need to be adapted depending on whe<strong>the</strong>r<br />
it is used for a focus group or an individual interview.<br />
Module 9: Conducting Interviews and Focus Groups with Recently or Currently Pregnant Women<br />
13
I. Information Sheet<br />
<strong>The</strong> following information sheet should be given to each potential interview participant.<br />
If <strong>the</strong> person cannot read or has low literacy skills, <strong>the</strong> information should be read aloud to<br />
her. All potential participants should receive a copy <strong>of</strong> <strong>the</strong> information sheet to take home.<br />
Notes to interviewer:<br />
• Explain everything in <strong>the</strong> local language or language <strong>of</strong> choice <strong>of</strong> <strong>the</strong> participant. Use words<br />
that are easily understood and tailor your explanations to <strong>the</strong> level <strong>of</strong> education <strong>of</strong> <strong>the</strong><br />
participant.<br />
• Do not force <strong>the</strong> person to agree to participate. You may need to explain <strong>the</strong> survey in several<br />
different ways if <strong>the</strong> person does not seem to understand. If <strong>the</strong> person looks confused or<br />
scared, try to clarify <strong>the</strong>ir concerns.<br />
• If participant refuses to participate, please remember that this was an INVITATION to<br />
participate. Thank <strong>the</strong> person for <strong>the</strong>ir time and trouble and go onto <strong>the</strong> next person.<br />
• KEEP A RECORD <strong>of</strong> <strong>the</strong> number <strong>of</strong> participants who accept and refuse. For those that refuse,<br />
keep a record <strong>of</strong> <strong>the</strong>ir reason for refusing, if possible.<br />
Introduction<br />
<strong>The</strong> Ministry <strong>of</strong> Health is trying to find out <strong>the</strong> best ways prevent <strong>the</strong> effects <strong>of</strong> malaria on<br />
pregnant women and <strong>the</strong>ir babies. To do this, we need to know what women know about<br />
malaria and its effects on pregnant women. We also need to know <strong>the</strong> places that women seek<br />
health care when <strong>the</strong>y are pregnant and what sorts <strong>of</strong> things <strong>the</strong>y do to prevent malaria when<br />
<strong>the</strong>y are pregnant. We plan to talk to ____________ (describe about how many women and o<strong>the</strong>rs<br />
will be involved in this component <strong>of</strong> <strong>the</strong> assessment).<br />
Purpose<br />
What we learn about women’s ideas and actions about malaria and what <strong>the</strong>y do when <strong>the</strong>y<br />
are pregnant will help us plan programs to decrease malaria in pregnant women.<br />
Procedures<br />
Being part <strong>of</strong> this individual interview/focus group is up to you. If you agree to participate/<br />
be part <strong>of</strong> this interview/focus group, we will ask you some questions about what you think<br />
and do about malaria, and about where you get help and information about malaria. You also<br />
do not need to answer any questions that we ask that you do not want to. If you agree to<br />
participate and during <strong>the</strong> interview/focus group, decide that you do not want to continue, you<br />
can withdraw at any time. We will not be asking for any blood or urine samples.<br />
Benefits<br />
Although what we learn might not help you directly, it will help us know how best to prevent<br />
malaria in pregnant women in this district.<br />
Risks or discomforts<br />
We will not be telling anyone about your individual answers to <strong>the</strong> questions.<br />
Would you like to participate?<br />
Thank you very much for your time.<br />
Please be sure to give this information sheet to <strong>the</strong> person with whom you spoke.<br />
4<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
J. Debriefing<br />
Daily debriefings are an essential element <strong>of</strong> good qualitative work. At <strong>the</strong> end <strong>of</strong> each day that<br />
focus groups or individual interviews are conducted, it is useful for <strong>the</strong> assessment team to<br />
hold a debriefing session lasting approximately 1 - 1.5 hours. <strong>The</strong> debriefing should be led by<br />
<strong>the</strong> coordinator or ano<strong>the</strong>r facilitator.<br />
Debriefings are a method to determine if a) <strong>the</strong> questions are adequate to obtain <strong>the</strong> needed<br />
data (qualitative methods are iterative, thus, you can change questions as needed as you<br />
conduct <strong>the</strong> assessment), b) if people have understood <strong>the</strong> question (for example: is it a<br />
sentence structure, content or a translation problem?), if c) data are similar across facilities or<br />
show wide variability, which might require adding questions to understand <strong>the</strong> variability, and<br />
if d) expressions in <strong>the</strong> local language are being translated appropriately.<br />
<strong>The</strong> team listens to what each interviewer has learned (aggregate summary <strong>of</strong> <strong>the</strong> data <strong>the</strong>y<br />
collected that day), identifies what is common, what is different, and mutually agrees on what<br />
local expressions mean. This is particularly important when <strong>the</strong> team is trying to understand<br />
local beliefs, including taboos, about malaria and/or drugs during pregnancy. Debriefings<br />
tend to be difficult as <strong>the</strong> team is tired and <strong>the</strong> process can be tedious, but having high-quality,<br />
clearly understandable data when analysis begins rewards <strong>the</strong> time spent in daily debriefings.<br />
During <strong>the</strong> debriefings, <strong>the</strong> coordinator or facilitator should keep notes on <strong>the</strong> outcomes <strong>of</strong><br />
each debriefing, explanations for trends seen in <strong>the</strong> data, and local language terms (using <strong>the</strong><br />
local language), as well as <strong>the</strong> agreed-upon translations.<br />
During this time, all recorded interviews can be reviewed for completeness and accuracy <strong>of</strong><br />
<strong>the</strong> recording. In addition, concepts can be clarified, traditional terms used for prevention<br />
and treatment strategies can be reviewed for linguistic accuracy and consistency, and<br />
understanding <strong>of</strong> local pregnancy taboos can be discussed.<br />
<strong>The</strong>se types <strong>of</strong> surveys can require <strong>the</strong> addition <strong>of</strong> new questions or probes to <strong>the</strong> survey tool<br />
during <strong>the</strong> survey period in order to make <strong>the</strong> questions wider, narrower, or more specific in<br />
order to obtain <strong>the</strong> needed information.<br />
K. Focus Group/Interview Analysis<br />
Recording and analyzing information for a focus group is somewhat different from recording<br />
and analyzing information for an individual interview.<br />
For focus groups:<br />
• <strong>The</strong> recorder must be able to record general <strong>the</strong>mes during <strong>the</strong> interview and fill in <strong>the</strong><br />
details afterwards.<br />
• Counting <strong>the</strong> number <strong>of</strong> responses is not important, but noting that most or many<br />
participants felt <strong>the</strong> same way is.<br />
• It is important to note if one person in <strong>the</strong> focus group has thoughts or behaviors very<br />
different from those <strong>of</strong> <strong>the</strong> rest <strong>of</strong> <strong>the</strong> group. This person is called an “outlier.”<br />
• Names should not be used in recording <strong>the</strong>mes, although speakers can be identified by <strong>the</strong>ir<br />
job description (for example, “<strong>the</strong> nurses felt…”) or o<strong>the</strong>r pertinent descriptors.<br />
When <strong>the</strong>re is a good quote in <strong>the</strong> local language, make sure it is written as it is said in <strong>the</strong><br />
local language and <strong>the</strong>n reach consensus (perhaps during debriefing) on what it means in <strong>the</strong><br />
primary language used in <strong>the</strong> rapid assessment, if different.<br />
Module 9: Conducting Interviews and Focus Groups with Recently or Currently Pregnant Women<br />
5
6<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
TOOL 9: INDIVIDUAL INTERVIEW/FOCUS GROUP GUIDE FOR<br />
PREGNANT WOMEN AND RECENTLY PREGNANT WOMEN<br />
This guide can be adapted to be used as a guide for conducting ei<strong>the</strong>r focus groups or individual interviews.<br />
Interview information<br />
Region___________________________<br />
Name <strong>of</strong> facility/facility area___________________________<br />
Date: ____/____/____<br />
Month Day Year<br />
Time______________________________________<br />
Interviewer_________________________________<br />
Recorder___________________________________<br />
INTRODUCTION: Introduce yourself and team members, describe your roles, and obtain agreement to<br />
participate (or informed consent if required). Tell <strong>the</strong> participant(s) <strong>the</strong> goal <strong>of</strong> <strong>the</strong> focus group.<br />
A. Demographics:<br />
For each <strong>of</strong> <strong>the</strong> participants, record <strong>the</strong> following information:<br />
Age<br />
Marital status<br />
Level <strong>of</strong> education: Highest level <strong>of</strong> school attended (primary, secondary, higher, unknown)<br />
Total number <strong>of</strong> pregnancies, including this one<br />
Date <strong>of</strong> last delivery<br />
Ethnic group<br />
Religion<br />
B. Topical Area: Preventive strategies<br />
1. In general, how do people protect <strong>the</strong>mselves in this area against malaria when <strong>the</strong>y are pregnant? (Probes: types<br />
<strong>of</strong> traditional remedies...infusions, teas, smoke, leaves for dousing <strong>the</strong> walls; use <strong>of</strong> nets or treated curtains; going to<br />
bed earlier; clo<strong>the</strong>s)<br />
Are any <strong>of</strong> <strong>the</strong>se strategies harmful to a pregnant woman? YES/NO<br />
IF YES: please describe how it will hurt <strong>the</strong> woman or <strong>the</strong> baby.<br />
2. What do you personally do to protect yourself against malaria when you are pregnant? (Probes: Would you be<br />
willing to try anything else? For example, would you be willing to take <strong>the</strong> drug Fansidar to guard against malaria?)<br />
3. Which things do you think work best to prevent malaria when someone is pregnant? [Can rank items]<br />
4. Do you routinely use a mosquito net? YES/NO<br />
IF YES: is it treated with an insecticide? YES/NO<br />
How many persons live in your house? ________ How many sleep under a net?__________<br />
If you have only one net, who sleeps under it? (Who made that decision?)<br />
5. What effect does malaria have on you when you are pregnant? (Probes: how does malaria affect <strong>the</strong> baby?<br />
What happens to you?)<br />
6. Do you take medicine at <strong>the</strong> antenatal clinic to help prevent malaria?<br />
<br />
Tool 9: Conducting Interviews and Focus Groups with Recently or Currently Pregnant Women<br />
1
C. Topical Area: Treatment sources<br />
1. Where do you go for antenatal care?<br />
2. In this area, where is <strong>the</strong> best place to go for antenatal care? Why?<br />
3. If you got sick with malaria when you were pregnant, what would you do?<br />
4. Have you ever taken <strong>the</strong> drug (insert <strong>the</strong> name <strong>of</strong> <strong>the</strong> recommended treatment drug) when you were pregnant?<br />
YES/NO<br />
IF YES: did you have any problems taking <strong>the</strong> drug? YES/NO<br />
5. Did <strong>the</strong> malaria go away/Did you feel better? YES/NO<br />
6. Have you ever taken <strong>the</strong> drug Fansidar when you were pregnant? YES/NO<br />
If YES: Was it given to you to prevent malaria? YES/NO<br />
IF YES: Did you have any problems taking <strong>the</strong> drug? YES/NO<br />
7. Did <strong>the</strong> malaria go away/Did you feel better? YES/NO<br />
8. What types <strong>of</strong> things have people recommended that you should do to treat malaria in pregnancy?<br />
9. Of <strong>the</strong>se, are <strong>the</strong>re any that you will not or can not do? WHY? (Probes: it is unsafe for you? Is it unsafe for <strong>the</strong> baby?<br />
Is it too expensive? Do you understand why <strong>the</strong>y are suggesting it?)<br />
D. Topical Area: Acceptance <strong>of</strong> antenatal care<br />
1. How far do you live from <strong>the</strong> clinic/hospital (probe: Where could you receive care for <strong>the</strong> pregnancy)?<br />
2. When you come for a visit, how do you get to <strong>the</strong> health care facility? (Probe: Is <strong>the</strong>re transport available? What do<br />
you do in emergency situations? How many hours must you travel for care?)<br />
3. Have you been referred to a higher level health facility for care during your pregnancy? YES/NO<br />
IF YES, did you follow-up and go to <strong>the</strong> clinic? YES/NO<br />
4. When do most pregnant women in this area start to get antenatal care from a clinic?<br />
IF SHE ANSWERS “IN SECOND or THIRD TRIMESTER”: Why do women wait until <strong>the</strong>n<br />
to get care?<br />
5. When did you first get care?<br />
IF ANSWERS “IN SECOND OR THIRD TRIMESTER”: Why did you wait until <strong>the</strong>n to get care?<br />
6. What is <strong>the</strong> cost <strong>of</strong> basic antenatal care in this community? [ ]<br />
Is that too expensive? YES/NO (Probes: How do you get <strong>the</strong> money to pay for it?<br />
Are <strong>the</strong>re times in <strong>the</strong> year that you can not come because you don’t have enough money? Does someone help you<br />
pay for it? IF YES: who? Do you ever barter goods for service?)<br />
7. When you come for care, are you satisfied with <strong>the</strong> services? (Probes: Are you treated well, do you receive any<br />
education while here? IF YES: from whom? Do you feel comfortable in asking questions?)<br />
What could be done to improve <strong>the</strong> services <strong>of</strong> <strong>the</strong> health care center?<br />
2<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
E. Topical Area: Acceptability <strong>of</strong> treatments for malaria during pregnancy<br />
1. Do you routinely go to <strong>the</strong> clinic/hospital for antenatal care? YES/NO<br />
If YES: Do you go during pregnancy because you have an appointment or because you think you need to go?<br />
IF YES to QE1: Do <strong>the</strong>y give you any medicine to prevent malaria in pregnancy? YES/NO<br />
IF YES: What do <strong>the</strong>y give you?<br />
Did anyone talk to you about <strong>the</strong> drug? What things did <strong>the</strong>y tell you? (Probes: When and how <strong>of</strong>ten should you take<br />
<strong>the</strong> drug? What side effects should you look for? When should you return to <strong>the</strong> clinic?}<br />
Are you currently using it?<br />
IF YES: how <strong>of</strong>ten?<br />
2. Are <strong>the</strong>re o<strong>the</strong>r treatments to use against malaria that can be used when you are pregnant? (Probes: Have you<br />
taken chloroquine, Fansidar, or o<strong>the</strong>r pills? How <strong>of</strong>ten? Are <strong>the</strong>re traditional medicines that can be used?)<br />
3. Can you please tell me all <strong>the</strong> traditional medicines, home remedies, or treatments that you know <strong>of</strong> that can be<br />
used to treat malaria in a pregnant woman?<br />
OF THIS LIST: which ones work best?<br />
4. Can you tell me about traditional taboos related to pregnancy and malaria in this area?<br />
F. Topical Area: Sources <strong>of</strong> advice for malaria prevention/treatment during pregnancy<br />
1. If you had a problem with <strong>the</strong> pregnancy, or got sick while pregnant, to whom would you ask advice?<br />
2. Who provides <strong>the</strong> best information about how to manage malaria when you are pregnant?<br />
What information have you been given about malaria from that person?<br />
3. What kind <strong>of</strong> roles do husbands in families play in deciding whe<strong>the</strong>r a woman should seek antenatal care or advice<br />
from lay midwives? (Probes: Do husbands play an active role in assisting pregnant women, or is this normally done<br />
by women in <strong>the</strong> household? Do you normally go to your mo<strong>the</strong>r or mo<strong>the</strong>r-in-law for advice? Do husbands ever go<br />
to clinic with you when you are pregnant?)<br />
Do husbands also play a role in deciding what to do if <strong>the</strong>ir pregnant wife gets malaria?<br />
4. If <strong>the</strong>re was a new treatment for malaria during pregnancy, how would you hear about it? (Probes: How do you hear<br />
about important news in your village? Is <strong>the</strong>re one person to whom everyone goes to ask advice, such as a village<br />
headman?)<br />
G. Topical Area: Drug-purchasing behaviors<br />
1. If you get sick when you are pregnant, where do you get medicine? (Probes: do you take bottles to <strong>the</strong> clinic with<br />
you and get drugs from <strong>the</strong> dispensary? Do you buy drugs from <strong>the</strong> regular market or o<strong>the</strong>r types <strong>of</strong> shops? Mobile<br />
drug vendors? If so, where? Do traditional healers in this area give out western medicines?)<br />
FOR EACH SOURCE OF MEDICINE MENTIONED ABOVE, ASK THE FOLLOWING QUESTION:<br />
2a. Do/does __________ <strong>of</strong>fer advice about how to take antimalarial drugs during pregnancy? YES/NO<br />
If YES: Is it helpful?<br />
2b. Do/does __________<strong>of</strong>fer advice about how to take antimalarial drugs during pregnancy? YES/NO<br />
If YES: Is it helpful?<br />
Tool 9: Individual Interview/ Focus Group Guide for Pregnant and Recently Pregnant Women<br />
3
2c. Do/does __________<strong>of</strong>fer advice about how to take antimalarial drugs during pregnancy? YES/NO<br />
If YES: Is it helpful?<br />
2d. Do/does __________<strong>of</strong>fer advice about how to take antimalarial drugs during pregnancy? YES/NO<br />
If YES: Is it helpful?<br />
3. Once you feel better, do you ever save <strong>the</strong> remaining pills to take <strong>the</strong> next time you are have malaria? YES/NO<br />
4. Where is <strong>the</strong> BEST place to get drugs to treat malaria when you are pregnant? WHY?<br />
5. What drugs would you take for malaria when you are pregnant?<br />
6. Who do you trust most in giving advice about drugs when you are pregnant?<br />
H. Topical Area: Role <strong>of</strong> traditional birth attendants and health care workers in<br />
influencing behaviors<br />
1. How do traditional birth attendants and health care workers give support and advice to pregnant women?<br />
2. Do traditional birth attendants and health care workers in this community recommend that pregnant women<br />
attend antenatal clinics or do <strong>the</strong>y leave that decision to individual women?<br />
3. Is it better to see a traditional birth attendant or go to a health center for antenatal care? Why?<br />
THANK RESPONDENT FOR HER TIME, AND ASK HER IF THERE ARE ANY QUESTIONS.<br />
PLEASE NOTE ANY ADDITIONAL OBSERVATIONS IN THE SPACE BELOW.<br />
4<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Module 10: Conducting Interviews with<br />
Key Informants<br />
Individual interviews with key informants are designed to determine<br />
• How pregnant women understand <strong>the</strong> problem <strong>of</strong> malaria in pregnancy<br />
• What types <strong>of</strong> preventive and treatment measures are currently being recommended and used<br />
• Factors that motivate or inhibit women from using antenatal care<br />
• Best methods for promoting health education messages to pregnant women<br />
This module contains sample materials relevant to conducting an individual interview.<br />
<strong>The</strong>se materials can and should be adapted to meet <strong>the</strong> needs <strong>of</strong> <strong>the</strong> local situation.<br />
A. Focus Group/Interview Timetable<br />
B. Number <strong>of</strong> Individual Interviews<br />
C. Eligibility Criteria<br />
D. Venues and Equipment<br />
E. <strong>Assessment</strong> Team Members<br />
F. <strong>Assessment</strong> Team Training<br />
Contents<br />
G. Notes Regarding <strong>the</strong> Focus Group/Interview Guide<br />
H. Information Sheet<br />
I. Debriefing<br />
J. Focus Group/Interview Analysis<br />
See Resource 2, which includes a Sample Interviewer Training Manual and a<br />
Resource List.<br />
Module 10: Conducting Interviews with Key Informants<br />
1
A. Interview Timetable<br />
To prepare for individual interviews, it is important to alert health facilities and community<br />
leaders well in advance (ideally, 2 weeks) <strong>of</strong> <strong>the</strong> qualitative team’s visits to <strong>the</strong> facilities so<br />
that potential participants know that this activity will be occurring and that <strong>the</strong>y will be asked<br />
to participate. In addition, advance notice is needed so that arrangements can be made for<br />
interview venues. It is helpful to follow up a week before <strong>the</strong> assigned meeting times.<br />
After planning for <strong>the</strong> interviews, selecting sites, and training interviewers, <strong>the</strong> interviews can<br />
begin.<br />
B. Number <strong>of</strong> Individual Interviews<br />
Individual interviews with two to four key informants per site. Individual interviews are<br />
strongly preferred to focus groups.<br />
C. Eligibility Criteria<br />
Key informants can include esteemed members <strong>of</strong> <strong>the</strong> community (“opinion leaders”), elders,<br />
someone who is trusted for advice and o<strong>the</strong>rs. Key informants can be identified by asking<br />
o<strong>the</strong>r assessment participants and health facility team members to identify community<br />
members from whom women sought advice concerning pregnancy. Names <strong>of</strong> key informants<br />
usually emerge consistently as people start to identify a few people known to have knowledge/<br />
expertise in this area. A leader <strong>of</strong> a local women’s group, for example, might be named as a key<br />
informant.<br />
D. Venues and Equipment<br />
Individual interviews can be conducted at health facilities or homes in villages near <strong>the</strong> health<br />
facilities.<br />
<strong>The</strong> decision about how to record what is said (and whe<strong>the</strong>r to use a tape recorder) should<br />
have been made before interviewers are selected and trained (see 4.1 in <strong>the</strong> Manual).<br />
E. <strong>Assessment</strong> Team Members<br />
An interviewer who can speak <strong>the</strong> woman’s mo<strong>the</strong>r tongue will be needed to conduct<br />
interviews.<br />
F. <strong>Assessment</strong> Team Training<br />
<strong>The</strong> training can be conducted concurrently, but separately, with training for Antenatal Clinic<br />
and Delivery Unit Surveys.<br />
Training can include <strong>the</strong> following subjects:<br />
• an overview <strong>of</strong> <strong>the</strong> local malaria program implementation plan<br />
• a review <strong>of</strong> malaria (transmission cycle, symptoms, diagnosis, prophylaxis and treatment,<br />
epidemiology <strong>of</strong> malaria, consequences <strong>of</strong> malaria during pregnancy, and local beliefs<br />
related to malaria)<br />
• differences between qualitative and quantitative studies<br />
• interviewing techniques<br />
• data recording techniques<br />
• differences between individual and focus group interviews<br />
42<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
For most <strong>of</strong> <strong>the</strong> training, <strong>the</strong> team conducting focus groups and individual interviews team<br />
can train alone, although both assessment teams can meet toge<strong>the</strong>r for <strong>the</strong> training related<br />
to proper interviewing techniques. Practice sessions can include role-playing <strong>of</strong> interview<br />
sessions.<br />
To assist in building capacity in qualitative research methodologies, all team members can be<br />
given information on qualitative assessments and methodology, as well as written handouts on<br />
interviewing techniques.<br />
<strong>The</strong> training period can also be used to ensure that <strong>the</strong> interview instruments are linguistically<br />
consistent. In addition, using <strong>the</strong> team members as community experts, each interview guide<br />
should be reviewed to ensure that questions are relevant to <strong>the</strong> context <strong>of</strong> this district, and<br />
minor modifications in <strong>the</strong> interview guides can be made.<br />
G. Notes Regarding <strong>the</strong> Interview Guide<br />
<strong>The</strong> interviewer will need a copy <strong>of</strong> <strong>the</strong> guide.<br />
It is important that <strong>the</strong> guide be flexible. If <strong>the</strong> questions as written in <strong>the</strong> guide do not elicit<br />
<strong>the</strong> intended responses, <strong>the</strong>y should be adapted as necessary. See I below, Debriefing.<br />
H. Information Sheet<br />
<strong>The</strong> following information sheet should be given to each potential interview participant. If <strong>the</strong><br />
person cannot read or has low literacy skills, <strong>the</strong> information should be read aloud to her. All<br />
potential participants should receive a copy <strong>of</strong> <strong>the</strong> information sheet to take home.<br />
Notes to interviewer:<br />
• Explain everything in <strong>the</strong> local language or language <strong>of</strong> choice <strong>of</strong> <strong>the</strong> participant. Use words<br />
that are easily understood and tailor your explanations to <strong>the</strong> level <strong>of</strong> education <strong>of</strong> <strong>the</strong><br />
participant.<br />
• Do not force <strong>the</strong> person to agree to participate. You may need to explain <strong>the</strong> survey in several<br />
different ways if <strong>the</strong> person does not seem to understand. If <strong>the</strong> person looks confused or<br />
scared, try to clarify <strong>the</strong>ir concerns.<br />
• If participant refuses to participate, please remember that this was an INVITATION to<br />
participate. Thank <strong>the</strong> person for <strong>the</strong>ir time and trouble and go onto <strong>the</strong> next person.<br />
• KEEP A RECORD <strong>of</strong> <strong>the</strong> number <strong>of</strong> participants who accept and refuse. For those that refuse,<br />
keep a record <strong>of</strong> <strong>the</strong>ir reason for refusing, if possible.<br />
Module 10: Conducting Interviews with Key Informants<br />
3
Introduction<br />
<strong>The</strong> Ministry <strong>of</strong> Health is trying to find out <strong>the</strong> best ways prevent <strong>the</strong> effects <strong>of</strong> malaria on<br />
pregnant women and <strong>the</strong>ir babies. To do this, we need to know what women know about<br />
malaria and its effects on pregnant women. We also need to know <strong>the</strong> places that women seek<br />
health care when <strong>the</strong>y are pregnant and what sorts <strong>of</strong> things <strong>the</strong>y do to prevent malaria when<br />
<strong>the</strong>y are pregnant. We plan to talk to ____________ (describe about how many women and o<strong>the</strong>rs<br />
will be involved in this component <strong>of</strong> <strong>the</strong> assessment).<br />
Purpose<br />
What we learn about women’s ideas and actions about malaria and what <strong>the</strong>y do when <strong>the</strong>y<br />
are pregnant will help us plan programs to decrease malaria in pregnant women.<br />
Procedures<br />
Being part <strong>of</strong> this individual interview/focus group is up to you. If you agree to participate/<br />
be part <strong>of</strong> this interview/focus group, we will ask you some questions about what you think<br />
and do about malaria, and about where you get help and information about malaria. You also<br />
do not need to answer any questions that we ask that you do not want to. If you agree to<br />
participate and during <strong>the</strong> interview/focus group, decide that you do not want to continue, you<br />
can withdraw at any time. We will not be asking for any blood or urine samples.<br />
Benefits<br />
Although what we learn might not help you directly, it will help us know how best to prevent<br />
malaria in pregnant women in this district.<br />
Risks or discomforts<br />
We will not be telling anyone about your individual answers to <strong>the</strong> questions.<br />
Would you like to participate?<br />
Thank you very much for your time.<br />
Please be sure to give this information sheet to <strong>the</strong> person with whom you spoke.<br />
4<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
I. Debriefing<br />
Daily debriefings are an essential element <strong>of</strong> good qualitative work. At <strong>the</strong> end <strong>of</strong> each day that<br />
focus groups or individual interviews are conducted, it is useful for <strong>the</strong> assessment team to<br />
hold a debriefing session lasting approximately 1 - 1.5 hours. <strong>The</strong> debriefing should be led by<br />
<strong>the</strong> coordinator or ano<strong>the</strong>r facilitator.<br />
Debriefings are a method to determine if a) <strong>the</strong> questions are adequate to obtain <strong>the</strong> needed<br />
data (qualitative methods are iterative, thus, you can change questions as needed as you<br />
conduct <strong>the</strong> assessment), b) if people have understood <strong>the</strong> question (for example: is it a<br />
sentence structure, content or a translation problem?), if c) data are similar across facilities or<br />
show wide variability, which might require adding questions to understand <strong>the</strong> variability, and<br />
if d) expressions in <strong>the</strong> local language are being translated appropriately.<br />
<strong>The</strong> team listens to what each interviewer has learned (aggregate summary <strong>of</strong> <strong>the</strong> data <strong>the</strong>y<br />
collected that day), identifies what is common, what is different, and mutually agrees on what<br />
local expressions mean. This is particularly important when <strong>the</strong> team is trying to understand<br />
local beliefs, including taboos, about malaria and/or drugs during pregnancy. Debriefings<br />
tend to be difficult as <strong>the</strong> team is tired and <strong>the</strong> process can be tedious, but having high-quality,<br />
clearly understandable data when analysis begins rewards <strong>the</strong> time spent in daily debriefings.<br />
During <strong>the</strong> debriefings, <strong>the</strong> coordinator or facilitator should keep notes on <strong>the</strong> outcomes <strong>of</strong><br />
each debriefing, explanations for trends seen in <strong>the</strong> data, and local language terms (using <strong>the</strong><br />
local language), as well as <strong>the</strong> agreed-upon translations.<br />
During this time, all recorded interviews can be reviewed for completeness and accuracy <strong>of</strong><br />
<strong>the</strong> recording. In addition, concepts can be clarified, traditional terms used for prevention<br />
and treatment strategies can be reviewed for linguistic accuracy and consistency, and<br />
understanding <strong>of</strong> local pregnancy taboos can be discussed.<br />
<strong>The</strong>se types <strong>of</strong> surveys can require <strong>the</strong> addition <strong>of</strong> new questions or probes to <strong>the</strong> survey tool<br />
during <strong>the</strong> survey period in order to make <strong>the</strong> questions wider, narrower, or more specific in<br />
order to obtain <strong>the</strong> needed information.<br />
J. Interview Analysis<br />
Recording and analyzing information for a focus group is somewhat different from recording<br />
and analyzing information for an individual interview.<br />
When <strong>the</strong>re is a good quote in <strong>the</strong> local language, make sure it is written as it is said in <strong>the</strong><br />
local language and <strong>the</strong>n reach consensus (perhaps during debriefing) on what it means in <strong>the</strong><br />
primary language used in <strong>the</strong> rapid assessment, if different.<br />
Module 10: Conducting Interviews with Key Informants<br />
5
6<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
TOOL 10: INDIVIDUAL INTERVIEW GUIDE<br />
FOR KEY INFORMANTS<br />
Region___________________________<br />
Name <strong>of</strong> facility/facility area___________________________<br />
Date: ____/____/____<br />
Month Day Year<br />
Time______________________________________<br />
Interviewer_________________________________<br />
Recorder___________________________________<br />
INTRODUCTION: Introduce yourself and team members, describe your roles, and obtain agreement to<br />
participate (or informed consent if required). Tell <strong>the</strong> participant(s) <strong>the</strong> goal <strong>of</strong> <strong>the</strong> information, as applicable<br />
A. Demographics<br />
Age:<br />
Level <strong>of</strong> education: Highest level <strong>of</strong> school attended (primary, secondary, higher, unknown)<br />
Ethnic group:<br />
Pr<strong>of</strong>ession or position in <strong>the</strong> community:<br />
B. Topical area: Prevailing health problems and malaria in pregnancy<br />
1. What are <strong>the</strong> 3 most common health problems among pregnant women in this area?<br />
List <strong>the</strong>m in order <strong>of</strong> how common <strong>the</strong>y are.<br />
2. Which <strong>of</strong> <strong>the</strong>se 3 problems is <strong>the</strong> most severe?<br />
<br />
3. (Ask if malaria is not mentioned in Question 1) Is malaria a serious or common health problem among pregnant<br />
women in this community?<br />
C. Topical area: Signs and symptoms <strong>of</strong> fever and malaria during pregnancy<br />
1. What are <strong>the</strong> 3 most common illnesses in pregnancy that cause fever in this area?<br />
(Be sure to note local terms.)<br />
2. What are <strong>the</strong> common signs and symptoms <strong>of</strong> malaria?<br />
3. Are <strong>the</strong>se signs and symptoms different for pregnant women? If so, how?<br />
Tool 10: Conducting Interviews with Key Informants<br />
1
D. Topical area: Causes and consequences <strong>of</strong> malaria in pregnancy<br />
1. What are <strong>the</strong> causes <strong>of</strong> malaria?<br />
2. Are <strong>the</strong> causes different for pregnant women than for o<strong>the</strong>r people?<br />
3. Are pregnant women more susceptible to malaria? If so, why? At what months <strong>of</strong> gestation?<br />
4. Do pregnant women with malaria get more severely ill than o<strong>the</strong>r people?<br />
5. What effect does malaria have on pregnant women? On <strong>the</strong> fetus? On <strong>the</strong> neonate?<br />
E. Topical area: Sources <strong>of</strong> advice for malaria prevention/treatment during pregnancy<br />
1. Do husbands play a role in deciding what to do if <strong>the</strong>ir pregnant wife gets malaria?<br />
If YES: Please describe <strong>the</strong>ir role.<br />
2. If <strong>the</strong>re were a new treatment for malaria during pregnancy, what would be <strong>the</strong> best way to get that information to<br />
pregnant women?<br />
(Probes: How do you hear about important news in your village? Is <strong>the</strong>re one person to whom everyone goes to ask<br />
advice, such as a village headman?)<br />
3. In <strong>the</strong> community, who provides <strong>the</strong> best information about how to treat malaria when someone is pregnant?<br />
F. Topical area: Preventive strategies<br />
1. In general, how do women protect <strong>the</strong>mselves in this area against malaria when <strong>the</strong>y are pregnant? (Probe<br />
for traditional methods: infusions, teas, smoke, leaves for dousing <strong>the</strong> walls, going to bed earlier; and modern<br />
methods: insecticides, use <strong>of</strong> nets or treated curtains; clo<strong>the</strong>s)<br />
Are any <strong>of</strong> <strong>the</strong>se strategies harmful to a pregnant woman?<br />
IF YES: please describe how it will hurt <strong>the</strong> woman or <strong>the</strong> baby.<br />
2. Which things do you think work best to prevent malaria when someone is pregnant?<br />
(Can rank items from most effective at top to least effective at bottom.)<br />
3. Do most pregnant women routinely use a mosquito net?<br />
4. Who in <strong>the</strong> family makes <strong>the</strong> decision about who sleeps under <strong>the</strong> net?<br />
G. Topical area: Treatment strategies<br />
1. What are available sources <strong>of</strong> care for fever or malaria during pregnancy in this area?<br />
2. What types <strong>of</strong> things do people (anybody) recommend that women should do to treat malaria in pregnancy?<br />
Of <strong>the</strong>se, what is <strong>the</strong> most effective strategy, in your opinion?<br />
3. Can you please tell me all <strong>the</strong> traditional medicines or treatments that can be used to treat malaria in a pregnant<br />
woman?<br />
(Be sure to note local names.)<br />
OF THIS LIST: Which ones work best?<br />
Which ones are used most <strong>of</strong>ten in this community?<br />
4. Can you tell me about traditional taboos for pregnant women? (examples: foods, medicines, or plants that should<br />
be avoided) Can you list <strong>the</strong> taboos?<br />
Are <strong>the</strong>re any specific taboos related to malaria?<br />
Do most pregnant women in this community listen to <strong>the</strong>se taboos?<br />
2<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
H. Topical Area: Acceptance <strong>of</strong> antenatal care from health facilities and traditional<br />
birth attendants<br />
1. Are <strong>the</strong>re traditional birth attendants in this community? Are <strong>the</strong>re o<strong>the</strong>r community-based workers that give care<br />
to pregnant women?<br />
IF YES: what are <strong>the</strong>y called and how do <strong>the</strong>ir roles differ from traditional birth attendants? (Note to interviewer:<br />
Add <strong>the</strong> name for <strong>the</strong> site-specific community-based worker in <strong>the</strong> questions where community-based worker is<br />
mentioned.)<br />
2. If yes, how do <strong>the</strong> traditional birth attendants or o<strong>the</strong>r community-based workers give support and advice to<br />
pregnant women?<br />
(Probe: do <strong>the</strong>y routinely make visits to a woman’s house?)<br />
3. Do traditional birth attendants and o<strong>the</strong>r community-based workers in this community advise that pregnant<br />
women attend antenatal clinics? (Note any differences between traditional birth attendants and community-based<br />
workers.)<br />
4. Where do most women in this community go for antenatal care?<br />
5. At how many months’ gestation do most pregnant women in this area start to get<br />
antenatal care:<br />
from a traditional birth attendant or o<strong>the</strong>r community-based worker?<br />
from a health facility?<br />
why at this gestational age?<br />
6. What are <strong>the</strong> reasons why women go to antenatal care?<br />
7. What is <strong>the</strong> cost <strong>of</strong> basic antenatal care in <strong>the</strong> health facility?<br />
Is that cost acceptable?<br />
8. What could be done to improve <strong>the</strong> services <strong>of</strong> <strong>the</strong> traditional birth attendants? Of <strong>the</strong> o<strong>the</strong>r community-based<br />
workers?<br />
9. What could be done to improve <strong>the</strong> services <strong>of</strong> <strong>the</strong> health facility?<br />
10. What roles do husbands in families play in deciding whe<strong>the</strong>r a woman should seek antenatal care or advice?<br />
(Probes: do husbands play an active role in assisting pregnant women? Do husbands<br />
ever go to clinic with pregnant women?)<br />
11. How could services for pregnant women regarding <strong>the</strong> prevention and treatment <strong>of</strong> malaria be improved?<br />
12. What is <strong>the</strong> best way to encourage women to receive antenatal care?<br />
I. Topical Area: Drug purchasing behaviors<br />
1. Where do pregnant women obtain antimalarials? Which is <strong>the</strong> best place to buy<br />
<strong>the</strong>se medicines?<br />
BE SURE TO THANK THE PERSON FOR HIS OR HER TIME, AND ASK IF HE OR SHE HAS ANY QUESTIONS FOR YOU.<br />
Tool 10: Individual Interview Guide for Key Informants<br />
3
24<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Resource 1: Articles<br />
Relevant Articles : <strong>Malaria</strong> in Pregnancy<br />
<strong>The</strong> <strong>Malaria</strong> in Pregnancy Consortium maintains a <strong>Malaria</strong> in Pregnancy (MiP) Library, a bibliographic database <strong>of</strong><br />
published and unpublished literature relating to malaria in pregnancy, including a trial registry <strong>of</strong> planned and ongoing<br />
trials, for use by scientists, policy makers, funding agencies, industry and o<strong>the</strong>r interested parties, at<br />
http://www.mip-consortium.org/resource_centre/index.htm. Many <strong>of</strong> <strong>the</strong> articles listed below are in this database.<br />
Ashwood-Smith, H., Y. Coombes, et al. (2002). "Availability and use <strong>of</strong> sulphadoxine-pyrimethamine (SP) in pregnancy<br />
in Blantyre District: A Safe Mo<strong>the</strong>rhood and Blantyre Integrated <strong>Malaria</strong> Initiative (BIMI) Joint Survey." Malawi Medical<br />
Journal 14(1): 8-11.<br />
Ayisi, J., A. van Eijk, et al. (2004). "Maternal malaria and perinatal HIV transmission, western Kenya." Emerging<br />
Infectious Diseases 10(4): 643-652.<br />
Brabin, B. (1991). "An assessment <strong>of</strong> low birthweight risk in primiparae as an indicator <strong>of</strong> malaria control in<br />
pregnancy." International Journal <strong>of</strong> Epidemiology 20(1): 276-83.<br />
Brabin, B. J., S. O. Agbaje, et al. (1999). "A birthweight nomogram for Africa, as a malaria-control indicator." Annals <strong>of</strong><br />
Tropical Medicine & Parasitology 93 Suppl 1: S43-57.<br />
Brabin, B. J., M. Hakimi, et al. (2001). "An analysis <strong>of</strong> anemia and pregnancy-related maternal mortality." Journal <strong>of</strong><br />
Nutrition 131(2S-2): 604S-614S; discussion 614S-615S.<br />
Briggs, G. G., R. K. Freeman, et al. (1998). Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk.<br />
Baltimore, Williams & Wilkins.<br />
Browne, E. N., G. H. Maude, et al. (2001). "<strong>The</strong> impact <strong>of</strong> insecticide-treated bednets on malaria and anaemia in<br />
pregnancy in Kassena-Nankana district, Ghana: a randomized controlled trial." Tropical Medicine & International<br />
Health 6(9): 667-76.<br />
Crawley, J., J. Hill, et al. (2007). "From evidence to action? Challenges to policy change and programme delivery for<br />
malaria in pregnancy." Lancet Infectious Diseases 7(2): 145-55.<br />
D'Alessandro, U. (1999). "A rational approach to malaria control in pregnancy in sub-Saharan Africa: <strong>the</strong> need for a<br />
link between scientific research and public-health interventions." Annals <strong>of</strong> Tropical Medicine & Parasitology 93<br />
Suppl 1: S75-7.<br />
D'Alessandro, U., P. Langerock, et al. (1996). "<strong>The</strong> impact <strong>of</strong> a national impregnated bed net programme on <strong>the</strong><br />
outcome <strong>of</strong> pregnancy in primigravidae in <strong>The</strong> Gambia." Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine &<br />
Hygiene 90(5): 487-92.<br />
Desai, M., F. O. ter Kuile, et al. (2007). "Epidemiology and burden <strong>of</strong> malaria in pregnancy." Lancet Infectious Diseases<br />
7(2): 93-104.<br />
Dolan, G., F. O. ter Kuile, et al. (1993). "Bed nets for <strong>the</strong> prevention <strong>of</strong> malaria and anaemia in pregnancy." Transactions<br />
<strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene 87(6): 620-6.<br />
Goodman, C. A., P. G. Coleman, et al. (2001). "<strong>The</strong> cost-effectiveness <strong>of</strong> antenatal malaria prevention in sub-Saharan<br />
Africa." American Journal <strong>of</strong> Tropical Medicine & Hygiene 64(1-2 Suppl): 45-56.<br />
Greenwood, B., P. Alonso, et al. (2007). "<strong>Malaria</strong> in pregnancy: priorities for research." Lancet Infectious Diseases<br />
7(2): 169-74.<br />
Resources<br />
1
Guyatt, H. L., M. H. Gotink, et al. (2002). "Free bednets to pregnant women through antenatal<br />
clinics in Kenya: a cheap, simple and equitable approach to delivery." Tropical Medicine and<br />
International Health 7(5): 409-20.<br />
Guyatt, H. L. and R. W. Snow (2001). "<strong>The</strong> epidemiology and burden <strong>of</strong> Plasmodium falciparumrelated<br />
anemia among pregnant women in sub-Saharan Africa." American Journal <strong>of</strong> Tropical<br />
Medicine & Hygiene 64(1-2 Suppl): 36-44.<br />
Hawley WA, Phillips-Howard PA, ter Kuile FO, Terlouw DJ, Vulule JM, Ombok M et al. (2003).<br />
"Community-wide effects <strong>of</strong> permethrin-treated bed nets on child mortality and malaria<br />
morbidity in western Kenya." American Journal <strong>of</strong> Tropical Medicine & Hygiene; 68 (4<br />
Suppl);121-7.<br />
Hawley WA, ter Kuile FO, Steketee RW, Nahlen BL, Terlouw DJ, Gimnig JE et al. (2003).<br />
Implications <strong>of</strong> <strong>the</strong> Western Kenya permethrin-treated bed net study for policy, program<br />
implementation, and future research. American Journal <strong>of</strong> Tropical Medicine & Hygiene;<br />
68 (4 Suppl): 168-73.<br />
Inion, I., F. Mwanyumba, et al. (2003). "Placental malaria and perinatal transmission <strong>of</strong> human<br />
immunodeficiency virus type 1." Journal <strong>of</strong> Infectious Diseases 188(11): 1675-8.<br />
Kayentao K, Kodio M, Newman RD, Maiga H, Doumtabe D, Ongoiba A, Coulibaly D, Keita AS,<br />
Maiga B, Mungai M, Parise ME, Doumbo O. (2005). "Comparison <strong>of</strong> intermittent preventive<br />
treatment with chemoprophylaxis for <strong>the</strong> prevention <strong>of</strong> malaria during pregnancy in Mali."<br />
Journal <strong>of</strong> Infectious Diseases 1;191(1):109-16.<br />
Ladner, J., V. Leroy, et al. (2002). "HIV infection, malaria, and pregnancy: a prospective cohort<br />
study in Kigali, Rwanda." American Journal <strong>of</strong> Tropical Medicine & Hygiene 66(1): 56-60.<br />
Le Hesran, J. Y., M. Cot, et al. (1997). "Maternal placental infection with Plasmodium falciparum<br />
and malaria morbidity during <strong>the</strong> first 2 years <strong>of</strong> life." American Journal <strong>of</strong> Epidemiology<br />
146(10): 826-31.<br />
Leke, R. F., R. R. Djokam, et al. (1999). "Detection <strong>of</strong> <strong>the</strong> Plasmodium falciparum antigen<br />
histidine-rich protein 2 in blood <strong>of</strong> pregnant women: implications for diagnosing placental<br />
malaria." Journal <strong>of</strong> Clinical Microbiology 37(9): 2992-6.<br />
Luxemburger, C., R. McGready, et al. (2001). "Effects <strong>of</strong> malaria during pregnancy on infant<br />
mortality in an area <strong>of</strong> low malaria transmission." American Journal <strong>of</strong> Epidemiology 154(5):<br />
459-65.<br />
Luxemburger, C., F. Ricci, et al. (1997). "<strong>The</strong> epidemiology <strong>of</strong> severe malaria in an area <strong>of</strong> low<br />
transmission in Thailand." Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene<br />
91(3): 256-62.<br />
Marchesini, P. and K. Crawley (2004). Reducing <strong>the</strong> burden <strong>of</strong> malaria in pregnancy. Geneva,<br />
Roll Back <strong>Malaria</strong>, World Health Organization.<br />
McCormick, M. C. (1985). "<strong>The</strong> contribution <strong>of</strong> low birth weight to infant mortality and<br />
childhood morbidity." New England Journal <strong>of</strong> Medicine 312(2): 82-90.<br />
McGready, R. (2002). <strong>The</strong> use <strong>of</strong> artemisinin derivatives in pregnancy: <strong>the</strong> experience on <strong>the</strong><br />
Thai-Burma border. PREMA-EU. 1: 6-11.<br />
McGready, R., K. A. Hamilton, et al. (2001). "Safety <strong>of</strong> <strong>the</strong> insect repellent N,N-diethyl-Mtoluamide<br />
(DEET) in pregnancy." American Journal <strong>of</strong> Tropical Medicine & Hygiene<br />
65(4): 285-9.<br />
2<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
McGready, R., J. A. Simpson, et al. (2001). "A double-blind randomized <strong>the</strong>rapeutic trial <strong>of</strong> insect repellents for <strong>the</strong><br />
prevention <strong>of</strong> malaria in pregnancy." Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene 95(2): 137-8.<br />
Menendez, C. (2003). Anaemia in pregnancy in developing areas: its causes and consequencies. <strong>Malaria</strong> and Anemia in<br />
Pregnancy, Amsterdam, PREMA-EU.<br />
Menendez, C. (1999). "Priority areas for current research on malaria during pregnancy." Annals <strong>of</strong> Tropical Medicine<br />
& Parasitology 93 Suppl 1: S71-4.<br />
Menendez, C., U. D'Alessandro, et al. (2007). "Reducing <strong>the</strong> burden <strong>of</strong> malaria in pregnancy by preventive strategies."<br />
Lancet Infectious Diseases 7(2): 126-35.<br />
Menendez, C., A. F. Fleming, et al. (2000). "<strong>Malaria</strong>-related anaemia." Parasitology Today 16(11): 469-76.<br />
Menendez, C., J. Ordi, et al. (2000). "<strong>The</strong> impact <strong>of</strong> placental malaria on gestational age and birth weight." Journal <strong>of</strong><br />
Infectious Diseases 181(5): 1740-5.<br />
Msyamboza, K., E. Senga, et al. (2007). "Estimation <strong>of</strong> effectiveness <strong>of</strong> interventions for malaria control in pregnancy<br />
using <strong>the</strong> screening method." International Journal <strong>of</strong> Epidemiology.<br />
Mutabingwa, T. K. (2002). Antimalarial Intermittent Treatment during Pregnancy in Africa. PREMA-EU Newsletter.<br />
Liverpool. 1: 4-6.<br />
Mwapasa, V., S. J. Rogerson, et al. (2004). "<strong>The</strong> effect <strong>of</strong> Plasmodium falciparum malaria on peripheral and placental<br />
HIV-1 RNA concentrations in pregnant Malawian women." Aids 18(7): 1051-1059.<br />
Nahlen, B. L. (2000). "Rolling back malaria in pregnancy. [letter; comment]." New England Journal <strong>of</strong> Medicine<br />
343(9): 651-2.<br />
Newman, R. D., A. Hailemariam, et al. (2003). "<strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy in Areas <strong>of</strong> Stable and Unstable<br />
Transmission in Ethiopia during a Nonepidemic Year." Journal <strong>of</strong> Infectious Diseases 187(11): 1765-72.<br />
Newman, R. D., M. E. Parise, et al. (2003). "Safety, efficacy and determinants <strong>of</strong> effectiveness <strong>of</strong> antimalarial drugs<br />
during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa."<br />
Tropical Medicine and International Health 8(6): 488-506.<br />
Nosten, F., R. McGready, et al. (2007). "Case management <strong>of</strong> malaria in pregnancy." Lancet Infectious Diseases<br />
7(2): 118-25.<br />
Nosten, F., R. McGready, et al. (1999). "Effects <strong>of</strong> Plasmodium vivax malaria in pregnancy." Lancet 354(9178): 546-9.<br />
Nosten, F., F. ter Kuile, et al. (1991). "<strong>Malaria</strong> during pregnancy in an area <strong>of</strong> unstable endemicity." Transactions <strong>of</strong> <strong>the</strong><br />
Royal Society <strong>of</strong> Tropical Medicine & Hygiene 85(4): 424-9.<br />
Ouma, P., M. E. Parise, et al. (2006). "A Randomized Controlled Trial <strong>of</strong> Folate Supplementation When Treating <strong>Malaria</strong><br />
in Pregnancy with Sulfadoxine-Pyrimethamine." PLoS Clin Trials 1(6): e28.<br />
Parise, M. E., J. G. Ayisi, et al. (1998). "Efficacy <strong>of</strong> sulfadoxine-pyrimethamine for prevention <strong>of</strong> placental malaria in an<br />
area <strong>of</strong> Kenya with a high prevalence <strong>of</strong> malaria and human immunodeficiency virus infection." American Journal <strong>of</strong><br />
Tropical Medicine & Hygiene 59(5): 813-22.<br />
Parise, M. E., L. S. Lewis, et al. (2003). "A rapid assessment approach for public health decision-making related to <strong>the</strong><br />
prevention <strong>of</strong> malaria during pregnancy." Bulletin <strong>of</strong> <strong>the</strong> World Health Organization 81(5): 316-23.<br />
Phillips-Howard, P. A. (1999). "Epidemiological and control issues related to malaria in pregnancy." Annals <strong>of</strong> Tropical<br />
Medicine & Parasitology 93 Suppl 1: S11-7.<br />
Rogerson, S. J., L. Hviid, et al. (2007). "<strong>Malaria</strong> in pregnancy: pathogenesis and immunity." Lancet Infectious Diseases<br />
7(2): 105-17.<br />
Resources<br />
3
Rogerson, S. J., E. Chaluluka, et al. (2000). "Intermittent sulfadoxine-pyrimethamine in<br />
pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99."<br />
Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene 94(5): 549-53.<br />
Saute, F., C. Menendez, et al. (2002). "<strong>Malaria</strong> in pregnancy in rural Mozambique: <strong>the</strong> role <strong>of</strong><br />
parity, submicroscopic and multiple Plasmodium falciparum infections." Tropical Medicine and<br />
International Health 7(1): 19-28.<br />
Schultz, L. J., R. W. Steketee, et al. (1994). "<strong>The</strong> efficacy <strong>of</strong> antimalarial regimens containing<br />
sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental<br />
Plasmodium falciparum infection among pregnant women in Malawi." American Journal <strong>of</strong><br />
Tropical Medicine & Hygiene 51(5): 515-22.<br />
Schultz, L. J., R. W. Steketee, et al. (1995). <strong>Malaria</strong> prevention during pregnancy: an antenatal<br />
intervention strategy whose time has come. <strong>The</strong> female client and <strong>the</strong> health-care provider. J. H.<br />
Roberts and C. Vlass<strong>of</strong>f. Ottawa, International Development Research Centre: 113-128.<br />
Schultz LJ, Steketee RW, Chitsulo L, Macheso A, Kazembe P, Wirima JJ. (1996). "Evaluation <strong>of</strong><br />
maternal practices, efficacy, and cost-effectiveness <strong>of</strong> alternative antimalaria regimens for use<br />
in pregnancy:chloroquine and sulfadoxine-pyrimethamine." American Journal <strong>of</strong> Tropical<br />
Medicine and Hygiene 55(1 Suppl): 87-94.<br />
Shulman, C. E. (1999). "<strong>Malaria</strong> in pregnancy: its relevance to safe-mo<strong>the</strong>rhood programmes."<br />
Annals <strong>of</strong> Tropical Medicine & Parasitology 93 Suppl 1: S59-66.<br />
Shulman, C. E. and E. K. Dorman (2003). "Importance and prevention <strong>of</strong> malaria in pregnancy."<br />
Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene 97(1): 30-5.<br />
Shulman, C. E., E. K. Dorman, et al. (2002). "<strong>Malaria</strong> as a cause <strong>of</strong> severe anaemia in pregnancy."<br />
Lancet 360(9331): 494.<br />
Shulman, C. E., E. K. Dorman, et al. (1999). "Intermittent sulphadoxine-pyrimethamine to<br />
prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled<br />
trial." Lancet 353(9153): 632-6.<br />
Shulman, C. E., E. K. Dorman, et al. (1998). "A community randomized controlled trial <strong>of</strong><br />
insecticide-treated bednets for <strong>the</strong> prevention <strong>of</strong> malaria and anaemia among primigravid<br />
women on <strong>the</strong> Kenyan coast." Tropical Medicine & International Health 3(3): 197-204.<br />
Singh, N., R. K. Mehra, et al. (2001). "<strong>Malaria</strong> during pregnancy and infancy, in an area <strong>of</strong> intense<br />
malaria transmission in central India." Annals <strong>of</strong> Tropical Medicine & Parasitology 95(1): 19-29.<br />
Singh, N., A. Saxena, et al. (1998). "Studies on malaria during pregnancy in a tribal area <strong>of</strong><br />
central India (Madhya Pradesh)." Sou<strong>the</strong>ast Asian Journal <strong>of</strong> Tropical Medicine & Public Health<br />
29(1): 10-7.<br />
Singh, N., M. M. Shukla, et al. (1999). "Epidemiology <strong>of</strong> malaria in pregnancy in central India."<br />
Bulletin <strong>of</strong> <strong>the</strong> World Health Organization 77(7): 567-72.<br />
Sirima, S. B., R. Sawadogo, et al. (2003). "Failure <strong>of</strong> a Chloroquine Chemoprophylaxis Program<br />
to Adequately Prevent <strong>Malaria</strong> during Pregnancy in Koupela District, Burkina Faso." Clinical<br />
Infectious Diseases 36(11): 1374-82.<br />
Steketee RW, Nahlen BL, Parise ME, Menendez C (2001). <strong>The</strong> burden <strong>of</strong> malaria during<br />
pregnancy in malaria-endemic areas. American Journal <strong>of</strong> Tropical Medicine & Hygiene; 64 (1-2<br />
Suppl): 28-35.<br />
Steketee, R. W., B. L. Nahlen, et al. (2001). "<strong>The</strong> burden <strong>of</strong> malaria in pregnancy in malariaendemic<br />
areas." American Journal <strong>of</strong> Tropical Medicine & Hygiene 64(1-2 Suppl): 28-35.<br />
4<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Steketee RW, Wirima JJ, Campbell CC (1996). Developing effective strategies for malaria prevention programs for<br />
pregnant African women. American Journal <strong>of</strong> Tropical Medicine & Hygiene; 55(1 Suppl): 95-100.<br />
Steketee RW, Wirima JJ, Slutsker L, Heymann DL, Breman JG (1996). <strong>The</strong> problem <strong>of</strong> malaria and malaria control in<br />
pregnancy in sub-Saharan Africa. American Journal <strong>of</strong> Tropical Medicine & Hygiene; 55 (1 Suppl): 2-7.<br />
Steketee, R. W., J. J. Wirima, et al. (1996). "Impairment <strong>of</strong> a pregnant woman's acquired ability to limit Plasmodium<br />
falciparum by infection with human immunodeficiency virus type-1." American Journal <strong>of</strong> Tropical Medicine & Hygiene<br />
55(1 Suppl): 42-9.<br />
ter Kuile, F. O., A. M. van Eijk, et al. (2007). "Effect <strong>of</strong> sulfadoxine-pyrimethamine resistance on <strong>the</strong> efficacy <strong>of</strong><br />
intermittent preventive <strong>the</strong>rapy for malaria control during pregnancy: a systematic review." Jama 297(23): 2603-16.<br />
ter Kuile, F. O., D. J. Terlouw, et al. (2003). "Reduction <strong>of</strong> malaria during pregnancy by permethrin-treated bed nets in an<br />
area <strong>of</strong> intense perennial malaria transmission in western Kenya." American Journal <strong>of</strong> Tropical Medicine & Hygiene<br />
68(4 Suppl): 50-60.<br />
van Eijk, A. (2004). "Effectiveness <strong>of</strong> intermittent preventive treatment with sulfadoxine-pyrimethamine for control<br />
<strong>of</strong> malaria in pregnancy in western Kenya: a hospital-based study." Tropical Medicine & International Health 9(3):<br />
351-360.<br />
van Eijk, A. M., J. G. Ayisi, et al. (2003). "HIV increases <strong>the</strong> risk <strong>of</strong> malaria in women <strong>of</strong> all gravidities in Kisumu, Kenya."<br />
Aids 17(4): 595-603.<br />
Verhoeff, F. H., B. J. Brabin, et al. (1998). "An evaluation <strong>of</strong> <strong>the</strong> effects <strong>of</strong> intermittent sulfadoxine-pyrimethamine<br />
treatment in pregnancy on parasite clearance and risk <strong>of</strong> low birthweight in rural Malawi." Annals <strong>of</strong> Tropical Medicine<br />
& Parasitology 92(2): 141-50.<br />
Verhoeff, F. H., P. Milligan, et al. (1997). "Gestational age assessment by nurses in a developing country using <strong>the</strong><br />
Ballard method, external criteria only." Annals <strong>of</strong> Tropical Paediatrics 17(4): 333-42.<br />
Ward, S. A., E. J. Sevene, et al. (2007). "Antimalarial drugs and pregnancy: safety, pharmacokinetics, and<br />
pharmacovigilance." Lancet Infectious Diseases 7(2): 136-44.<br />
Williams HA and Jones COH (2004). Review. A critical review <strong>of</strong> behavioral issues related to malaria control in sub-<br />
Saharan Africa: what contributions have social scientists made? Social Sciences and Medicine; 59: 501-523.<br />
Wolfe, E. B., M. E. Parise, et al. (2001). "Cost-effectiveness <strong>of</strong> sulfadoxine-pyrimethamine for <strong>the</strong> prevention <strong>of</strong> malariaassociated<br />
low birth weight." American Journal <strong>of</strong> Tropical Medicine & Hygiene 64(3-4): 178-86.<br />
World Health Organization (2003). <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> safety <strong>of</strong> artemisinin compounds in pregnancy: Report <strong>of</strong> two<br />
informal consultations convened by WHO in 2002. Geneva, World Health Organization.<br />
World Health Organization (2000). "Severe falciparum malaria. World Health Organization, Communicable Diseases<br />
Cluster." Transactions <strong>of</strong> <strong>the</strong> Royal Society <strong>of</strong> Tropical Medicine & Hygiene 94 Suppl 1: S1-90.<br />
World Health Organization and UNICEF (year). Antenatal Care in Developing Countries: Promises, achievements and<br />
missed opportunities. 1-32. (http://www.childinfo.org/eddb/antenatal/antenatal_full.pdf<br />
Resources<br />
5
6<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Resource 2: Resources for <strong>the</strong><br />
Qualitative <strong>Assessment</strong><br />
Sample Interviewer Training Manual<br />
List <strong>of</strong> Resources<br />
Sample Interviewer Training Manual<br />
II. Overview<br />
A. Introduction<br />
B. Health impacts caused by malaria<br />
II. Qualitative research components<br />
A. Differences between qualitative and quantitative research<br />
III. Qualitative research methods<br />
I. OVERVIEW:<br />
A. Introduction:<br />
We are here to help learn about [insert statement to describe purpose <strong>of</strong> study]. For example<br />
for a study about pregnant women and malaria: We are here to find out how women in <strong>the</strong><br />
XXX District [insert name <strong>of</strong> specific district] deal with malaria when <strong>the</strong>y are pregnant. We<br />
are trying to find out what women know about malaria and <strong>the</strong> risks that are associated with<br />
<strong>the</strong> illness when you are pregnant, what care women get when <strong>the</strong>y are pregnant, things that<br />
women in this area do to try to prevent malaria, and what <strong>the</strong>y think about <strong>the</strong> various places<br />
that <strong>the</strong>y can go in order to obtain care during <strong>the</strong>ir pregnancy. We want to understand also<br />
how women get support during <strong>the</strong>ir pregnancy and where <strong>the</strong>y get advice regarding what to<br />
do if <strong>the</strong>y get sick while being pregnant.<br />
In addition to talking to women who are currently pregnant or who were recently pregnant<br />
(defined as having delivered in <strong>the</strong> past two years), we will be talking to some health care<br />
workers, and lay midwives and traditional birth attendants (TBAs).<br />
This project is part <strong>of</strong> a bigger study that will look at (insert statement). It will first try to<br />
determine <strong>the</strong> extent <strong>of</strong> <strong>the</strong> problem in this area, looking at levels <strong>of</strong> parasitemia (how many<br />
parasites that cause malaria are in a person’s blood), levels <strong>of</strong> anemia, degree <strong>of</strong> placental<br />
parasitemia, and how many babies with low-birth weight are being born (a complication <strong>of</strong><br />
having malaria during pregnancy). All <strong>the</strong> information ga<strong>the</strong>red in <strong>the</strong> different parts <strong>of</strong> <strong>the</strong><br />
study will help us (insert statement). [insert names <strong>of</strong> assessment team members] Dr. XX will<br />
be leading <strong>the</strong> one part <strong>of</strong> <strong>the</strong> study and Dr. XX will be doing <strong>the</strong> qualitative part—<strong>the</strong> aspect <strong>of</strong><br />
<strong>the</strong> study for which you were hired.<br />
Resources<br />
7
B. Health Impacts Caused by <strong>Malaria</strong>:<br />
<strong>Malaria</strong>: Why is malaria important? <strong>Malaria</strong> is a very serious illness, particularly in sub-<br />
Saharan Africa. Each year between 300 and 500 million people in <strong>the</strong> world develop malaria<br />
and 1.5 to 2.7 million people die each year from malaria. Young children (those under 5<br />
years) who have not yet developed immunity (limited protection) against <strong>the</strong> illness are most<br />
vulnerable to <strong>the</strong> effects <strong>of</strong> malaria. Pregnant women, especially during <strong>the</strong>ir first pregnancy,<br />
are also at risk.<br />
<strong>Malaria</strong> is caused by a parasite carried by a female Anopheles mosquito. She bites a person<br />
to take a blood meal and injects parasites. <strong>The</strong>y take several weeks to develop and eventually<br />
attack <strong>the</strong> red blood cells in your body. <strong>The</strong> red blood cells carry oxygen, which is essential for<br />
your body to work. Destroying <strong>the</strong> red blood cells causes anemia, which is why people with<br />
malaria <strong>of</strong>ten feel very tired. In order for <strong>the</strong> infection to spread, ano<strong>the</strong>r female Anopheles<br />
mosquito must bite a person who is infected with malaria and <strong>the</strong> cycle starts again. If <strong>the</strong><br />
parasites go to <strong>the</strong> brain, it is called “cerebral malaria,” and it is a grave sign. This is <strong>of</strong>ten when<br />
people develop convulsions (seizures, or “fitting”) and need to be treated with quinine.<br />
<strong>The</strong>re are four types <strong>of</strong> malaria: Plasmodium vivax, Plasmodium ovale, Plasmodium malariae,<br />
and Plasmodium falciparum. Of <strong>the</strong> four types, P. falciparum is <strong>the</strong> only one that can<br />
potentially be fatal. P. ovale and P. vivax are <strong>the</strong> two relapsing forms, which means that <strong>the</strong><br />
illness can re-appear months to years later.<br />
Usually, malaria in Africa is diagnosed by clinical symptoms. [Note: this may not be pertinent<br />
depending in which area <strong>the</strong> study will occur.] When someone complains <strong>of</strong> fever, <strong>the</strong>y are<br />
treated for malaria. However, <strong>the</strong> only way to really know if someone has <strong>the</strong> parasite that<br />
causes malaria is to examine <strong>the</strong>ir blood under <strong>the</strong> microscope. We take a small sample <strong>of</strong><br />
blood from a finger stick and put it on a glass slide. <strong>The</strong> laboratory technologists can <strong>the</strong>n<br />
“read” <strong>the</strong> smear and tell us if <strong>the</strong> person has malaria or not. However, as many places in<br />
Africa do not have laboratory facilities, standard treatment is to assume someone has malaria<br />
if <strong>the</strong>y have fever or history <strong>of</strong> fever. Since malaria can kill quickly, <strong>the</strong> practice is to over-treat<br />
for malaria so that we don’t miss someone who may die if not treated.<br />
We can determine <strong>the</strong> type <strong>of</strong> malaria by looking at a blood smear under <strong>the</strong> microscope. We<br />
can also determine how severe <strong>the</strong> infection is by <strong>the</strong> number <strong>of</strong> parasites that we can count.<br />
Probably all <strong>of</strong> you in this room have experienced malaria as an illness. Symptoms include<br />
fever, chills, headache, vomiting, diarrhea and feeling bad. Problems related to malaria <strong>of</strong>ten<br />
are related to late diagnosis or inadequate or inappropriate treatment. Part <strong>of</strong> our job now is<br />
to try to figure out <strong>the</strong> best ways to insure that pregnant women in XX [insert name <strong>of</strong> district]<br />
District use preventive measures to guard against malaria. In addition, we need to help <strong>the</strong>m<br />
learn how to get prompt and effective treatment when <strong>the</strong>y develop malaria.<br />
<strong>Malaria</strong> and Pregnancy: <strong>Malaria</strong> causes serious complications in pregnancy that can affect not<br />
only <strong>the</strong> pregnant woman, but can also hurt <strong>the</strong> baby. Chloroquine (CQ) used to be <strong>the</strong> main<br />
drug that was used to treat malaria, but CQ is no longer working well in most parts <strong>of</strong> sub-<br />
Saharan Africa. <strong>Malaria</strong> can cause severe anemia, which means that you have fewer red blood<br />
cells to carry oxygen, which is needed for our body to work each day. <strong>Malaria</strong> can cause early<br />
labor, which means<br />
that <strong>the</strong> baby does not have sufficient time to develop fully, or it can cause higher rates <strong>of</strong><br />
miscarriage (losing <strong>the</strong> pregnancy). <strong>Malaria</strong> infections during pregnancy can also cause lowbirth<br />
weight babies and babies that are born “stillborn” (dead at birth).<br />
Antenatal care is an accepted means <strong>of</strong> finding complications in pregnancy and can help us<br />
teach women what to expect from malaria in pregnancy, and how to prevent it. We now know<br />
that if pregnant women use intermittent preventive treatment (IPTp) with an effective drug,<br />
Fansidar (called SP), during <strong>the</strong>ir second and third trimesters, we can reduce<br />
8<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
<strong>the</strong> problems caused by malaria. Part <strong>of</strong> this research will look at how we can best get women to accept using IPTp<br />
during pregnancy.<br />
Local Beliefs about <strong>Malaria</strong>: Many people think that malaria is caused by different things. For example, some people<br />
believe that you get malaria from sleeping beside someone who is infected. O<strong>the</strong>rs believe that eating unripe sugar<br />
cane or getting soaked from <strong>the</strong> rains causes <strong>the</strong> illness, or that malaria occurs after a long trip. Some people believe<br />
that malaria comes with “fitting.” O<strong>the</strong>rs believe that malaria is caused by witchcraft. Have any <strong>of</strong> you heard <strong>of</strong> o<strong>the</strong>r<br />
causes <strong>of</strong> malaria?<br />
Why do people believe <strong>the</strong>se things? Do any <strong>of</strong> <strong>the</strong>se explanations make sense when we know that malaria is caused by<br />
parasites carried by a female mosquito? How do people make up <strong>the</strong>se explanations?<br />
If you think about what people are telling you, you will start to see and understand that people’s beliefs <strong>of</strong>ten merge<br />
with scientific understandings. People base <strong>the</strong>ir beliefs on years <strong>of</strong> experience, watching <strong>the</strong> environment and how<br />
things happen. People look for sameness, for patterns in explanations, and <strong>the</strong>ir thinking reflects what has happened to<br />
<strong>the</strong>m personally, as well as what <strong>the</strong>y see in <strong>the</strong>ir communities. Most behavior has purpose and <strong>the</strong> purpose is derived<br />
from a meaning system. People actively make choices in <strong>the</strong>ir environments based on <strong>the</strong>se meanings.<br />
Let’s look at some <strong>of</strong> <strong>the</strong>se explanations:<br />
“Eating unripe fruit”—Mosquitoes are most plentiful when <strong>the</strong> outside conditions are warm and wet. At <strong>the</strong> end <strong>of</strong> <strong>the</strong><br />
rains come <strong>the</strong> harvest - this coincides with transmission season for malaria.<br />
“Sleeping with someone” —is <strong>of</strong>ten because a mosquito can bite two people in one night (<strong>the</strong> mosquitoes that carry<br />
malaria bite between dusk and dawn).<br />
“At <strong>the</strong> end <strong>of</strong> a long trip” —<strong>of</strong>ten traveling involves being outside at night, which is when <strong>the</strong>se mosquitoes bite.<br />
“Getting wet and rain soaked” —coincides with transmission season, <strong>the</strong> rainy time <strong>of</strong> <strong>the</strong> year.<br />
“Sleeping outside” —again, this increases your chance <strong>of</strong> being bitten.<br />
During this research, we will be looking at some <strong>of</strong> <strong>the</strong> beliefs that pregnant women have in regard to causes <strong>of</strong><br />
malaria and how to best prevent it. It will be important to understand <strong>the</strong> complexities <strong>of</strong> how people create <strong>the</strong>se<br />
explanations.<br />
Patterns <strong>of</strong> Treatment: For example, if you ask what do pregnant women do when <strong>the</strong>y have a fever or think <strong>the</strong>y have<br />
malaria, <strong>the</strong>y may come up with several different patterns <strong>of</strong> behavior:<br />
Day #1, 1st Day <strong>of</strong> Illness: go to a shop and buy medicines to take at home<br />
Day #2 <strong>of</strong> Illness: rest and see if <strong>the</strong> medicines are working<br />
Day #3 <strong>of</strong> Illness: seek advice from someone <strong>the</strong>y respect<br />
Day #4 <strong>of</strong> Illness: go to <strong>the</strong> health care facility.<br />
We need to ask how/why/when people make <strong>the</strong>se decisions and what are <strong>the</strong> factors that influence such decisions.<br />
For example, <strong>the</strong> first decision to go to a shop may be based on <strong>the</strong> perceived cause <strong>of</strong> <strong>the</strong> illness. If <strong>the</strong> person thinks it<br />
is due to “malaria,” <strong>the</strong>n seeking out shop medicines may be <strong>the</strong> accepted practices <strong>of</strong> that community. If <strong>the</strong> illness was<br />
perceived to be caused by something spiritual (e.g., personal transgressions), <strong>the</strong> person may instead go to a traditional<br />
healer on Day #1.<br />
Resources<br />
9
O<strong>the</strong>r factors that might influence how people make treatment decisions may include:<br />
• co-sharing cost <strong>of</strong> medications or treatments at health care facilities<br />
• perceived seriousness <strong>of</strong> illness<br />
• timing <strong>of</strong> illness (If illness starts during <strong>the</strong> day, <strong>the</strong> person may first go to a drug vendor<br />
or shop keeper. However, if illness starts at night, treatment options are more limited<br />
and <strong>the</strong>y may chose to wait until morning before seeking care. At this point, <strong>the</strong> person is<br />
much sicker and may go straight to <strong>the</strong> hospital or health care facility)<br />
• geographical distance to care (e.g., a shop keeper may be much closer than a health<br />
care facility)<br />
• availability <strong>of</strong> credit schemes for payment at a shop<br />
• advice from someone who is respected.<br />
Using <strong>the</strong>se examples, it becomes clearer how complicated <strong>the</strong> process is to understand how<br />
people think about things or make decisions about <strong>the</strong>ir behavior.<br />
Proposed Activities: We hope to do <strong>the</strong> activities in XX different sites [insert number <strong>of</strong> sites]<br />
throughout <strong>the</strong> district. We will be in health care facilities, as well as in individual homes or<br />
maybe a common ga<strong>the</strong>ring area. Each site should take about (insert estimate). We will start<br />
with “pilot” testing our activities prior to formally conducting <strong>the</strong> research, which means that<br />
we will practice our interviews with people who are not part <strong>of</strong> <strong>the</strong> study team. Piloting <strong>the</strong><br />
interview guides helps us to see what might need to be changed and we can change things<br />
before we start <strong>the</strong> assessment.<br />
1. Individual Interviews: <strong>The</strong>se will be done with currently or recently pregnant women, and<br />
health-care workers. In each site, we will aim to interview 4-5 pregnant or recently pregnant<br />
women, but we will need to see how much time this takes. In addition, we will be working with<br />
“key informants,” people in <strong>the</strong> area who have a particularly strong knowledge about what<br />
happens to pregnant women in this area. <strong>The</strong>se key informants will be identified by village<br />
leaders, community health care workers, community members or health care facility workers.<br />
Usually we will try to interview 2-4 key informants per facility area. We will also interview<br />
facility-based health care workers, interviewing from 1-10 per facility, depending on <strong>the</strong><br />
numbers employed in that facility.<br />
2. Focus Group Interviews: <strong>The</strong>se will be done with currently or recently pregnant women,<br />
as well as lay midwives and TBAs. For each focus group, we hope to have 5 -15 pregnant or<br />
recently pregnant participants and 5 -15 lay midwives and TBAs. We may also do health care<br />
worker interviews.<br />
II. Qualitative Research Components:<br />
A. Differences between Qualitative and Quantitative Research:<br />
We will be doing what is called “qualitative” research. It differs from quantitative research,<br />
which deals primarily with studying things that can be easily counted. Qualitative research<br />
focuses on what people think about things, what makes sense to <strong>the</strong>m (individually and from<br />
a community perspective), how <strong>the</strong>y describe things and <strong>the</strong> meaning <strong>of</strong> those things, to<br />
mention a few areas. In addition, qualitative research can be used to understand how much<br />
someone knows about something, such as what causes malaria or what are common childhood<br />
10<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
febrile illnesses. Ano<strong>the</strong>r area that we look at involves describing how people do things—what are common patterns <strong>of</strong><br />
behaviors, such as what parents actually do when <strong>the</strong>ir child has a fever, or what nurses say to patients when <strong>the</strong>y see<br />
<strong>the</strong>m at a health care facility.<br />
A key element in qualitative research is to remain “value-free” while listening to <strong>the</strong> information provided by <strong>the</strong><br />
participants. At <strong>the</strong> end <strong>of</strong> <strong>the</strong> assessment, it is also important to provide feedback about what was learned. Providing<br />
feedback acknowledges <strong>the</strong> participants’ contributions and may encourage participants to assist in future projects.<br />
While “quantitative” research strives to understand exactly how many people say something or how <strong>of</strong>ten an event<br />
happens, <strong>the</strong> same type <strong>of</strong> counting can be used with qualitative research. Qualitative research can be quantified,<br />
meaning that we can attach numbers to some <strong>of</strong> <strong>the</strong> information that we ga<strong>the</strong>r. For example, <strong>the</strong>re are times when we<br />
can count how many persons interviewed said that <strong>the</strong>y always first go to a traditional healer when <strong>the</strong>y are sick. We<br />
might also be able to count how many different illnesses are named when we ask participants (people who are being<br />
interviewed for <strong>the</strong> study) to tell us illnesses that cause fever in children or pregnant women.<br />
However, <strong>the</strong>re are o<strong>the</strong>r times when we listen to general <strong>the</strong>mes in conversations and want to summarize <strong>the</strong> thoughts<br />
without counting <strong>the</strong>m. For example, if we were to ask about something like “hope,” it would be very difficult to put a<br />
number on how much hope someone has.<br />
Certain activities that we will be doing, like focus groups, will be directed towards listening to understand general<br />
things people are telling us. O<strong>the</strong>r activities, such as individual or personal interviews, will allow us to count how<br />
many people do something. Both quantitative and qualitative research is important as <strong>the</strong>y give us different types <strong>of</strong><br />
information. Nei<strong>the</strong>r is better than <strong>the</strong> o<strong>the</strong>r, <strong>the</strong>y just are different. It is important to know what types <strong>of</strong> information<br />
you need, and that will guide you in <strong>the</strong> type <strong>of</strong> research to do.<br />
Summary <strong>of</strong> Differences Between Qualitative and Quantitative Research Methods<br />
QUALITATIVE<br />
Tries to understand meaning—to make<br />
sense <strong>of</strong> things that are observed in <strong>the</strong> “real<br />
world.”<br />
Looks at perceptions, knowledge, beliefs,<br />
ways <strong>of</strong> thinking, levels <strong>of</strong> understandings<br />
(meaning systems, ways <strong>of</strong> acting) behaviors,<br />
norms <strong>of</strong> behaviors<br />
Examples: research examining local terms for<br />
fever illnesses in children, or research asking<br />
about how people treat malaria.<br />
Researcher very involved with interviewing<br />
research participants. Often, community is<br />
very involved in process—both with data<br />
collection (finding out <strong>the</strong> information) and<br />
analysis (making sense <strong>of</strong> <strong>the</strong> information).<br />
More open to interpretation.<br />
Uses open or semi-structured questions<br />
(asking people to tell you about something).<br />
Depending on <strong>the</strong> question, you can use<br />
quantitative measures to analyze at times.<br />
QUANTITATIVE<br />
Primarily focuses on quantifying or using<br />
objective measurements.<br />
Uses research methods that allow <strong>the</strong><br />
variable (what you are studying) to be<br />
counted in some manner. For example,<br />
laboratory-controlled experiments, research<br />
on behaviors that can be observed (such as<br />
drug efficacy testing), or surveys to find out<br />
amounts <strong>of</strong> things.<br />
Examples: surveillance data that tell us <strong>the</strong><br />
number <strong>of</strong> people diagnosed with malaria<br />
at <strong>the</strong> health care facilities, <strong>the</strong> number <strong>of</strong><br />
stillborn babies born to pregnant women<br />
with malaria, or <strong>the</strong> number <strong>of</strong> children that<br />
get fever a few days after stopping malaria<br />
treatments.<br />
Researcher may or may not be involved much<br />
in process <strong>of</strong> data collection. Community<br />
rarely involved.<br />
Seeks to define outcomes in numbers.<br />
Generally has close-ended (“yes/no”) type<br />
questions, or asking for a count <strong>of</strong> something<br />
and <strong>of</strong>ten has pre-determined categories <strong>of</strong><br />
answers.<br />
Qualitative techniques are used in <strong>the</strong> writing<br />
<strong>of</strong> <strong>the</strong> research results.<br />
Resources<br />
11
III. Qualitative Research Methods:<br />
Often people confuse research methodologies. For example, people talk about surveys and<br />
interviews as if <strong>the</strong>y are <strong>the</strong> same thing. I will first show you how <strong>the</strong>y differ, and <strong>the</strong>n we will<br />
talk more in detail about interviewing. A survey may be done without personal contact, or<br />
with limited interaction with <strong>the</strong> research team.<br />
SURVEY<br />
(CAN BE EITHER QUALITATIVE OR<br />
QUANTITATIVE)<br />
1. Structured 1. Unstructured<br />
2. How many? (counting) 2. Why?<br />
3. Surveyor is expert: uses pre-determined<br />
responses<br />
INTERVIEW<br />
(QUALITATIVE)<br />
3. Community is expert: uses open-ended<br />
questions<br />
4. Quicker to administer 4. Slower to administer<br />
5. Done with limited involvement <strong>of</strong> research 5. Research team members are part <strong>of</strong><br />
<strong>the</strong> process<br />
6. Example: knowledge, attitudes, and<br />
practices (KAP) survey<br />
6. Example: determining what malaria<br />
treatments are.<br />
Interviews:<br />
In a situation where you have some knowledge about something (e.g., malaria) but want to<br />
learn more (e.g., information related to pregnancy women and malaria), we usually use <strong>the</strong><br />
technique <strong>of</strong> interviewing with “semi-structured” questions. For example, we start with a<br />
base <strong>of</strong> information about a topic, such as malaria. We know how malaria is caused and what<br />
happens when a pregnant woman gets malaria during her pregnancy, but we don’t know<br />
what women in this area do to prevent malaria. We also don’t know <strong>the</strong> best way to give <strong>the</strong>m<br />
information. So, we need to ask <strong>the</strong>m what <strong>the</strong>y do to prevent malaria and we need to ask <strong>the</strong><br />
women to identify <strong>the</strong> best people for <strong>of</strong>fering information.<br />
Our questions are “structured” or guided by <strong>the</strong> information that we know, as well as by what<br />
we need to know. “Semi” means that although we direct or focus <strong>the</strong> questions, we allow<br />
participants to <strong>of</strong>fer more information than we requested—in essence, we are asking <strong>the</strong>m<br />
to tell us stories and to share <strong>the</strong>ir knowledge and <strong>the</strong>ir viewpoints with us. Building on what<br />
information you know is important when time and money are issues, such as when you are<br />
doing a rapid community assessment (e.g., what we will be doing). We have limited time to<br />
find out a lot <strong>of</strong> information, and so we must focus on several specific areas and build on what<br />
we already know.<br />
Ano<strong>the</strong>r way to interview is to do what is called an “open” interview. Generally that happens<br />
when you know almost nothing about a topic or when you want to just find out what happens<br />
in a new area. For example, if someone comes to XX District [insert name <strong>of</strong> district] from a<br />
European country, <strong>the</strong>y may need to do open interviews to learn <strong>the</strong> rules about courtship<br />
and marriage, or to learn what to do if someone gets sick in <strong>the</strong> village. Sometimes an open<br />
interview has one or two main questions and participants can freely talk for hours. Once <strong>the</strong><br />
participants talk, new questions are formed and <strong>the</strong>y may differ interview by interview, even<br />
though <strong>the</strong> interviews may all happen in <strong>the</strong> same village. During this research, we will be<br />
using <strong>the</strong> semi-structured approach, ra<strong>the</strong>r than <strong>the</strong> open approach.<br />
12 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
1. Individual Interviews: This type <strong>of</strong> interview is done with a single person being interviewed by an interviewer. We are<br />
looking for <strong>the</strong> individual perspective, as compared to a group or community perspective. Often, <strong>the</strong>y can take a long<br />
time to complete (more than one hour) but you obtain very specific information. <strong>The</strong>se interviews usually yield a lot <strong>of</strong><br />
information. You need someone to interview, an interviewer, and sometimes you may need an additional person to help<br />
record <strong>the</strong> responses. You might want to use a tape recorder to record <strong>the</strong> information.<br />
2. Focus Group Interviews: <strong>The</strong>se are done in a group, usually composed <strong>of</strong> 5-15 people. <strong>The</strong> purpose <strong>of</strong> this type <strong>of</strong><br />
interview is to obtain <strong>the</strong> “normative” view <strong>of</strong> <strong>the</strong> community—what people generally think or what behaviors are<br />
considered acceptable, i.e., <strong>the</strong> norms <strong>of</strong> <strong>the</strong> community. For example, <strong>the</strong> normative view in an area may be that a<br />
person should only marry someone from his or her own specific sub-tribe or clan, and that is what most people do.<br />
However, some individual behaviors may differ from that as people do marry outside <strong>the</strong>ir clans or sub-tribes.<br />
For focus groups, you need a “facilitator” (someone who will direct <strong>the</strong> questions <strong>of</strong> <strong>the</strong> group, and guide its<br />
interactions), people to participate, and a “recorder,” who is someone who will write down what is happening in <strong>the</strong><br />
group. As with an individual interview, sometimes, audio tape players are used to also record <strong>the</strong> responses.<br />
<strong>The</strong> advantages <strong>of</strong> this type <strong>of</strong> interview are that you can explore a wide range <strong>of</strong> topics and <strong>the</strong>n narrow down <strong>the</strong><br />
topics. Ideas can be explored freely and many people can <strong>of</strong>fer <strong>the</strong>ir perspectives. Often when one person talks, it<br />
will stimulate <strong>the</strong> memory or thoughts <strong>of</strong> someone else in <strong>the</strong> group, and serves to move <strong>the</strong> discussion along. As<br />
participants raise new issues, you can go from topic to topic. It will also give you a sense <strong>of</strong> how well <strong>the</strong> community<br />
or group works toge<strong>the</strong>r, or whe<strong>the</strong>r <strong>the</strong> group/community is splintered in <strong>the</strong>ir thoughts. Focus group data can be<br />
“triangulated” with data collected from individual interviews to see if <strong>the</strong>re are similarities (thus streng<strong>the</strong>ning <strong>the</strong><br />
overall results), or it will show you that <strong>the</strong>re are big differences within <strong>the</strong> community. “Triangulation” is a research<br />
term used to describe using several different research methods to ask <strong>the</strong> same questions).<br />
Disadvantages to this method are that unless <strong>the</strong> facilitator and recorder are very good, <strong>the</strong>re may be problems using<br />
this method. <strong>The</strong> expectation for a focus group is that everyone should participate. <strong>The</strong> facilitator needs to be able to<br />
limit people who talk too much and monopolize <strong>the</strong> conversations, and also to be able to encourage shy, quiet people.<br />
<strong>The</strong> recorder must be able to listen for <strong>the</strong>mes and fill in <strong>the</strong> details later. He/she needs to be able to record <strong>the</strong><br />
dynamics <strong>of</strong> <strong>the</strong> group (for example, <strong>the</strong> group got very argumentative over a certain question) and needs to be able<br />
to focus when several people are talking at one time. Ano<strong>the</strong>r disadvantage, particularly when you hold focus groups<br />
outside, such as in a village, is that <strong>the</strong>ir size may grow quickly and soon be too big as many people are interested and<br />
want to be part <strong>of</strong> this activity. When <strong>the</strong> group becomes larger than 15 people, it becomes too difficult to manage <strong>the</strong><br />
group, to make sure everyone is participating, and to record. Lastly, it may be time-consuming and difficult to convene<br />
such a group.<br />
Recording <strong>the</strong> focus group is a bit different than recording an individual interview as <strong>the</strong> recorder must be able to<br />
record general <strong>the</strong>mes. Counting responses is not important, but identifying <strong>the</strong>mes and noting that most or many <strong>of</strong><br />
<strong>the</strong> participants felt <strong>the</strong> same way about issues is important. It is important to note if someone is very different from<br />
<strong>the</strong> group with <strong>the</strong>ir behaviors or thoughts. We call this type <strong>of</strong> person an “outlier” and we need to understand this<br />
dynamic <strong>of</strong> <strong>the</strong> group when we analyze <strong>the</strong> data. Names are never used in <strong>the</strong> recording, although you might identify a<br />
speaker by <strong>the</strong>ir job description, should you know it. For example, “<strong>the</strong> nurses in <strong>the</strong> group felt...”<br />
Resources<br />
13
Conducting an Interview:<br />
1) Components <strong>of</strong> interview:<br />
a) <strong>The</strong> person being interviewed: “interviewee,” (assessment or research participant)<br />
b) <strong>The</strong> person who does <strong>the</strong> interview: “interviewer” (staff)<br />
c) Subject matter:<br />
i) Coherent list <strong>of</strong> questions around <strong>the</strong>me<br />
ii) 1 - 2 broad questions that allow a person to talk freely<br />
iii) Historical perspective: “tell me what used to be done for malaria control”<br />
d) Venue (where to hold interview):<br />
i) Use a quiet space that is free <strong>of</strong> distractions<br />
ii) Ensure that it is as private as possible<br />
e) Equipment:<br />
i) Chairs for participants, interviewer and recorders<br />
ii) Copies <strong>of</strong> interview field guide<br />
iii) Writing materials (paper, pencils/pens with extra supplies as needed)<br />
iv) Optional: tape recorders (not recommended)<br />
2) Process <strong>of</strong> <strong>the</strong> interview:<br />
a) Introduction <strong>of</strong> study team<br />
b) Explain purpose <strong>of</strong> interview<br />
c) Types <strong>of</strong> information to be obtained<br />
d) Benefit to participant or to greater good<br />
e) Obtain informed consent (this depends on what is required in a particular country)<br />
f) Conduct interview<br />
g) Conclude, check for missing data and thank participant:<br />
i) Acknowledge that you understand that <strong>the</strong> participant came voluntarily and<br />
committed a length <strong>of</strong> time<br />
to be with you<br />
ii) Show respect for what <strong>the</strong>y have told you<br />
iii) Reassure <strong>the</strong>m that <strong>the</strong>y have given you valuable information<br />
14<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
3) Characteristics that improve interviewing skills:<br />
a) Values:<br />
i) Patience<br />
ii) Good sense <strong>of</strong> humor<br />
iii) Flexibility<br />
iv) Tolerance<br />
b) Ability to recognize <strong>the</strong> need to change interviewing style:<br />
i) May need to speed up or slow down<br />
ii) May require a different way <strong>of</strong> phrasing a question:<br />
(1) Use <strong>of</strong> paraphrasing, which is re-phrasing what you think <strong>the</strong> participant said (e.g.., “I understand that<br />
you just said that you think most women use antenatal care in this area—have I understood correctly<br />
what you meant?”)<br />
(2) Use <strong>of</strong> “third party” technique (e.g., “Someone told me that <strong>the</strong>y think… [insert a statement that you<br />
want <strong>the</strong> participant to respond to]. Do you agree with that?”]<br />
(3) Use <strong>of</strong> reflexive questioning, which is changing <strong>the</strong> responses into question format (e.g., Do I<br />
understand that you think XX drug is <strong>the</strong> best to use for malaria?)<br />
(4) Clarifying when something <strong>the</strong> participant said does not make sense to you (e.g., “I am sorry, I do not<br />
understand what you mean. Could you please help me by giving me an example <strong>of</strong> what you mean?”)<br />
iii) May need to direct participants back to <strong>the</strong> question if <strong>the</strong>ir response focuses on o<strong>the</strong>r issues<br />
c) Interviewer behaviors that encourage participants:<br />
i) Knowing <strong>the</strong> interview guide questions very well:<br />
(1) Practicing <strong>the</strong> questions many times before you start <strong>the</strong> assessment or study<br />
(2) Use <strong>the</strong> guide to only glance at <strong>the</strong> questions, ra<strong>the</strong>r than reading it<br />
(3) Recognizing if <strong>the</strong> participant has already given you information that would answer a later question (if<br />
you know <strong>the</strong> guide well enough, you will know where participants’ answers belong)<br />
ii) Demonstrating relaxed body language, leaning slightly forward in <strong>the</strong> direction <strong>of</strong> <strong>the</strong> participant, not<br />
appearing restless<br />
iii) Making direct eye contact with participant, nodding head or showing ano<strong>the</strong>r physical sign that you are<br />
hearing what <strong>the</strong> participant is saying (NOTE: this does not signify that you necessarily agree with <strong>the</strong><br />
participant, only that you are paying attention to what <strong>the</strong>y are saying)<br />
iv) Not interrupting <strong>the</strong> participant until he or she is finished<br />
v) Using encouraging language: e.g., “That is really interesting, no one ever told me that before.”<br />
Resources<br />
15
d) Demonstrating good “listening” skills:<br />
i) Be attentive while you write<br />
ii) Write quickly and use abbreviations that are known to you<br />
iii) Ask participant to slow down if needed<br />
iv) Record major <strong>the</strong>mes and fill in gaps later<br />
v) Write legibly:<br />
(1) Remember that sometimes o<strong>the</strong>r people must do <strong>the</strong> transcribing and analysis.<br />
Your data must be able to be read by <strong>the</strong>m or else it is considered “lost” data.<br />
vi) Make sure you do a thorough check <strong>of</strong> <strong>the</strong> data at <strong>the</strong> end <strong>of</strong> <strong>the</strong> interview:<br />
(1) Ensure that all questions have been answered BEFORE <strong>the</strong> participant leaves.<br />
If something is missing, ask <strong>the</strong> question.<br />
(2) Correct any abbreviations used and fill in gaps to make <strong>the</strong> data<br />
understandable to o<strong>the</strong>rs<br />
(3) Spell correctly<br />
(4) If including a quote given in a local language, write <strong>the</strong> quote exactly as given<br />
in <strong>the</strong> local language and include a translation. You can discuss <strong>the</strong> translation<br />
in debriefing sessions.<br />
4) Solutions to common problems during interviewing:<br />
a) Interviewer can not understand <strong>the</strong> words being used:<br />
i) Ask participant to slow down, ask for clarity, ask for a spelling <strong>of</strong> <strong>the</strong> word<br />
b) Interviewer can not understand <strong>the</strong> concepts or ideas expressed by participant:<br />
i) Ask for examples<br />
c) Answers given are too long or complicated:<br />
i) Re-phrase what you think you heard and ask participant if you have missed anything<br />
BEFORE going on<br />
to next question<br />
16<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
d) Environment is noisy and you cannot hear what is being said:<br />
i) Stop interview and see if you can change venue or position <strong>of</strong> where you are seated to<br />
maximize your hearing<br />
e) Participant seems uncomfortable with a question or topic:<br />
i) Acknowledge to participant that you understand it is a difficult or sensitive topic<br />
ii) Identify <strong>the</strong> benefit for <strong>the</strong> participant (e.g., “I understand that it is difficult to discuss your child’s serious<br />
illness. You might feel better if you are able to talk about your feelings. As well, your experience might assist<br />
o<strong>the</strong>r parents in this situation as we can learn from your experience.”)<br />
iii) Move to ano<strong>the</strong>r question if participant is too uncomfortable<br />
iv) Make notation in interview guide why question was not answered<br />
List <strong>of</strong> Resources<br />
Green, J. Qualitative Methods for Health Research. Thousand Oaks: Sage Publications, 2004.<br />
Johns Hopkins University. January 2000. Qualitative research for improved health programs: A Guide to Manuals for<br />
Qualitative and Participatory Research on Child Health, Nutrition, and Reproductive Health. (a review <strong>of</strong> manuals on<br />
rapid assessment procedures (RAP)http://sara.aed.org/publications/cross_cutting/qualitative/qualitative.pdf<br />
Patton, MQ. How to use Qualitative Methods in Evaluation. Thousand Oaks: Sage Publications, 1987.<br />
Resources<br />
17
18 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Resource 3: Resources for Training Sessions<br />
(PowerPoint presentations)<br />
Overview <strong>of</strong> rapid assessment: <strong>Rapid</strong> assessments:<br />
general issues<br />
Overview <strong>of</strong> modules: 1 & 2; 3, 4, 5 & 8; 6, 7, 9 & 10<br />
Epidemiology <strong>of</strong> malaria: Epidemiology and control <strong>of</strong><br />
malaria in pregnancy<br />
Clinical and laboratory methods: <strong>Assessment</strong> <strong>of</strong> gestational age, Body<br />
measurements, Laboratory methods<br />
O<strong>the</strong>r assessment topics: Data management and sample size calculation<br />
<strong>The</strong> Presentations are available only on <strong>the</strong> CD-ROM.<br />
Note: A CD-ROM will be enclosed that contains all <strong>the</strong> items listed.<br />
<strong>The</strong> entire package will be available electronically on<br />
CDC's <strong>Malaria</strong> Web site: www.cdc.gov/malaria.<br />
Resources<br />
19
20 18 <strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Resource 4: S<strong>of</strong>tware and Planning Tools<br />
(Costing Tool included in review package)<br />
Costing Tool<br />
Epi Info (for information and to download go to www.cdc.gov/epiinfo/)<br />
Note: A CD-ROM will be enclosed that contains all <strong>the</strong> items listed.<br />
<strong>The</strong> entire package will be available electronically on<br />
CDC's <strong>Malaria</strong> Web site: www.cdc.gov/malaria.<br />
Resources<br />
21
Costing Tool for <strong>Rapid</strong> <strong>Assessment</strong><br />
Adapted from UNICEF’s Multiple Indicator Cluster Survey End<br />
Decade <strong>Assessment</strong>, as accessed at http://www.childinfo.org/MICS2/<br />
finman/M2finM.htm, March 1, 2005.<br />
Table 1<br />
<strong>Assessment</strong> Budget Items and Estimates for a <strong>Rapid</strong> <strong>Assessment</strong><br />
Using Both Quantitative and Qualitative Components<br />
Budget item<br />
Basis for calculation<br />
Personnel (salaries plus indirect costs) Quantitative Component<br />
Quantitative assessment coordinator<br />
Data management coordinator<br />
Site supervisors<br />
Laboratory supervisor<br />
Interviewers<br />
Laboratorians<br />
Data entry clerks<br />
Computer programmers<br />
Drivers<br />
Qualitative Component<br />
Qualtitative assessment coordinator<br />
Interviewers<br />
Drivers<br />
Transportation<br />
Vehicle rental<br />
Public transportation allowance (urban areas)<br />
Fuel<br />
Contingency costs (repairs, ferries, etc.)<br />
Consumables<br />
Stationery (paper, pencils, pens, etc.)<br />
Identification cards<br />
Envelopes for filing<br />
Computing supplies<br />
(paper, diskettes, ribbons, cartridges)<br />
Lab supplies<br />
(microscope, RDTs, hemocues, etc.)<br />
O<strong>the</strong>r costs<br />
Questionnaire and form printing<br />
Photocopies <strong>of</strong> maps, listings and<br />
instruction manuals<br />
Anthropometric equipment<br />
(weighing scales, height/length boards, etc.)<br />
Communications (phone, fax, postage, etc.)<br />
Report writing and printing<br />
Training<br />
Hospital costs<br />
1 coordinator x 24 weeks<br />
1 coordinator x 12 weeks?<br />
4 supervisors x 8 - 9 weeks<br />
1 supervisor x 8-9 weeks<br />
8 interviewers x 8 - 9 weeks<br />
4 laboratorians x 8-9 weeks<br />
2 clerks x 5 weeks<br />
1 programmer x 8 weeks?<br />
4 drivers x 8 - 9 weeks<br />
1 coordinator x 24 weeks<br />
6 - 8 interviewers x 8 - 9 weeks<br />
1 driver x 8 - 9 weeks<br />
5 cars x 8 -9 weeks<br />
variable<br />
provision for 5 cars x 8 - 9 weeks<br />
variable<br />
variable<br />
variable<br />
120 envelopes<br />
variable<br />
variable<br />
variable<br />
variable<br />
variable<br />
variable<br />
variable<br />
variable<br />
variable<br />
22<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Table 2<br />
Costing Framework: Items Included in Cost and Activity Categories<br />
Personnel (salaries)<br />
Cost categories<br />
<strong>Assessment</strong> coordinator (Quantitative,<br />
qualitative)<br />
Data management coordinator<br />
Site supervisors<br />
Laboratory supervisor<br />
Interviewers<br />
Laboratorians<br />
Drivers<br />
Data entry clerks<br />
Computer programmers<br />
Drivers<br />
Transportation<br />
Vehicle rental<br />
Public transportation allowance<br />
Fuel<br />
Maintenance costs<br />
Consumables<br />
Stationery<br />
(papers, pencils, pens, etc.)<br />
Identification cards<br />
Envelopes for filing<br />
Computing supplies<br />
(paper, diskettes, ribbons,<br />
cartridges)<br />
Lab supplies<br />
(microscopes, RDTs, hemocues, etc.)<br />
Equipment<br />
Anthropometric equipment (weighing<br />
scales, height/length boards, etc.)<br />
O<strong>the</strong>r costs<br />
Printing (questionnaire, etc.)<br />
Photocopies <strong>of</strong> maps, listings,<br />
instruction manuals<br />
Equipment maintenance<br />
Communications (phone, fax, postage,<br />
etc.)<br />
Report writing and printing<br />
Training<br />
Hospital costs<br />
Activity categories<br />
Preparation/sensitization<br />
Adaptation <strong>of</strong> questionnaire<br />
Translation and back-translation<br />
Pre-testing <strong>of</strong> questionnaire<br />
Survey design and sample calculation<br />
Planning<br />
Sample calculation<br />
Training<br />
Preparation <strong>of</strong> training materials<br />
Translation into training language<br />
Implementation <strong>of</strong> training,<br />
including piloting<br />
<strong>Assessment</strong> implementation<br />
Implementation<br />
Monitoring and supervision<br />
Data retrieval<br />
Data input<br />
Data entry<br />
Error checking<br />
Data processing and analysis<br />
Data processing<br />
Data cleaning<br />
Tables <strong>of</strong> analysis<br />
Report writing<br />
Dissemination and fur<strong>the</strong>r analysis<br />
Report printing<br />
Distribution<br />
Feedback meetings, if needed<br />
Fur<strong>the</strong>r analysis, if needed<br />
Resources<br />
23
Table 3<br />
Costing Framework<br />
COST<br />
CATEGORIES<br />
TOTAL<br />
COSTS<br />
ACTIVITY CATEGORIES<br />
Preparation/<br />
sensitization<br />
Pilot<br />
study<br />
Survey<br />
adaptation<br />
and<br />
calculation<br />
<strong>of</strong> sample<br />
size<br />
Training<br />
<strong>Assessment</strong><br />
implementation<br />
Data<br />
input<br />
Data<br />
processing<br />
and<br />
analysis<br />
Report<br />
writing<br />
Dissemination<br />
and fur<strong>the</strong>r<br />
analysis<br />
Personnel<br />
Transportation<br />
Consumables<br />
Equipment<br />
O<strong>the</strong>r costs<br />
TOTAL COSTS<br />
Any<br />
participating<br />
agencies or<br />
institutions<br />
(names)<br />
Supplementary details<br />
1. Sample size: ________<br />
2. Number <strong>of</strong> interviewers/laboratorians/supervisors<br />
Interviewers: ______ Laboratorians: ______ Supervisors: ______<br />
3. Duration <strong>of</strong> training for assessment team (number <strong>of</strong> days): ________<br />
4. Duration <strong>of</strong> assessment (number <strong>of</strong> days): ________<br />
24<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy
Resources 25
26<br />
<strong>The</strong> <strong>Rapid</strong> <strong>Assessment</strong> <strong>of</strong> <strong>the</strong> <strong>Burden</strong> <strong>of</strong> <strong>Malaria</strong> during Pregnancy